{"1304000K0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0702020Z0": {"Conditions": [{"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Dequalinium Chloride", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003735": "Miscellaneous Anti-infectives"}, {"/categories/DBCAT002551": "Quinoline Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT001571": "Quinolinium Compounds"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0202080B0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Bendroflumethiazide/Potassium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "0102000L0": {"Conditions": [{"/indications/DBCOND0030070": "Airway Obstruction"}, {"/indications/DBCOND0029401": "Arrythmias"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0024446": "Hypersecretion gastric"}, {"/indications/DBCOND0019589": "Increased bronchial secretion"}, {"/indications/DBCOND0024444": "Muscarinic effects caused by neostigmine"}, {"/indications/DBCOND0024449": "Muscarinic effects caused by pyridostigmine"}, {"/indications/DBCOND0030389": "Neurocardiogenic Syncope"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0010371": "Salivary hypersecretion"}, {"/indications/DBCOND0024439": "Chronic, severe Salivary hypersecretion"}, {"/indications/DBCOND0021170": "Pharyngeal secretions"}], "Name": "Glycopyrronium Bromide", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}]}, "0107010C0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0205040S0": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}, {"/indications/DBCOND0095636": "Disturbed sleep/nightmares"}], "Name": "Prazosin Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT002386": "Alpha-Adrenoreceptor Antagonists and Diuretics"}, {"/categories/DBCAT002227": "Antiadrenergic Agents, Peripherally Acting"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1002010Q0": {"Conditions": [{"/indications/DBCOND0028961": "Myasthenia Gravis"}, {"/indications/DBCOND0033485": "Neuromuscular Blockade"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0000192": "Postpoliomyelitis Syndrome"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}, {"/indications/DBCOND0021666": "Soman nerve gas poisoning"}], "Name": "Pyridostigmine Bromide", "Categories": [{"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000962": "Pyridinium Compounds"}]}, "0411000E0": {"Conditions": [{"/indications/DBCOND0037266": "Diffuse Lewy Body Disease"}, {"/indications/DBCOND0024419": "Mild Dementia Alzheimer's type"}, {"/indications/DBCOND0025346": "Mild Dementia due to Parkinson's disease"}, {"/indications/DBCOND0024418": "Moderate Dementia Alzheimer's type"}, {"/indications/DBCOND0025345": "Moderate Dementia due to Parkinson's disease"}], "Name": "Rivastigmine", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002344": "Anti-Dementia Drugs"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000848": "Phenylcarbamates"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}]}, "0205051E0": {"Conditions": [{"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0036953": "Mild Essential Hypertension"}, {"/indications/DBCOND0040924": "Moderate Essential Hypertension"}], "Name": "Cilazapril", "Categories": [{"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT001326": "Pyridazines"}]}, "1203030N0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0030075": "Orofacial Pain"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}], "Name": "Menthol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1310011I0": {"Conditions": [{"/indications/DBCOND0050152": "Active Tuberculosis"}, {"/indications/DBCOND0013998": "Mycobacterium kansasii infection"}, {"/indications/DBCOND0025407": "Late phase Tuberculosis"}], "Name": "Isoniazid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001001": "Fatty Acid Synthesis Inhibitors"}, {"/categories/DBCAT002487": "Hydrazides"}, {"/categories/DBCAT000469": "Hydrazines"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001000": "Isonicotinic Acids"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0901012I0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Iron Sucrose", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000795": "Disaccharides"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000753": "Ferric Compounds"}, {"/categories/DBCAT005021": "Glucaric Acid"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT002587": "Iron Trivalent, Oral Preparations"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003555": "Parenteral Iron Replacement"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000971": "Sugar Acids"}]}, "0301020B0": {"Conditions": [{"/indications/DBCOND0001060": "Amblyopia"}, {"/indications/DBCOND0000504": "Bradycardia"}, {"/indications/DBCOND0004370": "Bronchial Spasm"}, {"/indications/DBCOND0012275": "Crying"}, {"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0089206": "Excessive bronchial secretion"}, {"/indications/DBCOND0089196": "Hypertonic uterine contraction"}, {"/indications/DBCOND0024342": "Hypertonicity of the small intestine"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0089375": "Poisoning by parasympathomimetics (cholinergics)"}, {"/indications/DBCOND0021805": "Poisoning caused by mushrooms"}, {"/indications/DBCOND0021784": "Poisoning caused by organophosphate anticholinesterase nerve agents"}, {"/indications/DBCOND0021782": "Poisoning caused by organophosphorus pesticides"}, {"/indications/DBCOND0011031": "Pylorospasm"}, {"/indications/DBCOND0020937": "Rhinorrhea"}, {"/indications/DBCOND0042990": "Sinus Bradycardia"}, {"/indications/DBCOND0021793": "Spasms"}, {"/indications/DBCOND0106144": "Toxic effect of organophosphate and carbamate"}, {"/indications/DBCOND0096790": "Atrioventricular (AV) block"}, {"/indications/DBCOND0024343": "Hypermobility of the colon"}, {"/indications/DBCOND0021797": "Laughing"}, {"/indications/DBCOND0021803": "Muscarinic side effects"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Atropine Sulfate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT002367": "Belladonna Alkaloids, Tertiary Amines"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "1301010K0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Macrogol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT001545": "Excipients"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001429": "Pharmaceutical Vehicles"}, {"/categories/DBCAT001605": "Polyethylene Glycols"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT004092": "Stimulation Large Intestine Fluid/Electrolyte Secretion"}, {"/categories/DBCAT000898": "Surface-Active Agents"}]}, "0408010AE": {"Conditions": [{"/indications/DBCOND0036250": "Diabetic Peripheral Neuropathic Pain (DPN)"}, {"/indications/DBCOND0002221": "Fibromyalgia"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Pregabalin", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000424": "Aminobutyrates"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000423": "gamma-Aminobutyric Acid"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0605010M0": {"Conditions": [{"/indications/DBCOND0066992": "Infertilities"}], "Name": "Urofollitropin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000107": "Gonadotropins"}, {"/categories/DBCAT004658": "Gonadotropins and Antigonadotropins"}, {"/categories/DBCAT000106": "Gonadotropins, Pituitary"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000203": "Menotropins"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}]}, "0803042A0": {"Conditions": [{"/indications/DBCOND0021415": "Stage D2 Prostatic carcinoma"}], "Name": "Bicalutamide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT004226": "Androgen Receptor Antagonists"}, {"/categories/DBCAT003360": "Androgen Receptor Inhibitor"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002767": "Antiandrogens, non-steroidal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001414": "Toluene"}]}, "0801050BZ": {"Conditions": [{"/indications/DBCOND0036667": "Advanced Gastric Cancer"}, {"/indications/DBCOND0025582": "Advanced gastro-esophageal junction adenocarcinoma"}, {"/indications/DBCOND0023209": "Refractory, metastatic Colorectal cancer"}, {"/indications/DBCOND0025490": "Refractory, metastatic Non small cell lung cancer"}], "Name": "Ramucirumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT003458": "Vascular Endothelial Growth Factor Receptor 2 Antagonist"}, {"/categories/DBCAT004246": "VEGFR2 Inhibitors"}]}, "1306010E0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0801050BY": {"Conditions": [{"/indications/DBCOND0028487": "Fallopian Tube Cancer"}, {"/indications/DBCOND0073968": "Malignant Peritoneal Neoplasm"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0054935": "Ovarian Epithelial Cancer"}, {"/indications/DBCOND0030277": "Primary Peritoneal Cancer"}, {"/indications/DBCOND0116830": "Advanced deleterious germline or somatic BRCA-mutated advanced epthelial ovarian cancer"}, {"/indications/DBCOND0116832": "Advanced deleterious germline or somatic BRCA-mutated fallopian tube cancer"}, {"/indications/DBCOND0116834": "Advanced deleterious germline or somatic BRCA-mutated peritoneal cancer"}, {"/indications/DBCOND0112032": "Refractory Advanced Ovarian Cancer"}], "Name": "Olaparib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001523": "Poly(ADP-ribose) Polymerase Inhibitors"}, {"/categories/DBCAT001326": "Pyridazines"}]}, "1103010U0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Sulfacetamide Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0601021M0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Gliclazide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000635": "Urea"}]}, "1310050M0": {"Conditions": [{"/indications/DBCOND0024161": "Convulsions"}, {"/indications/DBCOND0015901": "Hypomagnesaemia"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0022086": "Barium poisoning"}, {"/indications/DBCOND0022085": "Severe Exacerbation of asthma"}], "Name": "Magnesium Sulfate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003301": "Paramagnetic Contrast Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002361": "Tests for Bile Duct Patency"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0501040F0": {"Conditions": [{"/indications/DBCOND0021311": "Acute Crusting Rhinitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0039241": "Corneal Abrasions"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0021315": "Stye"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0021310": "Acute rhino-sinusitis"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0020325": "Nasal carriage of staphylococci"}], "Name": "Framycetin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000880": "Neomycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0704040J0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0501070H0": {"Conditions": [{"/indications/DBCOND0025199": "External ear infection NOS"}], "Name": "Colistin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}]}, "0408010U0": {"Conditions": [{"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0077746": "Seizures, Focal"}, {"/indications/DBCOND0035183": "Temporal Lobe Epilepsy"}, {"/indications/DBCOND0082481": "Tremor, Essential"}], "Name": "Primidone", "Categories": [{"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000728": "Barbiturates"}, {"/categories/DBCAT002391": "Barbiturates and Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002612": "Cytochrome P-450 CYP1A2 Inducers (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT001139": "Phenobarbital and similars"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "0403010B0": {"Conditions": [{"/indications/DBCOND0076765": "Acute Depression"}, {"/indications/DBCOND0052289": "Anorexia Nervosa (AN)"}, {"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0004523": "Bulimia"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0028190": "Diabetic Neuropathies"}, {"/indications/DBCOND0054959": "Headache, Tension-Type"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0058538": "Moderate Depression"}, {"/indications/DBCOND0001411": "Nocturnal Enuresis"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0078932": "Severe Depression"}, {"/indications/DBCOND0027764": "Sleep disorders and disturbances"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0106094": "Moderate Agitation"}, {"/indications/DBCOND0106093": "Moderate Anxiety"}, {"/indications/DBCOND0023114": "Severe Anxiety"}, {"/indications/DBCOND0102779": "Severe agitation"}], "Name": "Amitriptyline Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}]}, "0801050V0": {"Conditions": [{"/indications/DBCOND0046846": "Advanced Cervical Cancer"}, {"/indications/DBCOND0076376": "Advanced Head and Neck Cancer"}, {"/indications/DBCOND0037926": "Advanced Ovarian Cancer"}, {"/indications/DBCOND0060596": "Advanced Soft Tissue Sarcoma"}, {"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0028487": "Fallopian Tube Cancer"}, {"/indications/DBCOND0035013": "Kaposi s Sarcoma (KS)"}, {"/indications/DBCOND0039376": "Locally Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0073968": "Malignant Peritoneal Neoplasm"}, {"/indications/DBCOND0054408": "Metastatic Bladder Cancer"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0060224": "Pancreatic Adenocarcinoma Metastatic"}, {"/indications/DBCOND0021244": "Advanced Bladder cancer"}, {"/indications/DBCOND0021657": "Advanced Thymoma"}, {"/indications/DBCOND0021461": "Metastatic Penile cancer"}, {"/indications/DBCOND0021526": "Refractory Small cell lung cancer"}, {"/indications/DBCOND0022938": "Refractory Testicular germ cell cancer"}], "Name": "Paclitaxel", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003984": "BSEP/ABCB11 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001310": "Cyclodecanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000381": "Diterpenes"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004205": "Microtubule Inhibition"}, {"/categories/DBCAT002734": "Microtubule Inhibitors"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT002720": "Taxane Derivatives"}, {"/categories/DBCAT001309": "Taxoids"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "1305020T0": {"Conditions": [{"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0024214": "Benign facial lentigines"}, {"/indications/DBCOND0024211": "Facial fine wrinkling"}, {"/indications/DBCOND0024212": "Facial hyperpigmentation"}, {"/indications/DBCOND0024213": "Facial hypopigmentation"}, {"/indications/DBCOND0022328": "Mild Acne vulgaris"}, {"/indications/DBCOND0022329": "Moderate Acne vulgaris"}], "Name": "Tazarotene", "Categories": [{"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002153": "Antipsoriatics for Topical Use"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT001141": "Teratogens"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0408010AM": {"Conditions": [{"/indications/DBCOND0044732": "Disseminated Sclerosis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Cannabidiol", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002709": "Cannabinoids and similars"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0408010AL": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Brivaracetam", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004334": "Epoxide Hydrolase Inhibitors"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0303020Z0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0037544": "Chronic Urticaria"}], "Name": "Zafirlukast", "Categories": [{"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000910": "Leukotriene Antagonists"}, {"/categories/DBCAT003692": "Leukotriene Modifiers"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001414": "Toluene"}]}, "0503032C0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}, {"/indications/DBCOND0024500": "Chronic hepatitis C genotype 5"}, {"/indications/DBCOND0023526": "Genotype 6 chronic hepatitis C infection"}], "Name": "Sofosbuvir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003504": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT004208": "RNA Replicase Inhibitors"}, {"/categories/DBCAT001520": "Uracil Nucleotides"}, {"/categories/DBCAT001919": "Uridine Monophosphate"}]}, "0204000AB": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Nebivolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0204000AC": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0035554": "Mild Hypertension"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0061310": "Premature Ventricular Contractions"}, {"/indications/DBCOND0070681": "Supraventricular Arrhythmias"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}, {"/indications/DBCOND0021901": "Perioperative arrhythmia"}], "Name": "Bisoprolol Fumarate/Aspirin", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0601023V0": {"Conditions": [{"/indications/DBCOND0055384": "Polycystic Ovaries Syndrome"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Metformin Hydrochloride/Rosiglitazone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}]}, "0501040H0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0024199": "Bacterial corneal ulcer"}, {"/indications/DBCOND0009907": "Bacterial dacryocystitis"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0014101": "Dermatitis infected"}, {"/indications/DBCOND0005633": "Ecthyma"}, {"/indications/DBCOND0024202": "Eczematous dermatitis infected"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0024201": "Furunculosis"}, {"/indications/DBCOND0024204": "Gram-negative enteric bacilli neonatal sepsis"}, {"/indications/DBCOND0024200": "Impetigo contagious"}, {"/indications/DBCOND0009952": "Keratitis bacterial"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0009912": "Meibomianitis"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0066222": "Pustular Psoriasis"}, {"/indications/DBCOND0024203": "Pustular acne"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0014782": "Sycosis barbae"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0024206": "Complicated Respiratory tract infection bacterial"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0025307": "Severe Endocarditis enterococcal"}, {"/indications/DBCOND0024208": "Severe Infection Pseudomonas aeruginosa"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Gentamicin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001201": "Gentamicins"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0905030N0": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}], "Name": "Sodium Monofluorophosphate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT002594": "Caries Prophylactic Agents"}, {"/categories/DBCAT001982": "Cariostatic Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001983": "Fluorides"}, {"/categories/DBCAT001985": "Fluorine Compounds"}, {"/categories/DBCAT001984": "Hydrofluoric Acid"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001999": "Toothpastes"}]}, "0801050BV": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0025779": "Locally recurrent radioactive iodine-refractory Thyroid cancer"}, {"/indications/DBCOND0025778": "Metastatic radioactive iodine-refractory Thyroid cancer"}, {"/indications/DBCOND0025780": "Progressive radioactive iodine-refractory Thyroid cancer"}], "Name": "Lenvatinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004052": "Receptor Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT000635": "Urea"}]}, "0209000X0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0094088": "Thrombotic events"}], "Name": "Eptifibatide", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}]}, "0704020P0": {"Conditions": [{"/indications/DBCOND0042310": "Urinary Frequency"}, {"/indications/DBCOND0030460": "Urinary Incontinence (UI)"}, {"/indications/DBCOND0024753": "Urination urgency of"}], "Name": "Propiverine Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT001929": "Diphenylacetic Acids"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1302010T0": {"Conditions": [{"/indications/DBCOND0005372": "Sunburn"}], "Name": "Titanium Dioxide", "Categories": [{"/categories/DBCAT003794": "Astringents and Deodorants"}, {"/categories/DBCAT000985": "Biocompatible Materials"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001075": "Coloring Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT001341": "Metals"}, {"/categories/DBCAT001339": "Metals, Light"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT001388": "Transition Elements"}, {"/categories/DBCAT002011": "Water Pollutants, Chemical"}]}, "0408010AK": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0023494": "Primary Generalized tonic-clonic seizure"}], "Name": "Perampanel", "Categories": [{"/categories/DBCAT004475": "AMPA Receptor Antagonists"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003497": "Noncompetitive AMPA Glutamate Receptor Antagonist"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001477": "Receptors, AMPA, antagonists & inhibitors"}]}, "0502050B0": {"Conditions": [{"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0073150": "Tinea Unguium"}, {"/indications/DBCOND0014329": "Tinea barbae"}], "Name": "Griseofulvin", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002359": "Antifungals for Systemic Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004357": "Decreased Mitosis"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004205": "Microtubule Inhibition"}, {"/categories/DBCAT003343": "Tubulin Inhibiting Agent"}]}, "0801050BT": {"Conditions": [{"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}], "Name": "Nintedanib", "Categories": [{"/categories/DBCAT003767": "Antifibrotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0408010G0": {"Conditions": [{"/indications/DBCOND0017487": "Brachioradial pruritus"}, {"/indications/DBCOND0028190": "Diabetic Neuropathies"}, {"/indications/DBCOND0033306": "Fibromyalgia Syndrome"}, {"/indications/DBCOND0068470": "Menopausal Hot Flushes"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0073745": "Refractory Chronic Cough"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0033074": "Social Anxiety Disorder (SAD)"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Gabapentin", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000424": "Aminobutyrates"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000703": "Cyclohexanecarboxylic Acids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000423": "gamma-Aminobutyric Acid"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0601021A0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Glimepiride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801050BJ": {"Conditions": [{"/indications/DBCOND0039050": "Severe Aplastic Anemia (SAA)"}, {"/indications/DBCOND0023292": "Advanced Thyroid cancer"}, {"/indications/DBCOND0025596": "Refractory Aplastic anemia"}], "Name": "Axitinib", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT004052": "Receptor Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1304000E0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0033534": "Oesophagitis, Eosinophilic"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0089474": "Mild Crohn\u2019s Disease"}, {"/indications/DBCOND0089473": "Moderate Crohn\u2019s Disease"}], "Name": "Budesonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "0702020H0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0024466": "Tinea pedis of the interdigital"}], "Name": "Econazole Nitrate", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}]}, "1405020A0": {"Conditions": [{"/indications/DBCOND0000386": "Tetanus"}], "Name": "Tetanus Immunoglobulin", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002143": "Immune Sera and Immunoglobulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT002882": "Serum"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002142": "Specific Immunoglobulins"}]}, "0105020C0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106167": "Fulminating Pulmonary Tuberculosis"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Hydrocortisone", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1302020E0": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Oxide", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "0501022C0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0014040": "Pyelonephritis"}, {"/indications/DBCOND0025511": "Catheter related bloodstream infections"}], "Name": "Doripenem", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT001395": "Carbapenems"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003321": "Penem Antibacterial"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801030S0": {"Conditions": [{"/indications/DBCOND0036667": "Advanced Gastric Cancer"}], "Name": "Tegafur", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003851": "Fluoropyrimidines"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "0304030C0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0601022B0": {"Conditions": [{"/indications/DBCOND0055384": "Polycystic Ovaries Syndrome"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Metformin Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}]}, "1304000W0": {"Conditions": [{"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0112787": "Corticosteroid responsive, Inflammatory Dermatosis"}, {"/indications/DBCOND0112789": "Corticosteroid responsive, pruritic Dermatosis"}, {"/indications/DBCOND0112790": "Pruritic, corticosteroid responsive, Inflammatory Dermatosis"}], "Name": "Hydrocortisone Butyrate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0103010H0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0011120": "Gastritis"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0080549": "Acute Duodenal Ulcers"}, {"/indications/DBCOND0022473": "Acute benign gastric ulcers"}, {"/indications/DBCOND0021296": "Hypersecretory conditions"}, {"/indications/DBCOND0020951": "Multiple endocrine adenomas"}], "Name": "Famotidine", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0503031C0": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}], "Name": "Telbivudine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000858": "Thymidine"}]}, "0803042S0": {"Conditions": [{"/indications/DBCOND0043429": "Advanced Prostate Cancer"}], "Name": "Triptorelin Embonate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT001156": "Luteolytic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}]}, "0202020U0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Torasemide", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004546": "Ototoxic agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0409020C0": {"Conditions": [{"/indications/DBCOND0021042": "Extrapyramidal symptoms caused by butyrophenones"}, {"/indications/DBCOND0021033": "Extrapyramidal symptoms caused by dibenzoxazepines"}, {"/indications/DBCOND0021035": "Extrapyramidal symptoms caused by phenothiazines"}, {"/indications/DBCOND0021040": "Extrapyramidal symptoms caused by thioxanthenes"}, {"/indications/DBCOND0089213": "Parkinsonism post encephalitic"}, {"/indications/DBCOND0021037": "Arteriosclerotic Parkinsonism"}, {"/indications/DBCOND0100090": "Extrapyramidal disorders"}, {"/indications/DBCOND0021038": "Idiopathic Parkinsonism"}], "Name": "Trihexyphenidyl Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002324": "Tertiary Amines"}]}, "1103020M0": {"Conditions": [{"/indications/DBCOND0078869": "Diaper Dermatitis"}, {"/indications/DBCOND0080575": "Fungal infection of nail"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0022776": "Cutaneous candidiasis infection"}], "Name": "Miconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "1103010G0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0024199": "Bacterial corneal ulcer"}, {"/indications/DBCOND0009907": "Bacterial dacryocystitis"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0014101": "Dermatitis infected"}, {"/indications/DBCOND0005633": "Ecthyma"}, {"/indications/DBCOND0024202": "Eczematous dermatitis infected"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0024201": "Furunculosis"}, {"/indications/DBCOND0024204": "Gram-negative enteric bacilli neonatal sepsis"}, {"/indications/DBCOND0024200": "Impetigo contagious"}, {"/indications/DBCOND0009952": "Keratitis bacterial"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0009912": "Meibomianitis"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0066222": "Pustular Psoriasis"}, {"/indications/DBCOND0024203": "Pustular acne"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0014782": "Sycosis barbae"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0024206": "Complicated Respiratory tract infection bacterial"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0025307": "Severe Endocarditis enterococcal"}, {"/indications/DBCOND0024208": "Severe Infection Pseudomonas aeruginosa"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Gentamicin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001201": "Gentamicins"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0109040N0": {"Conditions": [{"/indications/DBCOND0000839": "Exocrine Pancreatic Insufficiency"}, {"/indications/DBCOND0082847": "Gastrointestinal Discomfort"}, {"/indications/DBCOND0020593": "Fat malabsorption"}, {"/indications/DBCOND0102291": "Severe or persistent diarrhea"}], "Name": "Pancreatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000189": "Carboxylic Ester Hydrolases"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002547": "Digestives, Incl. Enzymes"}, {"/categories/DBCAT003135": "Enzyme Preparations"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000188": "Lipase"}, {"/categories/DBCAT000191": "Pancreatic Extracts"}, {"/categories/DBCAT000192": "Tissue Extracts"}]}, "0604030L0": {"Conditions": [{"/indications/DBCOND0089208": "Chronic renal failure anemia"}], "Name": "Nandrolone Decanoate", "Categories": [{"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002677": "Nandrolone and esters"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT001014": "Testosterone Congeners"}]}, "1312000K0": {"Conditions": [{"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Methenamine Hippurate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000260": "Keto Acids"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}]}, "0607010T0": {"Conditions": [{"/indications/DBCOND0023575": "Idiopathic Hyperprolactinemia"}, {"/indications/DBCOND0020755": "Idiopathic hyperprolactinemic disorder"}], "Name": "Quinagolide Hydrochloride", "Categories": [{"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000838": "Dopamine D2 Receptor Agonists"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002256": "Prolactine Inhibitors"}, {"/categories/DBCAT000788": "Quinolines"}]}, "1315000D0": {"Conditions": [{"/indications/DBCOND0042295": "Insect Bites"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Diethyltoluamide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002371": "Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents"}, {"/categories/DBCAT002056": "Insect Repellents"}, {"/categories/DBCAT002606": "Insecticides and Repellents"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1103020C0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0024299": "Fungal infection of the dermal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0043009": "Ringworm"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0112599": "Symptomatic Tinea Corporis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112597": "Symptomatic Tinea Cruris caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112595": "Symptomatic Tinea Pedis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}], "Name": "Clotrimazole", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004500": "Cytochrome P-450 CYP3A7 Inducers (strong)"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003934": "OATP1B3 inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "1103010I0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0501090C0": {"Conditions": [{"/indications/DBCOND0053683": "Tuberculosis Infection"}], "Name": "Capreomycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}]}, "0503010M0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Fosamprenavir Calcium", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003961": "Amprenavir and Prodrugs"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1002020L0": {"Conditions": [{"/indications/DBCOND0022396": "Phlegm"}, {"/indications/DBCOND0094614": "Chest congestion"}], "Name": "Guaifenesin", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000847": "Guaiacol"}, {"/categories/DBCAT000561": "Methyl Ethers"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000132": "Respiratory System Agents"}]}, "1202030S0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0309020AH": {"Conditions": [{"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Ammonium Chloride/Diphenhydramine HCl", "Categories": [{"/categories/DBCAT002512": "Acidifiers"}, {"/categories/DBCAT003775": "Acidifying Agents"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1306020J0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0001518": "Sezary Syndrome"}, {"/indications/DBCOND0024438": "Refractory Acne vulgaris"}, {"/indications/DBCOND0120029": "Severe Recalcitrant nodular acne"}], "Name": "Isotretinoin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002491": "Anti-Acne Preparations for Systemic Use"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT002490": "Retinoids for Treatment of Acne"}, {"/categories/DBCAT001141": "Teratogens"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0905011E0": {"Conditions": [{"/indications/DBCOND0020582": "Hypocalcemia"}], "Name": "Calcium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}]}, "0309020AB": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0031602": "Oral Mucositis"}, {"/indications/DBCOND0024062": "Parkinsonian Syndromes"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0035432": "Skin Rash"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0024669": "Upper respiratory tract hypersensitivity reaction, site unspecified"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0022265": "Dermatographism"}], "Name": "Diphenhydramine HCl/Pholcodine", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003673": "Ethanolamine Derivatives"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003748": "First Generation Antihistamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}]}, "0309020AA": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0085997": "Menstrual Cramps"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Ibuprofen/Pseudoephed HCl", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003907": "COX-1 Inhibitors"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0309020AF": {"Conditions": [{"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Pseudoephedrine HCl/Dextrometh Hydrob", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002351": "Nasal Decongestants for Systemic Use"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0309020AG": {"Conditions": [{"/indications/DBCOND0093800": "Catheter site calcification caused by appatite"}, {"/indications/DBCOND0093799": "Catheter site calcification caused by struvite"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0057786": "Renal Stones"}], "Name": "Citric Acid Monohydrate/Ipecacuanha", "Categories": [{"/categories/DBCAT002546": "Acid Preparations"}, {"/categories/DBCAT004091": "Acidifying Activity"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004168": "Calcium Chelating Activity"}, {"/categories/DBCAT001213": "Calcium Chelating Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT004167": "Decreased Coagulation Factor Activity"}, {"/categories/DBCAT002547": "Digestives, Incl. Enzymes"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0309020AE": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine HCl/Ipecacuanha", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1201010R0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0024199": "Bacterial corneal ulcer"}, {"/indications/DBCOND0009907": "Bacterial dacryocystitis"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0014101": "Dermatitis infected"}, {"/indications/DBCOND0005633": "Ecthyma"}, {"/indications/DBCOND0024202": "Eczematous dermatitis infected"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0024201": "Furunculosis"}, {"/indications/DBCOND0024204": "Gram-negative enteric bacilli neonatal sepsis"}, {"/indications/DBCOND0024200": "Impetigo contagious"}, {"/indications/DBCOND0009952": "Keratitis bacterial"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0009912": "Meibomianitis"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0066222": "Pustular Psoriasis"}, {"/indications/DBCOND0024203": "Pustular acne"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0014782": "Sycosis barbae"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0024206": "Complicated Respiratory tract infection bacterial"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0025307": "Severe Endocarditis enterococcal"}, {"/indications/DBCOND0024208": "Severe Infection Pseudomonas aeruginosa"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Gentamicin Sulphate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001201": "Gentamicins"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0302000G0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Valerate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1001010V0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0027851": "Rheumatoid arthritis flare up"}, {"/indications/DBCOND0021417": "Adhesive capsulitis shoulder"}, {"/indications/DBCOND0021418": "Radiohumeral bursitis"}], "Name": "Tolmetin", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "0401020T0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0058122": "Depression, Anxiety"}, {"/indications/DBCOND0059192": "Feeling Anxious"}], "Name": "Oxazepam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "040201010": {"Conditions": [{"/indications/DBCOND0040804": "Acute Exacerbation of Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Zuclopenthixol Acetate", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002478": "Thioxanthene Derivatives"}, {"/categories/DBCAT001167": "Thioxanthenes"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "0704050R0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0035654": "Erectile Dysfunction (ED)"}, {"/indications/DBCOND0039281": "Pulmonary Arterial Hypertension (PAH)"}], "Name": "Tadalafil", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002410": "Antihypertensives for Pulmonary Arterial Hypertension"}, {"/categories/DBCAT001148": "Carbolines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1306020D0": {"Conditions": [{"/indications/DBCOND0070333": "Advanced Prostate Carcinoma"}, {"/indications/DBCOND0036371": "Metastatic Hormone Refractory Prostate Cancer"}, {"/indications/DBCOND0018486": "Paraphilia"}, {"/indications/DBCOND0077433": "Severe Acne"}], "Name": "Cyproterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT001625": "Cyproterone"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "0905011K0": {"Conditions": [{"/indications/DBCOND0020582": "Hypocalcemia"}], "Name": "Calcium Gluconate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001733": "Gluconates"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000971": "Sugar Acids"}]}, "0901020D0": {"Conditions": [{"/indications/DBCOND0004065": "Anemia, Pernicious"}, {"/indications/DBCOND0034596": "Vitamin B12 Deficiency"}, {"/indications/DBCOND0117813": "Vitamin B12 concentration"}], "Name": "Cyanocobalamin", "Categories": [{"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000237": "Corrinoids"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT004706": "Vitamin B 12, biosynthesis"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT004535": "VITAMIN B12 AND FOLIC ACID"}, {"/categories/DBCAT000230": "Vitamins"}]}, "1001010M0": {"Conditions": [{"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0012385": "Pyrexia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0112678": "Acute Shoulder Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Choline Magnesium Trisalicylate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0106040M0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Macrogol 3350", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT001545": "Excipients"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001429": "Pharmaceutical Vehicles"}, {"/categories/DBCAT001605": "Polyethylene Glycols"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT004092": "Stimulation Large Intestine Fluid/Electrolyte Secretion"}, {"/categories/DBCAT000898": "Surface-Active Agents"}]}, "1306010B0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024155": "Inflammatory lesions caused by rosacea"}], "Name": "Azelaic Acid", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT004151": "Decreased Protein Synthesis"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}]}, "0409010H0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0037676": "Parkinson's Disease, Idiopathic"}, {"/indications/DBCOND0045695": "Parkinsons's Disease"}, {"/indications/DBCOND0024275": "Moderate Restless Legs Syndrome"}, {"/indications/DBCOND0024274": "Severe Restless Legs Syndrome"}], "Name": "Ropinirole Hydrochloride", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}]}, "030902060": {"Conditions": [{"/indications/DBCOND0024457": "Allergic edema"}, {"/indications/DBCOND0024456": "Allergic urticaria"}, {"/indications/DBCOND0078258": "Anaphylactic Reaction"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0022721": "Dermographism"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0022333": "Postoperative pain"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0080552": "Acute Allergic Reactions"}, {"/indications/DBCOND0024459": "Perioperative nausea and vomiting"}, {"/indications/DBCOND0022511": "Upper respiratory symptoms"}], "Name": "Promethazine Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002337": "Phenothiazine Derivatives"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0301040M0": {"Conditions": [{"/indications/DBCOND0023007": "Severe COPD exacerbation"}], "Name": "Fenoterol Hydrobromide", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001334": "Metaproterenol"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002477": "Sympathomimetics, Labour Repressants"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "0401010W0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Zaleplon", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004210": "Central Nervous System Depression"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000427": "GABA Agonists"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000850": "GABA-A Receptor Agonists"}, {"/categories/DBCAT003556": "gamma-Aminobutyric Acid A Receptor Agonist"}, {"/categories/DBCAT002725": "Hypnotics (Nonbenzodiazepine)"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}]}, "0602010A0": {"Conditions": [{"/indications/DBCOND0063689": "Thyroid Cancers"}, {"/indications/DBCOND0020310": "Thyroid tissue remnants"}], "Name": "Thyrotropin Alfa", "Categories": [{"/categories/DBCAT004965": "Agents used to treat hypothyroidism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0410030A0": {"Conditions": [{"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Buprenorphine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002486": "Oripavine Derivatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "1203040W0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0042226": "Ocular Irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}], "Name": "Hydrocortisone Sodium Succinate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0206020C0": {"Conditions": [{"/indications/DBCOND0031732": "Anal Fissures"}, {"/indications/DBCOND0000553": "Angina Pectoris, Variant"}, {"/indications/DBCOND0066917": "Anginal Pain"}, {"/indications/DBCOND0000496": "Atrial Flutter"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0062051": "Idiopathic Dilated Cardiomyopathy"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0051788": "Pulmonary Hypertension (PH)"}, {"/indications/DBCOND0093960": "Leg cramps"}, {"/indications/DBCOND0024302": "Prophylaxis of migraine headaches"}], "Name": "Diltiazem Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT002326": "Benzothiazepine Derivatives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003976": "Calcium Channel Blockers (Nondihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003669": "Miscellaneous Calcium-channel Blocking Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002327": "Selective Calcium Channel Blockers With Direct Cardiac Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1106000N0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0002204": "Hypokalemic Periodic Paralysis"}, {"/indications/DBCOND0002205": "Paralysis, Hyperkalemic Periodic"}], "Name": "Diclofenamide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0407010A0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin & Papaveretum", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0304010P0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0053736": "Allergic Skin Reaction"}], "Name": "Diphenylpyraline Hydrochloride", "Categories": [{"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}]}, "1203020H0": {"Conditions": [{"/indications/DBCOND0078869": "Diaper Dermatitis"}, {"/indications/DBCOND0080575": "Fungal infection of nail"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0022776": "Cutaneous candidiasis infection"}], "Name": "Miconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "1303000P0": {"Conditions": [{"/indications/DBCOND0024457": "Allergic edema"}, {"/indications/DBCOND0024456": "Allergic urticaria"}, {"/indications/DBCOND0078258": "Anaphylactic Reaction"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0022721": "Dermographism"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0022333": "Postoperative pain"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0080552": "Acute Allergic Reactions"}, {"/indications/DBCOND0024459": "Perioperative nausea and vomiting"}, {"/indications/DBCOND0022511": "Upper respiratory symptoms"}], "Name": "Promethazine Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002337": "Phenothiazine Derivatives"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0101010Q0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0023344": "Sour stomach"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Magnesium Hydroxide", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003784": "Emollients Demulcents and Protectants"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001847": "Hydroxides"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004845": "Magnesium Hydroxide"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0206020Q0": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0021980": "Blood pressure >185/110 mm Hg arterial hypertension"}], "Name": "Nicardipine Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004488": "Cytochrome P-450 CYP3A5 Inhibitors (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0604020B0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0106237": "Symptomatic Benign Prostatic Hyperplasia"}], "Name": "Dutasteride", "Categories": [{"/categories/DBCAT001276": "5-alpha Reductase Inhibitors"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT001274": "Azasteroids"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1502010C0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0028410": "Hemolytic Anemia"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0106428": "Acute Idiopathic Nephrotic Syndrome"}, {"/indications/DBCOND0106435": "Acute Lupus Erythematosus"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0106427": "Bullous dermaitits herpetiformis"}, {"/indications/DBCOND0106425": "Cancer-associated hypercalcemia"}, {"/indications/DBCOND0106432": "Cystic tumors of aponeurosis"}, {"/indications/DBCOND0106433": "Cystic tumors of tendon"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106429": "Inflammatory lesions of granuloma annulare"}, {"/indications/DBCOND0106430": "Inflammatory lessions of lichen planus"}, {"/indications/DBCOND0106431": "Inflammatory lessions of lichen sumplex"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0106426": "Occular inflammatory conditions"}, {"/indications/DBCOND0106424": "Permphigus"}, {"/indications/DBCOND0106423": "Severe Allergic Reactions"}], "Name": "Bupivacaine Hydrochloride", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1001040K0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0054711": "Chronic Gouty Arthritis"}, {"/indications/DBCOND0083638": "Gout Chronic"}, {"/indications/DBCOND0004938": "Hyperuricemia"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0106223": "Excess of uric acid in blood"}], "Name": "Probenecid", "Categories": [{"/categories/DBCAT001242": "Adjuvants, Pharmaceutic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT002493": "Preparations Increasing Uric Acid Excretion"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT001241": "Uricosuric Agents"}]}, "0407010AA": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin & Caffeine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0407010AB": {"Conditions": [{"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0118556": "Minor aches and pains"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Paracetamol & Phenylephrine HCl", "Categories": [{"/categories/DBCAT003969": "Acetaminophen and Prodrugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003661": "Miscellaneous Analgesics and Antipyretics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0407010AD": {"Conditions": [{"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0118556": "Minor aches and pains"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Paracetamol & Ibuprofen", "Categories": [{"/categories/DBCAT003969": "Acetaminophen and Prodrugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003661": "Miscellaneous Analgesics and Antipyretics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0501050C0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0606020Z0": {"Conditions": [{"/indications/DBCOND0031952": "Bone Loss"}, {"/indications/DBCOND0016497": "Bone pain"}, {"/indications/DBCOND0078810": "Fracture Bone"}, {"/indications/DBCOND0003439": "Spinal Cord Compression"}, {"/indications/DBCOND0025622": "Bone destruction"}, {"/indications/DBCOND0023310": "Giant cell tumor of the bone"}, {"/indications/DBCOND0025619": "High risk of fracture Osteoporosis"}, {"/indications/DBCOND0023306": "Refractory Hypercalcemia of malignancy"}], "Name": "Denosumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT004389": "RANK Ligand Blocking Activity"}, {"/categories/DBCAT003473": "RANK Ligand Inhibitor"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0103050R0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0070241": "Erosive Esophagitis(EE)"}, {"/indications/DBCOND0033211": "GERD With Erosive Esophagitis"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0117234": "Conditions where a reduction of gastric acid secretion is required"}, {"/indications/DBCOND0022462": "Pathological hypersecretory conditions"}], "Name": "Pantoprazole", "Categories": [{"/categories/DBCAT000768": "2-Pyridinylmethylsulfinylbenzimidazoles"}, {"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000541": "Proton Pump Inhibitors"}, {"/categories/DBCAT003638": "Proton-pump Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0205052N0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0000515": "Marfan Syndrome"}, {"/indications/DBCOND0085133": "Strokes"}], "Name": "Losartan Potassium", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT001168": "Angiotensin II Type 2 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001053": "Biphenyl Compounds"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000407": "Tetrazoles"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0303020G0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Montelukast", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000910": "Leukotriene Antagonists"}, {"/categories/DBCAT003692": "Leukotriene Modifiers"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000132": "Respiratory System Agents"}]}, "0803043Q0": {"Conditions": [{"/indications/DBCOND0000951": "Acromegaly"}, {"/indications/DBCOND0036443": "Cushing's Disease"}], "Name": "Pasireotide", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT001948": "Pituitary Hormone Release Inhibiting Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003774": "Somatostatin Agonists"}, {"/categories/DBCAT002136": "Somatostatin and Analogues"}, {"/categories/DBCAT004140": "Somatostatin Receptor Agonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0212000U0": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0111554": "Deficiency, Vitamin"}, {"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0004063": "Pellagra"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0021999": "Severe Hyperlipidemia"}], "Name": "Nicotinic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT003706": "Miscellaneous Antilipemic Agents"}, {"/categories/DBCAT004745": "Niacin"}, {"/categories/DBCAT002431": "Nicotinic Acid and Derivatives"}, {"/categories/DBCAT000824": "Nicotinic Acids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT004603": "Thyroxine-binding globulin inhibitors"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0408010Z0": {"Conditions": [{"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0024115": "Seizures"}], "Name": "Phenytoin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT004675": "Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003887": "Cytochrome P-450 CYP2C19 Substrates (moderate)"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004507": "Cytochrome P-450 CYP2D6 Inducers (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004282": "Cytochrome P450 2D6 Inducers"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT004731": "Phenytoin"}, {"/categories/DBCAT002678": "Phenytoin and Prodrugs"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT002665": "UGT1A6 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0503032J0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}, {"/indications/DBCOND0024500": "Chronic hepatitis C genotype 5"}, {"/indications/DBCOND0023526": "Genotype 6 chronic hepatitis C infection"}], "Name": "Sofosbuvir/Velpatasvir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003504": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT004208": "RNA Replicase Inhibitors"}, {"/categories/DBCAT001520": "Uracil Nucleotides"}, {"/categories/DBCAT001919": "Uridine Monophosphate"}]}, "1202020L0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "1310020J0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0024466": "Tinea pedis of the interdigital"}], "Name": "Econazole Nitrate", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}]}, "0204000P0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}], "Name": "Pindolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1203050P0": {"Conditions": [{"/indications/DBCOND0038951": "Dry Mouth"}, {"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}], "Name": "Pilocarpine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003290": "Cholinergic Receptor Agonist"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000836": "Miotics"}, {"/categories/DBCAT000447": "Muscarinic Agonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT004766": "Pilocarpine"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0107010T0": {"Conditions": [{"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0033077": "Mouth Ulcers"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}, {"/indications/DBCOND0024463": "Teething pain"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0050555": "Tooth Pain"}, {"/indications/DBCOND0022739": "Pruritic dermatosis"}], "Name": "Benzocaine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT004767": "Benzocaine"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002455": "Esters of Aminobenzoic Acid"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0403030D0": {"Conditions": [{"/indications/DBCOND0052289": "Anorexia Nervosa (AN)"}, {"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0028190": "Diabetic Neuropathies"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0005024": "Premenstrual Dysphoric Disorder"}, {"/indications/DBCOND0033074": "Social Anxiety Disorder (SAD)"}], "Name": "Citalopram Hydrobromide", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004729": "Citalopram"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0801030L0": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0054528": "Acute Promyelocytic Leukemia (APL)"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0000794": "Hepatitis, Autoimmune"}, {"/indications/DBCOND0032744": "Lymphoma, Lymphoblastic"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}], "Name": "Mercaptopurine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002249": "Purine Analogues"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002714": "Thiopurine Analogs"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001034": "Xanthine derivatives"}]}, "1305030G0": {"Conditions": [{"/indications/DBCOND0025583": "Severe Plaque psoriasis"}, {"/indications/DBCOND0020390": "Moderate Plaque psoriasis"}], "Name": "Ixekizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT005031": "Interleukin-17"}, {"/categories/DBCAT003508": "Interleukin-17A Antagonist"}, {"/categories/DBCAT004179": "Interleukin-17A Antagonists"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0402010M0": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Loxapine Succinate", "Categories": [{"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002317": "Diazepines, Oxazepines, Thiazepines and Oxepines"}, {"/categories/DBCAT000832": "Dibenzoxazepines"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000960": "Loxapine"}, {"/categories/DBCAT003680": "Miscellaneous Antipsychotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0307000T0": {"Conditions": [{"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}], "Name": "Lumacaftor/Ivacaftor", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT001892": "Cystic Fibrosis Transmembrane Conductance Regulator"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT001989": "Dioxoles"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003895": "P-glycoprotein inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}]}, "1104020Z0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Olopatadine", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT003719": "Antihistamine Drugs"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT001120": "Dibenzoxepins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT003399": "Histamine H1 Inhibitors"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0106020L0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0042226": "Ocular Irritation"}], "Name": "Glycerol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT004060": "Increased IgG Production"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003529": "Non-Standardized Chemical Allergen"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003729": "Other Cold and Cough Preparations"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT004975": "Triose Sugar Alcohols"}]}, "0203020X0": {"Conditions": [{"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}], "Name": "Dronedarone Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT005004": "Amiodarone"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002208": "Antiarrhythmics, Class III"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002747": "Combined Inhibitors of CYP3A4 and P-glycoprotein"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0107010B0": {"Conditions": [{"/indications/DBCOND0011201": "Amoebiasis"}, {"/indications/DBCOND0110753": "Vaginitis caused by Trichomonas Vaginalis, candida albicans"}], "Name": "Acetarsol", "Categories": [{"/categories/DBCAT002322": "Agents Against Leishmaniasis and Trypanosomiasis"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT001515": "Arsenicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000755": "Organometallic Compounds"}]}, "1104020T0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0034753": "Conjunctivitis, Vernal"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0002834": "Urticaria Pigmentosa"}], "Name": "Sodium Cromoglicate", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001225": "Chromones"}, {"/categories/DBCAT004761": "Cromolyn Sodium"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT003742": "Mast-cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0802040AT": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0029144": "Refractory Hodgkin Lymphoma"}, {"/indications/DBCOND0055462": "Renal Cell Adenocarcinoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}, {"/indications/DBCOND0112025": "Refractory Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0112653": "Refractory Hepatocellular Carcinoma"}, {"/indications/DBCOND0112649": "Refractory, locally advanced Urothelial Carcinoma"}, {"/indications/DBCOND0112651": "Refractory, metastatic MSI-H/dMMR colorectal cancer"}, {"/indications/DBCOND0025490": "Refractory, metastatic Non small cell lung cancer"}, {"/indications/DBCOND0025678": "Refractory, metastatic Renal cell carcinoma"}, {"/indications/DBCOND0112646": "Refractory, metastatic Squamous Cell Carcinoma of Head and Neck"}, {"/indications/DBCOND0112648": "Refractory, metastatic Urothelial Carcinoma"}], "Name": "Nivolumab", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000025": "Immunoglobulin G"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT003510": "Programmed Death Receptor-1 Blocking Antibody"}, {"/categories/DBCAT004275": "Programmed Death Receptor-1-directed Antibody Interactions"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0607040A0": {"Conditions": [{"/indications/DBCOND0041585": "Primary Insulin-like Growth Factor-1 Deficiency"}], "Name": "Mecasermin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT001330": "Somatomedins"}, {"/categories/DBCAT002095": "Somatropin and Somatropin Agonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0802040AD": {"Conditions": [{"/indications/DBCOND0044732": "Disseminated Sclerosis"}], "Name": "Fingolimod", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT003615": "Immunomodulatory Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT001906": "Sphingosine"}, {"/categories/DBCAT003491": "Sphingosine 1-phosphate Receptor Modulator"}, {"/categories/DBCAT004396": "Sphingosine 1-Phosphate Receptor Modulators"}]}, "0604020T0": {"Conditions": [{"/indications/DBCOND0048343": "Hypergonadotropic Hypogonadism"}, {"/indications/DBCOND0031606": "Hypogonadotrophic Hypogonadism"}], "Name": "Testosterone Undecanoate", "Categories": [{"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001013": "Androstenols"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003981": "OAT3/SLC22A8 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003968": "Testosterone and derivatives"}, {"/categories/DBCAT001014": "Testosterone Congeners"}]}, "0802040AC": {"Conditions": [{"/indications/DBCOND0034416": "Familial Cold Autoinflammatory Syndrome (FCAS)"}, {"/indications/DBCOND0034417": "Muckle-Wells Syndrome (MWS)"}, {"/indications/DBCOND0080997": "Neonatal-onset multisystemic inflammatory disease"}, {"/indications/DBCOND0023275": "Active systemic Juvenile idiopathic arthritis"}], "Name": "Canakinumab", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT001766": "Interleukin-1beta, antagonists & inhibitors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0802040AL": {"Conditions": [{"/indications/DBCOND0044732": "Disseminated Sclerosis"}], "Name": "Teriflunomide", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT003030": "Cytochrome P-450 CYP1A2 Inducers (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004249": "Dihydroorotate Dehydrogenase Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT003615": "Immunomodulatory Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003496": "Pyrimidine Synthesis Inhibitor"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT001414": "Toluene"}]}, "0802040AM": {"Conditions": [{"/indications/DBCOND0043607": "Castleman's Disease"}], "Name": "Siltuximab", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT003511": "Interleukin-6 Antagonist"}, {"/categories/DBCAT004463": "Interleukin-6 Antagonists"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0205010X0": {"Conditions": [{"/indications/DBCOND0023836": "WHO Group 1 Pulmonary arterial hypertension"}], "Name": "Ambrisentan", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002410": "Antihypertensives for Pulmonary Arterial Hypertension"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000972": "Endothelin Receptor Antagonists"}, {"/categories/DBCAT001796": "Hypertension, Pulmonary"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0802040AI": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}], "Name": "Dabrafenib", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT003898": "Cytochrome P-450 CYP2C8 Inducers (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT002637": "Cytochrome P-450 CYP2C9 Inducers (strong)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000393": "Hydroxylamines"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004176": "Organic Anion Transporter 1 Inhibitors"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001918": "Proto-Oncogene Proteins B-raf, antagonists & inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0802040AJ": {"Conditions": [{"/indications/DBCOND0028542": "Refractory Multiple Myeloma"}], "Name": "Pomalidomide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000221": "Growth Inhibitors"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000723": "Phthalic Acids"}, {"/categories/DBCAT000722": "Phthalimides"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT000785": "Piperidones"}, {"/categories/DBCAT003357": "Thalidomide Analog"}]}, "0101010C0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Aluminium Hydroxide", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT002569": "Aluminium Compounds"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT001847": "Hydroxides"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}]}, "1310011Z0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Tyrothricin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "1203030C0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0014785": "Eczema impetiginous"}, {"/indications/DBCOND0093812": "Eczema of the nuchal nape of the neck"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0093810": "Fungal ear infection caused by Aspergillus niger"}, {"/indications/DBCOND0033173": "Infantile Eczema"}, {"/indications/DBCOND0005735": "Intertrigo"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0093819": "Moniliasis"}, {"/indications/DBCOND0088936": "Nummular Dermatitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0093817": "Pruritis of the scroti"}, {"/indications/DBCOND0005710": "Pruritus Ani"}, {"/indications/DBCOND0001342": "Pruritus Vulvae"}, {"/indications/DBCOND0014093": "Pyoderma"}, {"/indications/DBCOND0019955": "Stasis dermatitis"}, {"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0093818": "Bacterial dermatoses"}, {"/indications/DBCOND0093814": "Chronic otitis externa"}, {"/indications/DBCOND0093820": "Disseminated Neurodermatitis"}, {"/indications/DBCOND0093821": "Localized Neurodermatitis"}], "Name": "Clioquinol", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002552": "Hydroxyquinoline Derivatives"}, {"/categories/DBCAT001262": "Hydroxyquinolines"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003679": "Miscellaneous Antifungals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT001618": "Oxyquinoline"}, {"/categories/DBCAT002551": "Quinoline Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}]}, "0704040I0": {"Conditions": [{"/indications/DBCOND0004515": "Heartburn"}], "Name": "Sodium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001532": "Buffers"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT002728": "Citric Acid Derivatives"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT001548": "Food Preservatives"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003770": "Miscellaneous Anticoagulants"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0801050AF": {"Conditions": [{"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0047201": "Refractory Neuroblastoma"}, {"/indications/DBCOND0022642": "Metastatic Rhabdomyosarcoma"}, {"/indications/DBCOND0025384": "Recurrent, IV-B Cervical cancer"}, {"/indications/DBCOND0025386": "Refractory CNS lymphoma"}, {"/indications/DBCOND0025387": "Refractory CNS malignancy"}, {"/indications/DBCOND0025385": "Refractory, metastatic Ovarian cancer"}, {"/indications/DBCOND0022641": "Relapsed Small cell lung cancer"}], "Name": "Topotecan", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001239": "Camptothecin"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT004525": "MATE 1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT004526": "MATE 2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001116": "Topoisomerase I Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0801050AG": {"Conditions": [{"/indications/DBCOND0063579": "Metastatic Colorectal Cancers"}, {"/indications/DBCOND0075353": "Metastatic Squamous Cell Carcinoma of the Head and Neck"}, {"/indications/DBCOND0020223": "Advanced squamous cell carcinoma of the head and neck"}], "Name": "Cetuximab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003244": "Epidermal Growth Factor Receptor Antagonist"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT004099": "HER1 Antagonists"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050AD": {"Conditions": [{"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0119555": "Metastatic Adenocarcinoma of the Gastro-Esophageal Junction"}, {"/indications/DBCOND0119554": "Metastatic Adenocarcinoma of the Stomach"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0076921": "Metastatic Gastroesophageal Junction Adenocarcinoma"}], "Name": "Trastuzumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT003268": "HER2 Receptor Antagonist"}, {"/categories/DBCAT004073": "HER2/Neu/cerbB2 Antagonists"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050AE": {"Conditions": [{"/indications/DBCOND0039376": "Locally Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0040768": "Locally Advanced Pancreatic Cancer"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0058909": "Pancreatic Cancer Metastatic"}], "Name": "Erlotinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0801050AB": {"Conditions": [{"/indications/DBCOND0025586": "Refractory peripheral cutaneous T-cell lymphoma"}], "Name": "Bexarotene", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT001127": "Tetrahydronaphthalenes"}]}, "0801050AC": {"Conditions": [{"/indications/DBCOND0071979": "Mantle Cell Lymphoma (MCL)"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}], "Name": "Bortezomib", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000461": "Boron Compounds"}, {"/categories/DBCAT000460": "Boronic Acids"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003056": "Proteasome Inhibitors"}, {"/categories/DBCAT000459": "Pyrazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0803020L0": {"Conditions": [{"/indications/DBCOND0031019": "Advanced Breast Cancer"}, {"/indications/DBCOND0050728": "Advanced Endometrial Cancer"}, {"/indications/DBCOND0074030": "Anorexic"}, {"/indications/DBCOND0004466": "Cachexia"}], "Name": "Megestrol Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000780": "Appetite Stimulants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000779": "Megestrol"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002333": "Pregnadien Derivatives"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0801050AN": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0036419": "Chronic Myeloid Leukemia (CML)"}], "Name": "Dasatinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050AL": {"Conditions": [{"/indications/DBCOND0034287": "Advanced Colorectal Cancer"}, {"/indications/DBCOND0037926": "Advanced Ovarian Cancer"}, {"/indications/DBCOND0045345": "Advanced Pancreatic Cancer"}, {"/indications/DBCOND0032512": "Chronic Lymphocytic Leukemia (CLL) - Refractory"}, {"/indications/DBCOND0034227": "Colon Cancer Stage III"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0021495": "Advanced biliary adenocarcinoma"}, {"/indications/DBCOND0089464": "Refractory Neuroendocrine Tumour"}, {"/indications/DBCOND0024997": "Refractory Non-Hodgkin's lymphoma"}, {"/indications/DBCOND0021498": "Refractory Testicular cancer"}], "Name": "Oxaliplatin", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT004979": "Coordination Complexes"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003021": "Platinum Compounds"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0801050AM": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0063689": "Thyroid Cancers"}, {"/indications/DBCOND0080568": "Metastatic Pancreatic Neuroendocrine Tumors"}, {"/indications/DBCOND0023195": "Refractory Gastrointestinal stromal tumor"}, {"/indications/DBCOND0080567": "Unresectable, locally advanced Pancreatic Neuroendocrine Tumors"}], "Name": "Sunitinib", "Categories": [{"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000221": "Growth Inhibitors"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050AJ": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0000828": "Gastrointestinal Stromal Tumors"}, {"/indications/DBCOND0002815": "Hemangiosarcoma"}, {"/indications/DBCOND0033719": "Unresectable Hepatocellular Carcinoma"}, {"/indications/DBCOND0021107": "Locally recurrent refractory to radioactive iodine treatment Thyroid carcinoma"}, {"/indications/DBCOND0021108": "Metastatic refractory to radioactive iodine treatment Thyroid carcinoma"}], "Name": "Sorafenib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000824": "Nicotinic Acids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001627": "Phenylurea Compounds"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT000635": "Urea"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0801050AK": {"Conditions": [{"/indications/DBCOND0093186": "Advanced Head and Neck Squamous Cell Carcinoma"}], "Name": "Temoporfin", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT001084": "Porphyrins"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT002451": "Sensitizers Used in Photodynamic/radiation Therapy"}]}, "0403010C0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0021661": "Endogenous depression"}, {"/indications/DBCOND0021660": "Neurotic depression"}, {"/indications/DBCOND0036286": "Psychotic Depression"}, {"/indications/DBCOND0021659": "Reactive depression"}], "Name": "Amoxapine", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT003850": "Antidepressive Agents, Tetracyclic"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000832": "Dibenzoxazepines"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000960": "Loxapine"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0801050AV": {"Conditions": [{"/indications/DBCOND0075427": "Metastatic Leiomyosarcoma"}, {"/indications/DBCOND0055525": "Metastatic Liposarcoma"}, {"/indications/DBCOND0025576": "Relapsed platinum-sensitive Ovarian cancer"}, {"/indications/DBCOND0023202": "Unresectable Leiomyosarcoma"}, {"/indications/DBCOND0023199": "Unresectable Liposarcoma"}], "Name": "Trabectedin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT001989": "Dioxoles"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT001295": "Tetrahydroisoquinolines"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0801050AW": {"Conditions": [{"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}], "Name": "Gefitinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050AT": {"Conditions": [{"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}, {"/indications/DBCOND0023213": "Refractory, metastatic Breast cancer"}], "Name": "Lapatinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050AU": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}], "Name": "Temsirolimus", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}]}, "0801050AR": {"Conditions": [{"/indications/DBCOND0063579": "Metastatic Colorectal Cancers"}], "Name": "Panitumumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003244": "Epidermal Growth Factor Receptor Antagonist"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT004099": "HER1 Antagonists"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050AS": {"Conditions": [{"/indications/DBCOND0057382": "Chronic Phase Chronic Myeloid Leukemia"}, {"/indications/DBCOND0023195": "Refractory Gastrointestinal stromal tumor"}, {"/indications/DBCOND0021942": "Refractory, accelerated phase Chronic myeloid leukemia"}], "Name": "Nilotinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0801050AP": {"Conditions": [{"/indications/DBCOND0043840": "Glioblastomas"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0063579": "Metastatic Colorectal Cancers"}, {"/indications/DBCOND0030098": "Metastatic Renal Cell Carcinoma"}, {"/indications/DBCOND0028795": "Recurrent Cervical Cancer"}, {"/indications/DBCOND0020550": "Nonsquamous cell Non-small cell lung cancer"}, {"/indications/DBCOND0089459": "Recurrent platinum drug resistant Fallopian tube cancer"}, {"/indications/DBCOND0020553": "Recurrent platinum drug resistant Ovarian cancer"}, {"/indications/DBCOND0020559": "Recurrent platinum drug resistant primary peritoneal cancer"}, {"/indications/DBCOND0025384": "Recurrent, IV-B Cervical cancer"}, {"/indications/DBCOND0020546": "Refractory Cervical cancer"}], "Name": "Bevacizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000221": "Growth Inhibitors"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT003817": "Vascular Endothelial Growth Factor Inhibitor"}, {"/categories/DBCAT004320": "Vascular Endothelial Growth Factor Inhibitors"}, {"/categories/DBCAT004233": "Vascular Endothelial Growth Factor-directed Antibody Interactions"}]}, "0202080C0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}], "Name": "Bumetanide/Potassium", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002450": "High-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000601": "meta-Aminobenzoates"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801050AZ": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0060596": "Advanced Soft Tissue Sarcoma"}, {"/indications/DBCOND0023292": "Advanced Thyroid cancer"}], "Name": "Pazopanib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001819": "Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0801050AX": {"Conditions": [{"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0025534": "Renal angiomyolipoma, tuberous sclerosis complex"}, {"/indications/DBCOND0025535": "Subependymal giant cell astrocytoma, tuberous sclerosis complex"}, {"/indications/DBCOND0025536": "Advanced Carcinoid tumor"}, {"/indications/DBCOND0093541": "Locally advanced gastrointestinal origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0093546": "Locally advanced lung origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0093542": "Metastatic gastrointestinal origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0093547": "Metastatic lung origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0093538": "Pancreatic origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0112025": "Refractory Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0111657": "Refractory Waldenstrom's Macroglobulinaemia"}, {"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}, {"/indications/DBCOND0093543": "Unresectable gastrointestinal origin Progressive Neuroendocrine Tumors"}, {"/indications/DBCOND0093548": "Unresectable lung origin Progressive Neuroendocrine Tumors"}], "Name": "Everolimus", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004157": "Decreased Immunologic Activity"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT003412": "mTOR Inhibitor Immunosuppressant"}, {"/categories/DBCAT004158": "mTOR Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT004514": "Sirolimus"}]}, "0704040W0": {"Conditions": [{"/indications/DBCOND0047315": "Acetaminophen Overdose"}], "Name": "Acetylcysteine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003463": "Antidote for Acetaminophen Overdose"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000315": "Cysteine"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004189": "Increased Glutathione Concentration"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT004190": "Reduction Activity"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1302010K0": {"Conditions": [{"/indications/DBCOND0023722": "Mild Metabolic acidosis"}, {"/indications/DBCOND0023721": "Moderate Metabolic acidosis"}], "Name": "Lactic Acid", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001522": "Lactates"}, {"/categories/DBCAT004794": "Lactic Acid"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002544": "Organic Acids"}]}, "0905030M0": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}], "Name": "Stannous Fluoride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002594": "Caries Prophylactic Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0408010F0": {"Conditions": [{"/indications/DBCOND0022715": "Akinetic seizures"}, {"/indications/DBCOND0001972": "Burning Mouth Syndrome"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0023239": "Lennox-Gastaut Syndrome (LGS)"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0025419": "Rapid Eye Movement Sleep Disorder"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0031588": "Tardive Dyskinesia"}, {"/indications/DBCOND0082481": "Tremor, Essential"}, {"/indications/DBCOND0024512": "Acute Manic episode"}, {"/indications/DBCOND0022716": "Myoclonic seizures"}, {"/indications/DBCOND0024634": "Refractory absence Seizures"}], "Name": "Clonazepam", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}]}, "0501021H0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0106127": "Complicated Urinary Tract Infections caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0106130": "Ventilator-associated Bacterial Pneumonia caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0106129": "Hospital-acquired bacteral pneumonia caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0106125": "Susceptible Intra-Abdominal Infection caused by suceptible Gram-negative microorganism"}], "Name": "Ceftazidime Pentahydrate", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000867": "Cephaloridine"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "0801050A0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0074386": "Ovarian Cancer Stage III"}], "Name": "Altretamine", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000922": "Triazines"}]}, "0202050M0": {"Conditions": [{"/indications/DBCOND0081526": "Acute Renal Failure (ARF)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Mannitol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT001104": "Diuretics, Osmotic"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000376": "Flavoring Agents"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002460": "i.v. Solutions"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003715": "Kidney Function"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002459": "Solutions Producing Osmotic Diuresis"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT000378": "Sweetening Agents"}]}, "0701011D0": {"Conditions": [{"/indications/DBCOND0035654": "Erectile Dysfunction (ED)"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}], "Name": "Alprostadil", "Categories": [{"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001122": "Fatty Acids, Monounsaturated"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004182": "Genitourinary Arterial Vasodilation"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003720": "Miscellaneous Vasodilatating Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003402": "Prostaglandin E1 Agonist"}, {"/categories/DBCAT004145": "Prostaglandin Receptor Agonists"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT001121": "Prostaglandins E"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004183": "Venous Vasodilation"}]}, "1304000F0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Valerate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1310011P0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0202020D0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}], "Name": "Bumetanide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002450": "High-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000601": "meta-Aminobenzoates"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801030P0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0054528": "Acute Promyelocytic Leukemia (APL)"}, {"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0031545": "Central Nervous System Lymphoma"}, {"/indications/DBCOND0017311": "Choriocarcinoma"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0044732": "Disseminated Sclerosis"}, {"/indications/DBCOND0041407": "Extrauterine Pregnancy"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0028862": "Hydatidiform Mole"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0021713": "Meningeal leukemia"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0066692": "Squamous Cell Carcinoma of Lung"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021721": "Active Pauciarticular juvenile rheumatoid arthritis"}, {"/indications/DBCOND0024723": "Advanced Alibert-Bazin syndrome"}, {"/indications/DBCOND0021719": "Advanced non-Hodgkin lymphoma"}, {"/indications/DBCOND0021724": "Nonleukemic meningeal cancer"}, {"/indications/DBCOND0021726": "Refractory Takayasu arteritis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Methotrexate", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT000855": "Abortifacient Agents, Nonsteroidal"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000974": "Aminopterin"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002290": "Folic Acid Analogues"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004742": "Methotrexate"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000354": "Pterins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1303000F0": {"Conditions": [{"/indications/DBCOND0053691": "Bipolar Affective Disorders"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0028430": "Depression, Involutional"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0021660": "Neurotic depression"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0019903": "Pruritus"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0119119": "Psychotic depressive disorder"}], "Name": "Doxepin Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001120": "Dibenzoxepins"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000835": "Ethers, Cyclic"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0301011E0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0022551": "Nocturnal asthma"}], "Name": "Formoterol Fumarate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}]}, "0410020D0": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}, {"/indications/DBCOND0041559": "Nicotine Withdrawal"}], "Name": "Nicotine Bitartrate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003289": "Cholinergic Nicotinic Agonist"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002182": "Drugs Used in Nicotine Dependence"}, {"/categories/DBCAT001047": "Ganglion Blockers"}, {"/categories/DBCAT000446": "Ganglionic Stimulants"}, {"/categories/DBCAT003631": "Miscellaneous Autonomic Drugs"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT001706": "Nicotine"}, {"/categories/DBCAT001935": "Nicotine, antagonists & inhibitors"}, {"/categories/DBCAT004727": "Nicotine, metabolism"}, {"/categories/DBCAT000445": "Nicotinic Agonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT004978": "Smoking Cessation Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}]}, "0309010S0": {"Conditions": [{"/indications/DBCOND0020938": "Opioid type dependence"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Methadone Hydrochloride", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002316": "Diphenylpropylamine Derivatives"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}]}, "1304000P0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0020815": "Pruritis"}], "Name": "Fluocinonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001250": "Fluocinolone Acetonide"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "0902013S0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "1202010W0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0033683": "Chronic Rhinosinusitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Fluticasone Furoate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000309": "Steroids"}]}, "1001030Q0": {"Conditions": [{"/indications/DBCOND0023446": "Kidney stone formation"}], "Name": "Tiopronin", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT004371": "Cystine Disulfide Reduction"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001455": "Glycine"}, {"/categories/DBCAT001454": "N-substituted Glycines"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT001456": "Peptoids"}, {"/categories/DBCAT003485": "Reducing and Complexing Thiol"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0803042R0": {"Conditions": [{"/indications/DBCOND0043429": "Advanced Prostate Cancer"}], "Name": "Degarelix", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003613": "Gonadotropin-releasing Hormone Antagonists"}, {"/categories/DBCAT001838": "Gonadotropin-Releasing Hormone, antagonists & inhibitors"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0601023W0": {"Conditions": [{"/indications/DBCOND0055384": "Polycystic Ovaries Syndrome"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Metformin Hydrochloride/Pioglitazone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}]}, "0301011X0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Indacaterol Maleate", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000931": "Indenes"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0503010L0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Atazanavir", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004220": "UDP Glucuronosyltransferases Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "1307000K0": {"Conditions": [{"/indications/DBCOND0066347": "External Genital Warts"}, {"/indications/DBCOND0046617": "Perianal Warts"}], "Name": "Podophyllotoxin", "Categories": [{"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000417": "Benzyl Compounds"}, {"/categories/DBCAT004357": "Decreased Mitosis"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT000416": "Lignans"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT001127": "Tetrahydronaphthalenes"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "1001030C0": {"Conditions": [{"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0025558": "Malaria caused by Plasmodium malariae"}, {"/indications/DBCOND0025560": "Malaria caused by Plasmodium ovale"}, {"/indications/DBCOND0022743": "Malaria caused by plasmodium vivax"}, {"/indications/DBCOND0000759": "Porphyria Cutanea Tarda"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}], "Name": "Hydroxychloroquine Sulfate", "Categories": [{"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT001399": "Chloroquine"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "1002020C0": {"Conditions": [{"/indications/DBCOND0026745": "Muscle pains"}, {"/indications/DBCOND0100727": "Arthralgia/joint pain"}, {"/indications/DBCOND0116840": "Flexor spasm"}, {"/indications/DBCOND0020613": "Reversible Spasticity"}, {"/indications/DBCOND0020619": "Severe cerebral origin Spasticity"}, {"/indications/DBCOND0020616": "Severe spinal cord origin Spasticity"}], "Name": "Baclofen", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000424": "Aminobutyrates"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000427": "GABA Agonists"}, {"/categories/DBCAT000430": "GABA-B Receptor Agonists"}, {"/categories/DBCAT003630": "Gaba-derivative Skeletal Muscle Relaxants"}, {"/categories/DBCAT000423": "gamma-Aminobutyric Acid"}, {"/categories/DBCAT003288": "gamma-Aminobutyric Acid-ergic Agonist"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002205": "Muscle Relaxants, Peripherally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}]}, "0908010AR": {"Conditions": [{"/indications/DBCOND0025639": "Gaucher's Disease Type 1"}], "Name": "Eliglustat", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000146": "Gaucher Disease"}, {"/categories/DBCAT003346": "Glucosylceramide Synthase Inhibitor"}, {"/categories/DBCAT004429": "Glucosylceramide Synthase Inhibitors"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "0908010AP": {"Conditions": [{"/indications/DBCOND0060256": "Mucopolysaccharidosis Type IVA"}], "Name": "Elosulfase Alfa", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000168": "Carbon-Oxygen Lyases"}, {"/categories/DBCAT002907": "Chondroitinases and Chondroitin Lyases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003275": "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme"}, {"/categories/DBCAT000169": "Lyases"}, {"/categories/DBCAT000167": "Polysaccharide-Lyases"}, {"/categories/DBCAT000097": "Recombinant Proteins"}, {"/categories/DBCAT002901": "Sulfatases"}]}, "0908010AQ": {"Conditions": [{"/indications/DBCOND0028300": "Fabry's Disease"}], "Name": "Migalastat", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT001528": "Imino Pyranoses"}, {"/categories/DBCAT001529": "Imino Sugars"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "0901030B0": {"Conditions": [{"/indications/DBCOND0112590": "Anemia caused by Zidovudine"}, {"/indications/DBCOND0031070": "Anemias"}], "Name": "Erythropoietin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT004684": "Erythropoietin, genetics"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0401020E0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0021352": "Acute Anxiety"}, {"/indications/DBCOND0106140": "Pyschosomatic disease"}], "Name": "Chlordiazepoxide Hydrochloride", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000912": "Cytosine Nucleotides"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0908010AJ": {"Conditions": [{"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0062614": "Skin Irritation"}], "Name": "Zinc Acetate", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT001338": "Acetic Acid"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "0908010AH": {"Conditions": [{"/indications/DBCOND0042824": "Pompe's Disease"}], "Name": "Alglucosidase Alfa", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004138": "alpha-Glucosidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT001323": "Glucosidases"}, {"/categories/DBCAT001324": "Glycogen Storage Disease Type II"}, {"/categories/DBCAT000166": "Glycoside Hydrolases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003435": "Hydrolytic Lysosomal Glycogen-specific Enzyme"}]}, "0908010AN": {"Conditions": [{"/indications/DBCOND0051091": "Lysosomal Acid Lipase Deficiency"}], "Name": "Sebelipase Alfa", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000189": "Carboxylic Ester Hydrolases"}, {"/categories/DBCAT002075": "Cholesterol Ester Storage Disease, drug therapy"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003538": "Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme"}, {"/categories/DBCAT003539": "Hydrolytic Lysosomal Triacylglycerol-specific Enzyme"}, {"/categories/DBCAT002076": "Wolman Disease, drug therapy"}]}, "0105010A0": {"Conditions": [{"/indications/DBCOND0053683": "Tuberculosis Infection"}], "Name": "Aminosalicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT002242": "Aminosalicylic Acid and Derivatives"}, {"/categories/DBCAT000578": "Aminosalicylic Acids"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}]}, "0908010AM": {"Conditions": [{"/indications/DBCOND0023586": "Infantile-onset Hypophosphatasia"}, {"/indications/DBCOND0023582": "Juvenile-onset Hypophosphatasia"}, {"/indications/DBCOND0023584": "Perinatal-onset Hypophosphatasia"}], "Name": "Asfotase Alfa", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000147": "Enzyme Replacement Therapy"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT001949": "Hypophosphatasia, drug therapy"}, {"/categories/DBCAT000026": "Immunoglobulin Isotypes"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT001744": "Phosphoric Monoester Hydrolases"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000097": "Recombinant Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT003516": "Tissue-nonspecific Alkaline Phosphatase"}]}, "0908010AB": {"Conditions": [{"/indications/DBCOND0020490": "Type 1 Mucopolysaccharidosis"}], "Name": "Laronidase", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT003275": "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme"}]}, "0908010AC": {"Conditions": [{"/indications/DBCOND0025639": "Gaucher's Disease Type 1"}], "Name": "Miglustat", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000146": "Gaucher Disease"}, {"/categories/DBCAT003346": "Glucosylceramide Synthase Inhibitor"}, {"/categories/DBCAT004429": "Glucosylceramide Synthase Inhibitors"}, {"/categories/DBCAT000670": "Glycoside Hydrolase Inhibitors"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT001528": "Imino Pyranoses"}, {"/categories/DBCAT001529": "Imino Sugars"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "0908010AA": {"Conditions": [{"/indications/DBCOND0028300": "Fabry's Disease"}], "Name": "Agalsidase Alfa", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000216": "Galactosidases"}, {"/categories/DBCAT000166": "Glycoside Hydrolases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003279": "Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme"}, {"/categories/DBCAT002886": "Protein Isoforms"}, {"/categories/DBCAT000020": "Proteins"}]}, "0908010AF": {"Conditions": [{"/indications/DBCOND0020963": "Hereditary tyrosinemia type-1"}], "Name": "Nitisinone", "Categories": [{"/categories/DBCAT003331": "4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor"}, {"/categories/DBCAT000778": "4-Hydroxyphenylpyruvate Dioxygenase, antagonists & inhibitors"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004325": "Hydroxyphenylpyruvate Dioxygenase Inhibitors"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "0908010AG": {"Conditions": [{"/indications/DBCOND0002601": "Mucopolysaccharidosis VI"}], "Name": "Galsulfase", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002905": "Arylsulfatases"}, {"/categories/DBCAT000168": "Carbon-Oxygen Lyases"}, {"/categories/DBCAT002907": "Chondroitinases and Chondroitin Lyases"}, {"/categories/DBCAT002906": "Chondroitinsulfatases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003275": "Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme"}, {"/categories/DBCAT000169": "Lyases"}, {"/categories/DBCAT000167": "Polysaccharide-Lyases"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002901": "Sulfatases"}]}, "0908010AD": {"Conditions": [{"/indications/DBCOND0013194": "Hyperammonaemia"}], "Name": "Carglumic Acid", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT002151": "Amino Acids and Derivatives"}, {"/categories/DBCAT000289": "Amino Acids, Acidic"}, {"/categories/DBCAT000288": "Amino Acids, Dicarboxylic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT003702": "Ammonia Detoxicants"}, {"/categories/DBCAT003479": "Carbamoyl Phosphate Synthetase 1 Activator"}, {"/categories/DBCAT004135": "Carbamoyl Phosphate Synthetase 1 Activators"}]}, "0908010AE": {"Conditions": [{"/indications/DBCOND0028300": "Fabry's Disease"}], "Name": "Agalsidase Beta", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000216": "Galactosidases"}, {"/categories/DBCAT000166": "Glycoside Hydrolases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003279": "Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme"}, {"/categories/DBCAT002886": "Protein Isoforms"}, {"/categories/DBCAT000020": "Proteins"}]}, "0212000F0": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0020815": "Pruritis"}], "Name": "Colestyramine", "Categories": [{"/categories/DBCAT000811": "Anion Exchange Resins"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT002340": "Bile Acid Sequestrants"}, {"/categories/DBCAT004184": "Bile-acid Binding Activity"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000810": "Ion Exchange Resins"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001359": "Polystyrenes"}, {"/categories/DBCAT001361": "Styrene"}, {"/categories/DBCAT001362": "Styrenes"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0206010F0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0022215": "Angina attack"}, {"/indications/DBCOND0059462": "Chronic Anal Fissures"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0064285": "Coronary Artery Spasm"}, {"/indications/DBCOND0024761": "Gastroesophageal variceal hemorrhage prophylaxis"}, {"/indications/DBCOND0077899": "Perioperative Hypertension"}, {"/indications/DBCOND0022221": "Esophageal spastic disorders"}], "Name": "Glyceryl Trinitrate", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001096": "Explosive Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "120101060": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0109271": "Anaerobic Infection"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000922": "Balantidiasis"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0115192": "CNS Infection"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0046593": "Intraabdominal Infections"}, {"/indications/DBCOND0068891": "Lower Respiratory Infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0117815": "Parasitic infection NOS"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0000880": "Pouchitis"}, {"/indications/DBCOND0024985": "Septicemia bacterial anaerobic"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0024983": "Asymptomatic Trichomoniasis"}, {"/indications/DBCOND0020657": "Entamoeba histolytica"}, {"/indications/DBCOND0025546": "Hepatic abscess"}, {"/indications/DBCOND0024987": "Refractory Sinusitis"}, {"/indications/DBCOND0024984": "Symptomatic Trichomoniasis"}], "Name": "Metronidazole", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0602010V0": {"Conditions": [{"/indications/DBCOND0009036": "Hypothyroidism"}, {"/indications/DBCOND0020856": "Myxedema coma"}, {"/indications/DBCOND0020853": "Euthyroid Goitre"}, {"/indications/DBCOND0021309": "Thyrotropin dependent Thyroid cancer"}], "Name": "Levothyroxine Sodium", "Categories": [{"/categories/DBCAT004965": "Agents used to treat hypothyroidism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}]}, "0106040L0": {"Conditions": [{"/indications/DBCOND0024161": "Convulsions"}, {"/indications/DBCOND0015901": "Hypomagnesaemia"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0022086": "Barium poisoning"}, {"/indications/DBCOND0022085": "Severe Exacerbation of asthma"}], "Name": "Magnesium Sulfate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003301": "Paramagnetic Contrast Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002361": "Tests for Bile Duct Patency"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0409010I0": {"Conditions": [{"/indications/DBCOND0025481": "Paralysis agitans"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0022953": "Postencephalitic parkinsonism"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0022956": "Advanced Motor fluctuations"}], "Name": "Levodopa", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000464": "Dihydroxyphenylalanine"}, {"/categories/DBCAT002522": "Dopa and Dopa Derivatives"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004774": "Levodopa, antagonists & inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000465": "Tyrosine"}]}, "0205040M0": {"Conditions": [{"/indications/DBCOND0031696": "Micturition Disorder"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0001412": "Urinary Retention"}], "Name": "Phenoxybenzamine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT001810": "Phenoxybenzamine"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0902022K0": {"Conditions": [{"/indications/DBCOND0015822": "Hypovolaemia"}], "Name": "Hetastarch", "Categories": [{"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001054": "Biomimetic Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002592": "Blood and Related Products"}, {"/categories/DBCAT001950": "Blood Substitutes"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT002591": "Blood Substitutes and Plasma Protein Fractions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT004980": "Dietary Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT001022": "Glucans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004214": "Increased Intravascular Volume"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT001951": "Plasma Substitutes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT001021": "Starch"}]}, "1201030U0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0068622": "Hypertrophic Obstructive Cardiomyopathy"}, {"/indications/DBCOND0022418": "Ethylene glycol overdose"}, {"/indications/DBCOND0022419": "Fat occlusion in central venous catheter"}, {"/indications/DBCOND0022421": "Methanol overdose"}], "Name": "Ethanol", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004495": "Cytochrome P-450 CYP2E1 Inducers (moderate)"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000273": "Ethanol"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002481": "Nerve Depressants"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT001183": "Solvents"}]}, "1306010AB": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin/Tretinoin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "1306010AA": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin/Hydrocortisone", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0301040J0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Sulfate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0604012T0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}], "Name": "Norethisterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002454": "Estren Derivatives"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004982": "Norethindrone"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0503050B0": {"Conditions": [{"/indications/DBCOND0057091": "Chronic Hepatitis C Virus (HCV) Infection"}, {"/indications/DBCOND0046343": "Severe Respiratory Syncytial Virus Infection"}], "Name": "Ribavirin", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003306": "Nucleoside Analog Antiviral"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1203040T0": {"Conditions": [{"/indications/DBCOND0004938": "Hyperuricemia"}, {"/indications/DBCOND0068288": "Primary Gout"}, {"/indications/DBCOND0118354": "Recurrent calcium oxalate calculi"}, {"/indications/DBCOND0118353": "Secondary gout"}, {"/indications/DBCOND0089461": "Calcium oxalate calculi Renal Calculi"}], "Name": "Allopurinol", "Categories": [{"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002374": "Preparations Inhibiting Uric Acid Production"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT001241": "Uricosuric Agents"}, {"/categories/DBCAT002773": "Xanthine Oxidase Inhibitors"}]}, "0501012D0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0014196": "Pneumonia"}], "Name": "Cloxacillin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT002294": "Beta-Lactamase Resistant Penicillins"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000701": "Oxacillin"}, {"/categories/DBCAT003750": "Penicillinase-resistant Penicillins"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0202010L0": {"Conditions": [{"/indications/DBCOND0001374": "Acidosis, Renal Tubular"}, {"/indications/DBCOND0036164": "Calcium Nephrolithiasis"}, {"/indications/DBCOND0056665": "Cirrhosis of the Liver"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0029023": "Diabetes Insipidus"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0086660": "Hypertension,Essential"}, {"/indications/DBCOND0106208": "Hypokalemia caused by diuretics"}, {"/indications/DBCOND0022593": "Premenstrual tension with edema"}, {"/indications/DBCOND0015831": "Sodium retention"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0022495": "Prophylaxis of preeclampsia"}], "Name": "Hydrochlorothiazide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001224": "Chlorothiazide"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "1203010C0": {"Conditions": [{"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0033077": "Mouth Ulcers"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}, {"/indications/DBCOND0024463": "Teething pain"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0050555": "Tooth Pain"}, {"/indications/DBCOND0022739": "Pruritic dermatosis"}], "Name": "Benzocaine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT004767": "Benzocaine"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002455": "Esters of Aminobenzoic Acid"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0604020C0": {"Conditions": [{"/indications/DBCOND0031762": "Androgenetic Alopecia"}, {"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0106237": "Symptomatic Benign Prostatic Hyperplasia"}], "Name": "Finasteride", "Categories": [{"/categories/DBCAT001276": "5-alpha Reductase Inhibitors"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001274": "Azasteroids"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "100302020": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0501050B0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0021543": "Acute maxillary sinusitis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0022692": "Duodenal ulcer caused by helicobacter pylori"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0027964": "Lyme Disease"}, {"/indications/DBCOND0042605": "Mycobacterial Infection"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Clarithromycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003637": "Other Macrolides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0602020N0": {"Conditions": [{"/indications/DBCOND0009048": "Hyperthyroidism"}, {"/indications/DBCOND0009047": "Thyrotoxic crisis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}], "Name": "Propylthiouracil", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT004964": "Antithyroid agents"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT000964": "Thiouracil"}, {"/categories/DBCAT002406": "Thiouracils"}, {"/categories/DBCAT003370": "Thyroid Hormone Synthesis Inhibitor"}, {"/categories/DBCAT004343": "Thyroid Hormone Synthesis Inhibitors"}, {"/categories/DBCAT002707": "Thyroid Products"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "0607020C0": {"Conditions": [{"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0032889": "Fibrocystic Disease of Breast"}, {"/indications/DBCOND0032173": "Hereditary Angioedema"}, {"/indications/DBCOND0021524": "Refractory immune thrombocytopenia"}], "Name": "Danazol", "Categories": [{"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT002530": "Antigonadotropins and Similar Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0409030B0": {"Conditions": [{"/indications/DBCOND0001075": "Blepharospasm"}, {"/indications/DBCOND0031445": "Cervical Dystonia"}, {"/indications/DBCOND0042084": "Chronic Migraine"}, {"/indications/DBCOND0025134": "Equinus deformity of foot, acquired"}, {"/indications/DBCOND0067369": "Lower Limb Spasticity"}, {"/indications/DBCOND0001979": "Sialorrhea"}, {"/indications/DBCOND0009706": "Strabismus"}, {"/indications/DBCOND0036871": "Upper Limb Spasticity"}, {"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}, {"/indications/DBCOND0030460": "Urinary Incontinence (UI)"}, {"/indications/DBCOND0020477": "Detrusor overactivity, neurologic conditions"}, {"/indications/DBCOND0020482": "Hypertonicity disorders of the 7th nerve"}, {"/indications/DBCOND0020469": "Severe axillary hyperhidrosis"}], "Name": "Botulinum Toxin Type A", "Categories": [{"/categories/DBCAT000130": "Acetylcholine Release Inhibitors"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000186": "Bacterial Proteins"}, {"/categories/DBCAT000184": "Bacterial Toxins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000183": "Botulinum Toxins"}, {"/categories/DBCAT004699": "Botulinum Toxins, Type A"}, {"/categories/DBCAT004698": "Botulinum Toxins, Type A, antagonists & inhibitors"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000068": "Endopeptidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT001047": "Ganglion Blockers"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000140": "Metalloendopeptidases"}, {"/categories/DBCAT000141": "Metalloproteases"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002205": "Muscle Relaxants, Peripherally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT000125": "Neurotoxins"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000069": "Peptide Hydrolases"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000185": "Toxins, Biological"}]}, "0905030G0": {"Conditions": [{"/indications/DBCOND0037297": "Dental Decay"}, {"/indications/DBCOND0031213": "Dental Health"}], "Name": "Sodium Fluoride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT002594": "Caries Prophylactic Agents"}, {"/categories/DBCAT001982": "Cariostatic Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001983": "Fluorides"}, {"/categories/DBCAT001985": "Fluorine Compounds"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003782": "Mouthwashes and Gargles"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0906060Q0": {"Conditions": [{"/indications/DBCOND0002700": "Hypoprothrombinemias"}, {"/indications/DBCOND0022633": "Hemorrhagic disease of the newborn"}], "Name": "Phytomenadione", "Categories": [{"/categories/DBCAT000387": "Antifibrinolytic Agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000381": "Diterpenes"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT004197": "Increased Prothrombin Activity"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000382": "Naphthoquinones"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000380": "Phytol"}, {"/categories/DBCAT000386": "Quinones"}, {"/categories/DBCAT004198": "Reversed Anticoagulation Activity"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000379": "Vitamin K"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}, {"/categories/DBCAT003557": "Warfarin Reversal Agent"}]}, "1201010G0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0905022W0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Sucroferric Oxyhydroxide", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000795": "Disaccharides"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000753": "Ferric Compounds"}, {"/categories/DBCAT005021": "Glucaric Acid"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT002587": "Iron Trivalent, Oral Preparations"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003555": "Parenteral Iron Replacement"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000971": "Sugar Acids"}]}, "0106020A0": {"Conditions": [{"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0102992": "Contact dermatitis and other eczema"}, {"/indications/DBCOND0057011": "Dermatitis, Eczematous"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0005735": "Intertrigo"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0093819": "Moniliasis"}, {"/indications/DBCOND0088936": "Nummular Dermatitis"}, {"/indications/DBCOND0005710": "Pruritus Ani"}, {"/indications/DBCOND0014093": "Pyoderma"}, {"/indications/DBCOND0019955": "Stasis dermatitis"}, {"/indications/DBCOND0102993": "Ance"}, {"/indications/DBCOND0093820": "Disseminated Neurodermatitis"}, {"/indications/DBCOND0096746": "Genital pruritus"}, {"/indications/DBCOND0093821": "Localized Neurodermatitis"}], "Name": "Aloes", "Categories": []}, "1001022G0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0606020C0": {"Conditions": [{"/indications/DBCOND0030189": "Paget's Disease of Bone"}, {"/indications/DBCOND0022729": "Heterotropic ossification"}], "Name": "Etidronate Disodium", "Categories": [{"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}]}, "1305020D0": {"Conditions": [{"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}], "Name": "Calcipotriol", "Categories": [{"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002153": "Antipsoriatics for Topical Use"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0801040D0": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0065857": "Advanced Hodgkin's Lymphoma"}, {"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0040920": "Gestational Trophoblastic Disease"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0022309": "Merkel cell cancer"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0034799": "Neuroendocrine Tumours"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0062462": "Prostate Cancer"}, {"/indications/DBCOND0001198": "Retinoblastoma"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0021654": "Wilms' tumor"}, {"/indications/DBCOND0025301": "Locally advanced Thymoma"}, {"/indications/DBCOND0111896": "Metastatic Thymic Cancer"}, {"/indications/DBCOND0022305": "Refractory Sarcoma"}, {"/indications/DBCOND0021498": "Refractory Testicular cancer"}], "Name": "Etoposide", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000417": "Benzyl Compounds"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004492": "Cytochrome P-450 CYP3A5 Inducers (weak)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000871": "Glucosides"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000416": "Lignans"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001126": "Podophyllotoxin"}, {"/categories/DBCAT002380": "Podophyllotoxin Derivatives"}, {"/categories/DBCAT001127": "Tetrahydronaphthalenes"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1501042E0": {"Conditions": [{"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0029481": "Cystoid Macular Edema"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056180": "Ocular Itching"}, {"/indications/DBCOND0054268": "Ocular Pain"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0050988": "Pseudophakic Cystoid Macular Edema"}, {"/indications/DBCOND0021335": "Acute Pericarditis"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0021338": "Chronic aphakic cystoid macular edema"}, {"/indications/DBCOND0021341": "Intraoperative miosis"}, {"/indications/DBCOND0106137": "Postoperative ocular pain"}], "Name": "Ketorolac Trometamol", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002676": "Tromethamine"}]}, "0208020V0": {"Conditions": [{"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0077405": "Systemic Embolism"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0034329": "Thrombosis, Venous"}, {"/indications/DBCOND0022152": "Transient ischemia attacks"}], "Name": "Warfarin Sodium", "Categories": [{"/categories/DBCAT000640": "4-Hydroxycoumarins"}, {"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000641": "Coumarins"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT004675": "Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT003039": "Cytochrome P-450 CYP2C9 Inducers (weak)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT001065": "Rodenticides"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT002267": "Vitamin K Antagonists"}, {"/categories/DBCAT004164": "Vitamin K Inhibitors"}]}, "1001022U0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0406000R0": {"Conditions": [{"/indications/DBCOND0021397": "Refractory Nausea and vomiting"}], "Name": "Nabilone", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002709": "Cannabinoids and similars"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003691": "Miscellaneous Antiemetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0403030E0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0052289": "Anorexia Nervosa (AN)"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0003367": "Cataplexy"}, {"/indications/DBCOND0030402": "Depression, Bipolar"}, {"/indications/DBCOND0029248": "Depressive Disorders"}, {"/indications/DBCOND0017788": "Myoclonus"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0005024": "Premenstrual Dysphoric Disorder"}], "Name": "Fluoxetine Hydrochloride", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0107010S0": {"Conditions": [{"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0011120": "Gastritis"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0031004": "Indigestion"}, {"/indications/DBCOND0000885": "Mucositis"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0021007": "Active Duodenal ulcer"}], "Name": "Sucralfate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002569": "Aluminium Compounds"}, {"/categories/DBCAT003337": "Aluminum Complex"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003672": "Protectants"}, {"/categories/DBCAT000794": "Sucrose"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000796": "Thioglycosides"}]}, "110301030": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0025366": "Bacterial Urinary Tract Infections"}, {"/indications/DBCOND0013258": "Biliary tract infection bacterial"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0014247": "Genital infection"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0079683": "Respiratory Tract Infection Bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0047720": "Surgical Site Infections"}, {"/indications/DBCOND0025511": "Catheter related bloodstream infections"}], "Name": "Cefazolin Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT002385": "First-Generation Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0205051U0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0041982": "Left Ventricular Systolic Dysfunction"}], "Name": "Trandolapril", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0307000U0": {"Conditions": [{"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}], "Name": "Tezacaftor/Ivacaftor", "Categories": [{"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT001989": "Dioxoles"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}]}, "0403040W0": {"Conditions": [{"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0033074": "Social Anxiety Disorder (SAD)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}], "Name": "Venlafaxine", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000474": "Cyclohexanols"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000476": "Fatty Alcohols"}, {"/categories/DBCAT000475": "Hexanols"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002715": "Serotonin and Noradrenaline Reuptake Inhibitors"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0801030C0": {"Conditions": [{"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0071861": "Cutaneous T-Cell Lymphoma (CTCL)"}, {"/indications/DBCOND0046776": "Hairy Cell Leukemia (HCL)"}, {"/indications/DBCOND0113960": "Active confirmed by clinical features, confirmed by imaging features relapsing multiple sclerosis (MS)"}, {"/indications/DBCOND0099171": "Non-Hodgkin\u2019s lymphoma"}], "Name": "Cladribine", "Categories": [{"/categories/DBCAT000595": "2-Chloroadenosine"}, {"/categories/DBCAT000251": "Adenosine"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000596": "Deoxyadenosines"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002249": "Purine Analogues"}, {"/categories/DBCAT003303": "Purine Antimetabolite"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}]}, "0304020AA": {"Conditions": [{"/indications/DBCOND0078144": "Severe Eosinophilic Asthma"}], "Name": "Benralizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT004467": "Interleukin 5 Receptor alpha-directed Antibody Interactions"}, {"/categories/DBCAT003992": "Interleukin-5 Receptor alpha-directed Cytolytic Antibody"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "1313080S0": {"Conditions": [{"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0011120": "Gastritis"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0031004": "Indigestion"}, {"/indications/DBCOND0000885": "Mucositis"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0021007": "Active Duodenal ulcer"}], "Name": "Sucralfate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002569": "Aluminium Compounds"}, {"/categories/DBCAT003337": "Aluminum Complex"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003672": "Protectants"}, {"/categories/DBCAT000794": "Sucrose"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000796": "Thioglycosides"}]}, "0213000F0": {"Conditions": [{"/indications/DBCOND0046998": "Varices, Esophageal"}], "Name": "Ethanolamine Oleate", "Categories": [{"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001122": "Fatty Acids, Monounsaturated"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1310011K0": {"Conditions": [{"/indications/DBCOND0057796": "Second Degree Burns"}, {"/indications/DBCOND0060065": "Third Degree Burns"}], "Name": "Mafenide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0202030W0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0021067": "Idiopathic Edema"}], "Name": "Triamterene", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004229": "Decreased Renal K+ Excretion"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000817": "Epithelial Sodium Channel Blockers"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002346": "Potassium-Sparing Agents"}, {"/categories/DBCAT002702": "Potassium-Sparing Diuretics"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}]}, "0107020P0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0026236": "Corneal injuries"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0009942": "Cyclitis"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}, {"/indications/DBCOND0076158": "Herpes Zoster Keratitis"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027895": "Pneumonia, Aspiration"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0030946": "Rejection, Transplant"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0073800": "Secondary Adrenal Insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0022388": "Superficial punctate keratitis"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0024958": "Idiopathic Bronchiolitis obliterans with organizing pneumonia"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021956": "Primary adrenocoritical insufficiency"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0024953": "Severe Seborrhoeic dermatitis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0101010B0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0023344": "Sour stomach"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Almasilate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT001374": "Silicic Acid"}, {"/categories/DBCAT001377": "Silicon Compounds"}, {"/categories/DBCAT001375": "Silicon Dioxide"}]}, "1502010I0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1203030B0": {"Conditions": [{"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0033077": "Mouth Ulcers"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}, {"/indications/DBCOND0024463": "Teething pain"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0050555": "Tooth Pain"}, {"/indications/DBCOND0022739": "Pruritic dermatosis"}], "Name": "Benzocaine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT004767": "Benzocaine"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002455": "Esters of Aminobenzoic Acid"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1103010W0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0024177": "Entamoebic histolytica infection"}, {"/indications/DBCOND0026355": "Escherichia infections"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0032133": "Klebsiella Infections"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0051354": "Neisseria Gonorrhoeae Infection"}, {"/indications/DBCOND0024179": "Ornithosis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0089467": "Skin infection caused by Staphylococcus aureus"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0025276": "Bacterial upper respiratory tract infections"}, {"/indications/DBCOND0024183": "Clostridia infections"}], "Name": "Tetracycline Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004752": "Tetracycline, antagonists & inhibitors"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0902011P0": {"Conditions": [{"/indications/DBCOND0003949": "Hyperkalemia"}], "Name": "Sodium Polystyrene Sulfonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001337": "Cation Exchange Resins"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000810": "Ion Exchange Resins"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT004573": "Polystyrene Sulfonates"}, {"/categories/DBCAT003568": "Potassium Binder"}, {"/categories/DBCAT004335": "Potassium Ion Exchange Activity"}, {"/categories/DBCAT003761": "Potassium-removing Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT001361": "Styrene"}, {"/categories/DBCAT001362": "Styrenes"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0107020B0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0407020Z0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0112013": "Chronic, moderate Pain"}], "Name": "Oxycodone", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000929": "Codeine"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0105020F0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0026236": "Corneal injuries"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0009942": "Cyclitis"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}, {"/indications/DBCOND0076158": "Herpes Zoster Keratitis"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027895": "Pneumonia, Aspiration"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0030946": "Rejection, Transplant"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0073800": "Secondary Adrenal Insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0022388": "Superficial punctate keratitis"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0024958": "Idiopathic Bronchiolitis obliterans with organizing pneumonia"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021956": "Primary adrenocoritical insufficiency"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0024953": "Severe Seborrhoeic dermatitis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0402020Z0": {"Conditions": [{"/indications/DBCOND0040804": "Acute Exacerbation of Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Zuclopenthixol Decanoate", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002478": "Thioxanthene Derivatives"}, {"/categories/DBCAT001167": "Thioxanthenes"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "0801050P0": {"Conditions": [{"/indications/DBCOND0048758": "Essential Thrombocythemia (ET)"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0034131": "Hypereosinophilic Syndromes"}, {"/indications/DBCOND0020306": "Melanoma"}, {"/indications/DBCOND0038150": "Meningiomas"}, {"/indications/DBCOND0068543": "Ovarian Cancer Metastatic"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0051876": "Sickle Cell Disorders"}, {"/indications/DBCOND0112023": "Chronic, refractory Myeloid Leukemia"}, {"/indications/DBCOND0025356": "Inoperable Ovarian cancer"}], "Name": "Hydroxycarbamide", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001227": "Antisickling Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000635": "Urea"}]}, "0303010J0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0080546": "Itching of the eye"}], "Name": "Nedocromil Sodium", "Categories": [{"/categories/DBCAT001093": "4-Quinolones"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1108030P0": {"Conditions": [{"/indications/DBCOND0025076": "Acute radiation sickness"}], "Name": "Potassium Iodide", "Categories": [{"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT004964": "Antithyroid agents"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT001845": "Iodides"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT004827": "Potassium Iodide"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0408010W0": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0034367": "Bipolar Disorder (BD)"}, {"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0031292": "Seizure, Absence"}, {"/indications/DBCOND0119337": "Seizure, multiple types"}, {"/indications/DBCOND0024512": "Acute Manic episode"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Sodium Valproate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002301": "Fatty Acid Derivatives"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT001486": "Histone Deacetylase Inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003983": "OAT3/SLC22A8 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT000731": "Pentanoic Acids"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004612": "UGT1A3 substrates with narrow therapeutic index"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT004531": "UGT1A6 substrate with narrow therapeutic index"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004544": "UGT1A9 substrates with narrow therapeutic index"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT004613": "UGT2B7 substrates with narrow therapeutic index"}, {"/categories/DBCAT000732": "Valerates"}]}, "0503032A0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}], "Name": "Boceprevir", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004187": "Cytochrome P450 3A5 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004186": "HCV NS3/4A Protease Inhibitors"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT000388": "Imino Acids"}, {"/categories/DBCAT002768": "NS3/4A Protease Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0107010AB": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}], "Name": "Isosorbide Mononitrate", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001173": "Isosorbide"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000756": "Nitric Oxide Donors"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT000647": "Sorbitol"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}]}, "0107010AA": {"Conditions": [{"/indications/DBCOND0031732": "Anal Fissures"}, {"/indications/DBCOND0000553": "Angina Pectoris, Variant"}, {"/indications/DBCOND0066917": "Anginal Pain"}, {"/indications/DBCOND0000496": "Atrial Flutter"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0062051": "Idiopathic Dilated Cardiomyopathy"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0051788": "Pulmonary Hypertension (PH)"}, {"/indications/DBCOND0093960": "Leg cramps"}, {"/indications/DBCOND0024302": "Prophylaxis of migraine headaches"}], "Name": "Diltiazem Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT002326": "Benzothiazepine Derivatives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003976": "Calcium Channel Blockers (Nondihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003669": "Miscellaneous Calcium-channel Blocking Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002327": "Selective Calcium Channel Blockers With Direct Cardiac Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0702020X0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0109271": "Anaerobic Infection"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000922": "Balantidiasis"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0115192": "CNS Infection"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0046593": "Intraabdominal Infections"}, {"/indications/DBCOND0068891": "Lower Respiratory Infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0117815": "Parasitic infection NOS"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0000880": "Pouchitis"}, {"/indications/DBCOND0024985": "Septicemia bacterial anaerobic"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0024983": "Asymptomatic Trichomoniasis"}, {"/indications/DBCOND0020657": "Entamoeba histolytica"}, {"/indications/DBCOND0025546": "Hepatic abscess"}, {"/indications/DBCOND0024987": "Refractory Sinusitis"}, {"/indications/DBCOND0024984": "Symptomatic Trichomoniasis"}], "Name": "Metronidazole", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0202080D0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}], "Name": "Bumetanide/Amiloride Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002450": "High-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000601": "meta-Aminobenzoates"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1202030C0": {"Conditions": [{"/indications/DBCOND0106393": "Infective otitis externa"}], "Name": "Chlorobutanol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT002059": "Butanols"}, {"/categories/DBCAT000462": "Chlorohydrins"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000476": "Fatty Alcohols"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT002031": "Preservatives, Pharmaceutical"}]}, "0803020Q0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}], "Name": "Norethisterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002454": "Estren Derivatives"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004982": "Norethindrone"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0402020T0": {"Conditions": [{"/indications/DBCOND0033851": "Aggressive Behavior"}, {"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0003735": "Delirium"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0053941": "Huntington's Disease (HD)"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0051503": "Psychotic Disorder NOS"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0021429": "Severe Hyperactivity"}, {"/indications/DBCOND0021428": "Severe disruptive behaviour disorder"}], "Name": "Haloperidol Decanoate", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002383": "Butyrophenone Derivatives"}, {"/categories/DBCAT000878": "Butyrophenones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0408010A0": {"Conditions": [{"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0022716": "Myoclonic seizures"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Levetiracetam", "Categories": [{"/categories/DBCAT000493": "Acetamides"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000278": "Nootropic Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0501021K0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0027964": "Lyme Disease"}, {"/indications/DBCOND0000354": "Maxillary Sinusitis"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0022787": "Mild Streptococcal pharyngitis"}, {"/indications/DBCOND0022789": "Mild Streptococcal tonsillitis"}, {"/indications/DBCOND0022786": "Moderate Streptococcal pharyngitis"}, {"/indications/DBCOND0022788": "Moderate Streptococcal tonsillitis"}], "Name": "Cefuroxime Axetil", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "1310020Q0": {"Conditions": [{"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0073150": "Tinea Unguium"}, {"/indications/DBCOND0014329": "Tinea barbae"}], "Name": "Griseofulvin", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002359": "Antifungals for Systemic Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004357": "Decreased Mitosis"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004205": "Microtubule Inhibition"}, {"/categories/DBCAT003343": "Tubulin Inhibiting Agent"}]}, "1304000G0": {"Conditions": [{"/indications/DBCOND0025365": "Mild Plaque psoriasis"}, {"/indications/DBCOND0025364": "Moderate Dermatosis"}, {"/indications/DBCOND0020390": "Moderate Plaque psoriasis"}, {"/indications/DBCOND0025363": "Severe Dermatosis"}], "Name": "Clobetasol Propionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "0702020F0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0024299": "Fungal infection of the dermal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0043009": "Ringworm"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0112599": "Symptomatic Tinea Corporis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112597": "Symptomatic Tinea Cruris caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112595": "Symptomatic Tinea Pedis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}], "Name": "Clotrimazole", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004500": "Cytochrome P-450 CYP3A7 Inducers (strong)"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003934": "OATP1B3 inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0701011E0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0020934": "Tendinitis"}], "Name": "Indometacin", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1302020G0": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Paste", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "0211000Y0": {"Conditions": [{"/indications/DBCOND0089512": "Bleeding caused by Hemophilia A"}, {"/indications/DBCOND0089514": "Bleeding caused by Hemophilia B"}, {"/indications/DBCOND0089513": "Perioperative bleeding caused by Hemophilia A"}, {"/indications/DBCOND0089515": "Perioperative bleeding caused by Hemophilia B"}], "Name": "Factor VIII Inhibitor Bypassing Fraction", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT004198": "Reversed Anticoagulation Activity"}]}, "0203020M0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride Anhydrous", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0603020M0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0042226": "Ocular Irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}], "Name": "Hydrocortisone Sodium Succinate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0409010X0": {"Conditions": [{"/indications/DBCOND0025481": "Paralysis agitans"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0022953": "Postencephalitic parkinsonism"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0022956": "Advanced Motor fluctuations"}], "Name": "Levodopa/Carbidopa/Entacapone", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000464": "Dihydroxyphenylalanine"}, {"/categories/DBCAT002522": "Dopa and Dopa Derivatives"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004774": "Levodopa, antagonists & inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000465": "Tyrosine"}]}, "0102000Y0": {"Conditions": [{"/indications/DBCOND0031662": "Peptic Ulcers"}], "Name": "Propantheline Bromide", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "100101070": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0021344": "Backache"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0020934": "Tendinitis"}, {"/indications/DBCOND0001908": "Toothache"}], "Name": "Naproxen Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001137": "Naphthaleneacetic Acids"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1304000Q0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0042226": "Ocular Irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}], "Name": "Hydrocortisone Sodium Succinate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0203020C0": {"Conditions": [{"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0039281": "Pulmonary Arterial Hypertension (PAH)"}, {"/indications/DBCOND0022044": "SVT"}, {"/indications/DBCOND0029078": "Tachycardia, Supraventricular"}], "Name": "Adenosine", "Categories": [{"/categories/DBCAT000251": "Adenosine"}, {"/categories/DBCAT004746": "Adenosine, antagonists & inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003707": "Antiarrhythmics, Class V"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003978": "Class IV Antiarrythmics"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003708": "Miscellaneous Cardiac Drugs"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000142": "Oxidoreductases"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT001024": "Purinergic Agonists"}, {"/categories/DBCAT001025": "Purinergic P1 Receptor Agonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1202010T0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0103010N0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0021852": "Esophagitis"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0074522": "Stress Ulcers"}], "Name": "Nizatidine", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0503031A0": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}], "Name": "Adefovir Dipivoxil", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "0408010AD": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Zonisamide", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0408010AG": {"Conditions": [{"/indications/DBCOND0056599": "Dravet Syndrome"}], "Name": "Stiripentol", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001989": "Dioxoles"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}]}, "0408010AF": {"Conditions": [{"/indications/DBCOND0023239": "Lennox-Gastaut Syndrome (LGS)"}], "Name": "Rufinamide", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002411": "Carboxamide Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0408010AA": {"Conditions": [{"/indications/DBCOND0040955": "Refractory Partial Seizures"}, {"/indications/DBCOND0025330": "Refractory Lennox-Gastaut syndrome"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Felbamate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT000848": "Phenylcarbamates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0408010AB": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Tiagabine", "Categories": [{"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT002301": "Fatty Acid Derivatives"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT004989": "GABA Uptake Inhibitors"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004988": "Nipecotic Acids"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0801050BS": {"Conditions": [{"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0071979": "Mantle Cell Lymphoma (MCL)"}, {"/indications/DBCOND0092565": "Waldenstr\u00f6m's Macroglobulinemia (WM)"}], "Name": "Ibrutinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BR": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0023951": "Progressive, metastatic Medullary thyroid cancer"}], "Name": "Cabozantinib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001758": "Receptor Protein-Tyrosine Kinases, antagonists & inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BQ": {"Conditions": [{"/indications/DBCOND0024826": "Accelerated phase chronic myologenic leukemia"}, {"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0057382": "Chronic Phase Chronic Myeloid Leukemia"}, {"/indications/DBCOND0025342": "Blast phase Chronic myelocytic leukemia"}], "Name": "Ponatinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BP": {"Conditions": [{"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0023505": "Refractory, metastatic squamous cell Non-small cell lung cancer"}], "Name": "Afatinib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BW": {"Conditions": [{"/indications/DBCOND0028542": "Refractory Multiple Myeloma"}], "Name": "Panobinostat", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001486": "Histone Deacetylase Inhibitors"}, {"/categories/DBCAT001106": "Hydroxamic Acids"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000393": "Hydroxylamines"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0408010AH": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Lacosamide", "Categories": [{"/categories/DBCAT000493": "Acetamides"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0801050BU": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}], "Name": "Asparaginase", "Categories": [{"/categories/DBCAT000093": "Amidohydrolases"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT004271": "Asparaginase"}, {"/categories/DBCAT003249": "Asparagine-specific Enzyme"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT004603": "Thyroxine-binding globulin inhibitors"}]}, "0408010AJ": {"Conditions": [{"/indications/DBCOND0036956": "Refractory Partial Onset Seizures"}], "Name": "Retigabine", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000286": "Diamines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT003451": "Potassium Channel Opener"}, {"/categories/DBCAT004293": "Potassium Channel Openers"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0801050BK": {"Conditions": [{"/indications/DBCOND0017409": "Inflammatory carcinoma of the breast"}, {"/indications/DBCOND0034432": "Locally Advanced Breast Cancer (LABC)"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0059537": "Stage I Breast Carcinoma"}], "Name": "Pertuzumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT001793": "Breast Neoplasms"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT003268": "HER2 Receptor Antagonist"}, {"/categories/DBCAT004073": "HER2/Neu/cerbB2 Antagonists"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT001652": "Receptor, ErbB-2, antagonists & inhibitors"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0504010X0": {"Conditions": [{"/indications/DBCOND0021343": "Malaria caused by Plasmodium falciparum"}], "Name": "Quinine Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000904": "Cinchona Alkaloids"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002708": "Herbs (Hypotensive Properties)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT002335": "Methanolquinolines"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002394": "Quinine and Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0801050BI": {"Conditions": [{"/indications/DBCOND0054131": "Post Essential Thrombocythemia Myelofibrosis"}, {"/indications/DBCOND0062303": "Post Polycythemia Vera Myelofibrosis"}, {"/indications/DBCOND0023487": "High risk Myelofibrosis"}, {"/indications/DBCOND0023486": "Intermediate risk Myelofibrosis"}, {"/indications/DBCOND0023488": "Refractory Polycythemia vera"}], "Name": "Ruxolitinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001908": "Janus Kinases, antagonists & inhibitors"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BN": {"Conditions": [{"/indications/DBCOND0071940": "Metastatic Gastrointestinal Stromal Tumor"}, {"/indications/DBCOND0023498": "Locally advanced Gastrointestinal stromal tumor"}, {"/indications/DBCOND0023209": "Refractory, metastatic Colorectal cancer"}, {"/indications/DBCOND0021941": "Unresectable Gastrointestinal stromal tumor"}], "Name": "Regorafenib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT000635": "Urea"}]}, "0801050BM": {"Conditions": [{"/indications/DBCOND0062680": "Locally Advanced Basal Cell Carcinoma"}, {"/indications/DBCOND0023470": "Metastatic Basal cell carcinoma"}], "Name": "Vismodegib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003489": "Hedgehog Pathway Inhibitor"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004411": "Smoothened Receptor Antagonists"}]}, "0801050BL": {"Conditions": [{"/indications/DBCOND0025617": "Refractory, accelerated phase Chronic myelogenous leukemia"}, {"/indications/DBCOND0025616": "Refractory, blast phase Chronic myelogenous leukemia"}, {"/indications/DBCOND0025615": "Refractory, chronic phase Chronic myelogenous leukemia"}], "Name": "Bosutinib", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BC": {"Conditions": [{"/indications/DBCOND0032596": "Advanced Renal Cell Carcinoma"}, {"/indications/DBCOND0040978": "Cutaneous Melanoma"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}, {"/indications/DBCOND0112640": "Metastatic MSI-H/dMMR colorectal cancer"}], "Name": "Ipilimumab", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004286": "CTLA-4-directed Antibody Interactions"}, {"/categories/DBCAT003464": "CTLA-4-directed Blocking Antibody"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000025": "Immunoglobulin G"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT004287": "Increased T Lymphocyte Activation"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050BB": {"Conditions": [{"/indications/DBCOND0055525": "Metastatic Liposarcoma"}, {"/indications/DBCOND0023213": "Refractory, metastatic Breast cancer"}, {"/indications/DBCOND0023199": "Unresectable Liposarcoma"}], "Name": "Eribulin", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004205": "Microtubule Inhibition"}, {"/categories/DBCAT002734": "Microtubule Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0801050BA": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}], "Name": "Pegaspargase", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000093": "Amidohydrolases"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT004271": "Asparaginase"}, {"/categories/DBCAT003249": "Asparagine-specific Enzyme"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000159": "Enzymes, Immobilized"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT004603": "Thyroxine-binding globulin inhibitors"}]}, "0801050BG": {"Conditions": [{"/indications/DBCOND0040045": "Metastatic Medullary Thyroid Cancer"}, {"/indications/DBCOND0025580": "Locally advanced Medullary thyroid cancer"}], "Name": "Vandetanib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050BF": {"Conditions": [{"/indications/DBCOND0103406": "Malignant Ascites of the intraperitoneal"}], "Name": "Catumaxomab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050BD": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}, {"/indications/DBCOND0025673": "Refractory Erdheim-Chester disease"}, {"/indications/DBCOND0025672": "Refractory Non-small cell lung cancer"}], "Name": "Vemurafenib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004161": "Cytochrome P450 1A2 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0102000N0": {"Conditions": [{"/indications/DBCOND0026428": "Gastrointestinal spastic and hypermotility disorders"}, {"/indications/DBCOND0025719": "Genitourinary smooth muscle spasm"}], "Name": "Hyoscine Butylbromide", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT002580": "Belladonna Alkaloids, Semisynthetic, Quaternary Ammonium Compounds"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000888": "Scopolamine Derivatives"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0902011L0": {"Conditions": [{"/indications/DBCOND0003949": "Hyperkalemia"}], "Name": "Calcium Polystyrene Sulfonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001337": "Cation Exchange Resins"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000810": "Ion Exchange Resins"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT004573": "Polystyrene Sulfonates"}, {"/categories/DBCAT003568": "Potassium Binder"}, {"/categories/DBCAT004335": "Potassium Ion Exchange Activity"}, {"/categories/DBCAT003761": "Potassium-removing Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT001361": "Styrene"}, {"/categories/DBCAT001362": "Styrenes"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0503010K0": {"Conditions": [{"/indications/DBCOND0054009": "HIV-1-infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}, {"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Emtricitabine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0501014M0": {"Conditions": [{"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0058927": "Complicated Appendicitis"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0053994": "Postpartum Endometritis"}, {"/indications/DBCOND0047720": "Surgical Site Infections"}, {"/indications/DBCOND0080531": "Moderate Bacterial Infections"}, {"/indications/DBCOND0025267": "Moderate Community acquired pneumonia"}, {"/indications/DBCOND0025269": "Moderate Nosocomial pneumonia"}, {"/indications/DBCOND0080530": "Severe Bacterial Infections"}, {"/indications/DBCOND0025268": "Severe Nosocomial pneumonia"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Piperacillin Sodium", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003662": "Extended-spectrum Penicillins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0401020D0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0021352": "Acute Anxiety"}, {"/indications/DBCOND0106140": "Pyschosomatic disease"}], "Name": "Chlordiazepoxide", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000912": "Cytosine Nucleotides"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0601012V0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}, {"/indications/DBCOND0035700": "Hyperglycemias"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Insulin Glargine", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000138": "Insulin, Long-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002121": "Insulins and Analogues for Injection, Long-Acting"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0704050B0": {"Conditions": [{"/indications/DBCOND0035654": "Erectile Dysfunction (ED)"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}], "Name": "Alprostadil", "Categories": [{"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001122": "Fatty Acids, Monounsaturated"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004182": "Genitourinary Arterial Vasodilation"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003720": "Miscellaneous Vasodilatating Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003402": "Prostaglandin E1 Agonist"}, {"/categories/DBCAT004145": "Prostaglandin Receptor Agonists"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT001121": "Prostaglandins E"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004183": "Venous Vasodilation"}]}, "1309000R0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}], "Name": "Sulfur", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT001956": "Chalcogens"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT002550": "Preparations Containing Sulfur"}, {"/categories/DBCAT004849": "Sulfur"}]}, "1310030C0": {"Conditions": [{"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0005172": "Chickenpox"}, {"/indications/DBCOND0003600": "Encephalitis, Herpes Simplex"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0028191": "Herpes Zoster"}, {"/indications/DBCOND0024319": "Herpes simplex of the oral-labial"}, {"/indications/DBCOND0025063": "Herpes simplex type I reactivation"}, {"/indications/DBCOND0049565": "Infections, Cytomegalovirus"}, {"/indications/DBCOND0032971": "Recurrent Genital Herpes (RGH)"}, {"/indications/DBCOND0033308": "Recurrent Herpes Labialis"}, {"/indications/DBCOND0024387": "VZV re-activation"}, {"/indications/DBCOND0022321": "Acute Genital herpes"}, {"/indications/DBCOND0024389": "Acute Herpes labialis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0024381": "Severe Genital herpes"}], "Name": "Aciclovir", "Categories": [{"/categories/DBCAT002686": "Acyclovir and prodrug"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003553": "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0301011F0": {"Conditions": [{"/indications/DBCOND0023007": "Severe COPD exacerbation"}], "Name": "Fenoterol Hydrobromide", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001334": "Metaproterenol"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002477": "Sympathomimetics, Labour Repressants"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "0309020C0": {"Conditions": [{"/indications/DBCOND0028731": "Menopausal Symptoms"}], "Name": "Belladonna & Ipecacuanha", "Categories": [{"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}]}, "1201010T0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0503021E0": {"Conditions": [{"/indications/DBCOND0034712": "Acute Herpes Zoster"}, {"/indications/DBCOND0024317": "Herpes simplex of the genitals"}, {"/indications/DBCOND0024319": "Herpes simplex of the oral-labial"}, {"/indications/DBCOND0024323": "Recurrent Herpes simplex of the genital"}, {"/indications/DBCOND0024321": "Recurrent Herpes simplex of the oral-labial"}], "Name": "Famciclovir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0601012X0": {"Conditions": [{"/indications/DBCOND0022905": "Type 1 Insulin-Dependent Diabetes Mellitus"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Insulin Detemir", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000138": "Insulin, Long-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002121": "Insulins and Analogues for Injection, Long-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "1405000M0": {"Conditions": [{"/indications/DBCOND0093856": "Cytomegalovirus viremia"}], "Name": "Cytomegalovirus Immunoglobulin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003852": "Cytomegalovirus"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT003547": "Human Immunoglobulin G"}, {"/categories/DBCAT002143": "Immune Sera and Immunoglobulins"}, {"/categories/DBCAT001686": "Immunization, Passive"}, {"/categories/DBCAT000025": "Immunoglobulin G"}, {"/categories/DBCAT000026": "Immunoglobulin Isotypes"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT004070": "Passively Acquired Immunity"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002882": "Serum"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002142": "Specific Immunoglobulins"}, {"/categories/DBCAT004071": "Virus Neutralization"}]}, "0401020R0": {"Conditions": [{"/indications/DBCOND0027904": "Anxiety Disorders"}], "Name": "Meprobamate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1305000H0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Coal Tar", "Categories": [{"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003796": "Keratoplastic Agents"}, {"/categories/DBCAT002027": "Tars"}]}, "0601012AB": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}, {"/indications/DBCOND0035700": "Hyperglycemias"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Insulin Glargine/Lixisenatide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000138": "Insulin, Long-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002121": "Insulins and Analogues for Injection, Long-Acting"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1311050U0": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}, {"/indications/DBCOND0001896": "Dental Plaque"}, {"/indications/DBCOND0073735": "Gingival Inflammation"}], "Name": "Triclosan", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT001001": "Fatty Acid Synthesis Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT004833": "Triclosan"}]}, "0801010Y0": {"Conditions": [{"/indications/DBCOND0038690": "Adenocarcinoma of the Ovaries"}, {"/indications/DBCOND0029215": "Breast Adenocarcinoma"}, {"/indications/DBCOND0089350": "Papillary transitional cell carcinoma of bladder"}, {"/indications/DBCOND0024630": "Malignant effusion"}], "Name": "Thiotepa", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001595": "Aziridines"}, {"/categories/DBCAT000711": "Azirines"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002548": "Ethylene Imines"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000952": "Phosphoramides"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001594": "Triethylenephosphoramide"}]}, "0103030S0": {"Conditions": [{"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0011120": "Gastritis"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0031004": "Indigestion"}, {"/indications/DBCOND0000885": "Mucositis"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0021007": "Active Duodenal ulcer"}], "Name": "Sucralfate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002569": "Aluminium Compounds"}, {"/categories/DBCAT003337": "Aluminum Complex"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003672": "Protectants"}, {"/categories/DBCAT000794": "Sucrose"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000796": "Thioglycosides"}]}, "1003020N0": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0023821": "Minor aches"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Methyl Salicylate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT003228": "Betula"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001550": "Fixatives"}, {"/categories/DBCAT003229": "Gaultheria"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT001210": "Plant Preparations"}, {"/categories/DBCAT000579": "Salicylates"}]}, "0801020N0": {"Conditions": [{"/indications/DBCOND0035885": "Breast Cancer Stage II"}, {"/indications/DBCOND0052877": "Breast Cancer Stage III"}], "Name": "Epirubicin Hydrochloride", "Categories": [{"/categories/DBCAT003352": "Anthracycline Topoisomerase Inhibitor"}, {"/categories/DBCAT000874": "Anthracyclines"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000873": "Daunorubicin"}, {"/categories/DBCAT000872": "Doxorubicin"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0704030J0": {"Conditions": [{"/indications/DBCOND0004515": "Heartburn"}], "Name": "Sodium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001532": "Buffers"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT002728": "Citric Acid Derivatives"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT001548": "Food Preservatives"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003770": "Miscellaneous Anticoagulants"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0604012W0": {"Conditions": [{"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Dienogest", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002333": "Pregnadien Derivatives"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT001014": "Testosterone Congeners"}]}, "1201030T0": {"Conditions": [{"/indications/DBCOND0026745": "Muscle pains"}], "Name": "Triethanolamine", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002133": "Cicatrizants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002134": "Preparations for Treatment of Wounds and Ulcers"}]}, "1104010R0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0026236": "Corneal injuries"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0009942": "Cyclitis"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}, {"/indications/DBCOND0076158": "Herpes Zoster Keratitis"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027895": "Pneumonia, Aspiration"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0030946": "Rejection, Transplant"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0073800": "Secondary Adrenal Insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0022388": "Superficial punctate keratitis"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0024958": "Idiopathic Bronchiolitis obliterans with organizing pneumonia"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021956": "Primary adrenocoritical insufficiency"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0024953": "Severe Seborrhoeic dermatitis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisolone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1108020J0": {"Conditions": [{"/indications/DBCOND0074237": "Ocular Hypertension"}, {"/indications/DBCOND0025333": "Postsurgical ocular hypertension"}], "Name": "Apraclonidine", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000977": "Imidazolines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}]}, "0410030C0": {"Conditions": [{"/indications/DBCOND0020938": "Opioid type dependence"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Methadone Hydrochloride", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002316": "Diphenylpropylamine Derivatives"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}]}, "0301040K0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1203040U0": {"Conditions": [{"/indications/DBCOND0001896": "Dental Plaque"}], "Name": "Thymol", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001046": "Monoterpenes"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0409010D0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0022953": "Postencephalitic parkinsonism"}, {"/indications/DBCOND0116226": "Symptomatic Parkinson Disease"}, {"/indications/DBCOND0116841": "Levodopa-driven nausea and vomiting"}], "Name": "Carbidopa", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000471": "Aromatic Amino Acid Decarboxylase Inhibitors"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000469": "Hydrazines"}, {"/categories/DBCAT000420": "Phenols"}]}, "0206020A0": {"Conditions": [{"/indications/DBCOND0066917": "Anginal Pain"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0000554": "Coronary Artery Disease"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0039062": "Vasospastic Angina"}], "Name": "Amlodipine", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT002343": "Calcium Channel Blockers and Diuretics"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "030902010": {"Conditions": [{"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Ammonium Chloride", "Categories": [{"/categories/DBCAT002512": "Acidifiers"}, {"/categories/DBCAT003775": "Acidifying Agents"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0503050A0": {"Conditions": [{"/indications/DBCOND0064246": "Infections, Respiratory Syncytial Virus"}], "Name": "Palivizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004232": "Fusion Protein Inhibitors"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT002143": "Immune Sera and Immunoglobulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003282": "Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002142": "Specific Immunoglobulins"}]}, "0501080W0": {"Conditions": [{"/indications/DBCOND0112604": "Acute Bacterial Exacerbation of Chronic Bronchitis caused by Haemophilus Influenzae, Streptococcus Pneumoniae"}, {"/indications/DBCOND0112610": "Acute Conjunctivitis caused by Staphylococcus epidermidis, Streptococcus Pneumoniae, Streptococcus viridans, Haemophilus Influenzae, Pseudomonas Aeruginosa, Staphylococcus Aureus"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0112611": "Blepharoconjunctivitis caused by Staphylococcus epidermidis, Streptococcus Pneumoniae, Streptococcus viridans, Haemophilus Influenzae, Pseudomonas Aeruginosa, Staphylococcus Aureus"}, {"/indications/DBCOND0112609": "Ocular Infection caused by Staphylococcus epidermidis, Streptococcus Pneumoniae, Streptococcus viridans, Haemophilus Influenzae, Pseudomonas Aeruginosa, Staphylococcus Aureus"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0112607": "Shigellosis caused by Shigella sonnei, Shigella flexneri"}, {"/indications/DBCOND0106134": "Traveler's Diarrhea caused by Enterotoxigenic Escherichia coli"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0112601": "Urinary Tract Infection caused by Klebsiella Species, enterobacter species, Morganella morganii, Proteus mirabilis, Proteus vulgaris, Escherichia Coli"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0112603": "Acute Otitis Media caused by Haemophilus Influenzae, Streptococcus Pneumoniae"}, {"/indications/DBCOND0106131": "Pnuemonia caused by pneumocystis carinii"}], "Name": "Trimethoprim", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002375": "Trimethoprim and Derivatives"}]}, "0604030P0": {"Conditions": [{"/indications/DBCOND0015788": "Amino acid catabolism disorder"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Oxandrolone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT002428": "Anabolic Agents for Systemic Use"}, {"/categories/DBCAT002427": "Anabolic Steroids"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT002426": "Androstan Derivatives"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT001010": "Androstanols"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000309": "Steroids"}]}, "0601011L0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}, {"/indications/DBCOND0043991": "Gestational Diabetes Mellitus (GDM)"}, {"/indications/DBCOND0035700": "Hyperglycemias"}, {"/indications/DBCOND0086184": "Ketoacidosis, Diabetic"}], "Name": "Insulin Lispro", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000135": "Insulin, Short-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002120": "Insulins and Analogues for Injection, Fast-Acting"}, {"/categories/DBCAT002119": "Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "0501050S0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Spiramycin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000789": "Coccidiostats"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT001762": "Leucomycins"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT000497": "Polyketides"}]}, "0803041U0": {"Conditions": [{"/indications/DBCOND0045156": "Desmoid Tumors"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}], "Name": "Toremifene Citrate", "Categories": [{"/categories/DBCAT002405": "Anti-Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003358": "Estrogen Agonist/Antagonist"}, {"/categories/DBCAT000917": "Estrogen Receptor Modulators"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT000618": "Stilbenes"}, {"/categories/DBCAT000916": "Tamoxifen"}]}, "1203020J0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0109271": "Anaerobic Infection"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000922": "Balantidiasis"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0115192": "CNS Infection"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0046593": "Intraabdominal Infections"}, {"/indications/DBCOND0068891": "Lower Respiratory Infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0117815": "Parasitic infection NOS"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0000880": "Pouchitis"}, {"/indications/DBCOND0024985": "Septicemia bacterial anaerobic"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0024983": "Asymptomatic Trichomoniasis"}, {"/indications/DBCOND0020657": "Entamoeba histolytica"}, {"/indications/DBCOND0025546": "Hepatic abscess"}, {"/indications/DBCOND0024987": "Refractory Sinusitis"}, {"/indications/DBCOND0024984": "Symptomatic Trichomoniasis"}], "Name": "Metronidazole", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0604020D0": {"Conditions": [{"/indications/DBCOND0070333": "Advanced Prostate Carcinoma"}, {"/indications/DBCOND0036371": "Metastatic Hormone Refractory Prostate Cancer"}, {"/indications/DBCOND0018486": "Paraphilia"}, {"/indications/DBCOND0077433": "Severe Acne"}], "Name": "Cyproterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT001625": "Cyproterone"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "0905021L0": {"Conditions": [{"/indications/DBCOND0062804": "Acid-Base Imbalance"}, {"/indications/DBCOND0015998": "Acidosis"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0063975": "Drug Poisoning"}, {"/indications/DBCOND0015850": "Electrolyte imbalance"}, {"/indications/DBCOND0023801": "Hypophosphatemia"}, {"/indications/DBCOND0023151": "Minor burns"}, {"/indications/DBCOND0102291": "Severe or persistent diarrhea"}], "Name": "Sodium Dihydrogen Phosphate Dihydrate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003002": "Phosphate salts"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}]}, "0101010S0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Calcium Carbonate & Simeticone", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "1501030D0": {"Conditions": [{"/indications/DBCOND0001060": "Amblyopia"}, {"/indications/DBCOND0000504": "Bradycardia"}, {"/indications/DBCOND0004370": "Bronchial Spasm"}, {"/indications/DBCOND0012275": "Crying"}, {"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0089206": "Excessive bronchial secretion"}, {"/indications/DBCOND0089196": "Hypertonic uterine contraction"}, {"/indications/DBCOND0024342": "Hypertonicity of the small intestine"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0089375": "Poisoning by parasympathomimetics (cholinergics)"}, {"/indications/DBCOND0021805": "Poisoning caused by mushrooms"}, {"/indications/DBCOND0021784": "Poisoning caused by organophosphate anticholinesterase nerve agents"}, {"/indications/DBCOND0021782": "Poisoning caused by organophosphorus pesticides"}, {"/indications/DBCOND0011031": "Pylorospasm"}, {"/indications/DBCOND0020937": "Rhinorrhea"}, {"/indications/DBCOND0042990": "Sinus Bradycardia"}, {"/indications/DBCOND0021793": "Spasms"}, {"/indications/DBCOND0106144": "Toxic effect of organophosphate and carbamate"}, {"/indications/DBCOND0096790": "Atrioventricular (AV) block"}, {"/indications/DBCOND0024343": "Hypermobility of the colon"}, {"/indications/DBCOND0021797": "Laughing"}, {"/indications/DBCOND0021803": "Muscarinic side effects"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Atropine Sulfate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT002367": "Belladonna Alkaloids, Tertiary Amines"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0407010U0": {"Conditions": [{"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0118556": "Minor aches and pains"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Paracetamol & Caffeine", "Categories": [{"/categories/DBCAT003969": "Acetaminophen and Prodrugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003661": "Miscellaneous Analgesics and Antipyretics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0607020B0": {"Conditions": [{"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0021415": "Stage D2 Prostatic carcinoma"}], "Name": "Buserelin", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000060": "Fertility Agents"}, {"/categories/DBCAT000062": "Fertility Agents, Female"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}]}, "0103050P0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0070241": "Erosive Esophagitis(EE)"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0039707": "NSAID Associated Gastric Ulcers"}, {"/indications/DBCOND0028386": "Systemic Mastocytosis"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0021296": "Hypersecretory conditions"}, {"/indications/DBCOND0020951": "Multiple endocrine adenomas"}], "Name": "Omeprazole", "Categories": [{"/categories/DBCAT000768": "2-Pyridinylmethylsulfinylbenzimidazoles"}, {"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000541": "Proton Pump Inhibitors"}, {"/categories/DBCAT003638": "Proton-pump Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0606020X0": {"Conditions": [{"/indications/DBCOND0068054": "Severe Osteoporosis"}], "Name": "Strontium Ranelate", "Categories": [{"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001969": "Strontium"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0501070AC": {"Conditions": [{"/indications/DBCOND0059697": "Clostridium Difficile-Associated Diarrhea (CDAD)"}], "Name": "Fidaxomicin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003494": "Macrolide Antibacterial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT003637": "Other Macrolides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000497": "Polyketides"}]}, "1201010F0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0022093": "Otomycosis caused by Aspergillus niger"}], "Name": "Flumetasone Pivalate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "1001010N0": {"Conditions": [{"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Mefenamic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001132": "Fenamates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT001133": "ortho-Aminobenzoates"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}]}, "0204000J0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0029078": "Tachycardia, Supraventricular"}, {"/indications/DBCOND0000975": "Thyroid Crisis"}, {"/indications/DBCOND0020811": "Acute hemodynamically stable Myocardial infarction"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}], "Name": "Metoprolol Fumarate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000483": "Propanolamines"}]}, "0901040A0": {"Conditions": [{"/indications/DBCOND0020795": "Thrombocythemia"}], "Name": "Anagrelide Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004381": "Decreased Platelet Production"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000590": "Phosphodiesterase 3 Inhibitors"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT003647": "Platelet-reducing Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000632": "Thrombocytosis"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1310020L0": {"Conditions": [{"/indications/DBCOND0000148": "Blastomycosis"}, {"/indications/DBCOND0022874": "Chromomycosis"}, {"/indications/DBCOND0048700": "Chronic Mucocutaneous Candidiasis (CMC)"}, {"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0063178": "Endogenous Cushing's Syndrome"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0000150": "Paracoccidioidomycosis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0045797": "Systemic Candidiasis"}, {"/indications/DBCOND0121746": "Tinea Corporis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121745": "Tinea Corporis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121744": "Tinea Corporis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121742": "Tinea Cruris caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121741": "Tinea Cruris caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121740": "Tinea Cruris caused by Trichophyton rubrum"}, {"/indications/DBCOND0121749": "Tinea Pedis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121748": "Tinea Pedis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121747": "Tinea Pedis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121738": "Cutaneous candidiasis caused by candida spp."}, {"/indications/DBCOND0121750": "Recalcitrant Dermatophytosis"}, {"/indications/DBCOND0121736": "Tinea versicolor caused by Malassezia infection"}], "Name": "Ketoconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002616": "Cytochrome P-450 CYP2A6 Inhibitors (moderate)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004187": "Cytochrome P450 3A5 Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}]}, "0503040B0": {"Conditions": [{"/indications/DBCOND0036858": "Influenza A Virus Infection"}, {"/indications/DBCOND0051432": "Influenza A, Influenza B"}, {"/indications/DBCOND0046219": "Influenza B"}], "Name": "Oseltamivir Phosphate", "Categories": [{"/categories/DBCAT000493": "Acetamides"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002200": "Neuraminidase Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}]}, "0501130R0": {"Conditions": [{"/indications/DBCOND0058437": "Acute Cystitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Nitrofurantoin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000766": "Furans"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003393": "Nitrofuran Antibacterial"}, {"/categories/DBCAT002318": "Nitrofuran Derivatives"}, {"/categories/DBCAT000764": "Nitrofurans"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}]}, "0501011C0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0069365": "Clostridial Infection"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0089302": "Neisseria gonorrhoeae arthritis"}, {"/indications/DBCOND0024235": "Pasteurella infections"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0036867": "Severe Pneumonia"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0025806": "Rat bite fever"}, {"/indications/DBCOND0025804": "Severe Pneumococcal infection"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Benethamine Penicillin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT002365": "Beta-Lactamase Sensitive Penicillins"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003683": "Natural Penicillins"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0302000K0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0033534": "Oesophagitis, Eosinophilic"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0089474": "Mild Crohn\u2019s Disease"}, {"/indications/DBCOND0089473": "Moderate Crohn\u2019s Disease"}], "Name": "Budesonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "1310020T0": {"Conditions": [{"/indications/DBCOND0032341": "Vulvovaginal Candidiasis"}], "Name": "Tioconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}]}, "0102000AG": {"Conditions": [{"/indications/DBCOND0060222": "Constipation-predominant Irritable Bowel Syndrome (IBS-C)"}], "Name": "Tegaserod Maleate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0905012I0": {"Conditions": [{"/indications/DBCOND0003950": "Hypercalcemia"}], "Name": "Cinacalcet Hydrochloride", "Categories": [{"/categories/DBCAT002101": "Anti-Parathyroid Agents"}, {"/categories/DBCAT001231": "Calcimimetic Agents"}, {"/categories/DBCAT002102": "Calcium Homeostasis"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT003421": "Calcium-sensing Receptor Agonist"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004280": "Increased Calcium-sensing Receptor Sensitivity"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0102000AC": {"Conditions": [{"/indications/DBCOND0001060": "Amblyopia"}, {"/indications/DBCOND0000504": "Bradycardia"}, {"/indications/DBCOND0004370": "Bronchial Spasm"}, {"/indications/DBCOND0012275": "Crying"}, {"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0089206": "Excessive bronchial secretion"}, {"/indications/DBCOND0089196": "Hypertonic uterine contraction"}, {"/indications/DBCOND0024342": "Hypertonicity of the small intestine"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0089375": "Poisoning by parasympathomimetics (cholinergics)"}, {"/indications/DBCOND0021805": "Poisoning caused by mushrooms"}, {"/indications/DBCOND0021784": "Poisoning caused by organophosphate anticholinesterase nerve agents"}, {"/indications/DBCOND0021782": "Poisoning caused by organophosphorus pesticides"}, {"/indications/DBCOND0011031": "Pylorospasm"}, {"/indications/DBCOND0020937": "Rhinorrhea"}, {"/indications/DBCOND0042990": "Sinus Bradycardia"}, {"/indications/DBCOND0021793": "Spasms"}, {"/indications/DBCOND0106144": "Toxic effect of organophosphate and carbamate"}, {"/indications/DBCOND0096790": "Atrioventricular (AV) block"}, {"/indications/DBCOND0024343": "Hypermobility of the colon"}, {"/indications/DBCOND0021797": "Laughing"}, {"/indications/DBCOND0021803": "Muscarinic side effects"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Atropine Sulfate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT002367": "Belladonna Alkaloids, Tertiary Amines"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0102000AB": {"Conditions": [{"/indications/DBCOND0044407": "Biliary Colic"}, {"/indications/DBCOND0002278": "Colic"}, {"/indications/DBCOND0014043": "Cystitis"}, {"/indications/DBCOND0000210": "Diverticulitis"}, {"/indications/DBCOND0032425": "Heart Block"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0071172": "Neurogenic Bladder Dysfunction"}, {"/indications/DBCOND0076226": "Neurogenic Bowel Dysfunction"}, {"/indications/DBCOND0011544": "Pancreatitis"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0021163": "Poisoning caused by anticholinesterases"}, {"/indications/DBCOND0011031": "Pylorospasm"}, {"/indications/DBCOND0003832": "Renal Colic"}, {"/indications/DBCOND0021158": "Spastic bladder"}, {"/indications/DBCOND0089191": "Tracheo-bronchial secretion excess"}, {"/indications/DBCOND0021159": "Acute Enterocolitis"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0021171": "Gastric secretions"}, {"/indications/DBCOND0021155": "Hypermotility disorders of the lower urinary tract"}, {"/indications/DBCOND0021156": "Mild Dysentery"}, {"/indications/DBCOND0021170": "Pharyngeal secretions"}, {"/indications/DBCOND0021168": "Salivary secretions"}, {"/indications/DBCOND0021157": "Spastic colitis"}], "Name": "Hyoscyamine Sulfate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000849": "Atropine"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT002367": "Belladonna Alkaloids, Tertiary Amines"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0407042F0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0051106": "Human Growth Hormone Deficiency"}, {"/indications/DBCOND0068470": "Menopausal Hot Flushes"}, {"/indications/DBCOND0025068": "Opiate withdrawal symptoms"}, {"/indications/DBCOND0032311": "Oppositional Defiant Disorder"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0021809": "Sialorrhea caused by clozapine"}, {"/indications/DBCOND0021810": "Diabetic diarrhea"}, {"/indications/DBCOND0021815": "Methadone withdrawal"}, {"/indications/DBCOND0021807": "Severe Cancer pain"}], "Name": "Clonidine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT002214": "Antiadrenergic Agents, Centrally Acting"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002413": "Imidazoline Receptor Agonists"}, {"/categories/DBCAT000977": "Imidazolines"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000485": "Sympatholytics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}]}, "0602010M0": {"Conditions": [{"/indications/DBCOND0025200": "Autonomy of thyroid gland"}, {"/indications/DBCOND0009048": "Hyperthyroidism"}, {"/indications/DBCOND0009036": "Hypothyroidism"}, {"/indications/DBCOND0020856": "Myxedema coma"}, {"/indications/DBCOND0063689": "Thyroid Cancers"}, {"/indications/DBCOND0020853": "Euthyroid Goitre"}, {"/indications/DBCOND0020857": "Myxedema pre-coma"}], "Name": "Liothyronine Sodium", "Categories": [{"/categories/DBCAT004965": "Agents used to treat hypothyroidism"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003316": "l-Triiodothyronine"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}, {"/categories/DBCAT000658": "Thyronines"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT004075": "Triiodothyronine"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0102000AK": {"Conditions": [{"/indications/DBCOND0075933": "Diarrhoea Predominant Irritable Bowel Syndrome"}], "Name": "Eluxadoline", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002293": "Antipropulsives"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT001971": "Receptors, Opioid, delta, antagonists & inhibitors"}, {"/categories/DBCAT001771": "Receptors, Opioid, mu, agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0204000L0": {"Conditions": [{"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Carteolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0205051F0": {"Conditions": [{"/indications/DBCOND0022908": "Aldosteronism"}, {"/indications/DBCOND0022909": "Anatomic renal artery stenosis"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}, {"/indications/DBCOND0066284": "Non ST Segment Elevation Acute Coronary Syndrome"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}, {"/indications/DBCOND0022907": "Ejection fraction of 40% or less Left ventricular dysfunction"}], "Name": "Captopril", "Categories": [{"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT000388": "Imino Acids"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000927": "Proline"}]}, "1104020V0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024172": "FAB classification M3 Acute promyelocytic leukemia"}, {"/indications/DBCOND0036306": "Solar Lentigines"}, {"/indications/DBCOND0024211": "Facial fine wrinkling"}, {"/indications/DBCOND0025747": "Moderate Melasma"}, {"/indications/DBCOND0022269": "Mottled hyperpigmentation"}, {"/indications/DBCOND0025746": "Severe Melasma"}, {"/indications/DBCOND0024176": "Severe, recalcitrant Cystic acne"}, {"/indications/DBCOND0024174": "Tactile roughness of facial skin"}], "Name": "Tretinoin", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT003717": "Cell Stimulants and Proliferants"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0503032L0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}, {"/indications/DBCOND0024500": "Chronic hepatitis C genotype 5"}, {"/indications/DBCOND0023526": "Genotype 6 chronic hepatitis C infection"}], "Name": "Sofosbuvir/Velpatasvir/Voxilaprevir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003504": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT004208": "RNA Replicase Inhibitors"}, {"/categories/DBCAT001520": "Uracil Nucleotides"}, {"/categories/DBCAT001919": "Uridine Monophosphate"}]}, "0106070A0": {"Conditions": [{"/indications/DBCOND0037414": "Chronic Idiopathic Constipation"}, {"/indications/DBCOND0038981": "Opioid Induced Constipation (OIC)"}, {"/indications/DBCOND0025608": "Refractory Chronic idiopathic constipation"}], "Name": "Prucalopride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001723": "Serotonin 5-HT4 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}]}, "0205010V0": {"Conditions": [{"/indications/DBCOND0025753": "NYHA class III Pulmonary arterial hypertension"}, {"/indications/DBCOND0025754": "NYHA class IV Pulmonary arterial hypertension"}], "Name": "Iloprost", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT002688": "Prostacyclin Analogues"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1501043F0": {"Conditions": [{"/indications/DBCOND0051560": "Cancer Related Pain (Breakthrough Pain)"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}], "Name": "Fentanyl Citrate", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT000683": "Anesthetics, Intravenous"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT001085": "Fentanyl and fentanyl analogues"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT002452": "Opioid Anesthetics"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003009": "Opioids, Anilidopiperidine"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002384": "Phenylpiperidine Derivatives"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0601011P0": {"Conditions": [{"/indications/DBCOND0022905": "Type 1 Insulin-Dependent Diabetes Mellitus"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}, {"/indications/DBCOND0023008": "Hyperglycemia during critical illness"}], "Name": "Insulin Glulisine", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000135": "Insulin, Short-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002120": "Insulins and Analogues for Injection, Fast-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "1202020N0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0906025P0": {"Conditions": [{"/indications/DBCOND0020583": "Ariboflavinosis"}, {"/indications/DBCOND0017962": "Migraine"}], "Name": "Riboflavin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000223": "Coenzymes"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000330": "Flavins"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "040801050": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0059448": "Binge Eating Disorder (BED)"}, {"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0003590": "Cluster Headache"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0082377": "Infantile Spasms (IS)"}, {"/indications/DBCOND0023239": "Lennox-Gastaut Syndrome (LGS)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0062120": "Refractory Status Epilepticus"}, {"/indications/DBCOND0082481": "Tremor, Essential"}, {"/indications/DBCOND0024707": "Weight"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0020834": "Primary generalized tonic-clonic seizure Epilepsy"}, {"/indications/DBCOND0021975": "Weight gain therapy"}], "Name": "Topiramate", "Categories": [{"/categories/DBCAT000472": "Anti-Obesity Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT004805": "Fructose"}, {"/categories/DBCAT001567": "Hexoses"}, {"/categories/DBCAT001421": "Ketoses"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT001422": "Monosaccharides"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}]}, "0501120Y0": {"Conditions": [{"/indications/DBCOND0037906": "Acute Exacerbation of Chronic Bronchitis (AECB)"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0014061": "Sinusitis"}, {"/indications/DBCOND0106073": "Bacterial ocular infections"}, {"/indications/DBCOND0106074": "Post-operative infection"}, {"/indications/DBCOND0102820": "Post-operative inflammation"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Moxifloxacin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0601021P0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Glipizide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT000635": "Urea"}]}, "0704040G0": {"Conditions": [{"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0071172": "Neurogenic Bladder Dysfunction"}, {"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Oxybutynin Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0408010V0": {"Conditions": [{"/indications/DBCOND0089207": "Status epilepticus petit mal"}], "Name": "Trimethadione", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000626": "Oxazoles"}, {"/categories/DBCAT002331": "Oxazolidine Derivatives"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0902021V0": {"Conditions": [{"/indications/DBCOND0023722": "Mild Metabolic acidosis"}, {"/indications/DBCOND0023721": "Moderate Metabolic acidosis"}], "Name": "Sodium Lactate", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001522": "Lactates"}, {"/categories/DBCAT004794": "Lactic Acid"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002544": "Organic Acids"}]}, "1202020P0": {"Conditions": [{"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Xylometazoline Hydrochloride", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003719": "Antihistamine Drugs"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0501070M0": {"Conditions": [{"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0025273": "Mild Atopic dermatitis"}, {"/indications/DBCOND0106246": "Mild Dermatitis caused by Staphylococcus aureusis"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0106245": "Moderate Dermatitis caused by Staphylococcus aureusis"}], "Name": "Fusidic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT001504": "Cholestadienes"}, {"/categories/DBCAT001503": "Cholestadienols"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003765": "Other Miscellaneous Antibacterial Agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002542": "Steroid Antibacterials"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0801050Q0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0043840": "Glioblastomas"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0087260": "Malignant Neoplasm of Pancreas"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0065684": "Metastatic Colorectal Carcinoma"}, {"/indications/DBCOND0027071": "Rhabdomyosarcomas"}, {"/indications/DBCOND0025384": "Recurrent, IV-B Cervical cancer"}, {"/indications/DBCOND0024192": "Recurrent, metastatic Colorectal carcinoma"}, {"/indications/DBCOND0024189": "Refractory, metastatic Pancreatic adenocarcinoma"}], "Name": "Irinotecan Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001239": "Camptothecin"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000795": "Disaccharides"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT001116": "Topoisomerase I Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0704010C0": {"Conditions": [{"/indications/DBCOND0071172": "Neurogenic Bladder Dysfunction"}, {"/indications/DBCOND0057006": "Postoperative Urinary Retention"}, {"/indications/DBCOND0025372": "Postpartum urinary retention"}], "Name": "Bethanechol Chloride", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT001234": "Bethanechol Compounds"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT002364": "Choline Esters"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT000447": "Muscarinic Agonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0402030K0": {"Conditions": [{"/indications/DBCOND0034367": "Bipolar Disorder (BD)"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Lithium Carbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001348": "Lithium Compounds"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0801050CP": {"Conditions": [{"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}], "Name": "Brigatinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0303020Y0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0041467": "Chronic Asthma"}], "Name": "Zileuton", "Categories": [{"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004468": "Decreased Leukotriene Production"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000910": "Leukotriene Antagonists"}, {"/categories/DBCAT000422": "Lipoxygenase Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT000635": "Urea"}]}, "0801050CM": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}], "Name": "Encorafenib", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801050CN": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}], "Name": "Binimetinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001678": "MAP Kinase Kinase 1, antagonists & inhibitors"}, {"/categories/DBCAT001917": "MAP Kinase Kinase 2, antagonists & inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0801050CH": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}], "Name": "Trametinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT001678": "MAP Kinase Kinase 1, antagonists & inhibitors"}, {"/categories/DBCAT001917": "MAP Kinase Kinase 2, antagonists & inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000349": "Pyrimidines"}]}, "0801050CI": {"Conditions": [{"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}], "Name": "Cobimetinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001212": "Azetines"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004244": "Kinase Inhibitors"}, {"/categories/DBCAT001678": "MAP Kinase Kinase 1, antagonists & inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}]}, "0801050CJ": {"Conditions": [{"/indications/DBCOND0028487": "Fallopian Tube Cancer"}, {"/indications/DBCOND0054935": "Ovarian Epithelial Cancer"}, {"/indications/DBCOND0030277": "Primary Peritoneal Cancer"}], "Name": "Niraparib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001523": "Poly(ADP-ribose) Polymerase Inhibitors"}, {"/categories/DBCAT000650": "Pyrazoles"}]}, "0801050CK": {"Conditions": [{"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0007107": "Malignant mast cell neoplasm"}, {"/indications/DBCOND0028386": "Systemic Mastocytosis"}, {"/indications/DBCOND0089500": "Systemic mastocytosis with associated hematological neoplasm"}], "Name": "Midostaurin", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001187": "Carbazoles"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000527": "Indole Alkaloids"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT001440": "Protein Kinase C, antagonists & inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT004052": "Receptor Tyrosine Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050CD": {"Conditions": [{"/indications/DBCOND0025490": "Refractory, metastatic Non small cell lung cancer"}], "Name": "Alectinib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004244": "Kinase Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050CE": {"Conditions": [{"/indications/DBCOND0105292": "Refractory B-cell precursor Acute Lymphoblastic Anemia"}, {"/indications/DBCOND0105293": "Relapsed B-cell precursor Acute Lymphoblastic Anemia"}], "Name": "Inotuzumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004406": "CD22-directed Antibody Interactions"}, {"/categories/DBCAT003836": "CD22-directed Immunoconjugate"}, {"/categories/DBCAT004407": "Decreased DNA Integrity"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT004375": "Increased Cellular Death"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "1001010R0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Piroxicam", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002395": "Oxicams"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "0801050CG": {"Conditions": [{"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}], "Name": "Osimertinib", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT001443": "Acrylates"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004244": "Kinase Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT001447": "Tyrosine Kinase Inhibitors"}]}, "0801050CA": {"Conditions": [{"/indications/DBCOND0032507": "Cervical Cancers"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0031691": "Metastatic Solid Tumors"}, {"/indications/DBCOND0047213": "Unresectable Melanoma"}, {"/indications/DBCOND0089354": "Urothelial carcinoma ureter metastatic"}, {"/indications/DBCOND0089492": "Locally advanced Urothelial Carcinoma"}, {"/indications/DBCOND0110742": "Locally advanced gastroesphageal juntion adenocarcinoma"}, {"/indications/DBCOND0110741": "Metastatic gastroesphageal juntion adenocarcinoma"}, {"/indications/DBCOND0022053": "Metastatic nonsquamous non-small cell lung cancer"}, {"/indications/DBCOND0110729": "Recurrent, metastatic Head and Neck Squamous Cell Carcinoma"}, {"/indications/DBCOND0025490": "Refractory, metastatic Non small cell lung cancer"}, {"/indications/DBCOND0110731": "Refractory, relapsed Hodgkin Lymphoma"}, {"/indications/DBCOND0110733": "Refractory, relapsed Mediastinal Large B-cell Lymphoma"}, {"/indications/DBCOND0110737": "Unresectable Solid Tumors"}], "Name": "Pembrolizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT005020": "Programmed Cell Death 1 Receptor"}, {"/categories/DBCAT003510": "Programmed Death Receptor-1 Blocking Antibody"}, {"/categories/DBCAT004275": "Programmed Death Receptor-1-directed Antibody Interactions"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050CB": {"Conditions": [{"/indications/DBCOND0031019": "Advanced Breast Cancer"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}, {"/indications/DBCOND0023213": "Refractory, metastatic Breast cancer"}], "Name": "Palbociclib", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001450": "Cyclin-Dependent Kinases, antagonists & inhibitors"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004244": "Kinase Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}]}, "0801050CC": {"Conditions": [{"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}], "Name": "Ixazomib", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT003056": "Proteasome Inhibitors"}]}, "0501040K0": {"Conditions": [{"/indications/DBCOND0106329": "Bacterial Infection caused by Acinetobacter species"}, {"/indications/DBCOND0106321": "Bacterial Infection caused by E. coli"}, {"/indications/DBCOND0106325": "Bacterial Infection caused by Enterobacter aerogenes"}, {"/indications/DBCOND0106326": "Bacterial Infection caused by Klebsiella Pneumoniae"}, {"/indications/DBCOND0106323": "Bacterial Infection caused by Proteus species"}, {"/indications/DBCOND0106327": "Bacterial Infection caused by Serratia marcescens"}], "Name": "Kanamycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1310050V0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0501021J0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0027964": "Lyme Disease"}, {"/indications/DBCOND0000354": "Maxillary Sinusitis"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0022787": "Mild Streptococcal pharyngitis"}, {"/indications/DBCOND0022789": "Mild Streptococcal tonsillitis"}, {"/indications/DBCOND0022786": "Moderate Streptococcal pharyngitis"}, {"/indications/DBCOND0022788": "Moderate Streptococcal tonsillitis"}], "Name": "Cefuroxime Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0208010N0": {"Conditions": [{"/indications/DBCOND0022770": "Clotting"}, {"/indications/DBCOND0022765": "Consumption coagulopathy"}, {"/indications/DBCOND0052606": "Disseminated Intravascular Coagulation (DIC)"}, {"/indications/DBCOND0028936": "Interstitial Cystitis"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0048867": "ST Elevation Myocardial Infarction (STEMI)"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0034329": "Thrombosis, Venous"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0022766": "Embolization"}, {"/indications/DBCOND0022767": "Peripheral arterial embolism"}], "Name": "Heparin Calcium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT002505": "Heparin Group"}, {"/categories/DBCAT002743": "Heparins"}, {"/categories/DBCAT002447": "Heparins or Heparinoids for Topical Use"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0801050C0": {"Conditions": [{"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0043073": "Refractory Leukemia"}], "Name": "Amsacrine", "Categories": [{"/categories/DBCAT000656": "Acridines"}, {"/categories/DBCAT000655": "Aminoacridines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000657": "Intercalating Agents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}]}, "1310020P0": {"Conditions": [{"/indications/DBCOND0037929": "Fungal Keratitis"}, {"/indications/DBCOND0022362": "Fungal blepharitis"}, {"/indications/DBCOND0022360": "Fungal conjunctivitis"}], "Name": "Natamycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT003407": "Polyene Antimicrobial"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0702020E0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin Phosphate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "1501010R0": {"Conditions": [{"/indications/DBCOND0041916": "Treatment Resistant Depression (TRD)"}], "Name": "Esketamine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT003034": "Cytochrome P-450 CYP2B6 Inducers (weak)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}]}, "0906040N0": {"Conditions": [{"/indications/DBCOND0036228": "Hypophosphatemia, Familial"}, {"/indications/DBCOND0057073": "Vitamin D Resistant Rickets"}, {"/indications/DBCOND0022862": "Parathyroid deficiency"}], "Name": "Ergocalciferol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0701011F0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0085997": "Menstrual Cramps"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Ibuprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003907": "COX-1 Inhibitors"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0203020L0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0801030V0": {"Conditions": [{"/indications/DBCOND0025424": "Duke's C Colon cancer"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0041878": "Hepatobiliary Cancers"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0065684": "Metastatic Colorectal Carcinoma"}, {"/indications/DBCOND0058909": "Pancreatic Cancer Metastatic"}, {"/indications/DBCOND0022757": "Metastatic pancreatic endocrine carcinoma"}, {"/indications/DBCOND0022758": "Refractory Ovarian cancer"}, {"/indications/DBCOND0022760": "Refractory falopian tube cancer"}, {"/indications/DBCOND0022762": "Refractory peritoneal cancer"}, {"/indications/DBCOND0025425": "Refractory, metastatic Colorectal carcinoma"}], "Name": "Capecitabine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003851": "Fluoropyrimidines"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "0601023AW": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Semaglutide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000091": "Gastrointestinal Hormones"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003758": "Incretin Mimetics"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000120": "Proglucagon"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}]}, "0803042B0": {"Conditions": [{"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0021415": "Stage D2 Prostatic carcinoma"}], "Name": "Buserelin", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000060": "Fertility Agents"}, {"/categories/DBCAT000062": "Fertility Agents, Female"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}]}, "0908010C0": {"Conditions": [{"/indications/DBCOND0061815": "Carnitine Deficiency"}, {"/indications/DBCOND0008341": "Congenital carnitine deficiency"}, {"/indications/DBCOND0021846": "Secondary Carnitine deficiency"}], "Name": "Levocarnitine", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002151": "Amino Acids and Derivatives"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT003625": "Caloric Agents"}, {"/categories/DBCAT003380": "Carnitine Analog"}, {"/categories/DBCAT002740": "Dietary Supplements"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "1109000S0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Saline", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0409010Y0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Rasagiline Mesilate", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000931": "Indenes"}, {"/categories/DBCAT002494": "Monoamine Oxidase B Inhibitors"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "1202010U0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0038236": "Seasonal Allergies"}, {"/indications/DBCOND0087977": "Skin Inflammation"}], "Name": "Mometasone Furoate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0406000S0": {"Conditions": [{"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0013142": "Cholestatic pruritus"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0037608": "Uremic Pruritus"}, {"/indications/DBCOND0022946": "Radiation therapy induced nausea and vomiting"}, {"/indications/DBCOND0022424": "Severe Hyperemesis gravidarum"}], "Name": "Ondansetron Hydrochloride", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT001187": "Carbazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004178": "Serotonin 3 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "1103010Z0": {"Conditions": [{"/indications/DBCOND0059697": "Clostridium Difficile-Associated Diarrhea (CDAD)"}, {"/indications/DBCOND0021445": "Enterocolitis caused by Staphylococcus aureus"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Vancomycin Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT002402": "Glycopeptide Antibacterials"}, {"/categories/DBCAT000678": "Glycopeptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT004741": "Vancomycin"}]}, "1002020S0": {"Conditions": [{"/indications/DBCOND0012164": "Discomfort"}, {"/indications/DBCOND0053860": "Muscle Spasms"}, {"/indications/DBCOND0026745": "Muscle pains"}, {"/indications/DBCOND0000386": "Tetanus"}], "Name": "Methocarbamol", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT002357": "Carbamic Acid Esters"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000847": "Guaiacol"}, {"/categories/DBCAT000846": "Guaifenesin"}, {"/categories/DBCAT000561": "Methyl Ethers"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000848": "Phenylcarbamates"}]}, "0504010Y0": {"Conditions": [{"/indications/DBCOND0021343": "Malaria caused by Plasmodium falciparum"}], "Name": "Quinine Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000904": "Cinchona Alkaloids"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002708": "Herbs (Hypotensive Properties)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT002335": "Methanolquinolines"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002394": "Quinine and Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0208030N0": {"Conditions": [{"/indications/DBCOND0023670": "Heparin overdose"}], "Name": "Protamine Sulfate", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT003785": "Antiheparin Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001959": "Heparin Antagonists"}, {"/categories/DBCAT003519": "Heparin Reversal Agent"}, {"/categories/DBCAT001958": "Nuclear Proteins"}, {"/categories/DBCAT001957": "Nucleoproteins"}, {"/categories/DBCAT000020": "Proteins"}]}, "0205052W0": {"Conditions": [{"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Eprosartan", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1106000U0": {"Conditions": [{"/indications/DBCOND0074237": "Ocular Hypertension"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}], "Name": "Metipranolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "1202010K0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}], "Name": "Levocabastine", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1203010S0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0409020N0": {"Conditions": [{"/indications/DBCOND0053860": "Muscle Spasms"}, {"/indications/DBCOND0106241": "Mild Musculoskeletal Disorder"}, {"/indications/DBCOND0106240": "Moderate Musculoskeletal Disorder"}], "Name": "Orphenadrine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002516": "Ethers, Chemically Close to Antihistamines"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003751": "Miscellaneous Skeletal Muscle Relaxants"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0601023AI": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Lixisenatide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT005022": "Glucagon-Like Peptide-1 Receptor"}, {"/categories/DBCAT003758": "Incretin Mimetics"}]}, "1202020G0": {"Conditions": [{"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0099793": "Red eyes"}], "Name": "Oxymetazoline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT004278": "Increased Sympathetic Activity"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT004353": "Vasoconstriction"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0504010K0": {"Conditions": [{"/indications/DBCOND0025560": "Malaria caused by Plasmodium ovale"}, {"/indications/DBCOND0022743": "Malaria caused by plasmodium vivax"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}], "Name": "Primaquine", "Categories": [{"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "0407041D0": {"Conditions": [{"/indications/DBCOND0003590": "Cluster Headache"}, {"/indications/DBCOND0015253": "Deep vein thrombosis postoperative"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}], "Name": "Dihydroergotamine Mesilate", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003643": "Ergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT003327": "Ergotamine Derivative"}, {"/categories/DBCAT000741": "Ergotamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003663": "Sympatholytic (Adrenergic Blocking) Agents"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0503010J0": {"Conditions": [{"/indications/DBCOND0042885": "Human Immunodeficiency Virus Type 1 (HIV-1)"}], "Name": "Enfuvirtide", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT000035": "Antigens"}, {"/categories/DBCAT002888": "Antigens, Viral"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT002889": "env Gene Products, Human Immunodeficiency Virus"}, {"/categories/DBCAT004232": "Fusion Protein Inhibitors"}, {"/categories/DBCAT002890": "Gene Products, env"}, {"/categories/DBCAT002887": "HIV Antigens"}, {"/categories/DBCAT004972": "HIV Envelope Protein gp41"}, {"/categories/DBCAT000220": "HIV Fusion Inhibitors"}, {"/categories/DBCAT003281": "Human Immunodeficiency Virus 1 Fusion Inhibitor"}, {"/categories/DBCAT002896": "Human Immunodeficiency Virus Proteins"}, {"/categories/DBCAT002898": "Membrane Fusion Proteins"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT001722": "Peptide Fragments"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002895": "Polyproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002891": "Retroviridae Proteins"}, {"/categories/DBCAT002893": "Viral Envelope Proteins"}, {"/categories/DBCAT000219": "Viral Fusion Protein Inhibitors"}, {"/categories/DBCAT002897": "Viral Fusion Proteins"}, {"/categories/DBCAT002892": "Viral Proteins"}, {"/categories/DBCAT002894": "Viral Structural Proteins"}]}, "0105010C0": {"Conditions": [{"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}], "Name": "Olsalazine Sodium", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003404": "Aminosalicylate"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0402020G0": {"Conditions": [{"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Flupentixol Decanoate", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002478": "Thioxanthene Derivatives"}, {"/categories/DBCAT001167": "Thioxanthenes"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "0704020G0": {"Conditions": [{"/indications/DBCOND0014043": "Cystitis"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0025437": "Urethrotrigonitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0025438": "Urethrocystitis"}], "Name": "Flavoxate Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001225": "Chromones"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001280": "Flavones"}, {"/categories/DBCAT001281": "Flavonoids"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0303010Q0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0034753": "Conjunctivitis, Vernal"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0002834": "Urticaria Pigmentosa"}], "Name": "Sodium Cromoglicate", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001225": "Chromones"}, {"/categories/DBCAT004761": "Cromolyn Sodium"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT003742": "Mast-cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1308010W0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0121216": "Inflammatory Disease of the Oral Cavity"}, {"/indications/DBCOND0121217": "Inflammatory Disease of the throat"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0089301": "Operation site inflammation"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0001062": "Photophobia"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021856": "Acute Musculoskeletal injury"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0121215": "Localized soft tissue rheumatism"}, {"/indications/DBCOND0121211": "Mild to moderate joint pain"}, {"/indications/DBCOND0121212": "Mild to moderate pain"}, {"/indications/DBCOND0112720": "Minor pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0121206": "Perioperative miosis"}], "Name": "Diclofenac Sodium", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0212000D0": {"Conditions": [{"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0023044": "Fredrickson classification type IV Hyperlipidemia"}, {"/indications/DBCOND0023046": "Fredrickson classification type V Hyperlipidemia"}, {"/indications/DBCOND0089211": "Type IIb hyperlipoproteinaemia"}], "Name": "Bezafibrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000995": "Chlorobenzoates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT001018": "Fibric Acids"}, {"/categories/DBCAT003745": "Fribic Acid Derivatives"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001019": "Isobutyrates"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0401030Q0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0020922": "Severe Convulsion"}], "Name": "Pentobarbital Sodium", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000728": "Barbiturates"}, {"/categories/DBCAT002297": "Barbiturates, Plain"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT002618": "Cytochrome P-450 CYP2A6 Inducers (strong)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}]}, "0905013N0": {"Conditions": [{"/indications/DBCOND0024161": "Convulsions"}, {"/indications/DBCOND0015901": "Hypomagnesaemia"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0022086": "Barium poisoning"}, {"/indications/DBCOND0022085": "Severe Exacerbation of asthma"}], "Name": "Magnesium Sulfate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003301": "Paramagnetic Contrast Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002361": "Tests for Bile Duct Patency"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1303000E0": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0020815": "Pruritis"}], "Name": "Colestyramine", "Categories": [{"/categories/DBCAT000811": "Anion Exchange Resins"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT002340": "Bile Acid Sequestrants"}, {"/categories/DBCAT004184": "Bile-acid Binding Activity"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000810": "Ion Exchange Resins"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001359": "Polystyrenes"}, {"/categories/DBCAT001361": "Styrene"}, {"/categories/DBCAT001362": "Styrenes"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0501120L0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0106142": "Acute Otitis Externa caused by Pseudomonas Aeruginosa"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0032963": "Acute Uncomplicated Pyelonephritis"}, {"/indications/DBCOND0021622": "Acute exacerbation of chronic bronchitis caused by Moraxella catarrhalis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0021574": "Conjunctivitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080536": "Corneal Ulcers caused by Serratia marcescens"}, {"/indications/DBCOND0080537": "Corneal Ulcers caused by Staphylococcus aureus"}, {"/indications/DBCOND0080538": "Corneal Ulcers caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080539": "Corneal Ulcers caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0080540": "Corneal Ulcers caused by Streptococcus Viridans Group"}, {"/indications/DBCOND0080535": "Corneal Ulcers caused by pseudomonas aeruginosa"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0021614": "Lower respiratory tract infection caused by Enterobacter cloacae"}, {"/indications/DBCOND0021611": "Lower respiratory tract infection caused by Escherichia coli"}, {"/indications/DBCOND0021616": "Lower respiratory tract infection caused by Haemophilus influenzae"}, {"/indications/DBCOND0021618": "Lower respiratory tract infection caused by Haemophilus parainfluenzae"}, {"/indications/DBCOND0021612": "Lower respiratory tract infection caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021615": "Lower respiratory tract infection caused by Proteus mirabilis"}, {"/indications/DBCOND0021620": "Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021640": "Plague caused by Yersinia pestis"}, {"/indications/DBCOND0045585": "Sinusitis, Acute"}, {"/indications/DBCOND0021628": "Typhoid fever caused by Salmonella typhi"}, {"/indications/DBCOND0021593": "UTI caused by Citrobacter diversus"}, {"/indications/DBCOND0021595": "UTI caused by Citrobacter frendii"}, {"/indications/DBCOND0021602": "UTI caused by Entercococcus faecalis"}, {"/indications/DBCOND0089465": "UTI caused by Enterobacter cloacae"}, {"/indications/DBCOND0021582": "UTI caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021591": "UTI caused by Morganella morganii"}, {"/indications/DBCOND0021587": "UTI caused by Proteus mirabilis"}, {"/indications/DBCOND0021589": "UTI caused by Providencia rettgeri"}, {"/indications/DBCOND0021596": "UTI caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0021585": "UTI caused by Serratia marcescens"}, {"/indications/DBCOND0021598": "UTI caused by methicillin-susceptible Staphylococcus epidermidis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0021563": "Acute otitis externa caused by Staphylococcus aureus"}, {"/indications/DBCOND0021604": "Acute, uncomplicated Cystitis caused by Escherichia coli"}, {"/indications/DBCOND0021606": "Acute, uncomplicated Cystitis caused by Staphylococcus saprophyticus"}, {"/indications/DBCOND0021608": "Chronic Prostatitis caused by Escherichia coli"}, {"/indications/DBCOND0021610": "Chronic Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0021634": "Complicated Pyelonephritis caused by Escherichia coli"}, {"/indications/DBCOND0021632": "Complicated UTI caused by Escherichia coli"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0021637": "Inhaled anthrax caused by Bacillus anthracis"}, {"/indications/DBCOND0020975": "Skin-structure infections"}, {"/indications/DBCOND0021631": "Uncomplicated Gonorrhea caused by Neisseria gonorrhoeae"}], "Name": "Ciprofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001596": "Ciprofloxacin and isotope"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0102000AD": {"Conditions": [{"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0023568": "Functional disorders of the biliary tract"}], "Name": "Pinaverium Bromide", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0908010U0": {"Conditions": [{"/indications/DBCOND0047315": "Acetaminophen Overdose"}], "Name": "Acetylcysteine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003463": "Antidote for Acetaminophen Overdose"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000315": "Cysteine"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004189": "Increased Glutathione Concentration"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT004190": "Reduction Activity"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1203040D0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0304010A0": {"Conditions": [{"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Acrivastine", "Categories": [{"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1108020K0": {"Conditions": [{"/indications/DBCOND0025444": "Peritoneal dialysis therapy"}, {"/indications/DBCOND0068126": "Pneumocystis Jirovecii Pneumonia"}], "Name": "Fluorescein Sodium", "Categories": [{"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001075": "Coloring Agents"}, {"/categories/DBCAT002449": "Colouring Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000560": "Contrast Media"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT003392": "Diagnostic Dye"}, {"/categories/DBCAT000559": "Diagnostic Uses of Chemicals"}, {"/categories/DBCAT001073": "Fluoresceins"}, {"/categories/DBCAT001077": "Fluorescent Dyes"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT001076": "Luminescent Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003712": "Ocular Disorders"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000923": "Spiro Compounds"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "0304010AE": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0023358": "Hives"}, {"/indications/DBCOND0020815": "Pruritis"}], "Name": "Rupatadine Fumarate", "Categories": [{"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002084": "Platelet Activating Factor, antagonists & inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0304010AG": {"Conditions": [{"/indications/DBCOND0047182": "Asthma, Allergic"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}], "Name": "Ketotifen Fumarate", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT003719": "Antihistamine Drugs"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003399": "Histamine H1 Inhibitors"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003740": "Other Antihistamines"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "0304010AB": {"Conditions": [{"/indications/DBCOND0034097": "Chronic Idiopathic Urticaria"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0023064": "Nasal symptoms"}, {"/indications/DBCOND0106201": "Non-nasal symptoms"}], "Name": "Desloratadine", "Categories": [{"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000882": "Cyproheptadine"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0304010AC": {"Conditions": [{"/indications/DBCOND0034097": "Chronic Idiopathic Urticaria"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Levocetirizine", "Categories": [{"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT000771": "Hydroxyzine"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002325": "Piperazine Derivatives"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1103030C0": {"Conditions": [{"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0005172": "Chickenpox"}, {"/indications/DBCOND0003600": "Encephalitis, Herpes Simplex"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0028191": "Herpes Zoster"}, {"/indications/DBCOND0024319": "Herpes simplex of the oral-labial"}, {"/indications/DBCOND0025063": "Herpes simplex type I reactivation"}, {"/indications/DBCOND0049565": "Infections, Cytomegalovirus"}, {"/indications/DBCOND0032971": "Recurrent Genital Herpes (RGH)"}, {"/indications/DBCOND0033308": "Recurrent Herpes Labialis"}, {"/indications/DBCOND0024387": "VZV re-activation"}, {"/indications/DBCOND0022321": "Acute Genital herpes"}, {"/indications/DBCOND0024389": "Acute Herpes labialis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0024381": "Severe Genital herpes"}], "Name": "Aciclovir", "Categories": [{"/categories/DBCAT002686": "Acyclovir and prodrug"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003553": "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0401010R0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0022716": "Myoclonic seizures"}], "Name": "Nitrazepam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1501041T0": {"Conditions": [{"/indications/DBCOND0034792": "Seizures, Epileptic"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Midazolam Hydrochloride", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003829": "Triazolobenzodiazepines"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "1203040R0": {"Conditions": [{"/indications/DBCOND0112726": "Canker sores oral"}, {"/indications/DBCOND0033077": "Mouth Ulcers"}, {"/indications/DBCOND0112728": "Minor gum inflammation"}, {"/indications/DBCOND0023687": "Wound site"}], "Name": "Sodium Perborate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003149": "Boric Acids"}, {"/categories/DBCAT000461": "Boron Compounds"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003164": "Tooth Bleaching"}]}, "1106000I0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Betaxolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT003633": "Beta-adrenergic Agents"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "1001010E0": {"Conditions": [{"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Etodolac", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001109": "Indoleacetic Acids"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1502010R0": {"Conditions": [{"/indications/DBCOND0069560": "Pain, Acute"}], "Name": "Ropivacaine Hydrochloride", "Categories": [{"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1203020K0": {"Conditions": [{"/indications/DBCOND0037929": "Fungal Keratitis"}, {"/indications/DBCOND0022362": "Fungal blepharitis"}, {"/indications/DBCOND0022360": "Fungal conjunctivitis"}], "Name": "Natamycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT003407": "Polyene Antimicrobial"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0603010I0": {"Conditions": [{"/indications/DBCOND0028872": "Addison's Disease"}, {"/indications/DBCOND0039238": "Orthostatic Intolerance"}, {"/indications/DBCOND0062048": "Postural Orthostatic Tachycardia Syndrome (POTS)"}, {"/indications/DBCOND0022162": "Salt wasting form Congenital adrenal hyperplasia"}], "Name": "Fludrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001861": "Mineralocorticoids"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0904010G0": {"Conditions": [{"/indications/DBCOND0010699": "Nausea"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Fructose", "Categories": [{"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000376": "Flavoring Agents"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT004805": "Fructose"}, {"/categories/DBCAT002545": "General Nutrients"}, {"/categories/DBCAT001567": "Hexoses"}, {"/categories/DBCAT001421": "Ketoses"}, {"/categories/DBCAT001422": "Monosaccharides"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000378": "Sweetening Agents"}]}, "1307000G0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0025199": "External ear infection NOS"}, {"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Glacial Acetic Acid", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002544": "Organic Acids"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0101010R0": {"Conditions": [{"/indications/DBCOND0004513": "Flatulence"}], "Name": "Simeticone", "Categories": [{"/categories/DBCAT001607": "Antifoaming Agents"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002004": "Dimethylpolysiloxanes"}, {"/categories/DBCAT002008": "Emollients"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002007": "Organosilicon Compounds"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001377": "Silicon Compounds"}, {"/categories/DBCAT002005": "Silicones"}, {"/categories/DBCAT002006": "Siloxanes"}, {"/categories/DBCAT000898": "Surface-Active Agents"}]}, "0604020E0": {"Conditions": [{"/indications/DBCOND0009162": "Gonadotrophin releasing hormone deficiency"}, {"/indications/DBCOND0048343": "Hypergonadotropic Hypogonadism"}, {"/indications/DBCOND0037480": "Idiopathic Hypogonadotropic Hypogonadism"}, {"/indications/DBCOND0025204": "Pituitary gonadotropin hypofunction"}, {"/indications/DBCOND0001010": "Puberty, Delayed"}, {"/indications/DBCOND0009269": "Testicular failure"}, {"/indications/DBCOND0021988": "Inoperable, metastatic Breast cancer"}], "Name": "Fluoxymesterone", "Categories": [{"/categories/DBCAT002430": "3-Oxoandrosten (4) Derivatives"}, {"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT001287": "Androstenediols"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001013": "Androstenols"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "0601011A0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}, {"/indications/DBCOND0043991": "Gestational Diabetes Mellitus (GDM)"}, {"/indications/DBCOND0086184": "Ketoacidosis, Diabetic"}, {"/indications/DBCOND0022905": "Type 1 Insulin-Dependent Diabetes Mellitus"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}, {"/indications/DBCOND0023008": "Hyperglycemia during critical illness"}], "Name": "Insulin Aspart", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000135": "Insulin, Short-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002120": "Insulins and Analogues for Injection, Fast-Acting"}, {"/categories/DBCAT002119": "Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "0207020Y0": {"Conditions": [{"/indications/DBCOND0055853": "Symptomatic Orthostatic Hypotension"}], "Name": "Midodrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0606020Y0": {"Conditions": [{"/indications/DBCOND0002088": "Osteogenesis Imperfecta"}, {"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0022002": "Osteoporosis caused by glucocorticoid"}, {"/indications/DBCOND0038793": "Paget's Disease"}], "Name": "Alendronic Acid & Colecalciferol", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}]}, "0205052I0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Irbesartan", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT001238": "Angiotensin II"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT001168": "Angiotensin II Type 2 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001053": "Biphenyl Compounds"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000923": "Spiro Compounds"}, {"/categories/DBCAT000407": "Tetrazoles"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "0501080J0": {"Conditions": [{"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0020991": "Meningitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0014593": "Nocardiosis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0013910": "Toxoplasmosis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0060388": "Wound Sepsis"}, {"/indications/DBCOND0020994": "Bacterial otitis media caused by Haemophilus influenzae"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0020988": "Recurrent Rheumatic fever"}], "Name": "Sulfadiazine", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000789": "Coccidiostats"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT002336": "Intermediate-Acting Sulfonamides"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0406000B0": {"Conditions": [{"/indications/DBCOND0066647": "Meni\u00e8re's Disease"}], "Name": "Betahistine Hydrochloride", "Categories": [{"/categories/DBCAT002412": "Antivertigo Preparations"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000652": "Histamine Agonists"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0310000N0": {"Conditions": [{"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Pseudoephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002351": "Nasal Decongestants for Systemic Use"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0212000R0": {"Conditions": [{"/indications/DBCOND0040592": "Coronary Heart Disease (CHD)"}, {"/indications/DBCOND0032660": "Dyslipidemias"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0037835": "High Cholesterol"}, {"/indications/DBCOND0072083": "Peripheral Artery Disease (PAD)"}, {"/indications/DBCOND0020724": "Primary prevention Coronary artery disease"}, {"/indications/DBCOND0020720": "Primary prevention Myocardial infarction"}, {"/indications/DBCOND0020721": "Primary prevention Unstable angina"}], "Name": "Lovastatin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1202020I0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0060739": "Nasal Congestion Associated With the Common Cold"}, {"/indications/DBCOND0077443": "Non-Allergic Rhinitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0097126": "Acute asthma exacerbations"}], "Name": "Ipratropium Bromide", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "1311070K0": {"Conditions": [{"/indications/DBCOND0028900": "Skin Ulcers"}], "Name": "Becaplermin", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000215": "Angiogenesis Inducing Agents"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT002133": "Cicatrizants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000208": "DNA-Binding Proteins"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT003278": "Human Platelet-derived Growth Factor"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000212": "Neoplasm Proteins"}, {"/categories/DBCAT000211": "Oncogene Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT003002": "Phosphate salts"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000209": "Platelet-Derived Growth Factor"}, {"/categories/DBCAT002134": "Preparations for Treatment of Wounds and Ulcers"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000210": "Proto-Oncogene Proteins"}, {"/categories/DBCAT004971": "Proto-Oncogene Proteins c-sis"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0208020H0": {"Conditions": [{"/indications/DBCOND0035611": "Coronary Occlusions"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0077405": "Systemic Embolism"}, {"/indications/DBCOND0034329": "Thrombosis, Venous"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}], "Name": "Acenocoumarol", "Categories": [{"/categories/DBCAT000640": "4-Hydroxycoumarins"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000641": "Coumarins"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT002267": "Vitamin K Antagonists"}]}, "0503040C0": {"Conditions": [{"/indications/DBCOND0027953": "Cerebral Arteriosclerosis"}, {"/indications/DBCOND0017943": "Chorea"}, {"/indications/DBCOND0020744": "Extrapyramidal disorder caused by neuroleptic drugs without Tardive dyskinesia"}, {"/indications/DBCOND0036858": "Influenza A Virus Infection"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0089213": "Parkinsonism post encephalitic"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0068086": "Tiredness"}], "Name": "Amantadine Hydrochloride", "Categories": [{"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT002485": "Adamantane Derivatives"}, {"/categories/DBCAT003739": "Adamantanes"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003356": "Influenza A M2 Protein Inhibitor"}, {"/categories/DBCAT004305": "M2 Protein Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0406000P0": {"Conditions": [{"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0031743": "Diabetic Gastroparesis"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0010729": "Hiccups"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0036564": "Reflux, Gastroesophageal"}, {"/indications/DBCOND0022944": "Gastric bezoar"}, {"/indications/DBCOND0022946": "Radiation therapy induced nausea and vomiting"}], "Name": "Metoclopramide Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000995": "Chlorobenzoates"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001311": "Hydroxybenzoate Ethers"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003753": "Prokinetic Agents"}, {"/categories/DBCAT002422": "Propulsives"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0402010J0": {"Conditions": [{"/indications/DBCOND0033851": "Aggressive Behavior"}, {"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0003735": "Delirium"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0053941": "Huntington's Disease (HD)"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0051503": "Psychotic Disorder NOS"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0021429": "Severe Hyperactivity"}, {"/indications/DBCOND0021428": "Severe disruptive behaviour disorder"}], "Name": "Haloperidol", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002383": "Butyrophenone Derivatives"}, {"/categories/DBCAT000878": "Butyrophenones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0206040AM": {"Conditions": [{"/indications/DBCOND0025206": "Mental activity decreased"}], "Name": "Co-Dergocrine Mesilate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT001251": "Dihydroergotoxine"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003643": "Ergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT000741": "Ergotamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000278": "Nootropic Agents"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT003663": "Sympatholytic (Adrenergic Blocking) Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1310020U0": {"Conditions": [{"/indications/DBCOND0028285": "Oral Candidiasis"}, {"/indications/DBCOND0022068": "Mucocutaneous candida infection"}], "Name": "Nystatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001029": "Ionophores"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}]}, "0206040AG": {"Conditions": [{"/indications/DBCOND0000739": "Intermittent Claudication"}, {"/indications/DBCOND0066635": "Venous Leg Ulcer (VLU)"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}], "Name": "Pentoxifylline", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT003405": "Blood Viscosity Reducer"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004469": "Hematologic Activity Alteration"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT003722": "Hemorrheologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002469": "Purine Derivatives"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT001034": "Xanthine derivatives"}]}, "110301050": {"Conditions": [{"/indications/DBCOND0014043": "Cystitis"}, {"/indications/DBCOND0025415": "Gonococcal cervicitis"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0025413": "Pyelitis"}, {"/indications/DBCOND0014040": "Pyelonephritis"}, {"/indications/DBCOND0063099": "Spontaneous Bacterial Peritonitis (SBP)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0014600": "Urethritis gonococcal"}], "Name": "Norfloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0402010X0": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0024408": "Acute non-psychotic Anxiety"}], "Name": "Trifluoperazine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002373": "Phenothiazines With Piperazine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "1104020W0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}], "Name": "Azelastine Hydrochloride", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT000422": "Lipoxygenase Inhibitors"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT001326": "Pyridazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0205040W0": {"Conditions": [{"/indications/DBCOND0071316": "Pheochromocytomas"}], "Name": "Metirosine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT003401": "Catecholamine Synthesis Inhibitor"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001117": "Methyltyrosines"}, {"/categories/DBCAT000465": "Tyrosine"}, {"/categories/DBCAT002762": "Tyrosine Hydroxylase Inhibitors"}]}, "1002010U0": {"Conditions": [{"/indications/DBCOND0044732": "Disseminated Sclerosis"}], "Name": "Fampridine", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000588": "Aminopyridines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT004105": "Potassium Channel Antagonists"}, {"/categories/DBCAT000519": "Potassium Channel Blockers"}, {"/categories/DBCAT000227": "Pyridines"}]}, "0213000D0": {"Conditions": [{"/indications/DBCOND0023424": "Incompetent accessory saphenous veins"}, {"/indications/DBCOND0023423": "Incompetent great saphenous veins"}, {"/indications/DBCOND0025659": "Uncomplicated veins 1 to 3 mm in diameter reticular veins"}, {"/indications/DBCOND0080571": "Uncomplicated veins <1 mm in diameter Spider Veins"}, {"/indications/DBCOND0025660": "Varicosities of the great saphenous vein"}], "Name": "Laureth 9", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001419": "Detergents"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT001605": "Polyethylene Glycols"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT004100": "Sclerosing Activity"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT000898": "Surface-Active Agents"}, {"/categories/DBCAT004101": "Vascular Sclerosing Activity"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0407020J0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Levorphanol Tartrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0404000M0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0017525": "Narcolepsy"}], "Name": "Methylphenidate Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT002179": "Centrally Acting Sympathomimetics"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004580": "Methylphenidate and isomer"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT003636": "Respiratory and CNS Stimulants"}]}, "0106070B0": {"Conditions": [{"/indications/DBCOND0037414": "Chronic Idiopathic Constipation"}, {"/indications/DBCOND0060222": "Constipation-predominant Irritable Bowel Syndrome (IBS-C)"}], "Name": "Linaclotide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003063": "Enzyme Activators"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004134": "Guanylate Cyclase Activators"}, {"/categories/DBCAT003498": "Guanylate Cyclase-C Agonist"}, {"/categories/DBCAT005018": "Guanylyl Cyclase C Agonists"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}]}, "0107030P0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0501120X0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0046769": "Acute Pyelonephritis"}, {"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0014773": "Cellulitis"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0025434": "Cystic fibrosis pulmonary exacerbation caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0000210": "Diverticulitis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0014560": "Furuncle"}, {"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0033969": "Postoperative Wound Infection"}, {"/indications/DBCOND0021609": "Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0042748": "Prosthetic Joint Infection"}, {"/indications/DBCOND0014093": "Pyoderma"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0030388": "Wound Infections"}, {"/indications/DBCOND0025759": "Complicated Skin and subcutaneous tissue bacterial infection"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Levofloxacin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001277": "Ofloxacin"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0704040F0": {"Conditions": [{"/indications/DBCOND0028936": "Interstitial Cystitis"}], "Name": "Dimethyl Sulfoxide", "Categories": [{"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004769": "Dimethyl Sulfoxide"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002207": "Urologicals"}]}, "131002010": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}, {"/indications/DBCOND0001896": "Dental Plaque"}, {"/indications/DBCOND0073735": "Gingival Inflammation"}], "Name": "Triclosan", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT001001": "Fatty Acid Synthesis Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT004833": "Triclosan"}]}, "0205010E0": {"Conditions": [{"/indications/DBCOND0065242": "Hyperinsulinemic Hypoglycemia"}], "Name": "Diazoxide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002508": "Drugs for Treatment of Hypoglycemia"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002509": "Thiazide Derivatives"}, {"/categories/DBCAT000576": "Thiazides"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0801050R0": {"Conditions": [{"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0022070": "Inoperable Adrenocortical carcinoma"}], "Name": "Mitotane", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT000856": "Hydrocarbons, Chlorinated"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}]}, "0408010Q0": {"Conditions": [{"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0024115": "Seizures"}], "Name": "Phenytoin Sodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT004675": "Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003887": "Cytochrome P-450 CYP2C19 Substrates (moderate)"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004507": "Cytochrome P-450 CYP2D6 Inducers (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004282": "Cytochrome P450 2D6 Inducers"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT004731": "Phenytoin"}, {"/categories/DBCAT002678": "Phenytoin and Prodrugs"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT002665": "UGT1A6 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1309000W0": {"Conditions": [{"/indications/DBCOND0031762": "Androgenetic Alopecia"}, {"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0106237": "Symptomatic Benign Prostatic Hyperplasia"}], "Name": "Finasteride", "Categories": [{"/categories/DBCAT001276": "5-alpha Reductase Inhibitors"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001274": "Azasteroids"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0801030AA": {"Conditions": [{"/indications/DBCOND0083559": "Acute Lymphoblastic Leukaemia Recurrent"}, {"/indications/DBCOND0058624": "Refractory Acute Lymphoblastic Leukemia"}, {"/indications/DBCOND0036504": "Refractory Acute Myeloid Leukemia"}, {"/indications/DBCOND0022006": "Refractory Langerhans cell histiocytosis"}], "Name": "Clofarabine", "Categories": [{"/categories/DBCAT000290": "Adenine Nucleotides"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000481": "Arabinonucleosides"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002249": "Purine Analogues"}, {"/categories/DBCAT000293": "Purine Nucleotides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0801030AB": {"Conditions": [{"/indications/DBCOND0089326": "Lymphoblastic lymphoma (Precursor T-lymphoblastic lymphoma/leukemia) refractory"}, {"/indications/DBCOND0058624": "Refractory Acute Lymphoblastic Leukemia"}], "Name": "Nelarabine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002249": "Purine Analogues"}]}, "0801030AC": {"Conditions": [{"/indications/DBCOND0028572": "Chronic Myelomonocytic Leukemia"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0028565": "Refractory Anemia"}, {"/indications/DBCOND0028567": "Refractory Anemia With Excess Blasts in Transformation"}, {"/indications/DBCOND0028568": "Refractory Anemia With Ringed Sideroblasts"}, {"/indications/DBCOND0006906": "Refractory anaemia with an excess of blasts"}], "Name": "Azacitidine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0801030AD": {"Conditions": [{"/indications/DBCOND0036667": "Advanced Gastric Cancer"}], "Name": "Tegafur/Gimeracil/Oteracil", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003851": "Fluoropyrimidines"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "0801030AE": {"Conditions": [{"/indications/DBCOND0028572": "Chronic Myelomonocytic Leukemia"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0027951": "Myelodysplastic Syndromes"}, {"/indications/DBCOND0028565": "Refractory Anemia"}, {"/indications/DBCOND0028567": "Refractory Anemia With Excess Blasts in Transformation"}, {"/indications/DBCOND0028568": "Refractory Anemia With Ringed Sideroblasts"}], "Name": "Decitabine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT004993": "Azacitidine"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0801030AF": {"Conditions": [{"/indications/DBCOND0063579": "Metastatic Colorectal Cancers"}, {"/indications/DBCOND0021195": "Primary keratoconjunctivitis caused by herpes simplex virus type 2"}, {"/indications/DBCOND0021202": "Recurrent epithelial keratitis caused by herpes simplex 2"}, {"/indications/DBCOND0021205": "Vaccinia infection in the cornea and conjunctiva"}, {"/indications/DBCOND0021204": "Vaccinia virus ophthalmic infections"}], "Name": "Trifluridine/Tipiracil", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003306": "Nucleoside Analog Antiviral"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000858": "Thymidine"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0204000M0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0024761": "Gastroesophageal variceal hemorrhage prophylaxis"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0021770": "Thyrotoxicosis"}], "Name": "Nadolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0208020Z0": {"Conditions": [{"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0025031": "Deep vein thrombosis recurrent"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0023266": "Recurrent pulmonary embolism"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0077405": "Systemic Embolism"}], "Name": "Apixaban", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000012": "Antithrombins"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001775": "Factor Xa Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000001": "Serine Proteinase Inhibitors"}]}, "0801050L0": {"Conditions": [{"/indications/DBCOND0060596": "Advanced Soft Tissue Sarcoma"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0022381": "Advanced Medullary thyroid cancer"}, {"/indications/DBCOND0022987": "Advanced Pancreatic neuroendocrine tumor"}], "Name": "Dacarbazine", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001163": "Triazenes"}]}, "0408010C0": {"Conditions": [{"/indications/DBCOND0034548": "Acute Mania"}, {"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0060919": "Generalized Tonic Clonic Seizures"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0061516": "Partial Seizures With Secondary Generalization"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Carbamazepine", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT002411": "Carboxamide Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002612": "Cytochrome P-450 CYP1A2 Inducers (strong)"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT003110": "Cytochrome P-450 CYP2C19 Inducers (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004492": "Cytochrome P-450 CYP3A5 Inducers (weak)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT004046": "UGT1A6 inducer"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT004613": "UGT2B7 substrates with narrow therapeutic index"}]}, "0403010L0": {"Conditions": [{"/indications/DBCOND0053691": "Bipolar Affective Disorders"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0028430": "Depression, Involutional"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0021660": "Neurotic depression"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0019903": "Pruritus"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0119119": "Psychotic depressive disorder"}], "Name": "Doxepin", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001120": "Dibenzoxepins"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000835": "Ethers, Cyclic"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0704010V0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0051310": "Benign Prostatic Hypertrophy (BPH)"}, {"/indications/DBCOND0036147": "Bladder Outlet Obstruction"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}], "Name": "Tamsulosin & Dutasteride Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT003670": "Selective Alfa-1-adrenergic Blocking Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0702020D0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0030131": "Invasive Fungal Infections"}, {"/indications/DBCOND0013913": "Leishmaniasis"}, {"/indications/DBCOND0000139": "Meningitis, Cryptococcal"}, {"/indications/DBCOND0073780": "Meningitis, Fungal"}, {"/indications/DBCOND0051127": "Mucocutaneous Leishmaniasis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0033119": "Visceral Leishmaniasis"}, {"/indications/DBCOND0022121": "Candidal cystitis"}, {"/indications/DBCOND0022118": "Disseminated Cryptococcosis"}, {"/indications/DBCOND0022122": "Fungal endophthalmitis"}, {"/indications/DBCOND0022119": "Fungal osteoarticular infections"}, {"/indications/DBCOND0022123": "Ocular aspergillosis"}, {"/indications/DBCOND0025294": "Refractory aspergillosis"}, {"/indications/DBCOND0022131": "Severe Coccidioidomycosis"}, {"/indications/DBCOND0022126": "Severe Cryptococcosis"}, {"/indications/DBCOND0022140": "Severe Fungal infection caused by Basidiobolus spp."}, {"/indications/DBCOND0022137": "Severe Fungal infection caused by Conidiobolus spp."}, {"/indications/DBCOND0022143": "Severe Fungal infection caused by sporotrichosis spp."}, {"/indications/DBCOND0022132": "Severe Histoplasmosis"}, {"/indications/DBCOND0022144": "Severe Mucocutaneous leishmaniasis"}, {"/indications/DBCOND0022128": "Severe North American blastomycosis"}, {"/indications/DBCOND0022130": "Severe Systemic candidiasis"}], "Name": "Amphotericin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001054": "Biomimetic Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000064": "Drug Carriers"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001062": "Investigative Techniques"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003390": "Lipid-based Polyene Antifungal"}, {"/categories/DBCAT001064": "Liposomes"}, {"/categories/DBCAT000983": "Membranes, Artificial"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "1310020S0": {"Conditions": [{"/indications/DBCOND0024718": "Toxic effect of hydrocyanic acid and cyanides"}], "Name": "Sodium Thiosulfate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}]}, "0801000W0": {"Conditions": [{"/indications/DBCOND0031602": "Oral Mucositis"}], "Name": "Palifermin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000119": "Fibroblast Growth Factors"}, {"/categories/DBCAT004461": "Increased Epithelial Proliferation"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT003254": "Mucocutaneous Epithelial Cell Growth Factor"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0203020S0": {"Conditions": [{"/indications/DBCOND0070681": "Supraventricular Arrhythmias"}, {"/indications/DBCOND0085135": "Ventricular Tachycardia (VT)"}, {"/indications/DBCOND0025388": "Life-threatening ventricular arrhythmias"}, {"/indications/DBCOND0022645": "Pre-excited atrial fibrillation"}], "Name": "Procainamide Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002277": "Antiarrhythmics, Class Ia"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT004525": "MATE 1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT004526": "MATE 2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0801030W0": {"Conditions": [{"/indications/DBCOND0089403": "B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma refractory"}, {"/indications/DBCOND0024997": "Refractory Non-Hodgkin's lymphoma"}], "Name": "Fludarabine Phosphate", "Categories": [{"/categories/DBCAT000290": "Adenine Nucleotides"}, {"/categories/DBCAT000251": "Adenosine"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000481": "Arabinonucleosides"}, {"/categories/DBCAT002900": "Arabinonucleotides"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT004992": "DNA (Cytosine-5-)-Methyltransferases, antagonists & inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002249": "Purine Analogues"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000293": "Purine Nucleotides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1310040Q0": {"Conditions": [{"/indications/DBCOND0025572": "Norwegian scabies"}, {"/indications/DBCOND0000256": "Scabies"}, {"/indications/DBCOND0024506": "Lice of the head"}, {"/indications/DBCOND0024508": "Lice of the pubic area"}], "Name": "Permethrin", "Categories": [{"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002370": "Ectoparasiticides, Incl. Scabicides"}, {"/categories/DBCAT002371": "Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000857": "Insecticides"}, {"/categories/DBCAT001046": "Monoterpenes"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT002555": "Pyrethrines, Incl. Synthetic Compounds"}, {"/categories/DBCAT001640": "Pyrethrins"}, {"/categories/DBCAT003648": "Scabicides and Pediculicides"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0409010Z0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0025579": "Moderate restless leg syndrome"}, {"/indications/DBCOND0025578": "Severe restless leg syndrome"}], "Name": "Rotigotine", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0410020A0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0029996": "Seasonal Affective Disorder (SAD)"}], "Name": "Bupropion Hydrochloride", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003429": "Aminoketone"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004066": "Increased Dopamine Activity"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003624": "Miscellaneous Antidepressants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001282": "Propiophenones"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT004978": "Smoking Cessation Agents"}]}, "0801000Y0": {"Conditions": [{"/indications/DBCOND0024132": "Prophylaxis of cardiomyopathy"}], "Name": "Dexrazoxane", "Categories": [{"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003319": "Cytoprotective Agent"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000814": "Diketopiperazines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "1304000AB": {"Conditions": [{"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0087977": "Skin Inflammation"}], "Name": "Ulobetasol Propionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000201": "Psoriasis"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1001030R0": {"Conditions": [{"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0080997": "Neonatal-onset multisystemic inflammatory disease"}, {"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0020320": "Recurrent Pericarditis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Anakinra", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT004385": "Interleukin 1 Receptor Antagonists"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT002727": "Interleukin-1 Receptor Antagonist"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "1203030V0": {"Conditions": [{"/indications/DBCOND0001896": "Dental Plaque"}], "Name": "Thymol", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001046": "Monoterpenes"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0601023R0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Repaglinide", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT003395": "Glinide"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003738": "Meglitinides"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT004105": "Potassium Channel Antagonists"}, {"/categories/DBCAT001189": "Stereoisomerism"}]}, "1201020P0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone-Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "1310020Y0": {"Conditions": [{"/indications/DBCOND0014342": "Dermatophytosis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}], "Name": "Tolnaftate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000949": "Thiocarbamates"}]}, "130300010": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Oxide", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "1001030D0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0054533": "Hidradenitis Suppurativa (HS)"}, {"/indications/DBCOND0025601": "Polyarticular Juvenile Idiopathic Arthritis"}, {"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Etanercept", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT002952": "Immunoglobulin Constant Regions"}, {"/categories/DBCAT002951": "Immunoglobulin Fc Fragments"}, {"/categories/DBCAT001915": "Immunoglobulin Fragments"}, {"/categories/DBCAT000026": "Immunoglobulin Isotypes"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT001722": "Peptide Fragments"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000030": "Receptors, Cell Surface"}, {"/categories/DBCAT000028": "Receptors, Cytokine"}, {"/categories/DBCAT000029": "Receptors, Immunologic"}, {"/categories/DBCAT000027": "Receptors, Tumor Necrosis Factor"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002087": "Tumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors"}, {"/categories/DBCAT003245": "Tumor Necrosis Factor Blocker"}, {"/categories/DBCAT004095": "Tumor Necrosis Factor Receptor Blocking Activity"}]}, "0401010AD": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Melatonin", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT004764": "Melatonin"}, {"/categories/DBCAT002489": "Melatonin Receptor Agonists"}, {"/categories/DBCAT001822": "Melatonin, agonists"}, {"/categories/DBCAT004765": "Melatonin, antagonists & inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT001049": "Tryptamines"}]}, "0401010AC": {"Conditions": [{"/indications/DBCOND0003367": "Cataplexy"}, {"/indications/DBCOND0033391": "Excessive Daytime Sleepiness"}], "Name": "Sodium Oxybate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT000683": "Anesthetics, Intravenous"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001363": "Hydroxybutyrates"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT002148": "Nervous System"}]}, "0401020B0": {"Conditions": [{"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0018735": "Depression"}], "Name": "Buspirone Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002398": "Azaspirodecanedione Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000923": "Spiro Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0403020H0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}], "Name": "Isocarboxazid", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002461": "Monoamine Oxidase Inhibitors, Non-Selective"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0407041F0": {"Conditions": [{"/indications/DBCOND0003590": "Cluster Headache"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0000663": "Vascular Headaches"}], "Name": "Ergotamine Tartrate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003327": "Ergotamine Derivative"}, {"/categories/DBCAT000741": "Ergotamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003663": "Sympatholytic (Adrenergic Blocking) Agents"}, {"/categories/DBCAT000218": "Uterotonic agents"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1308010V0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024172": "FAB classification M3 Acute promyelocytic leukemia"}, {"/indications/DBCOND0036306": "Solar Lentigines"}, {"/indications/DBCOND0024211": "Facial fine wrinkling"}, {"/indications/DBCOND0025747": "Moderate Melasma"}, {"/indications/DBCOND0022269": "Mottled hyperpigmentation"}, {"/indications/DBCOND0025746": "Severe Melasma"}, {"/indications/DBCOND0024176": "Severe, recalcitrant Cystic acne"}, {"/indications/DBCOND0024174": "Tactile roughness of facial skin"}], "Name": "Tretinoin", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT003717": "Cell Stimulants and Proliferants"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0403020Q0": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}], "Name": "Tranylcypromine Sulfate", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002461": "Monoamine Oxidase Inhibitors, Non-Selective"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0406000M0": {"Conditions": [{"/indications/DBCOND0028521": "Nausea and vomiting"}], "Name": "Granisetron Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004178": "Serotonin 3 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0501090I0": {"Conditions": [{"/indications/DBCOND0050152": "Active Tuberculosis"}], "Name": "Ethionamide", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT001001": "Fatty Acid Synthesis Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001000": "Isonicotinic Acids"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT002423": "Thiocarbamide Derivatives"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0401020P0": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0003708": "Alcohol Withdrawal Delirium"}, {"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0003718": "Catatonia"}, {"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0003735": "Delirium"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0053860": "Muscle Spasms"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Lorazepam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0601012Z0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Insulin Degludec", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT003257": "Insulin Analog"}, {"/categories/DBCAT000138": "Insulin, Long-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT002119": "Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting"}, {"/categories/DBCAT002121": "Insulins and Analogues for Injection, Long-Acting"}, {"/categories/DBCAT004662": "Long-acting Insulins"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "0301011Z0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Olodaterol", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}]}, "0409010T0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Selegiline Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002494": "Monoamine Oxidase B Inhibitors"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT004089": "Monoamine Oxidase-B Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "1106000X0": {"Conditions": [{"/indications/DBCOND0038951": "Dry Mouth"}, {"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}], "Name": "Pilocarpine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003290": "Cholinergic Receptor Agonist"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000836": "Miotics"}, {"/categories/DBCAT000447": "Muscarinic Agonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT004766": "Pilocarpine"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0304010N0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0031602": "Oral Mucositis"}, {"/indications/DBCOND0024062": "Parkinsonian Syndromes"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0035432": "Skin Rash"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0024669": "Upper respiratory tract hypersensitivity reaction, site unspecified"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0022265": "Dermatographism"}], "Name": "Diphenhydramine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003673": "Ethanolamine Derivatives"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003748": "First Generation Antihistamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}]}, "0207010H0": {"Conditions": [{"/indications/DBCOND0000492": "Adams-Stokes Syndrome"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0031003": "Cardiac Arrest"}, {"/indications/DBCOND0115251": "Cardiac electrical storm"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0032425": "Heart Block"}, {"/indications/DBCOND0020135": "Hypoperfusion"}, {"/indications/DBCOND0000550": "Shock, Cardiogenic"}, {"/indications/DBCOND0000299": "Shock, Septic"}, {"/indications/DBCOND0070941": "Symptomatic Bradycardia"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}, {"/indications/DBCOND0022711": "Beta blocker overdose"}], "Name": "Isoprenaline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003747": "Non-selective Beta-adrenergic Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "1108020L0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0042226": "Ocular Irritation"}], "Name": "Glycerol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT004060": "Increased IgG Production"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003529": "Non-Standardized Chemical Allergen"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003729": "Other Cold and Cough Preparations"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT004975": "Triose Sugar Alcohols"}]}, "1106000J0": {"Conditions": [{"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}, {"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Carbachol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000510": "Choline"}, {"/categories/DBCAT002364": "Choline Esters"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003290": "Cholinergic Receptor Agonist"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000836": "Miotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0405020R0": {"Conditions": [{"/indications/DBCOND0023881": "BMI >30 kg/m2"}], "Name": "Phentermine", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000472": "Anti-Obesity Agents"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000473": "Appetite Depressants"}, {"/categories/DBCAT004277": "Appetite Suppression"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004278": "Increased Sympathetic Activity"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003292": "Sympathomimetic Amine Anorectic"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0803041AA": {"Conditions": [{"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}, {"/indications/DBCOND0023213": "Refractory, metastatic Breast cancer"}], "Name": "Fulvestrant", "Categories": [{"/categories/DBCAT002405": "Anti-Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT001293": "Estradiol"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT001199": "Estrogen Receptor Antagonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0905022H0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Calcium Carbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "0503010G0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Lopinavir & Ritonavir", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT003038": "Cytochrome P-450 CYP2C9 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0503021C0": {"Conditions": [{"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0005172": "Chickenpox"}, {"/indications/DBCOND0003600": "Encephalitis, Herpes Simplex"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0028191": "Herpes Zoster"}, {"/indications/DBCOND0024319": "Herpes simplex of the oral-labial"}, {"/indications/DBCOND0025063": "Herpes simplex type I reactivation"}, {"/indications/DBCOND0049565": "Infections, Cytomegalovirus"}, {"/indications/DBCOND0032971": "Recurrent Genital Herpes (RGH)"}, {"/indications/DBCOND0033308": "Recurrent Herpes Labialis"}, {"/indications/DBCOND0024387": "VZV re-activation"}, {"/indications/DBCOND0022321": "Acute Genital herpes"}, {"/indications/DBCOND0024389": "Acute Herpes labialis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0024381": "Severe Genital herpes"}], "Name": "Aciclovir", "Categories": [{"/categories/DBCAT002686": "Acyclovir and prodrug"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003553": "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1001040G0": {"Conditions": [{"/indications/DBCOND0028387": "Behcet's Syndrome"}, {"/indications/DBCOND0054711": "Chronic Gouty Arthritis"}, {"/indications/DBCOND0067538": "Familial Mediterranean Fever (FMF )"}, {"/indications/DBCOND0059958": "Gout Flares"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0000465": "Postpericardiotomy Syndrome"}], "Name": "Colchicine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT004339": "P-Glycoprotein Interactions"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002529": "Preparations With No Effect on Uric Acid Metabolism"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "0101010U0": {"Conditions": [{"/indications/DBCOND0004515": "Heartburn"}], "Name": "Sodium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001532": "Buffers"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT002728": "Citric Acid Derivatives"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT001548": "Food Preservatives"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003770": "Miscellaneous Anticoagulants"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0602020M0": {"Conditions": [{"/indications/DBCOND0029058": "Graves' Disease"}, {"/indications/DBCOND0009048": "Hyperthyroidism"}, {"/indications/DBCOND0021678": "Toxic multinodular goiter"}], "Name": "Thiamazole", "Categories": [{"/categories/DBCAT004964": "Antithyroid agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT003897": "Cytochrome P-450 CYP2A6 Inhibitors (weak)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002354": "Sulfur-Containing Imidazole Derivatives"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT003370": "Thyroid Hormone Synthesis Inhibitor"}, {"/categories/DBCAT004343": "Thyroid Hormone Synthesis Inhibitors"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0407010K0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0408020V0": {"Conditions": [{"/indications/DBCOND0034792": "Seizures, Epileptic"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Midazolam Maleate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003829": "Triazolobenzodiazepines"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "1201010H0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Chloramphenicol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002381": "Amphenicols"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001884": "Chloramphenicol"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT000875": "Nitrobenzenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1001010L0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0025357": "Postpartum pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Ketoprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0210020V0": {"Conditions": [{"/indications/DBCOND0042695": "Acute Ischemic Stroke (AIS)"}, {"/indications/DBCOND0032772": "Acute Myocardial Infarction (AMI)"}, {"/indications/DBCOND0025228": "Acute massive pulmonary embolism"}, {"/indications/DBCOND0020260": "Central venous access device thrombosis"}], "Name": "Alteplase", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000068": "Endopeptidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000069": "Peptide Hydrolases"}, {"/categories/DBCAT000074": "Plasminogen Activators"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000067": "Serine Endopeptidases"}, {"/categories/DBCAT000073": "Serine Proteases"}, {"/categories/DBCAT004683": "Tissue Plasminogen Activator"}, {"/categories/DBCAT004682": "Tissue Plasminogen Activator, antagonists & inhibitors"}]}, "0212000Q0": {"Conditions": [{"/indications/DBCOND0040592": "Coronary Heart Disease (CHD)"}, {"/indications/DBCOND0023044": "Fredrickson classification type IV Hyperlipidemia"}, {"/indications/DBCOND0023046": "Fredrickson classification type V Hyperlipidemia"}], "Name": "Gemfibrozil", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT001018": "Fibric Acids"}, {"/categories/DBCAT003745": "Fribic Acid Derivatives"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001019": "Isobutyrates"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000731": "Pentanoic Acids"}, {"/categories/DBCAT003423": "Peroxisome Proliferator Receptor alpha Agonist"}, {"/categories/DBCAT004318": "Peroxisome Proliferator-activated Receptor alpha Agonists"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004454": "UGT1A3 Inhibitors"}, {"/categories/DBCAT000732": "Valerates"}]}, "1310011M0": {"Conditions": [{"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0106112": "Impetigo caused by Staphylococccus aureus"}, {"/indications/DBCOND0106113": "Impetigo caused by streptococcus pyogenes"}, {"/indications/DBCOND0021118": "Secondary infection Skin infection"}, {"/indications/DBCOND0024316": "Staphylococcus aurea colonization of the nasal passage"}], "Name": "Mupirocin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000834": "Epoxy Compounds"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000835": "Ethers, Cyclic"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004737": "Mupirocin"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT003344": "RNA Synthetase Inhibitor Antibacterial"}, {"/categories/DBCAT004255": "RNA Synthetase Inhibitors"}]}, "1305010AF": {"Conditions": [{"/indications/DBCOND0109682": "Chronic Eczema of the hand"}, {"/indications/DBCOND0021486": "Cutaneous lesions"}, {"/indications/DBCOND0093522": "Refractory Eczema of the hand"}, {"/indications/DBCOND0109683": "Severe Eczema of the hand"}], "Name": "Alitretinoin", "Categories": [{"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "1305010AE": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Paste & Ichthammol", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "1305010AB": {"Conditions": [{"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}], "Name": "Mycophenolate Mofetil", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT003391": "Antimetabolite Immunosuppressant"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001071": "IMP Dehydrogenase, antagonists & inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1305010AC": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Paste & Calamine", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "1310020N0": {"Conditions": [{"/indications/DBCOND0078869": "Diaper Dermatitis"}, {"/indications/DBCOND0080575": "Fungal infection of nail"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0022776": "Cutaneous candidiasis infection"}], "Name": "Miconazole Nitrate", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "0408020D0": {"Conditions": [{"/indications/DBCOND0022715": "Akinetic seizures"}, {"/indications/DBCOND0001972": "Burning Mouth Syndrome"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0023239": "Lennox-Gastaut Syndrome (LGS)"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0025419": "Rapid Eye Movement Sleep Disorder"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0031588": "Tardive Dyskinesia"}, {"/indications/DBCOND0082481": "Tremor, Essential"}, {"/indications/DBCOND0024512": "Acute Manic episode"}, {"/indications/DBCOND0022716": "Myoclonic seizures"}, {"/indications/DBCOND0024634": "Refractory absence Seizures"}], "Name": "Clonazepam", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}]}, "0208020I0": {"Conditions": [{"/indications/DBCOND0013324": "Cystitis interstitial"}], "Name": "Pentosan Polysulfate Sodium", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0101021C0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Calcium Carbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "0102000Q0": {"Conditions": [{"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0071172": "Neurogenic Bladder Dysfunction"}, {"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Oxybutynin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0402010I0": {"Conditions": [{"/indications/DBCOND0017943": "Chorea"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0051503": "Psychotic Disorder NOS"}], "Name": "Fluphenazine Hydrochloride", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002373": "Phenothiazines With Piperazine Structure"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1003020R0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Piroxicam", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002395": "Oxicams"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "0801020R0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0034998": "Acute Myelogenous Leukaemia (AML)"}, {"/indications/DBCOND0054528": "Acute Promyelocytic Leukemia (APL)"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0042710": "Progressive Relapsing Multiple Sclerosis"}, {"/indications/DBCOND0035052": "Relapsed Leukemia"}, {"/indications/DBCOND0042144": "Relapsed Lymphomas"}, {"/indications/DBCOND0036413": "Relapsing Remitting Multiple Sclerosis (RRMS)"}, {"/indications/DBCOND0049960": "Secondary Progressive Multiple Sclerosis (SPMS)"}, {"/indications/DBCOND0022915": "Hormone refractory, advanced Prostate cancer"}, {"/indications/DBCOND0025000": "Relapsed Hepatocellular carcinoma"}], "Name": "Mitoxantrone", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT001196": "Anthracenes"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT001296": "Anthraquinones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000386": "Quinones"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0212000B0": {"Conditions": [{"/indications/DBCOND0066917": "Anginal Pain"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0022726": "Dysbetalipoproteinemia"}, {"/indications/DBCOND0106234": "Fredrickson Type III lipidemia"}, {"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0037835": "High Cholesterol"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0033563": "Hospitalization"}, {"/indications/DBCOND0044916": "Hypertriglyceridemias"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0106231": "Non-familial hypercholesterolemia"}, {"/indications/DBCOND0034849": "Revascularization"}, {"/indications/DBCOND0106232": "Serum triglycerides increased"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0106235": "Heterozygous familial hyperlipidemia"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0106236": "Non-familial hyperlipidemia"}, {"/indications/DBCOND0104979": "Non-fatal myocardial infarction"}, {"/indications/DBCOND0106230": "Revascularization procedures"}, {"/indications/DBCOND0106228": "Revascularization process"}], "Name": "Atorvastatin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001257": "Heptanoic Acids"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "0702010M0": {"Conditions": [{"/indications/DBCOND0023751": "Moderate Dyspareunia"}, {"/indications/DBCOND0023750": "Severe Dyspareunia"}], "Name": "Ospemifene", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003358": "Estrogen Agonist/Antagonist"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000618": "Stilbenes"}]}, "1310012K0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0109271": "Anaerobic Infection"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000922": "Balantidiasis"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0115192": "CNS Infection"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0046593": "Intraabdominal Infections"}, {"/indications/DBCOND0068891": "Lower Respiratory Infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0117815": "Parasitic infection NOS"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0000880": "Pouchitis"}, {"/indications/DBCOND0024985": "Septicemia bacterial anaerobic"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0024983": "Asymptomatic Trichomoniasis"}, {"/indications/DBCOND0020657": "Entamoeba histolytica"}, {"/indications/DBCOND0025546": "Hepatic abscess"}, {"/indications/DBCOND0024987": "Refractory Sinusitis"}, {"/indications/DBCOND0024984": "Symptomatic Trichomoniasis"}], "Name": "Metronidazole", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1306010Z0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024298": "Acne vulgaris of the back"}, {"/indications/DBCOND0024297": "Acne vulgaris of the chest"}, {"/indications/DBCOND0024296": "Acne vulgaris of the face"}], "Name": "Adapalene & Benzoyl Peroxide", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "100302010": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0025357": "Postpartum pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Ketoprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0501030Z0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0116954": "Acute epididymo-orchitis caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0011318": "Anal chlamydia infection"}, {"/indications/DBCOND0106325": "Bacterial Infection caused by Enterobacter aerogenes"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0069537": "Chlamydial Urethritis"}, {"/indications/DBCOND0014462": "Chlamydial cervicitis"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0031183": "Clostridium Infections"}, {"/indications/DBCOND0014610": "Epididymo-orchitis gonococcal"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0077690": "Infection Due to Escherichia Coli"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0053857": "Inhalational Anthrax (Post-Exposure)"}, {"/indications/DBCOND0080081": "Intestinal Amebiasis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0116947": "Rectal infection"}, {"/indications/DBCOND0116946": "Rectal infection caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0116948": "Recurring fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0021921": "Relapsing fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0056153": "Secondary Syphilis"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0014242": "Tick-borne fever"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020776": "Trachoma inclusion conjunctivitis"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0053861": "Typhus Fever"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Doxycycline Monohydrate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0402010W0": {"Conditions": [{"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Thioridazine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002446": "Phenothiazines With Piperidine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0107010N0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0501020V0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0025366": "Bacterial Urinary Tract Infections"}, {"/indications/DBCOND0013258": "Biliary tract infection bacterial"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0014247": "Genital infection"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0079683": "Respiratory Tract Infection Bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0047720": "Surgical Site Infections"}, {"/indications/DBCOND0025511": "Catheter related bloodstream infections"}], "Name": "Cefazolin Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT002385": "First-Generation Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "1104020P0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}], "Name": "Levocabastine", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0205040V0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}], "Name": "Terazosin Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0801050CF": {"Conditions": [{"/indications/DBCOND0093769": "Locally advanced disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC)"}, {"/indications/DBCOND0093773": "Locally advanced disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC)"}, {"/indications/DBCOND0093764": "Metastatic Merkel Cell Carcinoma (MCC)"}, {"/indications/DBCOND0093768": "Metastatic disease has progressed during or following platinum-containing chemotherapy urothelial carcinoma (UC)"}, {"/indications/DBCOND0093772": "Metastatic disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC)"}], "Name": "Avelumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT004242": "Programmed Death Ligand-1 Antagonists"}, {"/categories/DBCAT003819": "Programmed Death Ligand-1 Blocker"}, {"/categories/DBCAT004243": "Programmed Death Ligand-1-directed Antibody Interactions"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0106070C0": {"Conditions": [{"/indications/DBCOND0037414": "Chronic Idiopathic Constipation"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0038981": "Opioid Induced Constipation (OIC)"}], "Name": "Lubiprostone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001248": "Alprostadil"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT001249": "Chloride Channel Agonists"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001122": "Fatty Acids, Monounsaturated"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT001121": "Prostaglandins E"}]}, "0407020M0": {"Conditions": [{"/indications/DBCOND0020938": "Opioid type dependence"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Methadone Hydrochloride", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002316": "Diphenylpropylamine Derivatives"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}]}, "0601011R0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}], "Name": "Insulin Human", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT000135": "Insulin, Short-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT003127": "Insulins and Analogues for Inhalation"}, {"/categories/DBCAT002120": "Insulins and Analogues for Injection, Fast-Acting"}, {"/categories/DBCAT002119": "Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "0605010S0": {"Conditions": [{"/indications/DBCOND0072078": "Adult Onset Growth Hormone Deficiency"}, {"/indications/DBCOND0004466": "Cachexia"}, {"/indications/DBCOND0030698": "Childhood-onset Growth Hormone Deficiency"}, {"/indications/DBCOND0037491": "Growth Failure"}, {"/indications/DBCOND0060188": "Short Bowel Syndrome (SBS)"}, {"/indications/DBCOND0031074": "Short Stature"}], "Name": "Somatropin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT000145": "Growth Hormone"}, {"/categories/DBCAT004692": "Growth Hormone, antagonists & inhibitors"}, {"/categories/DBCAT004968": "Growth Hormone, metabolism"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004693": "Human Growth Hormone, antagonists & inhibitors"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT003608": "Pituitary"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT003261": "Recombinant Human Growth Hormone"}, {"/categories/DBCAT003614": "Somatotropin Agonists"}, {"/categories/DBCAT002095": "Somatropin and Somatropin Agonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0202080E0": {"Conditions": [{"/indications/DBCOND0036164": "Calcium Nephrolithiasis"}], "Name": "Chlortalidone/Potassium", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000719": "Benzophenones"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002299": "Low-Ceiling Diuretics, Excl. Thiazides"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT000723": "Phthalic Acids"}, {"/categories/DBCAT000722": "Phthalimides"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003322": "Thiazide-like Diuretic"}]}, "0205010T0": {"Conditions": [{"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}], "Name": "Sodium Nitroprusside", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000751": "Cyanides"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000753": "Ferric Compounds"}, {"/categories/DBCAT000750": "Ferricyanides"}, {"/categories/DBCAT000752": "Hydrogen Cyanide"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000756": "Nitric Oxide Donors"}, {"/categories/DBCAT002306": "Nitroferricyanide Derivatives"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}]}, "0103050L0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0068332": "Gastrointestinal Bleed"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0021296": "Hypersecretory conditions"}], "Name": "Lansoprazole", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004261": "Inhibition Gastric Acid Secretion"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000541": "Proton Pump Inhibitors"}, {"/categories/DBCAT003638": "Proton-pump Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1305020A0": {"Conditions": [{"/indications/DBCOND0021324": "Keratinization disorders"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}], "Name": "Acitretin", "Categories": [{"/categories/DBCAT004740": "Acitretin"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002388": "Antipsoriatics for Systemic Use"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002387": "Retinoids for Treatment of Psoriasis"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0407041Z0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}], "Name": "Zolmitriptan", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000626": "Oxazoles"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}]}, "0601021V0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Tolazamide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000635": "Urea"}]}, "0301020I0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0060739": "Nasal Congestion Associated With the Common Cold"}, {"/indications/DBCOND0077443": "Non-Allergic Rhinitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0097126": "Acute asthma exacerbations"}], "Name": "Ipratropium Bromide", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0601023A0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Acarbose", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000670": "Glycoside Hydrolase Inhibitors"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000667": "Trisaccharides"}]}, "0801050S0": {"Conditions": [{"/indications/DBCOND0089382": "B-Lymphocytic, prolymphocytic leukemia (Kiel Classification) refractory"}, {"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0090317": "Graft Versus Host Disease, Acute"}, {"/indications/DBCOND0046776": "Hairy Cell Leukemia (HCL)"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001518": "Sezary Syndrome"}, {"/indications/DBCOND0021682": "Chronic, steroid refractory Graft versus host disease"}], "Name": "Pentostatin", "Categories": [{"/categories/DBCAT000967": "Adenosine Deaminase Inhibitors"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000965": "Coformycin"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000966": "Formycins"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0704010A0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}], "Name": "Alfuzosin Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000776": "Prostatic Hyperplasia"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003670": "Selective Alfa-1-adrenergic Blocking Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1501042H0": {"Conditions": [{"/indications/DBCOND0035847": "Post-Operative Pain"}], "Name": "Parecoxib Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1105000T0": {"Conditions": [{"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0000550": "Shock, Cardiogenic"}], "Name": "Phenylephrine HCl & Tropicamide", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002351": "Nasal Decongestants for Systemic Use"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0501070AF": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}], "Name": "Dalbavancin Hydrochloride", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT002402": "Glycopeptide Antibacterials"}, {"/categories/DBCAT000678": "Glycopeptides"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003450": "Lipoglycopeptide Antibacterial"}, {"/categories/DBCAT004291": "Lipoglycopeptides"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000052": "Peptides"}]}, "0403040T0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}], "Name": "Nefazodone Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT003849": "Antidepressive Agents, Triazolopyridine"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002715": "Serotonin and Noradrenaline Reuptake Inhibitors"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0802020D0": {"Conditions": [{"/indications/DBCOND0066662": "Kidney Transplant Rejection"}], "Name": "Basiliximab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004302": "Interleukin 2 Receptor Antagonists"}, {"/categories/DBCAT004303": "Interleukin 2 Receptor-directed Antibody Interactions"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT003270": "Interleukin-2 Receptor Blocking Antibody"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0901030E0": {"Conditions": [{"/indications/DBCOND0112590": "Anemia caused by Zidovudine"}, {"/indications/DBCOND0031070": "Anemias"}], "Name": "Epoetin Beta", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT004684": "Erythropoietin, genetics"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0802040Y0": {"Conditions": [{"/indications/DBCOND0032512": "Chronic Lymphocytic Leukemia (CLL) - Refractory"}, {"/indications/DBCOND0071979": "Mantle Cell Lymphoma (MCL)"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0028333": "Myelodysplastic Syndrome"}, {"/indications/DBCOND0073957": "Refractory Diffuse Large B Cell Lymphoma"}, {"/indications/DBCOND0021385": "Light chain amyloidosis"}], "Name": "Lenalidomide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000221": "Growth Inhibitors"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000723": "Phthalic Acids"}, {"/categories/DBCAT000722": "Phthalimides"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT000785": "Piperidones"}, {"/categories/DBCAT003357": "Thalidomide Analog"}]}, "0501021L0": {"Conditions": [{"/indications/DBCOND0045557": "Bone Infection"}, {"/indications/DBCOND0014024": "Genitourinary tract infection"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0021743": "Acute Prostatitis"}], "Name": "Cefalexin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002385": "First-Generation Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "040702020": {"Conditions": [{"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Morphine Tartrate & Cyclizine Tartrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0704010W0": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Solifenacin/Tamsulosin", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT001295": "Tetrahydroisoquinolines"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1304000B0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}], "Name": "Alclometasone Dipropionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}]}, "0702020C0": {"Conditions": [{"/indications/DBCOND0011201": "Amoebiasis"}, {"/indications/DBCOND0110753": "Vaginitis caused by Trichomonas Vaginalis, candida albicans"}], "Name": "Acetarsol", "Categories": [{"/categories/DBCAT002322": "Agents Against Leishmaniasis and Trypanosomiasis"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT001515": "Arsenicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000755": "Organometallic Compounds"}]}, "0801000V0": {"Conditions": [{"/indications/DBCOND0025045": "Nephrotoxicity"}, {"/indications/DBCOND0023846": "Xerostomia"}, {"/indications/DBCOND0025756": "Prophylaxis of Radiation proctitis"}], "Name": "Amifostine", "Categories": [{"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003319": "Cytoprotective Agent"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT004431": "Free Radical Scavenging Activity"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001125": "Organophosphates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT001123": "Organothiophosphates"}, {"/categories/DBCAT001124": "Organothiophosphorus Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0601023AX": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Ertugliflozin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT004076": "Sodium-Glucose Transporter 2 Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0601023AV": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Saxagliptin/Dapagliflozin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0503022B0": {"Conditions": [{"/indications/DBCOND0075539": "CMV Infections"}, {"/indications/DBCOND0000283": "Cytomegalovirus Retinitis"}], "Name": "Valganciclovir Hydrochloride", "Categories": [{"/categories/DBCAT004570": "Acyclovir"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003339": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004762": "Ganciclovir"}, {"/categories/DBCAT002865": "Ganciclovir and prodrug"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003306": "Nucleoside Analog Antiviral"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}]}, "0203020R0": {"Conditions": [{"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0055036": "Paroxysmal Atrial Fibrillation (PAF)"}, {"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Propafenone Hydrochloride", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002518": "Antiarrhythmics, Class Ic"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT001282": "Propiophenones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0801030T0": {"Conditions": [{"/indications/DBCOND0048632": "Acute Nonlymphocytic Leukemia"}, {"/indications/DBCOND0020969": "Nonlymphocytic Acute myeloid leukemia"}], "Name": "Tioguanine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002249": "Purine Analogues"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT002714": "Thiopurine Analogs"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0601023AR": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Empagliflozin/Metformin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT004076": "Sodium-Glucose Transporter 2 Inhibitors"}]}, "0601023AS": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Albiglutide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000091": "Gastrointestinal Hormones"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT001826": "Glucagon-Like Peptides"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000120": "Proglucagon"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000097": "Recombinant Proteins"}]}, "0601023AP": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Canagliflozin/Metformin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000871": "Glucosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0601023AQ": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Dulaglutide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000091": "Gastrointestinal Hormones"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002952": "Immunoglobulin Constant Regions"}, {"/categories/DBCAT001915": "Immunoglobulin Fragments"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT003758": "Incretin Mimetics"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT001722": "Peptide Fragments"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000120": "Proglucagon"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000097": "Recombinant Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0601023AN": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Empagliflozin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT004076": "Sodium-Glucose Transporter 2 Inhibitors"}]}, "0601023AL": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Dapagliflozin/Metformin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT001788": "Sodium-Glucose Transport Proteins, antagonists & inhibitors"}, {"/categories/DBCAT004076": "Sodium-Glucose Transporter 2 Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0601023AM": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Canagliflozin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000871": "Glucosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0601023AJ": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Alogliptin/Metformin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}]}, "0601023AK": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Alogliptin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}]}, "0601023AH": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Saxagliptin/Metformin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0202020H0": {"Conditions": [{"/indications/DBCOND0004927": "Ascites"}, {"/indications/DBCOND0075595": "Congenital Heart Disease (CHD)"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}], "Name": "Etacrynic Acid", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002482": "Aryloxyacetic Acid Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT001186": "Glycolates"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT004546": "Ototoxic agents"}, {"/categories/DBCAT001185": "Phenoxyacetates"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}]}, "0601023AF": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Linagliptin/Metformin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000883": "Quinazolines"}]}, "0601023AG": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Dapagliflozin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004600": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors"}, {"/categories/DBCAT003772": "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors"}, {"/categories/DBCAT001788": "Sodium-Glucose Transport Proteins, antagonists & inhibitors"}, {"/categories/DBCAT004076": "Sodium-Glucose Transporter 2 Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0601023AD": {"Conditions": [{"/indications/DBCOND0055384": "Polycystic Ovaries Syndrome"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Metformin Hydrochloride/Sitagliptin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}]}, "0601023AE": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Linagliptin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000883": "Quinazolines"}]}, "0601023AB": {"Conditions": [{"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0064693": "Cardiovascular Risk Reduction"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Liraglutide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000091": "Gastrointestinal Hormones"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT001327": "Glucagon-Like Peptide 1"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT001826": "Glucagon-Like Peptides"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003758": "Incretin Mimetics"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000120": "Proglucagon"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}]}, "0601023AC": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Saxagliptin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0601023AA": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Vildagliptin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001327": "Glucagon-Like Peptide 1"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0402020AD": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0020745": "Bipolar 1 Disorder"}, {"/indications/DBCOND0012283": "Irritability"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0036286": "Psychotic Depression"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0040918": "Tourette's Disorder"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Aripiprazole", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003890": "QTc shortening agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0402020AB": {"Conditions": [{"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0033299": "Schizoaffective Disorders"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Paliperidone", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0908010E0": {"Conditions": [{"/indications/DBCOND0081940": "Cystinosis, Nephropathic"}, {"/indications/DBCOND0022379": "Corneal cystine crystal accumulation"}], "Name": "Mercaptamine", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002151": "Amino Acids and Derivatives"}, {"/categories/DBCAT001162": "Cystine Depleting Agents"}, {"/categories/DBCAT004371": "Cystine Disulfide Reduction"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT001161": "Mercaptoethylamines"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0402020AA": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0034548": "Acute Mania"}, {"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0012283": "Irritability"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0031101": "Posttraumatic Stress Disorders"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0044715": "Treatment Resistant Major Depressive Disorder"}, {"/indications/DBCOND0022235": "Severe Dementia Alzheimer's type"}], "Name": "Risperidone", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0103010S0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0070241": "Erosive Esophagitis(EE)"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0118756": "Pathological gastric hypersecretion"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0028386": "Systemic Mastocytosis"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0108495": "Active duodenal ulcers"}, {"/indications/DBCOND0022472": "Benign gastric ulcers"}], "Name": "Ranitidine Bismuth Citrate", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002835": "Elements, Radioactive"}, {"/categories/DBCAT000766": "Furans"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT002980": "Isotopes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003839": "Radioisotopes"}]}, "0906040B0": {"Conditions": [{"/indications/DBCOND0033035": "Hyperparathyroidism, Secondary"}, {"/indications/DBCOND0020582": "Hypocalcemia"}, {"/indications/DBCOND0016488": "Osteodystrophy"}], "Name": "Alfacalcidol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "100101040": {"Conditions": [{"/indications/DBCOND0021344": "Backache"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Tenoxicam", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002395": "Oxicams"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0501090A0": {"Conditions": [{"/indications/DBCOND0053683": "Tuberculosis Infection"}], "Name": "Aminosalicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT002242": "Aminosalicylic Acid and Derivatives"}, {"/categories/DBCAT000578": "Aminosalicylic Acids"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}]}, "0503031D0": {"Conditions": [{"/indications/DBCOND0054009": "HIV-1-infection"}, {"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}], "Name": "Tenofovir Alafenamide", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT003858": "Tenofovir and prodrugs"}]}, "1203030Y0": {"Conditions": [{"/indications/DBCOND0051417": "Acute Sore Throat"}, {"/indications/DBCOND0025691": "Mucositis of the oro-pharyngeal"}], "Name": "Benzydamine Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT003782": "Mouthwashes and Gargles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "1001030U0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0054528": "Acute Promyelocytic Leukemia (APL)"}, {"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0031545": "Central Nervous System Lymphoma"}, {"/indications/DBCOND0017311": "Choriocarcinoma"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0044732": "Disseminated Sclerosis"}, {"/indications/DBCOND0041407": "Extrauterine Pregnancy"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0028862": "Hydatidiform Mole"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0021713": "Meningeal leukemia"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0066692": "Squamous Cell Carcinoma of Lung"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021721": "Active Pauciarticular juvenile rheumatoid arthritis"}, {"/indications/DBCOND0024723": "Advanced Alibert-Bazin syndrome"}, {"/indications/DBCOND0021719": "Advanced non-Hodgkin lymphoma"}, {"/indications/DBCOND0021724": "Nonleukemic meningeal cancer"}, {"/indications/DBCOND0021726": "Refractory Takayasu arteritis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Methotrexate", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT000855": "Abortifacient Agents, Nonsteroidal"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000974": "Aminopterin"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002290": "Folic Acid Analogues"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004742": "Methotrexate"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000354": "Pterins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0704050AD": {"Conditions": [{"/indications/DBCOND0020044": "Hypertensive crisis"}, {"/indications/DBCOND0024361": "Necrosis caused by Administration site extravasation, Norepinephrine"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}], "Name": "Phentolamine/Aviptadil", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002448": "Imidazoline Derivatives"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003711": "Non-selective Alfa-adrenergic Blocking Agents"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT003663": "Sympatholytic (Adrenergic Blocking) Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0407041T0": {"Conditions": [{"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0022102": "Acute Cluster headaches"}], "Name": "Sumatriptan Succinate", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003231": "Triptans"}, {"/categories/DBCAT001049": "Tryptamines"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0704050AA": {"Conditions": [{"/indications/DBCOND0035654": "Erectile Dysfunction (ED)"}], "Name": "Vardenafil", "Categories": [{"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0503010Z0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Abacavir & Lamivudine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0704050AC": {"Conditions": [{"/indications/DBCOND0035654": "Erectile Dysfunction (ED)"}], "Name": "Avanafil", "Categories": [{"/categories/DBCAT001777": "Cyclic Nucleotide Phosphodiesterases, Type 5"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0601023S0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Rosiglitazone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT003345": "Peroxisome Proliferator Receptor gamma Agonist"}, {"/categories/DBCAT004402": "Peroxisome Proliferator-activated Receptor Activity"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT002198": "Thiazolidinediones"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0407020Q0": {"Conditions": [{"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Morphine Sulfate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0605020W0": {"Conditions": [{"/indications/DBCOND0046632": "Acute Circulatory Failure"}], "Name": "Argipressin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000116": "Antidiuretic Agents"}, {"/categories/DBCAT000110": "Arginine Vasopressin"}, {"/categories/DBCAT004695": "Arginine Vasopressin, agonists"}, {"/categories/DBCAT004696": "Arginine Vasopressin, analogs & derivatives"}, {"/categories/DBCAT004694": "Arginine Vasopressin, antagonists & inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT003608": "Pituitary"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000112": "Pituitary Hormones, Posterior"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}, {"/categories/DBCAT002108": "Vasopressin and Analogues"}, {"/categories/DBCAT000111": "Vasopressins"}, {"/categories/DBCAT004697": "Vasopressins, antagonists & inhibitors"}]}, "0404000R0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0017525": "Narcolepsy"}, {"/indications/DBCOND0040865": "Obstructive Sleep Apnea (OSA)"}, {"/indications/DBCOND0025087": "Shift-work related sleep disturbance"}, {"/indications/DBCOND0068086": "Tiredness"}], "Name": "Modafinil", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT002179": "Centrally Acting Sympathomimetics"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT003034": "Cytochrome P-450 CYP2B6 Inducers (weak)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004492": "Cytochrome P-450 CYP3A5 Inducers (weak)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004488": "Cytochrome P-450 CYP3A5 Inhibitors (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004278": "Increased Sympathetic Activity"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT002730": "Stimulants"}, {"/categories/DBCAT003397": "Sympathomimetic-like Agent"}, {"/categories/DBCAT001105": "Wakefulness-Promoting Agents"}]}, "0703050A0": {"Conditions": [{"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0018394": "Pregnancy"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Levonorgestrel", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004113": "Inhibit Ovum Fertilization"}, {"/categories/DBCAT000797": "Norgestrel"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT003338": "Progestin-containing Intrauterine Device"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "1103010N0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "1203010Q0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0503010H0": {"Conditions": [{"/indications/DBCOND0040812": "HIV -1 Infection"}, {"/indications/DBCOND0083001": "HIV 1 Infection"}, {"/indications/DBCOND0054009": "HIV-1-infection"}, {"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}], "Name": "Tenofovir Disoproxil", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003858": "Tenofovir and prodrugs"}]}, "0401020A0": {"Conditions": [{"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}], "Name": "Alprazolam", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000273": "Ethanol"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003829": "Triazolobenzodiazepines"}]}, "1002020G0": {"Conditions": [{"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0106109": "Acute Discomfort"}], "Name": "Carisoprodol", "Categories": [{"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT002357": "Carbamic Acid Esters"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}]}, "0504010M0": {"Conditions": [{"/indications/DBCOND0021343": "Malaria caused by Plasmodium falciparum"}, {"/indications/DBCOND0022803": "Acute, uncomplicated Malaria caused by plasmodium falciparum"}], "Name": "Proguanil Hydrochloride", "Categories": [{"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0502010D0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0024159": "Fungal meningitis caused by Exserohilum Infection"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0021837": "Disseminated Candidiasis"}, {"/indications/DBCOND0021836": "Non-neutropenic Candidemia"}, {"/indications/DBCOND0080541": "Refractory Fungal Infections"}], "Name": "Voriconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002193": "Triazole Derivatives"}, {"/categories/DBCAT000486": "Triazoles"}]}, "0403020K0": {"Conditions": [{"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}], "Name": "Moclobemide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000995": "Chlorobenzoates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002515": "Monoamine Oxidase A Inhibitors"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0901030K0": {"Conditions": [{"/indications/DBCOND0060728": "Chronic Iron Overload"}], "Name": "Deferasirox", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004161": "Cytochrome P450 1A2 Inhibitors"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT003716": "Heavy Metal Antagonists"}, {"/categories/DBCAT004279": "Iron Chelating Activity"}, {"/categories/DBCAT001107": "Iron Chelating Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT000486": "Triazoles"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004454": "UGT1A3 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}]}, "0501070W0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0053868": "Uncomplicated Skin and Skin Structure Infections"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}], "Name": "Linezolid", "Categories": [{"/categories/DBCAT000493": "Acetamides"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000626": "Oxazoles"}, {"/categories/DBCAT003381": "Oxazolidinone Antibacterial"}, {"/categories/DBCAT000625": "Oxazolidinones"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0304030H0": {"Conditions": [{"/indications/DBCOND0025589": "Angioedema caused by ACE inhibitors"}, {"/indications/DBCOND0025587": "Hereditary angioedema breakthrough attack"}], "Name": "Icatibant Acetate", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT001770": "Bradykinin B2 Receptor Antagonists"}, {"/categories/DBCAT001656": "Bradykinin Receptor Antagonists"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT001769": "Complement Inactivating Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002563": "Drugs Used in Hereditary Angioedema"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT001752": "Kinins"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0603020J0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106167": "Fulminating Pulmonary Tuberculosis"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Hydrocortisone", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0501090H0": {"Conditions": [{"/indications/DBCOND0028938": "Mycobacterium Infections"}, {"/indications/DBCOND0013995": "Mycobacterium avium complex infection"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}], "Name": "Ethambutol Hydrochloride", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000286": "Diamines"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000760": "Ethylenediamines"}, {"/categories/DBCAT000281": "Polyamines"}]}, "0208010C0": {"Conditions": [{"/indications/DBCOND0093560": "Deep Vein Thrombosis caused by Major Abdominal Surgery"}, {"/indications/DBCOND0093559": "Deep Vein Thrombosis caused by Orthopedic Surgery"}, {"/indications/DBCOND0093561": "Deep Vein Thrombosis caused by Thoracic Surgery"}, {"/indications/DBCOND0020245": "Cardiac surgery, heparin-induced thrombocytopenia and thrombosis syndrome"}, {"/indications/DBCOND0093562": "Non-hemorrhagic stroke"}], "Name": "Danaparoid Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001976": "Chondroitin"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT001857": "Heparinoids"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "1201030K0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0801000T0": {"Conditions": [{"/indications/DBCOND0023593": "Hemorrhagic cystitis caused by cyclophosphamide"}, {"/indications/DBCOND0023590": "Hemorrhagic cystitis caused by ifosfamide"}], "Name": "Mesna", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000889": "Alkanesulfonates"}, {"/categories/DBCAT000890": "Alkanesulfonic Acids"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT003319": "Cytoprotective Agent"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT004846": "Mesna"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1311050R0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0401010B0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0025068": "Opiate withdrawal symptoms"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0023116": "Barbiturate withdrawal"}], "Name": "Chloral Hydrate", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002185": "Psycholeptics"}]}, "0409010U0": {"Conditions": [{"/indications/DBCOND0020755": "Idiopathic hyperprolactinemic disorder"}], "Name": "Cabergoline", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000605": "Ergolines"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003643": "Ergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002256": "Prolactine Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}]}, "1106000Y0": {"Conditions": [{"/indications/DBCOND0038951": "Dry Mouth"}, {"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}], "Name": "Pilocarpine Nitrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003290": "Cholinergic Receptor Agonist"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000836": "Miotics"}, {"/categories/DBCAT000447": "Muscarinic Agonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT004766": "Pilocarpine"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0906040P0": {"Conditions": [{"/indications/DBCOND0033035": "Hyperparathyroidism, Secondary"}], "Name": "Paricalcitol", "Categories": [{"/categories/DBCAT002101": "Anti-Parathyroid Agents"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002102": "Calcium Homeostasis"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "1202010I0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0033534": "Oesophagitis, Eosinophilic"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0089474": "Mild Crohn\u2019s Disease"}, {"/indications/DBCOND0089473": "Moderate Crohn\u2019s Disease"}], "Name": "Budesonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "1108010AA": {"Conditions": [{"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0030791": "Bone Marrow Transplant Rejection"}, {"/indications/DBCOND0030834": "Connective Tissue Disorders"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0001365": "Glomerulosclerosis, Focal Segmental"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0028936": "Interstitial Cystitis"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0034112": "Nephritis, Lupus"}, {"/indications/DBCOND0069251": "Ocular Rosacea"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0116963": "Blistering disorder"}, {"/indications/DBCOND0025249": "Refractory Ulcerative colitis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}, {"/indications/DBCOND0020494": "Severe, recalcitrant Plaque psoriasis"}, {"/indications/DBCOND0020498": "Suppressed tear production"}], "Name": "Ciclosporin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003276": "Calcineurin Inhibitor Immunosuppressant"}, {"/categories/DBCAT000199": "Calcineurin Inhibitors"}, {"/categories/DBCAT000198": "Cyclosporins"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT003899": "Cytochrome P-450 CYP3A7 Inducers (moderate)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "1311010S0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0401010L0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Flurazepam Hydrochloride", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0301030B0": {"Conditions": [{"/indications/DBCOND0037906": "Acute Exacerbation of Chronic Bronchitis (AECB)"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0029977": "Chronic Bronchitis"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}], "Name": "Aminophylline", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000286": "Diamines"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000760": "Ethylenediamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000508": "Purinergic P1 Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003651": "Respiratory Smooth Muscle Relaxants"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT001034": "Xanthine derivatives"}, {"/categories/DBCAT002274": "Xanthines and Adrenergics"}]}, "1001040V0": {"Conditions": [{"/indications/DBCOND0023191": "Chronic, symptomatic Hyperuricemia"}], "Name": "Febuxostat", "Categories": [{"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002374": "Preparations Inhibiting Uric Acid Production"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT002773": "Xanthine Oxidase Inhibitors"}]}, "0801010N0": {"Conditions": [{"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0032507": "Cervical Cancers"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0087260": "Malignant Neoplasm of Pancreas"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0035375": "Testicular Germ Cell Cancer"}, {"/indications/DBCOND0022523": "Advanced thymic carcinoma"}], "Name": "Ifosfamide", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001286": "Cyclophosphamide"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000681": "Mustard Compounds"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002289": "Nitrogen Mustard Analogues"}, {"/categories/DBCAT000680": "Nitrogen Mustard Compounds"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT000951": "Phosphoramide Mustards"}, {"/categories/DBCAT000952": "Phosphoramides"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1106000K0": {"Conditions": [{"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Carteolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0501050T0": {"Conditions": [{"/indications/DBCOND0022547": "Mild community-acquired pneumonia"}, {"/indications/DBCOND0022546": "Moderate community-acquired pneumonia"}], "Name": "Telithromycin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003419": "Ketolide Antibacterial"}, {"/categories/DBCAT002744": "Ketolides"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001214": "RNA, Ribosomal, 23S"}]}, "0205052Y0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0058109": "Severe Hypertension"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}], "Name": "Olmesartan Medoxomil/Hydrochlorothiazide", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT002173": "Angiotensin II Antagonists, Plain"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT000407": "Tetrazoles"}]}, "0301012A0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1203040P0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "1902070G0": {"Conditions": [{"/indications/DBCOND0020582": "Hypocalcemia"}], "Name": "Calcium Gluconate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001733": "Gluconates"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000971": "Sugar Acids"}]}, "0503010F0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Abacavir/Lamivudine/Zidovudine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0309020F0": {"Conditions": [{"/indications/DBCOND0025127": "Primary apnea of premature newborns"}, {"/indications/DBCOND0068086": "Tiredness"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Caffeine & Sodium Iodide", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT003635": "Anorexigenic Agents & Respiratory and CNS Stimulants"}, {"/categories/DBCAT000505": "Apnea"}, {"/categories/DBCAT004728": "Caffeine"}, {"/categories/DBCAT002675": "Caffeine and Caffeine Containing Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000508": "Purinergic P1 Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003636": "Respiratory and CNS Stimulants"}, {"/categories/DBCAT002181": "Tests for Gastric Secretion"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT001034": "Xanthine derivatives"}]}, "0503021B0": {"Conditions": [{"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0005172": "Chickenpox"}, {"/indications/DBCOND0003600": "Encephalitis, Herpes Simplex"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0028191": "Herpes Zoster"}, {"/indications/DBCOND0024319": "Herpes simplex of the oral-labial"}, {"/indications/DBCOND0025063": "Herpes simplex type I reactivation"}, {"/indications/DBCOND0049565": "Infections, Cytomegalovirus"}, {"/indications/DBCOND0032971": "Recurrent Genital Herpes (RGH)"}, {"/indications/DBCOND0033308": "Recurrent Herpes Labialis"}, {"/indications/DBCOND0024387": "VZV re-activation"}, {"/indications/DBCOND0022321": "Acute Genital herpes"}, {"/indications/DBCOND0024389": "Acute Herpes labialis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0024381": "Severe Genital herpes"}], "Name": "Aciclovir Sodium", "Categories": [{"/categories/DBCAT002686": "Acyclovir and prodrug"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003553": "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0101010T0": {"Conditions": [{"/indications/DBCOND0024161": "Convulsions"}, {"/indications/DBCOND0015901": "Hypomagnesaemia"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0022086": "Barium poisoning"}, {"/indications/DBCOND0022085": "Severe Exacerbation of asthma"}], "Name": "Magnesium Sulphate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003301": "Paramagnetic Contrast Agent"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002361": "Tests for Bile Duct Patency"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1501030G0": {"Conditions": [{"/indications/DBCOND0030070": "Airway Obstruction"}, {"/indications/DBCOND0029401": "Arrythmias"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0024446": "Hypersecretion gastric"}, {"/indications/DBCOND0019589": "Increased bronchial secretion"}, {"/indications/DBCOND0024444": "Muscarinic effects caused by neostigmine"}, {"/indications/DBCOND0024449": "Muscarinic effects caused by pyridostigmine"}, {"/indications/DBCOND0030389": "Neurocardiogenic Syncope"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0010371": "Salivary hypersecretion"}, {"/indications/DBCOND0024439": "Chronic, severe Salivary hypersecretion"}, {"/indications/DBCOND0021170": "Pharyngeal secretions"}], "Name": "Glycopyrronium Bromide", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}]}, "0501050F0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin Estolate", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0407010H0": {"Conditions": [{"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0118556": "Minor aches and pains"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Paracetamol", "Categories": [{"/categories/DBCAT003969": "Acetaminophen and Prodrugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003661": "Miscellaneous Analgesics and Antipyretics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0408020W0": {"Conditions": [{"/indications/DBCOND0034792": "Seizures, Epileptic"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Midazolam Hydrochloride", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003829": "Triazolobenzodiazepines"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "0803041B0": {"Conditions": [{"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0034432": "Locally Advanced Breast Cancer (LABC)"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0052931": "Recurrent Ovarian Cancer"}, {"/indications/DBCOND0059537": "Stage I Breast Carcinoma"}, {"/indications/DBCOND0021457": "Metastatic Endometrial cancer"}, {"/indications/DBCOND0025469": "Metastatic Uterine cancer"}, {"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}], "Name": "Anastrozole", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000787": "Aromatase Inhibitors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000486": "Triazoles"}]}, "1303000B0": {"Conditions": [{"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0033077": "Mouth Ulcers"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}, {"/indications/DBCOND0024463": "Teething pain"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0050555": "Tooth Pain"}, {"/indications/DBCOND0022739": "Pruritic dermatosis"}], "Name": "Benzocaine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT004767": "Benzocaine"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002455": "Esters of Aminobenzoic Acid"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0301012S0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0029977": "Chronic Bronchitis"}, {"/indications/DBCOND0004300": "Pulmonary Emphysema"}], "Name": "Orciprenaline Sulfate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003747": "Non-selective Beta-adrenergic Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "0212000P0": {"Conditions": [{"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0025391": "Severe Fredrickson Type IV Hypertriglyceridemia"}, {"/indications/DBCOND0025394": "Severe Fredrickson Type V Hypertriglyceridemia"}], "Name": "Fenofibrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000719": "Benzophenones"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT001018": "Fibric Acids"}, {"/categories/DBCAT003745": "Fribic Acid Derivatives"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001019": "Isobutyrates"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003423": "Peroxisome Proliferator Receptor alpha Agonist"}, {"/categories/DBCAT004318": "Peroxisome Proliferator-activated Receptor alpha Agonists"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0210020U0": {"Conditions": [{"/indications/DBCOND0048867": "ST Elevation Myocardial Infarction (STEMI)"}], "Name": "Tenecteplase", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000068": "Endopeptidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000069": "Peptide Hydrolases"}, {"/categories/DBCAT000074": "Plasminogen Activators"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000067": "Serine Endopeptidases"}, {"/categories/DBCAT000073": "Serine Proteases"}, {"/categories/DBCAT004683": "Tissue Plasminogen Activator"}]}, "1001010AH": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0031751": "Familial Adenomatous Polyposis (FAP)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}], "Name": "Celecoxib", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1001010AG": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0121216": "Inflammatory Disease of the Oral Cavity"}, {"/indications/DBCOND0121217": "Inflammatory Disease of the throat"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0089301": "Operation site inflammation"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0001062": "Photophobia"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021856": "Acute Musculoskeletal injury"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0121215": "Localized soft tissue rheumatism"}, {"/indications/DBCOND0121211": "Mild to moderate joint pain"}, {"/indications/DBCOND0121212": "Mild to moderate pain"}, {"/indications/DBCOND0112720": "Minor pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0121206": "Perioperative miosis"}], "Name": "Diclofenac Potassium", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1001010AD": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0085997": "Menstrual Cramps"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Ibuprofen Lysine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003907": "COX-1 Inhibitors"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1001010AA": {"Conditions": [{"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0021720": "Pauciarticular juvenile rheumatoid arthritis"}, {"/indications/DBCOND0024827": "Polyarticular juvenile rheumatoid arthritis, chronic or unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Meloxicam", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002395": "Oxicams"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0901060I0": {"Conditions": [{"/indications/DBCOND0020289": "Hematopoietic Subsyndrome of Acute Radiation Syndrome"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0026814": "Neutropenias"}, {"/indications/DBCOND0100788": "Neutropenia aggravated"}, {"/indications/DBCOND0020526": "Neutropenia-related sequelae"}, {"/indications/DBCOND0020515": "Neutrophil suppression"}, {"/indications/DBCOND0024109": "Severe idiopathic neutropenia"}], "Name": "Filgrastim", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000207": "Granulocyte Colony-Stimulating Factor"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004143": "Increased Myeloid Cell Production"}, {"/categories/DBCAT003248": "Leukocyte Growth Factor"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0503040A0": {"Conditions": [{"/indications/DBCOND0021701": "Flu caused by Influenza"}], "Name": "Zanamivir", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000338": "Amino Sugars"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000970": "Neuraminic Acids"}, {"/categories/DBCAT002200": "Neuraminidase Inhibitors"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000969": "Sialic Acids"}, {"/categories/DBCAT000971": "Sugar Acids"}]}, "0502010A0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0024800": "Invasive bronchopulmonary aspergillosis"}, {"/indications/DBCOND0000151": "Mucormycosis"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0022983": "Prophylaxis of Aspergillus infection"}, {"/indications/DBCOND0024242": "Prophylaxis of Candida Infections"}, {"/indications/DBCOND0022985": "Pulmonary cryptococcosis infection"}], "Name": "Posaconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002193": "Triazole Derivatives"}, {"/categories/DBCAT001101": "Trypanocidal Agents"}]}, "1105000E0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}], "Name": "Cyclopentolate Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0501011F0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0069365": "Clostridial Infection"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0089302": "Neisseria gonorrhoeae arthritis"}, {"/indications/DBCOND0024235": "Pasteurella infections"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0036867": "Severe Pneumonia"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0025806": "Rat bite fever"}, {"/indications/DBCOND0025804": "Severe Pneumococcal infection"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Benzathine Penicillin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT002365": "Beta-Lactamase Sensitive Penicillins"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003683": "Natural Penicillins"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "130501010": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Oxide", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "120101050": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1104020G0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0037418": "Pain, Inflammatory"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Flurbiprofen Sodium", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001053": "Biphenyl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0801020Q0": {"Conditions": [{"/indications/DBCOND0029532": "Adenocarcinoma of the Pancreas"}, {"/indications/DBCOND0030353": "Adenocarcinoma of the Stomach"}, {"/indications/DBCOND0036463": "Anal Carcinoma"}, {"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0032507": "Cervical Cancers"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0017375": "Mesothelioma"}, {"/indications/DBCOND0020914": "Ab externo surgery Glaucoma"}], "Name": "Mitomycin", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000711": "Azirines"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000713": "Cross-Linking Reagents"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000712": "Indolequinones"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000710": "Mitomycins"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000386": "Quinones"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1306010Y0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}], "Name": "Benzoyl Peroxide & Clindamycin Phosphate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT002029": "Peroxides"}]}, "0205051Q0": {"Conditions": [{"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0025783": "Symptomatic left ventricular ejection fraction \u2264 35% Chronic heart failure"}], "Name": "Quinapril Hydrochloride", "Categories": [{"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT001295": "Tetrahydroisoquinolines"}]}, "0213000T0": {"Conditions": [{"/indications/DBCOND0021327": "Uncomplicated Varicose vein"}], "Name": "Sodium Tetradecyl Sulphate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000889": "Alkanesulfonates"}, {"/categories/DBCAT000890": "Alkanesulfonic Acids"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000476": "Fatty Alcohols"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000898": "Surface-Active Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0501030Y0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}], "Name": "Tigecycline", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003698": "Glycylcyclines"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0206020Z0": {"Conditions": [{"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0033563": "Hospitalization"}, {"/indications/DBCOND0036953": "Mild Essential Hypertension"}, {"/indications/DBCOND0040924": "Moderate Essential Hypertension"}, {"/indications/DBCOND0033676": "Pediatric Hypertension"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}, {"/indications/DBCOND0025716": "Chronic heart failure with reduced ejection fraction (NYHA Class IV)"}, {"/indications/DBCOND0116973": "Hospitalization due to cardiac failure"}, {"/indications/DBCOND0025783": "Symptomatic left ventricular ejection fraction \u2264 35% Chronic heart failure"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Valsartan/Amlodipine", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT002172": "Angiotensin II Antagonists and Diuretics"}, {"/categories/DBCAT002173": "Angiotensin II Antagonists, Plain"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT001168": "Angiotensin II Type 2 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}]}, "1103030W0": {"Conditions": [{"/indications/DBCOND0075539": "CMV Infections"}, {"/indications/DBCOND0022602": "CMV colitis"}, {"/indications/DBCOND0000283": "Cytomegalovirus Retinitis"}, {"/indications/DBCOND0025048": "Cytomegalovirus gastroesophagitis"}, {"/indications/DBCOND0022605": "Varicella-zoster Progressive outer retinal necrosis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0025216": "Cytomegalovirus neurological disease"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Ganciclovir", "Categories": [{"/categories/DBCAT004570": "Acyclovir"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003339": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004762": "Ganciclovir"}, {"/categories/DBCAT002865": "Ganciclovir and prodrug"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003306": "Nucleoside Analog Antiviral"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0801030G0": {"Conditions": [{"/indications/DBCOND0111822": "Metastatic Hepatic Cancer"}, {"/indications/DBCOND0020929": "Stage 4 gastrointestinal adenocarcinoma"}], "Name": "Floxuridine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000608": "Deoxyuridine"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000609": "Uridine"}]}, "0205051C0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Moexipril Hydrochloride", "Categories": [{"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0307000C0": {"Conditions": [{"/indications/DBCOND0047315": "Acetaminophen Overdose"}], "Name": "Acetylcysteine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003463": "Antidote for Acetaminophen Overdose"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000315": "Cysteine"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004189": "Increased Glutathione Concentration"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT004190": "Reduction Activity"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1104010K0": {"Conditions": [{"/indications/DBCOND0020932": "Bacterial eye infection"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Fluorometholone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000746": "Pregnadienediols"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0604011R0": {"Conditions": [{"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0023753": "Moderate Vulvovaginal atrophy"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023752": "Severe Vulvovaginal atrophy"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Estropipate", "Categories": [{"/categories/DBCAT001040": "17-Ketosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT001131": "Estrogens, Conjugated (USP)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT001041": "Ketosteroids"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "0601040E0": {"Conditions": [{"/indications/DBCOND0065242": "Hyperinsulinemic Hypoglycemia"}], "Name": "Diazoxide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002508": "Drugs for Treatment of Hypoglycemia"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002509": "Thiazide Derivatives"}, {"/categories/DBCAT000576": "Thiazides"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0205010U0": {"Conditions": [{"/indications/DBCOND0021025": "NYHA Functional Class II-IV Pulmonary arterial hypertension"}], "Name": "Bosentan", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002410": "Antihypertensives for Pulmonary Arterial Hypertension"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT003109": "Cytochrome P-450 CYP2C9 Inducers (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT000972": "Endothelin Receptor Antagonists"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0703010S0": {"Conditions": [{"/indications/DBCOND0001269": "Atrophic Vaginitis"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0022319": "Advanced androgen dependent Prostate cancer"}], "Name": "Estradiol & Nomegestrol", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002429": "Androgens and Estrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001293": "Estradiol"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT004753": "Estradiol, agonists"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004754": "Estrogens, agonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002465": "Intravaginal Contraceptives"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0101010F0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023806": "Bladder calculus"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0057786": "Renal Stones"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Magnesium Carbonate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT002035": "Bleaching Agents"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003148": "Hygroscopic Agents"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT001341": "Metals"}, {"/categories/DBCAT001352": "Metals, Alkaline Earth"}, {"/categories/DBCAT001339": "Metals, Light"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT001830": "Oxidants"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1202020C0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0803041L0": {"Conditions": [{"/indications/DBCOND0031019": "Advanced Breast Cancer"}, {"/indications/DBCOND0009297": "Anovulatory cycle"}, {"/indications/DBCOND0054935": "Ovarian Epithelial Cancer"}, {"/indications/DBCOND0059537": "Stage I Breast Carcinoma"}, {"/indications/DBCOND0106217": "Advanced HR + HER2 - breast cancer"}, {"/indications/DBCOND0106218": "Metastatic HR + HER2 - breast cancer"}], "Name": "Letrozole", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000787": "Aromatase Inhibitors"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000486": "Triazoles"}]}, "040801060": {"Conditions": [{"/indications/DBCOND0035279": "Epilepsies"}], "Name": "Clobazam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000427": "GABA Agonists"}, {"/categories/DBCAT000850": "GABA-A Receptor Agonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0601023B0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Pioglitazone Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT003423": "Peroxisome Proliferator Receptor alpha Agonist"}, {"/categories/DBCAT003345": "Peroxisome Proliferator Receptor gamma Agonist"}, {"/categories/DBCAT004402": "Peroxisome Proliferator-activated Receptor Activity"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT002198": "Thiazolidinediones"}]}, "0404000A0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0017525": "Narcolepsy"}, {"/indications/DBCOND0056178": "Pain, Chronic"}], "Name": "Amfetamine Sulfate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT002179": "Centrally Acting Sympathomimetics"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT003897": "Cytochrome P-450 CYP2A6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0408010S0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0054185": "Febrile Convulsions"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0025451": "Hyperbilirubinemia"}, {"/indications/DBCOND0028731": "Menopausal Symptoms"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0068142": "Withdrawal Symptoms"}, {"/indications/DBCOND0021688": "Generalized seizure"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Phenobarbital & Phenytoin", "Categories": [{"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000728": "Barbiturates"}, {"/categories/DBCAT002391": "Barbiturates and Derivatives"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT004670": "Cytochrome P-450 2C18 Inducers"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002612": "Cytochrome P-450 CYP1A2 Inducers (strong)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT004674": "Cytochrome P-450 CYP2C18 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004491": "Cytochrome P-450 CYP3A5 Inducers (strong)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT001139": "Phenobarbital and similars"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT004611": "UGT2B7 inducers"}]}, "0209000L0": {"Conditions": [{"/indications/DBCOND0000554": "Coronary Artery Disease"}, {"/indications/DBCOND0054784": "Postoperative Thromboembolism"}, {"/indications/DBCOND0085133": "Strokes"}], "Name": "Dipyridamole", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003720": "Miscellaneous Vasodilatating Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0105020B0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0902012P0": {"Conditions": [{"/indications/DBCOND0023722": "Mild Metabolic acidosis"}, {"/indications/DBCOND0023721": "Moderate Metabolic acidosis"}], "Name": "Sodium Lactate", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001522": "Lactates"}, {"/categories/DBCAT004794": "Lactic Acid"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002544": "Organic Acids"}]}, "0702020T0": {"Conditions": [{"/indications/DBCOND0028285": "Oral Candidiasis"}, {"/indications/DBCOND0022068": "Mucocutaneous candida infection"}], "Name": "Nystatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001029": "Ionophores"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}]}, "1001010W0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Sodium Salicylate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0204000K0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0029078": "Tachycardia, Supraventricular"}, {"/indications/DBCOND0000975": "Thyroid Crisis"}, {"/indications/DBCOND0020811": "Acute hemodynamically stable Myocardial infarction"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}], "Name": "Metoprolol Tartrate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000483": "Propanolamines"}]}, "0901030D0": {"Conditions": [{"/indications/DBCOND0112590": "Anemia caused by Zidovudine"}, {"/indications/DBCOND0031070": "Anemias"}], "Name": "Epoetin Alfa", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT004684": "Erythropoietin, genetics"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0704010T0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}], "Name": "Terazosin Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0208020AA": {"Conditions": [{"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0077405": "Systemic Embolism"}], "Name": "Edoxaban", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000012": "Antithrombins"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001775": "Factor Xa Inhibitors"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000001": "Serine Proteinase Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0503032K0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}, {"/indications/DBCOND0024500": "Chronic hepatitis C genotype 5"}, {"/indications/DBCOND0023526": "Genotype 6 chronic hepatitis C infection"}, {"/indications/DBCOND0093787": "Previously treated with an HCV regimen containing an NS3/4A protease inhibitor Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0093786": "Previously treated with an HCV regimen containing an NS5A inhibitor Chronic Hepatitis C Genotype 1"}], "Name": "Glecaprevir/Pibrentasvir", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT004161": "Cytochrome P450 1A2 Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004186": "HCV NS3/4A Protease Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002768": "NS3/4A Protease Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "1001030S0": {"Conditions": [{"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0092758": "Non-infectious Intermediate, Posterior and Panuveitis"}, {"/indications/DBCOND0057260": "Pediatric Crohn's Disease"}, {"/indications/DBCOND0025138": "Psoriatic arthritis aggravated"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0025583": "Severe Plaque psoriasis"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0020385": "Active Ankylosing spondylitis"}, {"/indications/DBCOND0020392": "Moderate Hidradenitis Suppurativa"}, {"/indications/DBCOND0025507": "Moderate Juvenile idiopathic arthritis"}, {"/indications/DBCOND0020390": "Moderate Plaque psoriasis"}, {"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0020388": "Moderate Ulcerative colitis"}, {"/indications/DBCOND0020391": "Severe Hidradenitis Suppurativa"}, {"/indications/DBCOND0025506": "Severe Juvenile idiopathic arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Adalimumab", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002087": "Tumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors"}, {"/categories/DBCAT003245": "Tumor Necrosis Factor Blocker"}, {"/categories/DBCAT004095": "Tumor Necrosis Factor Receptor Blocking Activity"}]}, "1304000C0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0033683": "Chronic Rhinosinusitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0021673": "Corticosteroid-responsive Dermatosis"}, {"/indications/DBCOND0021089": "Recurrent nasal polyps"}], "Name": "Beclometasone Dipropionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "0702020B0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0025199": "External ear infection NOS"}, {"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Acetic Acid", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002544": "Organic Acids"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0503022C0": {"Conditions": [{"/indications/DBCOND0000283": "Cytomegalovirus Retinitis"}, {"/indications/DBCOND0044371": "Herpes Simplex Virus"}, {"/indications/DBCOND0000119": "Monkeypox"}, {"/indications/DBCOND0005195": "Smallpox"}], "Name": "Cidofovir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003339": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT001267": "Cytosine"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}]}, "0205053A0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Aliskiren", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000327": "Dicarboxylic Acids"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000561": "Methyl Ethers"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT002219": "Renin-Inhibitors"}]}, "0205051M0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0086660": "Hypertension,Essential"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0025304": "NYHA Class I Congestive heart failure"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}], "Name": "Perindopril Erbumine", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0307000M0": {"Conditions": [{"/indications/DBCOND0023593": "Hemorrhagic cystitis caused by cyclophosphamide"}, {"/indications/DBCOND0023590": "Hemorrhagic cystitis caused by ifosfamide"}], "Name": "Mesna", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000889": "Alkanesulfonates"}, {"/categories/DBCAT000890": "Alkanesulfonic Acids"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT003319": "Cytoprotective Agent"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT004846": "Mesna"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1203030F0": {"Conditions": [{"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Dequalinium Chloride", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003735": "Miscellaneous Anti-infectives"}, {"/categories/DBCAT002551": "Quinoline Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT001571": "Quinolinium Compounds"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0604011D0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0005024": "Premenstrual Dysphoric Disorder"}, {"/indications/DBCOND0040526": "Severe Acne Vulgaris"}, {"/indications/DBCOND0022329": "Moderate Acne vulgaris"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Ethinylestradiol", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT001215": "Estrogenic Steroids, Alkylated"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT001216": "Norpregnatrienes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0203020G0": {"Conditions": [{"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Disopyramide Phosphate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002277": "Antiarrhythmics, Class Ia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0802040AQ": {"Conditions": [{"/indications/DBCOND0020366": "High Risk Neuroblastoma"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0030098": "Metastatic Renal Cell Carcinoma"}], "Name": "Aldesleukin", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004234": "Increased Lymphocyte Activation"}, {"/categories/DBCAT004235": "Increased Lymphocyte Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000118": "Interleukins"}, {"/categories/DBCAT003255": "Lymphocyte Growth Factor"}, {"/categories/DBCAT002874": "Lymphokines"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0503010Y0": {"Conditions": [{"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}, {"/indications/DBCOND0021408": "Perinatal HIV transmission"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Zidovudine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000858": "Thymidine"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1001030T0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}], "Name": "Infliximab", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002087": "Tumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors"}, {"/categories/DBCAT003245": "Tumor Necrosis Factor Blocker"}, {"/categories/DBCAT004095": "Tumor Necrosis Factor Receptor Blocking Activity"}]}, "1310040M0": {"Conditions": [{"/indications/DBCOND0024506": "Lice of the head"}], "Name": "Malathion", "Categories": [{"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002370": "Ectoparasiticides, Incl. Scabicides"}, {"/categories/DBCAT002371": "Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000857": "Insecticides"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT001125": "Organophosphates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT001123": "Organothiophosphates"}, {"/categories/DBCAT001124": "Organothiophosphorus Compounds"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0601021E0": {"Conditions": [{"/indications/DBCOND0029023": "Diabetes Insipidus"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Chlorpropamide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000635": "Urea"}]}, "0404000S0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}], "Name": "Atomoxetine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT003318": "Norepinephrine Reuptake Inhibitor"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0407020P0": {"Conditions": [{"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Morphine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0501040N0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0211000AA": {"Conditions": [{"/indications/DBCOND0054784": "Postoperative Thromboembolism"}, {"/indications/DBCOND0018181": "Postpartum thrombosis"}], "Name": "Antithrombin Alfa", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT004167": "Decreased Coagulation Factor Activity"}, {"/categories/DBCAT001775": "Factor Xa Inhibitors"}, {"/categories/DBCAT003597": "Recombinant Antithrombin"}, {"/categories/DBCAT004228": "Thrombin Inhibitors"}]}, "1307000V0": {"Conditions": [{"/indications/DBCOND0080547": "Actinic Keratoses of the face"}, {"/indications/DBCOND0080548": "Actinic Keratoses of the scalp"}, {"/indications/DBCOND0030723": "Condylomata Acuminata"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0032565": "Superficial Basal Cell Carcinoma"}], "Name": "Imiquimod", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004408": "Increased Cytokine Activity"}, {"/categories/DBCAT004409": "Increased Cytokine Production"}, {"/categories/DBCAT001094": "Interferon Inducers"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "1103020E0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0024466": "Tinea pedis of the interdigital"}], "Name": "Econazole Nitrate", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}]}, "1001030F0": {"Conditions": [{"/indications/DBCOND0034009": "Poisoning, Lead"}, {"/indications/DBCOND0032702": "Wilson's Disease"}, {"/indications/DBCOND0022351": "Cystine renal calculi"}, {"/indications/DBCOND0025310": "Refractory Rheumatoid arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Penicillamine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003716": "Heavy Metal Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002475": "Penicillamine and Similar Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT002476": "Specific Antirheumatic Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0504010N0": {"Conditions": [{"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0013910": "Toxoplasmosis"}, {"/indications/DBCOND0020683": "Acute Malaria"}], "Name": "Pyrimethamine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002213": "Diaminopyrimidines"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT000349": "Pyrimidines"}]}, "0208010L0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0022770": "Clotting"}, {"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0057165": "Symptomatic Venous Thromboembolism"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}], "Name": "Dalteparin Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002680": "Heparin (Low Molecular Weight)"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "0501021A0": {"Conditions": [{"/indications/DBCOND0093523": "Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0093530": "Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenza"}, {"/indications/DBCOND0093531": "Acute Exacerbations of Chronic Bronchitis caused by Moraxella catarrhalis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0025366": "Bacterial Urinary Tract Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0024409": "Streptococcus pyogenes skin infection"}], "Name": "Cefaclor", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001072": "Cephalexin"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0901030J0": {"Conditions": [{"/indications/DBCOND0031070": "Anemias"}], "Name": "Darbepoetin Alfa", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0501015P0": {"Conditions": [{"/indications/DBCOND0089485": "Urinary tract infection caused by E. coli"}, {"/indications/DBCOND0089487": "Urinary tract infection caused by enterobacteria"}, {"/indications/DBCOND0089483": "Urinary tract infection caused by klebsiella"}, {"/indications/DBCOND0089489": "Urinary tract infection caused by proteus"}], "Name": "Pivmecillinam Hydrochloride", "Categories": [{"/categories/DBCAT001398": "Amdinocillin"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0603020I0": {"Conditions": [{"/indications/DBCOND0066749": "Duchenne's Muscular Dystrophy (DMD)"}], "Name": "Deflazacort", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0501070V0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0080545": "Infections caused by penicillinase-producing staphylococci"}, {"/indications/DBCOND0025759": "Complicated Skin and subcutaneous tissue bacterial infection"}], "Name": "Quinupristin/Dalfopristin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT003441": "Streptogramin Antibacterial"}, {"/categories/DBCAT001412": "Streptogramins"}]}, "0204000I0": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0078508": "Hypertensive Emergency"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0029809": "Subarachnoid Hemorrhage"}], "Name": "Labetalol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002420": "Alpha and Beta Blocking Agents"}, {"/categories/DBCAT002419": "Alpha and Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000989": "Salicylamides"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1303000J0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0031602": "Oral Mucositis"}, {"/indications/DBCOND0024062": "Parkinsonian Syndromes"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0035432": "Skin Rash"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0024669": "Upper respiratory tract hypersensitivity reaction, site unspecified"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0022265": "Dermatographism"}], "Name": "Diphenhydramine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003673": "Ethanolamine Derivatives"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003748": "First Generation Antihistamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}]}, "0901020N0": {"Conditions": [{"/indications/DBCOND0004065": "Anemia, Pernicious"}, {"/indications/DBCOND0024718": "Toxic effect of hydrocyanic acid and cyanides"}, {"/indications/DBCOND0034596": "Vitamin B12 Deficiency"}], "Name": "Hydroxocobalamin", "Categories": [{"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000237": "Corrinoids"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT002733": "Nutritional Support"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT004535": "VITAMIN B12 AND FOLIC ACID"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0704020J0": {"Conditions": [{"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0071172": "Neurogenic Bladder Dysfunction"}, {"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Oxybutynin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0603020G0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0301040Y0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Indacaterol/Glycopyrronium", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000931": "Indenes"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0106040G0": {"Conditions": [{"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Lactulose", "Categories": [{"/categories/DBCAT004091": "Acidifying Activity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003702": "Ammonia Detoxicants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000795": "Disaccharides"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT004092": "Stimulation Large Intestine Fluid/Electrolyte Secretion"}]}, "0908010X0": {"Conditions": [{"/indications/DBCOND0023710": "Deficiencies in enzymes of the urea cycle"}], "Name": "Phenylbutyric Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004166": "Ammonium Ion Binding Activity"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT002683": "Urea Cycle Disorder Agents"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "1106000Z0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Timolol", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "1201010K0": {"Conditions": [{"/indications/DBCOND0028285": "Oral Candidiasis"}, {"/indications/DBCOND0022068": "Mucocutaneous candida infection"}], "Name": "Nystatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001029": "Ionophores"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}]}, "0409010V0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Entacapone", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002655": "COMT Inhibitors"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "1202010N0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0027870": "Eye Infections"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0025350": "Infection due to indwelling catheter"}, {"/indications/DBCOND0022567": "Superficial skin infections"}], "Name": "Neomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "1306010J0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin Lactobionate", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0206020M0": {"Conditions": [{"/indications/DBCOND0021086": "Hunt and Hess Grades I-V Subarachnoid hemorrhage"}], "Name": "Nimodipine", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000824": "Nicotinic Acids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1106000T0": {"Conditions": [{"/indications/DBCOND0074237": "Ocular Hypertension"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}], "Name": "Levobunolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT003633": "Beta-adrenergic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT001298": "Bunolol"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}, {"/categories/DBCAT001127": "Tetrahydronaphthalenes"}]}, "0406000AA": {"Conditions": [{"/indications/DBCOND0079187": "Flu Symptoms"}, {"/indications/DBCOND0039696": "Mild Allergic Rhinitis"}, {"/indications/DBCOND0010699": "Nausea"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0010697": "Vomiting"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Doxylamine Succinate/Pyridoxine HCl", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003673": "Ethanolamine Derivatives"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT004215": "Histamine Receptor Antagonists"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0406000AB": {"Conditions": [{"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0021047": "Acute chemotherapy induced nausea and vomiting"}, {"/indications/DBCOND0021045": "Delayed chemotherapy induced nausea and vomiting"}], "Name": "Palonosetron Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004178": "Serotonin 3 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0406000AC": {"Conditions": [{"/indications/DBCOND0025341": "Labyrinthine disorder"}, {"/indications/DBCOND0066647": "Meni\u00e8re's Disease"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0022946": "Radiation therapy induced nausea and vomiting"}], "Name": "Dimenhydrinate/Cinnarizine", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT001217": "Diphenhydramine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0406000AD": {"Conditions": [{"/indications/DBCOND0028521": "Nausea and vomiting"}], "Name": "Aprepitant", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT003971": "Aprepitant and Prodrugs"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT004213": "Neurokinin 1 Antagonists"}, {"/categories/DBCAT001050": "Neurokinin-1 Receptor Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003389": "Substance P/Neurokinin-1 Receptor Antagonist"}]}, "0406000AE": {"Conditions": [{"/indications/DBCOND0025637": "Acute chemotherapy-induced nausea and vomiting"}, {"/indications/DBCOND0023978": "Delayed chemotherapy induced naused and vomiting"}], "Name": "Fosaprepitant", "Categories": [{"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT003971": "Aprepitant and Prodrugs"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT003691": "Miscellaneous Antiemetics"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT004213": "Neurokinin 1 Antagonists"}, {"/categories/DBCAT001050": "Neurokinin-1 Receptor Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003389": "Substance P/Neurokinin-1 Receptor Antagonist"}]}, "0406000AF": {"Conditions": [{"/indications/DBCOND0028521": "Nausea and vomiting"}], "Name": "Granisetron", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004178": "Serotonin 3 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0406000AG": {"Conditions": [{"/indications/DBCOND0106271": "Acute naused and vomiting caused by Chemotherapy"}, {"/indications/DBCOND0106272": "Delayed Nausea and Vomiting caused by Chemotherapy"}], "Name": "Netupitant/Palonosetron Hcl", "Categories": [{"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004213": "Neurokinin 1 Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003389": "Substance P/Neurokinin-1 Receptor Antagonist"}]}, "0406000AH": {"Conditions": [{"/indications/DBCOND0023978": "Delayed chemotherapy induced naused and vomiting"}], "Name": "Rolapitant", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004213": "Neurokinin 1 Antagonists"}, {"/categories/DBCAT001050": "Neurokinin-1 Receptor Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003389": "Substance P/Neurokinin-1 Receptor Antagonist"}]}, "0201010F0": {"Conditions": [{"/indications/DBCOND0065022": "Chronic Atrial Fibrillation"}, {"/indications/DBCOND0119560": "Heart failure, mild"}, {"/indications/DBCOND0119561": "Heart failure, moderate"}, {"/indications/DBCOND0099902": "Mild to moderate heart failure"}], "Name": "Digoxin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003984": "BSEP/ABCB11 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000822": "Cardanolides"}, {"/categories/DBCAT000823": "Cardenolides"}, {"/categories/DBCAT000821": "Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000820": "Digitalis Glycosides"}, {"/categories/DBCAT003177": "Digoxin and derivatives"}, {"/categories/DBCAT004735": "Digoxin, antagonists & inhibitors"}, {"/categories/DBCAT004734": "Digoxin, immunology"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0607020P0": {"Conditions": [{"/indications/DBCOND0040295": "Central Precocious Puberty (CPP)"}, {"/indications/DBCOND0001340": "Endometriosis"}], "Name": "Nafarelin Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000060": "Fertility Agents"}, {"/categories/DBCAT000062": "Fertility Agents, Female"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT004658": "Gonadotropins and Antigonadotropins"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "1203020N0": {"Conditions": [{"/indications/DBCOND0028285": "Oral Candidiasis"}, {"/indications/DBCOND0022068": "Mucocutaneous candida infection"}], "Name": "Nystatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001029": "Ionophores"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}]}, "1307000D0": {"Conditions": [{"/indications/DBCOND0030938": "Warts"}], "Name": "Cantharidin", "Categories": [{"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001178": "Irritants"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "010200030": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Trospium Chloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001929": "Diphenylacetic Acids"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT000602": "Tropanes"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0503021A0": {"Conditions": [{"/indications/DBCOND0075539": "CMV Infections"}, {"/indications/DBCOND0005172": "Chickenpox"}, {"/indications/DBCOND0030497": "Genital Herpes"}, {"/indications/DBCOND0118177": "Genital herpes, initial episode"}, {"/indications/DBCOND0000240": "Herpes Labialis"}, {"/indications/DBCOND0030237": "Herpes Simplex Infection"}, {"/indications/DBCOND0088629": "Infection Transmission"}, {"/indications/DBCOND0032971": "Recurrent Genital Herpes (RGH)"}, {"/indications/DBCOND0021826": "Shingles"}, {"/indications/DBCOND0059021": "Varicella Zoster Virus Infection"}, {"/indications/DBCOND0021819": "Symptomatic for no more than 72 hours Herpes zoster"}], "Name": "Valaciclovir", "Categories": [{"/categories/DBCAT004570": "Acyclovir"}, {"/categories/DBCAT002686": "Acyclovir and prodrug"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000344": "Amino Acids, Branched-Chain"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003347": "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003553": "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}]}, "0501090K0": {"Conditions": [{"/indications/DBCOND0050152": "Active Tuberculosis"}, {"/indications/DBCOND0013998": "Mycobacterium kansasii infection"}, {"/indications/DBCOND0025407": "Late phase Tuberculosis"}], "Name": "Isoniazid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001001": "Fatty Acid Synthesis Inhibitors"}, {"/categories/DBCAT002487": "Hydrazides"}, {"/categories/DBCAT000469": "Hydrazines"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001000": "Isonicotinic Acids"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0309020G0": {"Conditions": [{"/indications/DBCOND0022396": "Phlegm"}, {"/indications/DBCOND0094614": "Chest congestion"}], "Name": "Guaifenesin", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000847": "Guaiacol"}, {"/categories/DBCAT000561": "Methyl Ethers"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000132": "Respiratory System Agents"}]}, "0503010E0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Abacavir", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0212000AJ": {"Conditions": [{"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0025391": "Severe Fredrickson Type IV Hypertriglyceridemia"}, {"/indications/DBCOND0025394": "Severe Fredrickson Type V Hypertriglyceridemia"}], "Name": "Fenofibrate/Simvastatin", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000719": "Benzophenones"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT001018": "Fibric Acids"}, {"/categories/DBCAT003745": "Fribic Acid Derivatives"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT001019": "Isobutyrates"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT003423": "Peroxisome Proliferator Receptor alpha Agonist"}, {"/categories/DBCAT004318": "Peroxisome Proliferator-activated Receptor alpha Agonists"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0212000AI": {"Conditions": [{"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}], "Name": "Alirocumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT001977": "Hypercholesterolemia, drug therapy"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT003524": "PCSK9 Inhibitor"}, {"/categories/DBCAT003788": "Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0212000AH": {"Conditions": [{"/indications/DBCOND0078488": "Atherosclerotic Cardiovascular Diseases"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}], "Name": "Evolocumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003524": "PCSK9 Inhibitor"}, {"/categories/DBCAT003788": "Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Inhibitors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1502010Y0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine & Tetracaine", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0212000AC": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0037835": "High Cholesterol"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0022047": "History of coronary heart disease cardiovascular event"}, {"/indications/DBCOND0022051": "History of stroke or other cerebrovacular disease cardiovascular event"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}], "Name": "Simvastatin & Ezetimibe", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0212000AB": {"Conditions": [{"/indications/DBCOND0048891": "Severe Hypertriglyceridemia"}], "Name": "Omega-3-Acid Ethyl Esters", "Categories": [{"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000296": "Dietary Fats"}, {"/categories/DBCAT000295": "Dietary Fats, Unsaturated"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000297": "Fats"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000294": "Fatty Acids, Omega-3"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000298": "Fish Oils"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000278": "Nootropic Agents"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000235": "Physiological Phenomena"}]}, "0212000AA": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0078488": "Atherosclerotic Cardiovascular Diseases"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0022726": "Dysbetalipoproteinemia"}, {"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0044916": "Hypertriglyceridemias"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}], "Name": "Rosuvastatin Calcium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001265": "Fluorobenzenes"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001266": "Hydrocarbons, Fluorinated"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0212000AF": {"Conditions": [{"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}], "Name": "Lomitapide", "Categories": [{"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT003488": "Microsomal Triglyceride Transfer Protein Inhibitor"}, {"/categories/DBCAT004347": "Microsomal Triglyceride Transfer Protein Inhibitors"}, {"/categories/DBCAT003706": "Miscellaneous Antilipemic Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}]}, "0212000AE": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0111554": "Deficiency, Vitamin"}, {"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0004063": "Pellagra"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0021999": "Severe Hyperlipidemia"}], "Name": "Nicotinic Acid/Laropiprant", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT003706": "Miscellaneous Antilipemic Agents"}, {"/categories/DBCAT004745": "Niacin"}, {"/categories/DBCAT002431": "Nicotinic Acid and Derivatives"}, {"/categories/DBCAT000824": "Nicotinic Acids"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002432": "Peripheral Vasodilators"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT004603": "Thyroxine-binding globulin inhibitors"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0212000AD": {"Conditions": [{"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0031916": "Hyperlipidemias"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Colesevelam Hydrochloride", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT001195": "Allyl Compounds"}, {"/categories/DBCAT001194": "Allylamine"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT002340": "Bile Acid Sequestrants"}, {"/categories/DBCAT004184": "Bile-acid Binding Activity"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0803041C0": {"Conditions": [{"/indications/DBCOND0059537": "Stage I Breast Carcinoma"}, {"/indications/DBCOND0023190": "Refractory, advanced Breast cancer"}], "Name": "Exemestane", "Categories": [{"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000787": "Aromatase Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}]}, "0408020T0": {"Conditions": [{"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0024115": "Seizures"}], "Name": "Phenytoin Sodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT004675": "Cytochrome P-450 CYP2C18 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003887": "Cytochrome P-450 CYP2C19 Substrates (moderate)"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004507": "Cytochrome P-450 CYP2D6 Inducers (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004282": "Cytochrome P450 2D6 Inducers"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT004731": "Phenytoin"}, {"/categories/DBCAT002678": "Phenytoin and Prodrugs"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT002665": "UGT1A6 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0406000A0": {"Conditions": [{"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}], "Name": "Hyoscine", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000888": "Scopolamine Derivatives"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0501090U0": {"Conditions": [{"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0025049": "Disseminated mycobacterium avium complex infection"}, {"/indications/DBCOND0021701": "Flu caused by Influenza"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0066647": "Meni\u00e8re's Disease"}, {"/indications/DBCOND0013995": "Mycobacterium avium complex infection"}, {"/indications/DBCOND0013998": "Mycobacterium kansasii infection"}, {"/indications/DBCOND0013997": "Mycobacterium marinum infection"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Streptomycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002498": "Streptomycins"}]}, "0309020Y0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0106050T0": {"Conditions": [{"/indications/DBCOND0015839": "Hypokalaemia"}], "Name": "Potassium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002463": "Potassium"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "0403030P0": {"Conditions": [{"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}, {"/indications/DBCOND0001304": "Premature Ejaculation"}, {"/indications/DBCOND0005024": "Premenstrual Dysphoric Disorder"}, {"/indications/DBCOND0033074": "Social Anxiety Disorder (SAD)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}], "Name": "Paroxetine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004750": "Paroxetine"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "1001022N0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0026236": "Corneal injuries"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0009942": "Cyclitis"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}, {"/indications/DBCOND0076158": "Herpes Zoster Keratitis"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027895": "Pneumonia, Aspiration"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0030946": "Rejection, Transplant"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0073800": "Secondary Adrenal Insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0022388": "Superficial punctate keratitis"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0024958": "Idiopathic Bronchiolitis obliterans with organizing pneumonia"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021956": "Primary adrenocoritical insufficiency"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0024953": "Severe Seborrhoeic dermatitis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisolone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0802020T0": {"Conditions": [{"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0030626": "Oral Lichen Planus"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0005560": "Vitiligo"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0025272": "Refractory Atopic dermatitis"}, {"/indications/DBCOND0025310": "Refractory Rheumatoid arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Tacrolimus", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003276": "Calcineurin Inhibitor Immunosuppressant"}, {"/categories/DBCAT000199": "Calcineurin Inhibitors"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004756": "Tacrolimus"}]}, "0402010G0": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0039365": "Chemotherapy-Induced Nausea and Vomiting (CINV)"}, {"/indications/DBCOND0003735": "Delirium"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}], "Name": "Droperidol", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT002383": "Butyrophenone Derivatives"}, {"/categories/DBCAT000878": "Butyrophenones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0801020P0": {"Conditions": [{"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}], "Name": "Idarubicin Hydrochloride", "Categories": [{"/categories/DBCAT003352": "Anthracycline Topoisomerase Inhibitor"}, {"/categories/DBCAT000874": "Anthracyclines"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000873": "Daunorubicin"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0307000R0": {"Conditions": [{"/indications/DBCOND0081526": "Acute Renal Failure (ARF)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Mannitol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT001104": "Diuretics, Osmotic"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000376": "Flavoring Agents"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002460": "i.v. Solutions"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003715": "Kidney Function"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002459": "Solutions Producing Osmotic Diuresis"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT000378": "Sweetening Agents"}]}, "1003020P0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0085997": "Menstrual Cramps"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Ibuprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003907": "COX-1 Inhibitors"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1107000N0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1306010X0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Sulfacetamide Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0604020H0": {"Conditions": [{"/indications/DBCOND0048343": "Hypergonadotropic Hypogonadism"}, {"/indications/DBCOND0037480": "Idiopathic Hypogonadotropic Hypogonadism"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0001010": "Puberty, Delayed"}], "Name": "Methyltestosterone", "Categories": [{"/categories/DBCAT002430": "3-Oxoandrosten (4) Derivatives"}, {"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT002429": "Androgens and Estrogens"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001013": "Androstenols"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003981": "OAT3/SLC22A8 Inducers"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT001014": "Testosterone Congeners"}]}, "1106000F0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1309000C0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Coal Tar", "Categories": [{"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003796": "Keratoplastic Agents"}, {"/categories/DBCAT002027": "Tars"}]}, "1104020R0": {"Conditions": [{"/indications/DBCOND0023338": "Eye redness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Naphazoline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1001030J0": {"Conditions": [{"/indications/DBCOND0076051": "Felty's Syndrome"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}], "Name": "Sodium Aurothiomalate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000327": "Dicarboxylic Acids"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003194": "Gold Compounds"}, {"/categories/DBCAT002492": "Gold Preparations"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001973": "Malates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001223": "Organogold Compounds"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT002476": "Specific Antirheumatic Agents"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001972": "Thiomalates"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0501030V0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0024177": "Entamoebic histolytica infection"}, {"/indications/DBCOND0026355": "Escherichia infections"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0032133": "Klebsiella Infections"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0051354": "Neisseria Gonorrhoeae Infection"}, {"/indications/DBCOND0024179": "Ornithosis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0089467": "Skin infection caused by Staphylococcus aureus"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0025276": "Bacterial upper respiratory tract infections"}, {"/indications/DBCOND0024183": "Clostridia infections"}], "Name": "Tetracycline", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004752": "Tetracycline, antagonists & inhibitors"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0101010I0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}], "Name": "Magnesium Oxide", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}]}, "0501014S0": {"Conditions": [{"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0058927": "Complicated Appendicitis"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0053994": "Postpartum Endometritis"}, {"/indications/DBCOND0047720": "Surgical Site Infections"}, {"/indications/DBCOND0080531": "Moderate Bacterial Infections"}, {"/indications/DBCOND0025267": "Moderate Community acquired pneumonia"}, {"/indications/DBCOND0025269": "Moderate Nosocomial pneumonia"}, {"/indications/DBCOND0080530": "Severe Bacterial Infections"}, {"/indications/DBCOND0025268": "Severe Nosocomial pneumonia"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Piperacillin Sodium/Tazobactam Sodium", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003662": "Extended-spectrum Penicillins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1202020B0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0606020R0": {"Conditions": [{"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0038793": "Paget's Disease"}], "Name": "Risedronate Sodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000227": "Pyridines"}]}, "0501090N0": {"Conditions": [{"/indications/DBCOND0050152": "Active Tuberculosis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}], "Name": "Pyrazinamide", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000459": "Pyrazines"}]}, "0407020A0": {"Conditions": [{"/indications/DBCOND0051560": "Cancer Related Pain (Breakthrough Pain)"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}], "Name": "Fentanyl", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT000683": "Anesthetics, Intravenous"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT001085": "Fentanyl and fentanyl analogues"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT002452": "Opioid Anesthetics"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003009": "Opioids, Anilidopiperidine"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002384": "Phenylpiperidine Derivatives"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0209000C0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0032772": "Acute Myocardial Infarction (AMI)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0106173": "Atherothrombotic events"}], "Name": "Clopidogrel", "Categories": [{"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003400": "P2Y12 Platelet Inhibitor"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000531": "Purinergic P2 Receptor Antagonists"}, {"/categories/DBCAT000532": "Purinergic P2Y Receptor Antagonists"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000530": "Thienopyridines"}, {"/categories/DBCAT000374": "Thiophenes"}, {"/categories/DBCAT004983": "Ticlopidine"}]}, "0801050AH": {"Conditions": [{"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0074232": "Esophagus, Barrett"}, {"/indications/DBCOND0022196": "Completely obstructive Non-small cell lung cancer"}, {"/indications/DBCOND0022194": "Microinvasive endobrachial Non-small cell lung cancer"}, {"/indications/DBCOND0022198": "Partially obstructive Non-small cell lung cancer"}], "Name": "Porfimer Sodium", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001082": "Hematoporphyrin Derivative"}, {"/categories/DBCAT001083": "Hematoporphyrins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004154": "Photoabsorption"}, {"/categories/DBCAT003372": "Photoactivated Radical Generator"}, {"/categories/DBCAT004155": "Photosensitizing Activity"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT001084": "Porphyrins"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT002451": "Sensitizers Used in Photodynamic/radiation Therapy"}]}, "0801040M0": {"Conditions": [{"/indications/DBCOND0083559": "Acute Lymphoblastic Leukaemia Recurrent"}, {"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0017311": "Choriocarcinoma"}, {"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0040920": "Gestational Trophoblastic Disease"}, {"/indications/DBCOND0026492": "Hepatoblastomas"}, {"/indications/DBCOND0028467": "Immune Thrombocytopenic Purpura ( ITP )"}, {"/indications/DBCOND0035013": "Kaposi s Sarcoma (KS)"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0016977": "Ovarian germ cell tumour"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0001198": "Retinoblastoma"}, {"/indications/DBCOND0027071": "Rhabdomyosarcomas"}, {"/indications/DBCOND0021654": "Wilms' tumor"}, {"/indications/DBCOND0021657": "Advanced Thymoma"}], "Name": "Vincristine Sulfate", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000527": "Indole Alkaloids"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000526": "Secologanin Tryptamine Alkaloids"}, {"/categories/DBCAT000718": "Tubulin Modulators"}, {"/categories/DBCAT000714": "Vinca Alkaloids"}]}, "0605010G0": {"Conditions": [{"/indications/DBCOND0045186": "Ovulatory Dysfunction"}], "Name": "Clomifene Citrate", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT001851": "Clomiphene"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003693": "Estrogen Agonist-antagonists"}, {"/categories/DBCAT003358": "Estrogen Agonist/Antagonist"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT000917": "Estrogen Receptor Modulators"}, {"/categories/DBCAT000060": "Fertility Agents"}, {"/categories/DBCAT000062": "Fertility Agents, Female"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002480": "Ovulation Stimulants, Synthetic"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000618": "Stilbenes"}]}, "1310020B0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0030131": "Invasive Fungal Infections"}, {"/indications/DBCOND0013913": "Leishmaniasis"}, {"/indications/DBCOND0000139": "Meningitis, Cryptococcal"}, {"/indications/DBCOND0073780": "Meningitis, Fungal"}, {"/indications/DBCOND0051127": "Mucocutaneous Leishmaniasis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0033119": "Visceral Leishmaniasis"}, {"/indications/DBCOND0022121": "Candidal cystitis"}, {"/indications/DBCOND0022118": "Disseminated Cryptococcosis"}, {"/indications/DBCOND0022122": "Fungal endophthalmitis"}, {"/indications/DBCOND0022119": "Fungal osteoarticular infections"}, {"/indications/DBCOND0022123": "Ocular aspergillosis"}, {"/indications/DBCOND0025294": "Refractory aspergillosis"}, {"/indications/DBCOND0022131": "Severe Coccidioidomycosis"}, {"/indications/DBCOND0022126": "Severe Cryptococcosis"}, {"/indications/DBCOND0022140": "Severe Fungal infection caused by Basidiobolus spp."}, {"/indications/DBCOND0022137": "Severe Fungal infection caused by Conidiobolus spp."}, {"/indications/DBCOND0022143": "Severe Fungal infection caused by sporotrichosis spp."}, {"/indications/DBCOND0022132": "Severe Histoplasmosis"}, {"/indications/DBCOND0022144": "Severe Mucocutaneous leishmaniasis"}, {"/indications/DBCOND0022128": "Severe North American blastomycosis"}, {"/indications/DBCOND0022130": "Severe Systemic candidiasis"}], "Name": "Amphotericin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001054": "Biomimetic Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000064": "Drug Carriers"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001062": "Investigative Techniques"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003390": "Lipid-based Polyene Antifungal"}, {"/categories/DBCAT001064": "Liposomes"}, {"/categories/DBCAT000983": "Membranes, Artificial"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0702020AA": {"Conditions": [{"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}], "Name": "Secnidazole", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}]}, "1314000M0": {"Conditions": [{"/indications/DBCOND0093852": "Generalized joint pain"}, {"/indications/DBCOND0093850": "Localized muscle pain"}, {"/indications/DBCOND0093851": "Muscle ache"}], "Name": "Methyl Nicotinate", "Categories": [{"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT003234": "Erythema"}, {"/categories/DBCAT003235": "Inflammation"}, {"/categories/DBCAT000824": "Nicotinic Acids"}, {"/categories/DBCAT000227": "Pyridines"}]}, "0204000H0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0035554": "Mild Hypertension"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0061310": "Premature Ventricular Contractions"}, {"/indications/DBCOND0070681": "Supraventricular Arrhythmias"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}, {"/indications/DBCOND0021901": "Perioperative arrhythmia"}], "Name": "Bisoprolol Fumarate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0501080Q0": {"Conditions": [{"/indications/DBCOND0023111": "Acute Otitis Media"}], "Name": "Sulphafurazole", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002262": "Short-Acting Sulfonamides"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0410010D0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0103636": "Opioid Intoxication"}, {"/indications/DBCOND0058333": "Opioid Overdose"}], "Name": "Nalmefene", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000473": "Appetite Depressants"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002441": "Drugs Used in Alcohol Dependence"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT001081": "Naloxone"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0107010L0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0000554": "Coronary Artery Disease"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Isosorbide Dinitrate", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001173": "Isosorbide"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000756": "Nitric Oxide Donors"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT000647": "Sorbitol"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0403030L0": {"Conditions": [{"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}], "Name": "Fluvoxamine Maleate", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000393": "Hydroxylamines"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000392": "Oximes"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0801030D0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0054528": "Acute Promyelocytic Leukemia (APL)"}, {"/indications/DBCOND0029125": "Leptomeningeal Metastases"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0021713": "Meningeal leukemia"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0025342": "Blast phase Chronic myelocytic leukemia"}], "Name": "Cytarabine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000481": "Arabinonucleosides"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1305020S0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0802040W0": {"Conditions": [{"/indications/DBCOND0036413": "Relapsing Remitting Multiple Sclerosis (RRMS)"}], "Name": "Natalizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT003615": "Immunomodulatory Agents"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003280": "Integrin Receptor Antagonist"}, {"/categories/DBCAT004289": "Integrin Receptor Antagonists"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "1312000G0": {"Conditions": [{"/indications/DBCOND0030070": "Airway Obstruction"}, {"/indications/DBCOND0029401": "Arrythmias"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0024446": "Hypersecretion gastric"}, {"/indications/DBCOND0019589": "Increased bronchial secretion"}, {"/indications/DBCOND0024444": "Muscarinic effects caused by neostigmine"}, {"/indications/DBCOND0024449": "Muscarinic effects caused by pyridostigmine"}, {"/indications/DBCOND0030389": "Neurocardiogenic Syncope"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0010371": "Salivary hypersecretion"}, {"/indications/DBCOND0024439": "Chronic, severe Salivary hypersecretion"}, {"/indications/DBCOND0021170": "Pharyngeal secretions"}], "Name": "Glycopyrronium Bromide", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}]}, "0704010U0": {"Conditions": [{"/indications/DBCOND0033444": "Benign Prostatic Hyperplasia (BPH)"}, {"/indications/DBCOND0051310": "Benign Prostatic Hypertrophy (BPH)"}, {"/indications/DBCOND0036147": "Bladder Outlet Obstruction"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}], "Name": "Tamsulosin Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT003670": "Selective Alfa-1-adrenergic Blocking Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0603020Z0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0202080K0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Furosemide/Potassium", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002450": "High-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004546": "Ototoxic agents"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "040702040": {"Conditions": [{"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Tramadol Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000474": "Cyclohexanols"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000477": "Dimethylamines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0203020P0": {"Conditions": [{"/indications/DBCOND0021052": "Severe Ventricular tachycardia"}, {"/indications/DBCOND0025284": "Severe ventricular arrhythmias"}], "Name": "Mexiletine Hydrochloride", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0801030Z0": {"Conditions": [{"/indications/DBCOND0034287": "Advanced Colorectal Cancer"}, {"/indications/DBCOND0029910": "Pleural Mesotheliomas"}], "Name": "Raltitrexed", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002290": "Folic Acid Analogues"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000684": "Thymidylate Synthase, antagonists & inhibitors"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0803042N0": {"Conditions": [{"/indications/DBCOND0043429": "Advanced Prostate Cancer"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0040295": "Central Precocious Puberty (CPP)"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0066992": "Infertilities"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0018486": "Paraphilia"}, {"/indications/DBCOND0034798": "Uterine Leiomyomas"}, {"/indications/DBCOND0106038": "Symptom recurrence"}], "Name": "Leuprorelin Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000060": "Fertility Agents"}, {"/categories/DBCAT000062": "Fertility Agents, Female"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000107": "Gonadotropins"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}]}, "0202030X0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0022182": "LVEF <40% Congestive heart failure"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}], "Name": "Eplerenone", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003684": "Mineralocorticoid (Aldosterone) Receptor Antagonists"}, {"/categories/DBCAT000844": "Mineralocorticoid Receptor Antagonists"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT002346": "Potassium-Sparing Agents"}, {"/categories/DBCAT002702": "Potassium-Sparing Diuretics"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "1203030I0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0042226": "Ocular Irritation"}], "Name": "Glycerol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT004060": "Increased IgG Production"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003529": "Non-Standardized Chemical Allergen"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003729": "Other Cold and Cough Preparations"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT004975": "Triose Sugar Alcohols"}]}, "0407020AA": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0034822": "Perioperative Pain"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Butorphanol Tartrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT002424": "Morphinan Derivatives"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT003382": "Opioid Agonist/Antagonist"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0205051L0": {"Conditions": [{"/indications/DBCOND0032772": "Acute Myocardial Infarction (AMI)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}], "Name": "Lisinopril", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000375": "Dipeptides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}]}, "0407020AD": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0112013": "Chronic, moderate Pain"}], "Name": "Oxycodone Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000929": "Codeine"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0407020AG": {"Conditions": [{"/indications/DBCOND0036250": "Diabetic Peripheral Neuropathic Pain (DPN)"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0112013": "Chronic, moderate Pain"}], "Name": "Tapentadol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0407020AF": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0038329": "Severe, Chronic Pain"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0112013": "Chronic, moderate Pain"}], "Name": "Oxycodone HCl/Naloxone HCl", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000929": "Codeine"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0801000Z0": {"Conditions": [{"/indications/DBCOND0034287": "Advanced Colorectal Cancer"}, {"/indications/DBCOND0024088": "Folic acid antagonist overdose"}, {"/indications/DBCOND0063579": "Metastatic Colorectal Cancers"}], "Name": "Levofolinic Acid", "Categories": [{"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000223": "Coenzymes"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT004536": "Folate Analog"}, {"/categories/DBCAT004537": "Folic Acid"}, {"/categories/DBCAT002290": "Folic Acid Analogues"}, {"/categories/DBCAT001033": "Folic Acid and Derivatives"}, {"/categories/DBCAT004981": "Formyltetrahydrofolates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004543": "Leucovorin"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000354": "Pterins"}, {"/categories/DBCAT004542": "Tetrahydrofolates"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0211000P0": {"Conditions": [{"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0032173": "Hereditary Angioedema"}, {"/indications/DBCOND0020902": "Chronic heavy menstrual bleeding"}], "Name": "Tranexamic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000387": "Antifibrinolytic Agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT000703": "Cyclohexanecarboxylic Acids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT004136": "Decreased Fibrinolysis"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}]}, "0501070AB": {"Conditions": [{"/indications/DBCOND0004279": "Ascariasis"}, {"/indications/DBCOND0026172": "Cestode infections"}, {"/indications/DBCOND0024824": "Clostridium difficile infection recurrence"}, {"/indications/DBCOND0011291": "Cryptosporidiosis infection"}, {"/indications/DBCOND0021433": "Diarrhea caused by Cryptosporidium parvum"}, {"/indications/DBCOND0021436": "Diarrhea caused by Giardia lamblia"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0004262": "Trichuriasis"}], "Name": "Nitazoxanide", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0203020F0": {"Conditions": [{"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Disopyramide", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002277": "Antiarrhythmics, Class Ia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1001030W0": {"Conditions": [{"/indications/DBCOND0025601": "Polyarticular Juvenile Idiopathic Arthritis"}, {"/indications/DBCOND0039050": "Severe Aplastic Anemia (SAA)"}, {"/indications/DBCOND0075611": "Systemic Juvenile Idiopathic Arthritis (SJIA)"}, {"/indications/DBCOND0025596": "Refractory Aplastic anemia"}], "Name": "Tocilizumab", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004312": "Interleukin 6 Receptor Antagonists"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT003466": "Interleukin-6 Receptor Antagonist"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0502030A0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0030131": "Invasive Fungal Infections"}, {"/indications/DBCOND0013913": "Leishmaniasis"}, {"/indications/DBCOND0000139": "Meningitis, Cryptococcal"}, {"/indications/DBCOND0073780": "Meningitis, Fungal"}, {"/indications/DBCOND0051127": "Mucocutaneous Leishmaniasis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0033119": "Visceral Leishmaniasis"}, {"/indications/DBCOND0022121": "Candidal cystitis"}, {"/indications/DBCOND0022118": "Disseminated Cryptococcosis"}, {"/indications/DBCOND0022122": "Fungal endophthalmitis"}, {"/indications/DBCOND0022119": "Fungal osteoarticular infections"}, {"/indications/DBCOND0022123": "Ocular aspergillosis"}, {"/indications/DBCOND0025294": "Refractory aspergillosis"}, {"/indications/DBCOND0022131": "Severe Coccidioidomycosis"}, {"/indications/DBCOND0022126": "Severe Cryptococcosis"}, {"/indications/DBCOND0022140": "Severe Fungal infection caused by Basidiobolus spp."}, {"/indications/DBCOND0022137": "Severe Fungal infection caused by Conidiobolus spp."}, {"/indications/DBCOND0022143": "Severe Fungal infection caused by sporotrichosis spp."}, {"/indications/DBCOND0022132": "Severe Histoplasmosis"}, {"/indications/DBCOND0022144": "Severe Mucocutaneous leishmaniasis"}, {"/indications/DBCOND0022128": "Severe North American blastomycosis"}, {"/indications/DBCOND0022130": "Severe Systemic candidiasis"}], "Name": "Amphotericin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001054": "Biomimetic Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000064": "Drug Carriers"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001062": "Investigative Techniques"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003390": "Lipid-based Polyene Antifungal"}, {"/categories/DBCAT001064": "Liposomes"}, {"/categories/DBCAT000983": "Membranes, Artificial"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "110600030": {"Conditions": [{"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}], "Name": "Methazolamide", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0601023M0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Miglitol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000670": "Glycoside Hydrolase Inhibitors"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT001528": "Imino Pyranoses"}, {"/categories/DBCAT001529": "Imino Sugars"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000695": "Piperidines"}]}, "0605020Y0": {"Conditions": [{"/indications/DBCOND0050861": "Autosomal Dominant Polycystic Kidney Disease \uff08ADPKD)"}, {"/indications/DBCOND0023255": "Symptomatic euvolemic Hyponatremia"}, {"/indications/DBCOND0023258": "Symptomatic hypervolemic Hyponatremia"}], "Name": "Tolvaptan", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT001166": "Antidiuretic Hormone Receptor Antagonists"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003559": "Vasopressin V2 Receptor Antagonist"}, {"/categories/DBCAT004476": "Vasopressin V2 Receptor Antagonists"}]}, "0104020P0": {"Conditions": [{"/indications/DBCOND0089496": "Chronic Functional Diarrhea"}, {"/indications/DBCOND0024414": "Intestinal stoma leak"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0102291": "Severe or persistent diarrhea"}], "Name": "Loperamide Hydrochloride & Simeticone", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT001158": "Antidiarrheals"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002293": "Antipropulsives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0404000T0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}], "Name": "Dexmethylphenidate Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT002179": "Centrally Acting Sympathomimetics"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT001839": "Methylphenidate"}, {"/categories/DBCAT004580": "Methylphenidate and isomer"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0205010N0": {"Conditions": [{"/indications/DBCOND0031762": "Androgenetic Alopecia"}, {"/indications/DBCOND0020964": "Severe, symptomatic Hypertension"}], "Name": "Minoxidil", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT004240": "Arteriolar Vasodilation"}, {"/categories/DBCAT003332": "Arteriolar Vasodilator"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002332": "Pyrimidine Derivatives"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "131002030": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0000154": "Onychomycosis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0000158": "Sporotrichosis"}, {"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}], "Name": "Terbinafine Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003396": "Allylamine Antifungal"}, {"/categories/DBCAT003734": "Allylamines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002359": "Antifungals for Systemic Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000383": "Naphthalenes"}]}, "1307000U0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0076899": "Malignant Neoplasm of Colon"}, {"/indications/DBCOND0087260": "Malignant Neoplasm of Pancreas"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0041015": "Rectal Carcinoma"}, {"/indications/DBCOND0032565": "Superficial Basal Cell Carcinoma"}, {"/indications/DBCOND0106143": "Hyperkeratotic actinic keratosis"}], "Name": "Fluorouracil", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003851": "Fluoropyrimidines"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "1002020E0": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0106101": "Moderate Muscle Spasm"}, {"/indications/DBCOND0106100": "Severe Muscle Spasm"}], "Name": "Chlorzoxazone", "Categories": [{"/categories/DBCAT000783": "Benzoxazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002334": "Oxazol, Thiazine, and Triazine Derivatives"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}]}, "0502010B0": {"Conditions": [{"/indications/DBCOND0020648": "Candida intertrigo"}, {"/indications/DBCOND0014426": "Candida pneumonia"}, {"/indications/DBCOND0000135": "Candidemia"}, {"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0114657": "Fungal peritonitis caused by Candida"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0000139": "Meningitis, Cryptococcal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0011143": "Peritoneal candidiasis"}, {"/indications/DBCOND0014408": "Pneumonia cryptococcal"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0117284": "Systemic Candida Infections caused by Candida"}, {"/indications/DBCOND0037345": "Vaginal Candidiasis"}, {"/indications/DBCOND0025427": "Candidiasis infection"}, {"/indications/DBCOND0021837": "Disseminated Candidiasis"}, {"/indications/DBCOND0020640": "Urinary tract candidiasis"}], "Name": "Fluconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004488": "Cytochrome P-450 CYP3A5 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002193": "Triazole Derivatives"}, {"/categories/DBCAT000486": "Triazoles"}]}, "0408010AI": {"Conditions": [{"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Eslicarbazepine Acetate", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002411": "Carboxamide Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002640": "Cytochrome P-450 CYP2C19 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0501070U0": {"Conditions": [{"/indications/DBCOND0059697": "Clostridium Difficile-Associated Diarrhea (CDAD)"}, {"/indications/DBCOND0021445": "Enterocolitis caused by Staphylococcus aureus"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Vancomycin Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT002402": "Glycopeptide Antibacterials"}, {"/categories/DBCAT000678": "Glycopeptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT004741": "Vancomycin"}]}, "0403010Y0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0001411": "Nocturnal Enuresis"}, {"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Trimipramine Maleate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0901030I0": {"Conditions": [{"/indications/DBCOND0035658": "Transfusional Iron Overload"}], "Name": "Deferiprone", "Categories": [{"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003716": "Heavy Metal Antagonists"}, {"/categories/DBCAT004279": "Iron Chelating Activity"}, {"/categories/DBCAT001107": "Iron Chelating Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001044": "Pyridones"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0603020H0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0303030B0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Roflumilast", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001410": "Phosphodiesterase 4 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}]}, "0410020B0": {"Conditions": [{"/indications/DBCOND0068550": "Dental Cavity"}, {"/indications/DBCOND0041559": "Nicotine Withdrawal"}], "Name": "Nicotine", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003289": "Cholinergic Nicotinic Agonist"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002182": "Drugs Used in Nicotine Dependence"}, {"/categories/DBCAT001047": "Ganglion Blockers"}, {"/categories/DBCAT000446": "Ganglionic Stimulants"}, {"/categories/DBCAT003631": "Miscellaneous Autonomic Drugs"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT001706": "Nicotine"}, {"/categories/DBCAT001935": "Nicotine, antagonists & inhibitors"}, {"/categories/DBCAT004727": "Nicotine, metabolism"}, {"/categories/DBCAT000445": "Nicotinic Agonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT004978": "Smoking Cessation Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}]}, "0109010U0": {"Conditions": [{"/indications/DBCOND0080519": "Primary Biliary Cholangitis"}, {"/indications/DBCOND0023122": "Gallstone formation"}], "Name": "Ursodeoxycholic Acid", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002534": "Bile Acid Preparations"}, {"/categories/DBCAT004599": "Bile acids and derivatives"}, {"/categories/DBCAT001384": "Bile Acids and Salts"}, {"/categories/DBCAT002536": "Bile and Liver Therapy"}, {"/categories/DBCAT002535": "Bile Therapy"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001385": "Cholagogues and Choleretics"}, {"/categories/DBCAT001383": "Cholanes"}, {"/categories/DBCAT003763": "Cholelitholytic Agents"}, {"/categories/DBCAT001382": "Cholic Acids"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001381": "Deoxycholic Acid"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "0905011B0": {"Conditions": [{"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0020582": "Hypocalcemia"}, {"/indications/DBCOND0020933": "Hypocalcemic tetany"}, {"/indications/DBCOND0022711": "Beta blocker overdose"}, {"/indications/DBCOND0022863": "Calcium channel blocker overdose"}], "Name": "Calcium Chloride", "Categories": [{"/categories/DBCAT002512": "Acidifiers"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT002729": "Supplements"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1303000I0": {"Conditions": [{"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0000256": "Scabies"}], "Name": "Crotamiton", "Categories": [{"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT003648": "Scabicides and Pediculicides"}, {"/categories/DBCAT001414": "Toluene"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1201030I0": {"Conditions": [{"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Isopropyl Alcohol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT001183": "Solvents"}]}, "0603020F0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Cortisone Acetate", "Categories": [{"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0409010W0": {"Conditions": [{"/indications/DBCOND0034367": "Bipolar Disorder (BD)"}, {"/indications/DBCOND0118935": "Moderate restless legs syndrome (RLS)"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0118936": "Severe restless legs syndrome (RLS)"}], "Name": "Pramipexole", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000726": "Benzothiazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000840": "Restless Legs Syndrome"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0908010Y0": {"Conditions": [{"/indications/DBCOND0008412": "Sucrase-isomaltase deficiency"}], "Name": "Sacrosidase", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000166": "Glycoside Hydrolases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003477": "Sucrose-specific Enzyme"}]}, "0409010AB": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Opicapone", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002655": "COMT Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000626": "Oxazoles"}]}, "0409010AC": {"Conditions": [{"/indications/DBCOND0012298": "Mobility decreased"}], "Name": "Apomorphine Hydrochloride Hemihydrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT001090": "Aporphines"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT001091": "Benzylisoquinolines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT001092": "Emetics"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0409010AA": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Safinamide", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000417": "Benzyl Compounds"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002494": "Monoamine Oxidase B Inhibitors"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT004089": "Monoamine Oxidase-B Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "1001030V0": {"Conditions": [{"/indications/DBCOND0025507": "Moderate Juvenile idiopathic arthritis"}, {"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0025506": "Severe Juvenile idiopathic arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Abatacept", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004354": "Decreased Cytokine Activity"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000152": "Immunoconjugates"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT003439": "Selective T Cell Costimulation Modulator"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0211000B0": {"Conditions": [{"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0024150": "Bleeding caused by thrombocytopenia"}, {"/indications/DBCOND0024333": "Bleeding of the oral"}, {"/indications/DBCOND0022978": "Hemorrhage"}, {"/indications/DBCOND0021452": "Secondary subarachnoid hemorrhage"}], "Name": "Aminocaproic Acid", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000937": "Aminocaproates"}, {"/categories/DBCAT000387": "Antifibrinolytic Agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000938": "Caproates"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT004136": "Decreased Fibrinolysis"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT000178": "Lipids"}]}, "0202010P0": {"Conditions": [{"/indications/DBCOND0077364": "Body Fluid Retention"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0112036": "Recurrent Nephrolithiasis"}], "Name": "Indapamide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002299": "Low-Ceiling Diuretics, Excl. Thiazides"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003322": "Thiazide-like Diuretic"}]}, "0501030I0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0116954": "Acute epididymo-orchitis caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0011318": "Anal chlamydia infection"}, {"/indications/DBCOND0106325": "Bacterial Infection caused by Enterobacter aerogenes"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0069537": "Chlamydial Urethritis"}, {"/indications/DBCOND0014462": "Chlamydial cervicitis"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0031183": "Clostridium Infections"}, {"/indications/DBCOND0014610": "Epididymo-orchitis gonococcal"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0077690": "Infection Due to Escherichia Coli"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0053857": "Inhalational Anthrax (Post-Exposure)"}, {"/indications/DBCOND0080081": "Intestinal Amebiasis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0116947": "Rectal infection"}, {"/indications/DBCOND0116946": "Rectal infection caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0116948": "Recurring fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0021921": "Relapsing fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0056153": "Secondary Syphilis"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0014242": "Tick-borne fever"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020776": "Trachoma inclusion conjunctivitis"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0053861": "Typhus Fever"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Doxycycline Hyclate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0703022I0": {"Conditions": [{"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0018394": "Pregnancy"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Levonorgestrel", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004113": "Inhibit Ovum Fertilization"}, {"/categories/DBCAT000797": "Norgestrel"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT003338": "Progestin-containing Intrauterine Device"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0409010A0": {"Conditions": [{"/indications/DBCOND0012298": "Mobility decreased"}], "Name": "Apomorphine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT001090": "Aporphines"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT001091": "Benzylisoquinolines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT001092": "Emetics"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0202010B0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Bendroflumethiazide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "1203010E0": {"Conditions": [{"/indications/DBCOND0051417": "Acute Sore Throat"}, {"/indications/DBCOND0025691": "Mucositis of the oro-pharyngeal"}], "Name": "Benzydamine Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT003782": "Mouthwashes and Gargles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "0503010D0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Efavirenz", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002640": "Cytochrome P-450 CYP2C19 Inhibitors (moderate)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT003899": "Cytochrome P-450 CYP3A7 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003302": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002245": "Non-Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003641": "Nonnucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "0309020H0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0042226": "Ocular Irritation"}], "Name": "Glycerol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT004060": "Increased IgG Production"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003529": "Non-Standardized Chemical Allergen"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003729": "Other Cold and Cough Preparations"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT004975": "Triose Sugar Alcohols"}]}, "0208010AB": {"Conditions": [{"/indications/DBCOND0038128": "Acute Pulmonary Embolism"}, {"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0045439": "Non ST Segment Elevation Myocardial Infarction (NSTEMI)"}, {"/indications/DBCOND0048867": "ST Elevation Myocardial Infarction (STEMI)"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}, {"/indications/DBCOND0112015": "Acute, superficial, symptomatic Vein Thrombosis"}], "Name": "Fondaparinux Sodium", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000012": "Antithrombins"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001775": "Factor Xa Inhibitors"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000001": "Serine Proteinase Inhibitors"}]}, "0501050H0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin Ethylsuccinate", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1502010X0": {"Conditions": [{"/indications/DBCOND0038329": "Severe, Chronic Pain"}], "Name": "Ziconotide Acetate", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT001367": "Bodily Secretions"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT001786": "Calcium Channels, N-Type"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002963": "Conotoxins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT001368": "Fluids and Secretions"}, {"/categories/DBCAT001494": "Marine Toxins"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002964": "Mollusk Venoms"}, {"/categories/DBCAT004414": "N-Calcium Channel Receptor Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000185": "Toxins, Biological"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT001328": "Venoms"}]}, "0408020U0": {"Conditions": [{"/indications/DBCOND0024115": "Seizures"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Fosphenytoin Sodium", "Categories": [{"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004507": "Cytochrome P-450 CYP2D6 Inducers (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002678": "Phenytoin and Prodrugs"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT002665": "UGT1A6 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}]}, "1310011G0": {"Conditions": [{"/indications/DBCOND0021311": "Acute Crusting Rhinitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0039241": "Corneal Abrasions"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0021315": "Stye"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0021310": "Acute rhino-sinusitis"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0020325": "Nasal carriage of staphylococci"}], "Name": "Framycetin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000880": "Neomycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1310012I0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0024199": "Bacterial corneal ulcer"}, {"/indications/DBCOND0009907": "Bacterial dacryocystitis"}, {"/indications/DBCOND0022572": "Blepharoconjunctivitis"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0014101": "Dermatitis infected"}, {"/indications/DBCOND0005633": "Ecthyma"}, {"/indications/DBCOND0024202": "Eczematous dermatitis infected"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0024201": "Furunculosis"}, {"/indications/DBCOND0024204": "Gram-negative enteric bacilli neonatal sepsis"}, {"/indications/DBCOND0024200": "Impetigo contagious"}, {"/indications/DBCOND0009952": "Keratitis bacterial"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0009912": "Meibomianitis"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0066222": "Pustular Psoriasis"}, {"/indications/DBCOND0024203": "Pustular acne"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0014782": "Sycosis barbae"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0024206": "Complicated Respiratory tract infection bacterial"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0025307": "Severe Endocarditis enterococcal"}, {"/indications/DBCOND0024208": "Severe Infection Pseudomonas aeruginosa"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Gentamicin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001201": "Gentamicins"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1104020AC": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}], "Name": "Epinastine Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003399": "Histamine H1 Inhibitors"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}]}, "0905013D0": {"Conditions": [{"/indications/DBCOND0004074": "Magnesium Deficiency"}], "Name": "Magnesium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}]}, "1201010M0": {"Conditions": [{"/indications/DBCOND0025199": "External ear infection NOS"}], "Name": "Colistin Sulphate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}]}, "0406000F0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0035529": "Motion Sickness"}], "Name": "Cyclizine Hydrochloride", "Categories": [{"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002325": "Piperazine Derivatives"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1003020C0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0208010W0": {"Conditions": [{"/indications/DBCOND0022770": "Clotting"}, {"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0023440": "Pulmonary embolism, Deep vein thrombosis"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}], "Name": "Tinzaparin Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002680": "Heparin (Low Molecular Weight)"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "1108010C0": {"Conditions": [{"/indications/DBCOND0047315": "Acetaminophen Overdose"}], "Name": "Acetylcysteine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003463": "Antidote for Acetaminophen Overdose"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000315": "Cysteine"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004189": "Increased Glutathione Concentration"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT004190": "Reduction Activity"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1306010I0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1001010G0": {"Conditions": [{"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Fenoprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0406000T0": {"Conditions": [{"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0021210": "Non-psychotic generalized anxiety"}, {"/indications/DBCOND0021212": "Severe Nausea and vomiting"}], "Name": "Prochlorperazine Maleate", "Categories": [{"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002373": "Phenothiazines With Piperazine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001645": "Schizophrenia"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0802020U0": {"Conditions": [{"/indications/DBCOND0042698": "Chordomas"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0066453": "Lung Transplant Rejection"}, {"/indications/DBCOND0001546": "Lymphangioleiomyomatosis"}, {"/indications/DBCOND0069874": "Renal Angiomyolipomas"}, {"/indications/DBCOND0022400": "Moderate renal transplant rejection"}], "Name": "Sirolimus", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004157": "Decreased Immunologic Activity"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT003412": "mTOR Inhibitor Immunosuppressant"}, {"/categories/DBCAT004158": "mTOR Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0704030A0": {"Conditions": [{"/indications/DBCOND0021680": "Chronic urea-splitting urinary infection"}], "Name": "Acetohydroxamic Acid", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000393": "Hydroxylamines"}, {"/categories/DBCAT003371": "Urease Inhibitor"}, {"/categories/DBCAT004222": "Urease Inhibitors"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1306010M0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0001518": "Sezary Syndrome"}, {"/indications/DBCOND0024438": "Refractory Acne vulgaris"}, {"/indications/DBCOND0120029": "Severe Recalcitrant nodular acne"}], "Name": "Isotretinoin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002491": "Anti-Acne Preparations for Systemic Use"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT002490": "Retinoids for Treatment of Acne"}, {"/categories/DBCAT001141": "Teratogens"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1306010W0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0024177": "Entamoebic histolytica infection"}, {"/indications/DBCOND0026355": "Escherichia infections"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0032133": "Klebsiella Infections"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0051354": "Neisseria Gonorrhoeae Infection"}, {"/indications/DBCOND0024179": "Ornithosis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0089467": "Skin infection caused by Staphylococcus aureus"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0025276": "Bacterial upper respiratory tract infections"}, {"/indications/DBCOND0024183": "Clostridia infections"}], "Name": "Tetracycline Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004752": "Tetracycline, antagonists & inhibitors"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0307000S0": {"Conditions": [{"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}], "Name": "Ivacaftor", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT004131": "Chloride Channel Activation Potentiators"}, {"/categories/DBCAT001249": "Chloride Channel Agonists"}, {"/categories/DBCAT001892": "Cystic Fibrosis Transmembrane Conductance Regulator"}, {"/categories/DBCAT003776": "Cystic Fibrosis Transmembrane Conductance Regulator Potentiators"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000788": "Quinolines"}]}, "1108010U0": {"Conditions": [{"/indications/DBCOND0023722": "Mild Metabolic acidosis"}, {"/indications/DBCOND0023721": "Moderate Metabolic acidosis"}], "Name": "Sodium Lactate", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001522": "Lactates"}, {"/categories/DBCAT004794": "Lactic Acid"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002544": "Organic Acids"}]}, "0107040B0": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0078508": "Hypertensive Emergency"}, {"/indications/DBCOND0073410": "Premature Labour"}, {"/indications/DBCOND0041552": "Pulmonary Edemas"}, {"/indications/DBCOND0051788": "Pulmonary Hypertension (PH)"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}, {"/indications/DBCOND0039062": "Vasospastic Angina"}], "Name": "Nifedipine", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT002343": "Calcium Channel Blockers and Diuretics"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "100302040": {"Conditions": [{"/indications/DBCOND0028936": "Interstitial Cystitis"}], "Name": "Dimethyl Sulfoxide", "Categories": [{"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004769": "Dimethyl Sulfoxide"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0801010B0": {"Conditions": [{"/indications/DBCOND0048758": "Essential Thrombocythemia (ET)"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0023301": "Chronic Chronic myelogenous leukemia"}], "Name": "Busulfan", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000889": "Alkanesulfonates"}, {"/categories/DBCAT000890": "Alkanesulfonic Acids"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001228": "Butylene Glycols"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001229": "Mesylates"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0501020U0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}], "Name": "Ceftibuten", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "1104010I0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1104020S0": {"Conditions": [{"/indications/DBCOND0023338": "Eye redness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Naphazoline Nitrate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1308010U0": {"Conditions": [{"/indications/DBCOND0005372": "Sunburn"}], "Name": "Titanium Dioxide", "Categories": [{"/categories/DBCAT003794": "Astringents and Deodorants"}, {"/categories/DBCAT000985": "Biocompatible Materials"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001075": "Coloring Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT001341": "Metals"}, {"/categories/DBCAT001339": "Metals, Light"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT001388": "Transition Elements"}, {"/categories/DBCAT002011": "Water Pollutants, Chemical"}]}, "0407020N0": {"Conditions": [{"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Morphine", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0205010AA": {"Conditions": [{"/indications/DBCOND0023836": "WHO Group 1 Pulmonary arterial hypertension"}], "Name": "Macitentan", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002410": "Antihypertensives for Pulmonary Arterial Hypertension"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001698": "Endothelin A Receptor Antagonists"}, {"/categories/DBCAT001699": "Endothelin B Receptor Antagonists"}, {"/categories/DBCAT000972": "Endothelin Receptor Antagonists"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0205010AB": {"Conditions": [{"/indications/DBCOND0034891": "Chronic Thromboembolic Pulmonary Hypertension"}, {"/indications/DBCOND0039281": "Pulmonary Arterial Hypertension (PAH)"}], "Name": "Riociguat", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002410": "Antihypertensives for Pulmonary Arterial Hypertension"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003063": "Enzyme Activators"}, {"/categories/DBCAT002760": "Guanylate Cyclase"}, {"/categories/DBCAT004472": "Guanylate Cyclase Stimulators"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003503": "Soluble Guanylate Cyclase Stimulator"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1502010J0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0503010AF": {"Conditions": [{"/indications/DBCOND0023289": "Non-nucleoside reverse transcriptase inhibitor resistant HIV-1 infection"}], "Name": "Etravirine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003302": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT002245": "Non-Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003641": "Nonnucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "0409030R0": {"Conditions": [{"/indications/DBCOND0029898": "Amyotrophic Lateral Sclerosis (ALS)"}], "Name": "Riluzole", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000726": "Benzothiazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0704040B0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0025199": "External ear infection NOS"}, {"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Acetic Acid", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002544": "Organic Acids"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0605010D0": {"Conditions": [{"/indications/DBCOND0037480": "Idiopathic Hypogonadotropic Hypogonadism"}, {"/indications/DBCOND0033671": "Undescended Testis"}, {"/indications/DBCOND0023601": "Secondary Hypogonadotrophic hypogonadism"}], "Name": "Chorionic Gonadotrophin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT001930": "Chorionic Gonadotropin"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000107": "Gonadotropins"}, {"/categories/DBCAT004658": "Gonadotropins and Antigonadotropins"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT001932": "Placental Hormones"}, {"/categories/DBCAT001931": "Pregnancy Proteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}]}, "1314000L0": {"Conditions": [{"/indications/DBCOND0022770": "Clotting"}, {"/indications/DBCOND0022765": "Consumption coagulopathy"}, {"/indications/DBCOND0052606": "Disseminated Intravascular Coagulation (DIC)"}, {"/indications/DBCOND0028936": "Interstitial Cystitis"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0048867": "ST Elevation Myocardial Infarction (STEMI)"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0034329": "Thrombosis, Venous"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0022766": "Embolization"}, {"/indications/DBCOND0022767": "Peripheral arterial embolism"}], "Name": "Heparin Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT002505": "Heparin Group"}, {"/categories/DBCAT002743": "Heparins"}, {"/categories/DBCAT002447": "Heparins or Heparinoids for Topical Use"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0502050C0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0000154": "Onychomycosis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0000158": "Sporotrichosis"}, {"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}], "Name": "Terbinafine Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003396": "Allylamine Antifungal"}, {"/categories/DBCAT003734": "Allylamines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002359": "Antifungals for Systemic Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000383": "Naphthalenes"}]}, "0902021S0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0501013B0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0019741": "Bronchiectasis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0022692": "Duodenal ulcer caused by helicobacter pylori"}, {"/indications/DBCOND0014098": "Erysipeloid"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000208": "Lyme Neuroborreliosis"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0014061": "Sinusitis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0025416": "Acute Gonorrhea"}, {"/indications/DBCOND0020981": "Uncomplicated Gonorrhea"}], "Name": "Amoxicillin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003682": "Aminopenicillins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0702020R0": {"Conditions": [{"/indications/DBCOND0037929": "Fungal Keratitis"}, {"/indications/DBCOND0022362": "Fungal blepharitis"}, {"/indications/DBCOND0022360": "Fungal conjunctivitis"}], "Name": "Natamycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT003407": "Polyene Antimicrobial"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0901012Q0": {"Conditions": [{"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Ferumoxytol", "Categories": [{"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000753": "Ferric Compounds"}, {"/categories/DBCAT001773": "Ferrous Compounds"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT004125": "Magnetic Resonance Contrast Activity"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003301": "Paramagnetic Contrast Agent"}, {"/categories/DBCAT003555": "Parenteral Iron Replacement"}, {"/categories/DBCAT001774": "Parenteral Nutrition Solutions"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT000895": "Solutions"}]}, "0802010M0": {"Conditions": [{"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}], "Name": "Mycophenolate Mofetil", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT003391": "Antimetabolite Immunosuppressant"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001071": "IMP Dehydrogenase, antagonists & inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0802020G0": {"Conditions": [{"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0030791": "Bone Marrow Transplant Rejection"}, {"/indications/DBCOND0030834": "Connective Tissue Disorders"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0001365": "Glomerulosclerosis, Focal Segmental"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0028936": "Interstitial Cystitis"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0034112": "Nephritis, Lupus"}, {"/indications/DBCOND0069251": "Ocular Rosacea"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0116963": "Blistering disorder"}, {"/indications/DBCOND0025249": "Refractory Ulcerative colitis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}, {"/indications/DBCOND0020494": "Severe, recalcitrant Plaque psoriasis"}, {"/indications/DBCOND0020498": "Suppressed tear production"}], "Name": "Ciclosporin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003276": "Calcineurin Inhibitor Immunosuppressant"}, {"/categories/DBCAT000199": "Calcineurin Inhibitors"}, {"/categories/DBCAT000198": "Cyclosporins"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT003899": "Cytochrome P-450 CYP3A7 Inducers (moderate)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "0403040Y0": {"Conditions": [{"/indications/DBCOND0035149": "Back Pain Lower Back Chronic"}, {"/indications/DBCOND0070113": "Chemotherapy-induced Peripheral Neuropathy (CIPN)"}, {"/indications/DBCOND0033876": "Chronic Musculoskeletal Pain"}, {"/indications/DBCOND0049986": "Diabetic Peripheral Neuropathy (DPN)"}, {"/indications/DBCOND0002221": "Fibromyalgia"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0066726": "Stress Urinary Incontinence (SUI)"}], "Name": "Duloxetine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002715": "Serotonin and Noradrenaline Reuptake Inhibitors"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "1310011AA": {"Conditions": [{"/indications/DBCOND0014554": "Staphylococcal impetigo"}, {"/indications/DBCOND0014528": "Streptococcal impetigo"}], "Name": "Retapamulin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003434": "Pleuromutilin Antibacterial"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0902012L0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0603020Y0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0501070F0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Chloramphenicol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002381": "Amphenicols"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001884": "Chloramphenicol"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT000875": "Nitrobenzenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0503032I0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0023732": "Chronic hepatitis C genotype 1a"}, {"/indications/DBCOND0023728": "Chronic hepatitis C genotype 1b"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}], "Name": "Elbasvir/Grazoprevir", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003507": "Hepatitis C Virus NS5A Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}]}, "0106010H0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Methylcellulose", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT002593": "Bulk-Forming Laxatives"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001448": "Cellulose"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT001022": "Glucans"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "0204000G0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Betaxolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT003633": "Beta-adrenergic Agents"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "1203030H0": {"Conditions": [{"/indications/DBCOND0093835": "Hemmorhoids"}], "Name": "Domiphen Bromide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003735": "Miscellaneous Anti-infectives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0704020Z0": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Trospium Chloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001929": "Diphenylacetic Acids"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT000602": "Tropanes"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0906040G0": {"Conditions": [{"/indications/DBCOND0036228": "Hypophosphatemia, Familial"}, {"/indications/DBCOND0057073": "Vitamin D Resistant Rickets"}, {"/indications/DBCOND0022862": "Parathyroid deficiency"}], "Name": "Colecalciferol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT004724": "Cholecalciferol, antagonists & inhibitors"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0402020L0": {"Conditions": [{"/indications/DBCOND0017943": "Chorea"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0051503": "Psychotic Disorder NOS"}], "Name": "Fluphenazine Decanoate", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002373": "Phenothiazines With Piperazine Structure"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0203020E0": {"Conditions": [{"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0085135": "Ventricular Tachycardia (VT)"}], "Name": "Bretylium Tosilate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002208": "Antiarrhythmics, Class III"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT001273": "Benzylammonium Compounds"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT001283": "Bretylium Compounds"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}]}, "0503021D0": {"Conditions": [{"/indications/DBCOND0005113": "Subacute Sclerosing Panencephalitis"}], "Name": "Inosine Pranobex", "Categories": [{"/categories/DBCAT000598": "Acetanilides"}, {"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT001184": "Inosine"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0704060B0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine/Prilocaine (Prem Ejaculation)", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1203030Z0": {"Conditions": [{"/indications/DBCOND0112729": "Mouth infection"}, {"/indications/DBCOND0099523": "Throat infection"}], "Name": "Dichlorobenzyl Alcohol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000417": "Benzyl Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0502030B0": {"Conditions": [{"/indications/DBCOND0028285": "Oral Candidiasis"}, {"/indications/DBCOND0022068": "Mucocutaneous candida infection"}], "Name": "Nystatin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001029": "Ionophores"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}]}, "0901011Q0": {"Conditions": [{"/indications/DBCOND0031349": "Iron Deficiency"}, {"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0020262": "Concomitant myelosuppressive chemotherapy"}], "Name": "Iron & Folic Acid", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004561": "Iron"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT001341": "Metals"}, {"/categories/DBCAT001387": "Metals, Heavy"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002729": "Supplements"}, {"/categories/DBCAT001391": "Trace Elements"}, {"/categories/DBCAT001388": "Transition Elements"}]}, "1304000N0": {"Conditions": [{"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0115089": "Non-infectious Posterior Uveitis Chronic Uveitis"}, {"/indications/DBCOND0024346": "Psoriasis of the scalp"}, {"/indications/DBCOND0024347": "Seborrheic dermatitis of the scalp"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021868": "Chronic eczematous otitis externa"}], "Name": "Fluocinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0107020J0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106167": "Fulminating Pulmonary Tuberculosis"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Hydrocortisone", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1002020V0": {"Conditions": [{"/indications/DBCOND0053860": "Muscle Spasms"}, {"/indications/DBCOND0106241": "Mild Musculoskeletal Disorder"}, {"/indications/DBCOND0106240": "Moderate Musculoskeletal Disorder"}], "Name": "Orphenadrine Citrate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002516": "Ethers, Chemically Close to Antihistamines"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003751": "Miscellaneous Skeletal Muscle Relaxants"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0404000U0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0059448": "Binge Eating Disorder (BED)"}], "Name": "Lisdexamfetamine Dimesylate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT002179": "Centrally Acting Sympathomimetics"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "1103010X0": {"Conditions": [{"/indications/DBCOND0020977": "Cystic fibrosis, Pseudomonas aeruginosa infection"}, {"/indications/DBCOND0009894": "Eye infection bacterial"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0112044": "Recurrent Complicated Urinary Tract Infection"}, {"/indications/DBCOND0106159": "Steroid-responsive inflammation"}], "Name": "Tobramycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000915": "Kanamycin"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT001066": "Nebramycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0605010J0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0013571": "Erythema multiforme"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0082377": "Infantile Spasms (IS)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}], "Name": "Corticotropin", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001331": "Adrenocorticotropic Hormone"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001332": "Melanocortins"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT001333": "Pro-Opiomelanocortin"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0403010H0": {"Conditions": [{"/indications/DBCOND0052289": "Anorexia Nervosa (AN)"}, {"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0028190": "Diabetic Neuropathies"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Desipramine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004770": "Desipramine"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "1302010L0": {"Conditions": [{"/indications/DBCOND0002265": "Ichthyosis Vulgaris"}, {"/indications/DBCOND0012296": "Xerosis"}], "Name": "Ammonium Lactate", "Categories": [{"/categories/DBCAT003478": "alpha-Hydroxy Acid"}]}, "1310050S0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone-Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "1103010A0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0106127": "Complicated Urinary Tract Infections caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0106130": "Ventilator-associated Bacterial Pneumonia caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0106129": "Hospital-acquired bacteral pneumonia caused by susceptible Gram-negative microorganisms"}, {"/indications/DBCOND0106125": "Susceptible Intra-Abdominal Infection caused by suceptible Gram-negative microorganism"}], "Name": "Ceftazidime", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000867": "Cephaloridine"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "1203010V0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine/Cetylpyridinium", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0503010U0": {"Conditions": [{"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}], "Name": "Ritonavir", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004281": "Cytochrome P450 1A2 Inducers"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT004300": "UDP Glucuronosyltransferases Inducers"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "0601023X0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Sitagliptin", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002653": "DPP-IV Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000486": "Triazoles"}]}, "0502010C0": {"Conditions": [{"/indications/DBCOND0020999": "Aspergillosis"}, {"/indications/DBCOND0000148": "Blastomycosis"}, {"/indications/DBCOND0022874": "Chromomycosis"}, {"/indications/DBCOND0022877": "Coccidioidal meningitis"}, {"/indications/DBCOND0022875": "Dermatomycoses"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0000154": "Onychomycosis"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0000150": "Paracoccidioidomycosis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0025124": "Pulmonary coccidioides"}, {"/indications/DBCOND0000158": "Sporotrichosis"}, {"/indications/DBCOND0032341": "Vulvovaginal Candidiasis"}, {"/indications/DBCOND0022880": "Disseminated Other specified protozoal diseases"}], "Name": "Itraconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002193": "Triazole Derivatives"}, {"/categories/DBCAT000486": "Triazoles"}]}, "1311060E0": {"Conditions": [{"/indications/DBCOND0110725": "Bacterial Infection of the umbilical cord area"}, {"/indications/DBCOND0110724": "Fungal Infection of the umbilical cord area"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0034299": "Infections, Fungal"}], "Name": "Crystal Violet", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT003679": "Miscellaneous Antifungals"}]}, "0901030H0": {"Conditions": [{"/indications/DBCOND0052025": "Acquired Aplastic Anemia"}, {"/indications/DBCOND0030436": "Agnogenic Myeloid Metaplasia"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0007164": "Congenital aplastic anaemia"}], "Name": "Oxymetholone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT002428": "Anabolic Agents for Systemic Use"}, {"/categories/DBCAT002427": "Anabolic Steroids"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT002426": "Androstan Derivatives"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT001010": "Androstanols"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000309": "Steroids"}]}, "0403010V0": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0042349": "Myofascial Pain Syndrome"}, {"/indications/DBCOND0030075": "Orofacial Pain"}, {"/indications/DBCOND0056178": "Pain, Chronic"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}], "Name": "Nortriptyline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "1308010Z0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}], "Name": "Ingenol Mebutate", "Categories": [{"/categories/DBCAT003452": "Cell Death Inducer"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004375": "Increased Cellular Death"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0501021C0": {"Conditions": [{"/indications/DBCOND0093523": "Acute Exacerbation of Chronic Bronchitis caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0093528": "Acute Exacerbations of Chronic Bronchitis caused by Haemophilus Influenzae"}, {"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0022104": "Gonorrhea of anus"}, {"/indications/DBCOND0027964": "Lyme Disease"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0028431": "Salmonella Infections"}, {"/indications/DBCOND0087961": "Salmonella Typhi Infection"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}, {"/indications/DBCOND0020981": "Uncomplicated Gonorrhea"}], "Name": "Cefixime", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000566": "Cefotaxime"}, {"/categories/DBCAT000567": "Cephacetrile"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "0501023A0": {"Conditions": [{"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0080532": "Respiratory Symptoms caused by Cystic fibrosis, Pseudomonas aeruginosa infection"}, {"/indications/DBCOND0037400": "Septic Arthritis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0020975": "Skin-structure infections"}, {"/indications/DBCOND0020981": "Uncomplicated Gonorrhea"}], "Name": "Aztreonam", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003333": "Monobactam Antibacterial"}, {"/categories/DBCAT000782": "Monobactams"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0504080P0": {"Conditions": [{"/indications/DBCOND0068126": "Pneumocystis Jirovecii Pneumonia"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0013916": "Trypanosomiasis"}], "Name": "Pentamidine Isetionate", "Categories": [{"/categories/DBCAT002322": "Agents Against Leishmaniasis and Trypanosomiasis"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT001100": "Benzamidines"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001101": "Trypanocidal Agents"}]}, "0704010F0": {"Conditions": [{"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0021122": "Acute Angle closure glaucoma"}, {"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Carbachol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000510": "Choline"}, {"/categories/DBCAT002364": "Choline Esters"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000444": "Cholinergic Agonists"}, {"/categories/DBCAT003290": "Cholinergic Receptor Agonist"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000836": "Miotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0207010D0": {"Conditions": [{"/indications/DBCOND0053807": "Cardiac Decompensation"}, {"/indications/DBCOND0000554": "Coronary Artery Disease"}], "Name": "Dobutamine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003733": "Selective Beta 1-adrenergic Agonists"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0407041AB": {"Conditions": [{"/indications/DBCOND0049607": "Menstrual Migraines"}, {"/indications/DBCOND0031385": "Migraine With Aura"}, {"/indications/DBCOND0031386": "Migraine Without Aura"}], "Name": "Frovatriptan", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT001190": "Migraine Disorders"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}]}, "0908010Z0": {"Conditions": [{"/indications/DBCOND0061815": "Carnitine Deficiency"}, {"/indications/DBCOND0008341": "Congenital carnitine deficiency"}, {"/indications/DBCOND0021846": "Secondary Carnitine deficiency"}], "Name": "Levocarnitine", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002151": "Amino Acids and Derivatives"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT003625": "Caloric Agents"}, {"/categories/DBCAT003380": "Carnitine Analog"}, {"/categories/DBCAT002740": "Dietary Supplements"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "0304010J0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}, {"/indications/DBCOND0019903": "Pruritus"}, {"/indications/DBCOND0028415": "Psychomotor Agitation"}, {"/indications/DBCOND0021352": "Acute Anxiety"}], "Name": "Hydroxyzine Hydrochloride", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002409": "Diphenylmethane Derivatives"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT004215": "Histamine Receptor Antagonists"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1103010AC": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Colistimethate Sodium", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT003403": "Polymyxin-class Antibacterial"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}]}, "1103010AA": {"Conditions": [{"/indications/DBCOND0047809": "Bacterial Sepsis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0009899": "Endophthalmitis"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0014184": "Infective pulmonary exacerbation of cystic fibrosis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0030048": "Lung Infection"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0013995": "Mycobacterium avium complex infection"}, {"/indications/DBCOND0042236": "Neonatal Sepsis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0079683": "Respiratory Tract Infection Bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0023151": "Minor burns"}, {"/indications/DBCOND0080530": "Severe Bacterial Infections"}, {"/indications/DBCOND0020905": "Severe Urinary tract infection"}], "Name": "Amikacin", "Categories": [{"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000915": "Kanamycin"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}]}, "1103010AG": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0046769": "Acute Pyelonephritis"}, {"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0014773": "Cellulitis"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0025434": "Cystic fibrosis pulmonary exacerbation caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0000210": "Diverticulitis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0014560": "Furuncle"}, {"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0033969": "Postoperative Wound Infection"}, {"/indications/DBCOND0021609": "Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0042748": "Prosthetic Joint Infection"}, {"/indications/DBCOND0014093": "Pyoderma"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0030388": "Wound Infections"}, {"/indications/DBCOND0025759": "Complicated Skin and subcutaneous tissue bacterial infection"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Levofloxacin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001277": "Ofloxacin"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "1103010AK": {"Conditions": [{"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}], "Name": "Gatifloxacin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001236": "Ophthalmic Solutions"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "1103010AI": {"Conditions": [{"/indications/DBCOND0040750": "Acute Bacterial Sinusitis (ABS)"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0117154": "Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections"}, {"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0014179": "Cervicitis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0059547": "Genital Ulcer Disease (GUD)"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0010494": "Pharyngitis"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0014722": "Tonsillitis bacterial"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0053868": "Uncomplicated Skin and Skin Structure Infections"}, {"/indications/DBCOND0001395": "Urethritis"}], "Name": "Azithromycin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1001040U0": {"Conditions": [{"/indications/DBCOND0004938": "Hyperuricemia"}], "Name": "Rasburicase", "Categories": [{"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000142": "Oxidoreductases"}, {"/categories/DBCAT000097": "Recombinant Proteins"}, {"/categories/DBCAT004382": "Urate Oxidase"}, {"/categories/DBCAT004691": "Urate Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT003259": "Uric Acid-specific Enzyme"}]}, "0801010Q0": {"Conditions": [{"/indications/DBCOND0058867": "Metastatic Brain Tumors"}, {"/indications/DBCOND0033936": "Primary Brain Tumors"}, {"/indications/DBCOND0029144": "Refractory Hodgkin Lymphoma"}], "Name": "Lomustine", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000634": "Nitroso Compounds"}, {"/categories/DBCAT000633": "Nitrosourea Compounds"}, {"/categories/DBCAT002264": "Nitrosoureas"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000635": "Urea"}]}, "0409010B0": {"Conditions": [{"/indications/DBCOND0027953": "Cerebral Arteriosclerosis"}, {"/indications/DBCOND0017943": "Chorea"}, {"/indications/DBCOND0020744": "Extrapyramidal disorder caused by neuroleptic drugs without Tardive dyskinesia"}, {"/indications/DBCOND0036858": "Influenza A Virus Infection"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0089213": "Parkinsonism post encephalitic"}, {"/indications/DBCOND0032885": "Restless Legs Syndrome (RLS)"}, {"/indications/DBCOND0068086": "Tiredness"}], "Name": "Amantadine Hydrochloride", "Categories": [{"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT002485": "Adamantane Derivatives"}, {"/categories/DBCAT003739": "Adamantanes"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003356": "Influenza A M2 Protein Inhibitor"}, {"/categories/DBCAT004305": "M2 Protein Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0803041S0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0045156": "Desmoid Tumors"}, {"/indications/DBCOND0040363": "Endometrial Cancers"}, {"/indications/DBCOND0005547": "Gynecomastia"}, {"/indications/DBCOND0031787": "Invasive Breast Carcinoma"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0001006": "Puberty, Precocious"}], "Name": "Tamoxifen Citrate", "Categories": [{"/categories/DBCAT002405": "Anti-Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003358": "Estrogen Agonist/Antagonist"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT000917": "Estrogen Receptor Modulators"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT000618": "Stilbenes"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}]}, "1201010Z0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1203010D0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1902070D0": {"Conditions": [{"/indications/DBCOND0003711": "Arsenic Poisoning"}, {"/indications/DBCOND0034009": "Poisoning, Lead"}, {"/indications/DBCOND0025650": "Acute Mercury poisoning"}, {"/indications/DBCOND0023407": "Gold poisoning"}], "Name": "Dimercaprol", "Categories": [{"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003716": "Heavy Metal Antagonists"}, {"/categories/DBCAT004317": "Metal Chelating Activity"}, {"/categories/DBCAT003480": "Metal Chelator"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0501090E0": {"Conditions": [{"/indications/DBCOND0020793": "Refractory Tuberculosis"}, {"/indications/DBCOND0024123": "Refractory Urinary Tract Infection"}], "Name": "Cycloserine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000626": "Oxazoles"}, {"/categories/DBCAT000625": "Oxazolidinones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0503010C0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Nelfinavir Mesilate", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "1002020J0": {"Conditions": [{"/indications/DBCOND0004999": "Malignant Hyperthermia"}, {"/indications/DBCOND0020611": "Spasticity"}], "Name": "Dantrolene Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002520": "Dantrolene and Derivatives"}, {"/categories/DBCAT004296": "Decreased Striated Muscle Contraction"}, {"/categories/DBCAT004297": "Decreased Striated Muscle Tone"}, {"/categories/DBCAT003756": "Direct-acting Skeletal Muscle Relaxants"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}]}, "0602020I0": {"Conditions": [{"/indications/DBCOND0025076": "Acute radiation sickness"}], "Name": "Potassium Iodide", "Categories": [{"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT004964": "Antithyroid agents"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT001845": "Iodides"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT004827": "Potassium Iodide"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0501050K0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin Lactobionate", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1108010Z0": {"Conditions": [{"/indications/DBCOND0106365": "Inflammation caused by corticosteroid-responsive dermatoses"}, {"/indications/DBCOND0106366": "Pruritus caused by corticosteroid-responsive dermatoses"}], "Name": "Carbomer 974P", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT001702": "Dental Materials"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT002940": "Resins, Synthetic"}, {"/categories/DBCAT001608": "Spermatocidal Agents"}]}, "0205052V0": {"Conditions": [{"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0033563": "Hospitalization"}, {"/indications/DBCOND0036953": "Mild Essential Hypertension"}, {"/indications/DBCOND0040924": "Moderate Essential Hypertension"}, {"/indications/DBCOND0033676": "Pediatric Hypertension"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}, {"/indications/DBCOND0025716": "Chronic heart failure with reduced ejection fraction (NYHA Class IV)"}, {"/indications/DBCOND0116973": "Hospitalization due to cardiac failure"}, {"/indications/DBCOND0025783": "Symptomatic left ventricular ejection fraction \u2264 35% Chronic heart failure"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Valsartan", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT002172": "Angiotensin II Antagonists and Diuretics"}, {"/categories/DBCAT002173": "Angiotensin II Antagonists, Plain"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT001168": "Angiotensin II Type 2 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}]}, "0106020C0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Bisacodyl", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002553": "Contact Laxatives"}, {"/categories/DBCAT001243": "Cresols"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004129": "Increased Large Intestinal Motility"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT004092": "Stimulation Large Intestine Fluid/Electrolyte Secretion"}]}, "0701010W0": {"Conditions": [{"/indications/DBCOND0080092": "Postpartum Haemorrhage (PPH)"}, {"/indications/DBCOND0042045": "Uterine Atony"}], "Name": "Carbetocin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001062": "Investigative Techniques"}, {"/categories/DBCAT002139": "Oxytocin and Analogues"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000112": "Pituitary Hormones, Posterior"}, {"/categories/DBCAT002109": "Posterior Pituitary Lobe Hormones"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT000218": "Uterotonic agents"}]}, "0406000G0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0035529": "Motion Sickness"}], "Name": "Cyclizine Lactate", "Categories": [{"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002325": "Piperazine Derivatives"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0501090W0": {"Conditions": [{"/indications/DBCOND0072806": "Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)"}], "Name": "Delamanid", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0206010I0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0000554": "Coronary Artery Disease"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Isosorbide Dinitrate", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001173": "Isosorbide"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000756": "Nitric Oxide Donors"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT000647": "Sorbitol"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0301040E0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1306010H0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024298": "Acne vulgaris of the back"}, {"/indications/DBCOND0024297": "Acne vulgaris of the chest"}, {"/indications/DBCOND0024296": "Acne vulgaris of the face"}], "Name": "Adapalene", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0802020V0": {"Conditions": [{"/indications/DBCOND0044896": "Relapsing Multiple Sclerosis (RMS)"}], "Name": "Daclizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT003615": "Immunomodulatory Agents"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004302": "Interleukin 2 Receptor Antagonists"}, {"/categories/DBCAT004303": "Interleukin 2 Receptor-directed Antibody Interactions"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT003270": "Interleukin-2 Receptor Blocking Antibody"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0501130H0": {"Conditions": [{"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Methenamine Hippurate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000260": "Keto Acids"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}]}, "1105000B0": {"Conditions": [{"/indications/DBCOND0001060": "Amblyopia"}, {"/indications/DBCOND0000504": "Bradycardia"}, {"/indications/DBCOND0004370": "Bronchial Spasm"}, {"/indications/DBCOND0012275": "Crying"}, {"/indications/DBCOND0033407": "Detrusor Hyperreflexia"}, {"/indications/DBCOND0089206": "Excessive bronchial secretion"}, {"/indications/DBCOND0089196": "Hypertonic uterine contraction"}, {"/indications/DBCOND0024342": "Hypertonicity of the small intestine"}, {"/indications/DBCOND0017874": "Parkinsonism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0089375": "Poisoning by parasympathomimetics (cholinergics)"}, {"/indications/DBCOND0021805": "Poisoning caused by mushrooms"}, {"/indications/DBCOND0021784": "Poisoning caused by organophosphate anticholinesterase nerve agents"}, {"/indications/DBCOND0021782": "Poisoning caused by organophosphorus pesticides"}, {"/indications/DBCOND0011031": "Pylorospasm"}, {"/indications/DBCOND0020937": "Rhinorrhea"}, {"/indications/DBCOND0042990": "Sinus Bradycardia"}, {"/indications/DBCOND0021793": "Spasms"}, {"/indications/DBCOND0106144": "Toxic effect of organophosphate and carbamate"}, {"/indications/DBCOND0096790": "Atrioventricular (AV) block"}, {"/indications/DBCOND0024343": "Hypermobility of the colon"}, {"/indications/DBCOND0021797": "Laughing"}, {"/indications/DBCOND0021803": "Muscarinic side effects"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Atropine Sulfate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000762": "Atropine Derivatives"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000763": "Belladonna Alkaloids"}, {"/categories/DBCAT002367": "Belladonna Alkaloids, Tertiary Amines"}, {"/categories/DBCAT002368": "Belladonna and Derivatives, Plain"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT000602": "Tropanes"}]}, "1002010H0": {"Conditions": [{"/indications/DBCOND0028961": "Myasthenia Gravis"}, {"/indications/DBCOND0042825": "Neuromuscular Block"}, {"/indications/DBCOND0034868": "Respiratory Depression"}], "Name": "Edrophonium Chloride", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT001230": "Phenylammonium Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}]}, "1309000S0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Selenium Sulfide", "Categories": [{"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002602": "Selenium Compounds"}]}, "0205040D0": {"Conditions": [{"/indications/DBCOND0051310": "Benign Prostatic Hypertrophy (BPH)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0021864": "Ureteric calculus"}], "Name": "Doxazosin Mesilate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT002227": "Antiadrenergic Agents, Peripherally Acting"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000883": "Quinazolines"}]}, "1003020V0": {"Conditions": [{"/indications/DBCOND0026745": "Muscle pains"}, {"/indications/DBCOND0100727": "Arthralgia/joint pain"}], "Name": "Turpentine Oil", "Categories": [{"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001178": "Irritants"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT001459": "Oils, Volatile"}, {"/categories/DBCAT002021": "Plant Exudates"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT002033": "Resins, Plant"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1306010V0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024172": "FAB classification M3 Acute promyelocytic leukemia"}, {"/indications/DBCOND0036306": "Solar Lentigines"}, {"/indications/DBCOND0024211": "Facial fine wrinkling"}, {"/indications/DBCOND0025747": "Moderate Melasma"}, {"/indications/DBCOND0022269": "Mottled hyperpigmentation"}, {"/indications/DBCOND0025746": "Severe Melasma"}, {"/indications/DBCOND0024176": "Severe, recalcitrant Cystic acne"}, {"/indications/DBCOND0024174": "Tactile roughness of facial skin"}], "Name": "Tretinoin", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT003717": "Cell Stimulants and Proliferants"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0205051R0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0079215": "Heart Failure With Reduced Ejection Fraction (HFrEF)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0116961": "Nondiabetic proteinuric chronic kidney disease"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0020605": "High risk cardiovascular event"}], "Name": "Ramipril", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0501030F0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0054672": "Chlamydia Trachomatis Infection"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0021916": "Conjunctivitis caused by chlamydia"}, {"/indications/DBCOND0080563": "Gram-negative infections Bacterial Infections"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0021921": "Relapsing fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0035121": "Rickettsia Infections"}, {"/indications/DBCOND0021912": "SIADH"}, {"/indications/DBCOND0040526": "Severe Acne Vulgaris"}, {"/indications/DBCOND0081133": "Sexually Transmitted Infections (STIs)"}, {"/indications/DBCOND0089467": "Skin infection caused by Staphylococcus aureus"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0021913": "Acute Intestinal amebiasis"}], "Name": "Demeclocycline Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0401010Y0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Zolpidem Tartrate", "Categories": [{"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004210": "Central Nervous System Depression"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000427": "GABA Agonists"}, {"/categories/DBCAT000850": "GABA-A Receptor Agonists"}, {"/categories/DBCAT003288": "gamma-Aminobutyric Acid-ergic Agonist"}, {"/categories/DBCAT002725": "Hypnotics (Nonbenzodiazepine)"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}]}, "0304010V0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0021701": "Flu caused by Influenza"}, {"/indications/DBCOND0023141": "Red eye"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Pheniramine Maleate", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1103010J0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0024299": "Fungal infection of the dermal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0043009": "Ringworm"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0112599": "Symptomatic Tinea Corporis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112597": "Symptomatic Tinea Cruris caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112595": "Symptomatic Tinea Pedis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}], "Name": "Clotrimazole", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004500": "Cytochrome P-450 CYP3A7 Inducers (strong)"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003934": "OATP1B3 inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "1001040C0": {"Conditions": [{"/indications/DBCOND0004938": "Hyperuricemia"}, {"/indications/DBCOND0068288": "Primary Gout"}, {"/indications/DBCOND0118354": "Recurrent calcium oxalate calculi"}, {"/indications/DBCOND0118353": "Secondary gout"}, {"/indications/DBCOND0089461": "Calcium oxalate calculi Renal Calculi"}], "Name": "Allopurinol", "Categories": [{"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002374": "Preparations Inhibiting Uric Acid Production"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT001241": "Uricosuric Agents"}, {"/categories/DBCAT002773": "Xanthine Oxidase Inhibitors"}]}, "0206020W0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Nisoldipine", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004209": "Decreased Blood Pressure"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1103010H0": {"Conditions": [{"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0025273": "Mild Atopic dermatitis"}, {"/indications/DBCOND0106246": "Mild Dermatitis caused by Staphylococcus aureusis"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0106245": "Moderate Dermatitis caused by Staphylococcus aureusis"}], "Name": "Fusidic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT001504": "Cholestadienes"}, {"/categories/DBCAT001503": "Cholestadienols"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003765": "Other Miscellaneous Antibacterial Agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002542": "Steroid Antibacterials"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0407041AA": {"Conditions": [{"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0025093": "Migraine with acute onset aura"}], "Name": "Eletriptan", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}]}, "1310040I0": {"Conditions": [{"/indications/DBCOND0043220": "Pediculosis Capitis"}, {"/indications/DBCOND0000256": "Scabies"}, {"/indications/DBCOND0021190": "Crab lice"}], "Name": "Lindane", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002369": "Chlorine Containing Products"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002370": "Ectoparasiticides, Incl. Scabicides"}, {"/categories/DBCAT002371": "Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents"}, {"/categories/DBCAT000856": "Hydrocarbons, Chlorinated"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000857": "Insecticides"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0606020P0": {"Conditions": [{"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0020866": "Osteolytic lesion"}, {"/indications/DBCOND0038793": "Paget's Disease"}, {"/indications/DBCOND0022211": "Osteolytic Bone metastases"}], "Name": "Pamidronate Disodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}]}, "0501110G0": {"Conditions": [{"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0078039": "Sexually Transmitted Disease (STD)"}, {"/indications/DBCOND0013923": "Trichomoniasis"}], "Name": "Tinidazole", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT001003": "Antitrichomonal Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0404000D0": {"Conditions": [{"/indications/DBCOND0025127": "Primary apnea of premature newborns"}, {"/indications/DBCOND0068086": "Tiredness"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Caffeine", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT003635": "Anorexigenic Agents & Respiratory and CNS Stimulants"}, {"/categories/DBCAT000505": "Apnea"}, {"/categories/DBCAT004728": "Caffeine"}, {"/categories/DBCAT002675": "Caffeine and Caffeine Containing Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000508": "Purinergic P1 Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003636": "Respiratory and CNS Stimulants"}, {"/categories/DBCAT002181": "Tests for Gastric Secretion"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT001034": "Xanthine derivatives"}]}, "0207020Z0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0407020C0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Codeine Phosphate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002302": "Opium Alkaloids and Derivatives"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0105020A0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0033534": "Oesophagitis, Eosinophilic"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0089474": "Mild Crohn\u2019s Disease"}, {"/indications/DBCOND0089473": "Moderate Crohn\u2019s Disease"}], "Name": "Budesonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "0209000A0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "1303000Q0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1103010Y0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0014179": "Cervicitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0064479": "Hansen's Disease"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0063099": "Spontaneous Bacterial Peritonitis (SBP)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0022868": "Acute Pelvic inflammatory disease"}, {"/indications/DBCOND0022865": "Acute, uncomplicated Gonorrhea"}, {"/indications/DBCOND0022871": "Chronic suppurative Otitis media"}, {"/indications/DBCOND0022869": "Uncomplicated Cystitis"}], "Name": "Ofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0901012P0": {"Conditions": [{"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Iron Carboxymaltose", "Categories": [{"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000795": "Disaccharides"}, {"/categories/DBCAT001022": "Glucans"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000668": "Oligosaccharides"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003555": "Parenteral Iron Replacement"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "0702020Q0": {"Conditions": [{"/indications/DBCOND0023722": "Mild Metabolic acidosis"}, {"/indications/DBCOND0023721": "Moderate Metabolic acidosis"}], "Name": "Lactic Acid", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT001522": "Lactates"}, {"/categories/DBCAT004794": "Lactic Acid"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002544": "Organic Acids"}]}, "0501013C0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0019741": "Bronchiectasis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0022692": "Duodenal ulcer caused by helicobacter pylori"}, {"/indications/DBCOND0014098": "Erysipeloid"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000208": "Lyme Neuroborreliosis"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0014061": "Sinusitis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0025416": "Acute Gonorrhea"}, {"/indications/DBCOND0020981": "Uncomplicated Gonorrhea"}], "Name": "Amoxicillin Sodium", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003682": "Aminopenicillins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0403040X0": {"Conditions": [{"/indications/DBCOND0022478": "Depressive illness"}, {"/indications/DBCOND0006119": "Dysthymic Disorder"}, {"/indications/DBCOND0002221": "Fibromyalgia"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0054959": "Headache, Tension-Type"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0068470": "Menopausal Hot Flushes"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}, {"/indications/DBCOND0029313": "Neurological Disorders"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0059160": "PTSD Symptoms"}, {"/indications/DBCOND0040613": "Pain, Cancer"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0119338": "Poststroke depression"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0027764": "Sleep disorders and disturbances"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0027901": "Social Phobia"}, {"/indications/DBCOND0045663": "Substance Abuse Disorders"}, {"/indications/DBCOND0102603": "Low body weight"}], "Name": "Mirtazapine", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT001356": "Adrenergic alpha-2 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT003850": "Antidepressive Agents, Tetracyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003624": "Miscellaneous Antidepressants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0802020X0": {"Conditions": [{"/indications/DBCOND0020508": "Acute cellular rejection"}, {"/indications/DBCOND0063610": "Antibody-mediated Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0028333": "Myelodysplastic Syndrome"}], "Name": "Antithymocyte Immunoglobulin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT004395": "Antibody-Surface Protein Interactions"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT002883": "Blood"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002884": "Body Fluids"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT001368": "Fluids and Secretions"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT002885": "Hemic and Immune Systems"}, {"/categories/DBCAT002881": "Immune Sera"}, {"/categories/DBCAT000025": "Immunoglobulin G"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004394": "Increased T Lymphocyte Destruction"}, {"/categories/DBCAT004393": "Lymphocyte Function Alteration"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT002882": "Serum"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "1001010T0": {"Conditions": [{"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Tiaprofenic Acid", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT001397": "Prostaglandin Antagonists"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0410010B0": {"Conditions": [{"/indications/DBCOND0057965": "Chronic Alcoholism"}], "Name": "Disulfiram", "Categories": [{"/categories/DBCAT001150": "Acetaldehyde Dehydrogenase Inhibitors"}, {"/categories/DBCAT004120": "Acetyl Aldehyde Dehydrogenase Inhibitors"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT001048": "Alcohol Deterrents"}, {"/categories/DBCAT003406": "Aldehyde Dehydrogenase Inhibitor"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000317": "Disulfides"}, {"/categories/DBCAT001149": "Ditiocarb"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002441": "Drugs Used in Alcohol Dependence"}, {"/categories/DBCAT002370": "Ectoparasiticides, Incl. Scabicides"}, {"/categories/DBCAT002371": "Ectoparasiticides, Incl. Scabicides, Insecticides and Repellents"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000320": "Gases"}, {"/categories/DBCAT000319": "Hydrogen Sulfide"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000318": "Sulfides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002472": "Sulfur Containing Products"}, {"/categories/DBCAT000949": "Thiocarbamates"}]}, "0801030J0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0076899": "Malignant Neoplasm of Colon"}, {"/indications/DBCOND0087260": "Malignant Neoplasm of Pancreas"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0041015": "Rectal Carcinoma"}, {"/indications/DBCOND0032565": "Superficial Basal Cell Carcinoma"}, {"/indications/DBCOND0106143": "Hyperkeratotic actinic keratosis"}], "Name": "Fluorouracil/Glucose", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003851": "Fluoropyrimidines"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004602": "Thyroxine-binding globulin inducers"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000961": "Uracil"}]}, "1202010L0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}], "Name": "Flunisolide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "1001010C0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0121216": "Inflammatory Disease of the Oral Cavity"}, {"/indications/DBCOND0121217": "Inflammatory Disease of the throat"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0089301": "Operation site inflammation"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0001062": "Photophobia"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021856": "Acute Musculoskeletal injury"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0121215": "Localized soft tissue rheumatism"}, {"/indications/DBCOND0121211": "Mild to moderate joint pain"}, {"/indications/DBCOND0121212": "Mild to moderate pain"}, {"/indications/DBCOND0112720": "Minor pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0121206": "Perioperative miosis"}], "Name": "Diclofenac Sodium", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0605020E0": {"Conditions": [{"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0051168": "Central Diabetes Insipidus"}, {"/indications/DBCOND0004540": "Nocturia"}, {"/indications/DBCOND0009141": "Polydipsia"}, {"/indications/DBCOND0001413": "Polyuria"}, {"/indications/DBCOND0032706": "Primary Nocturnal Enuresis"}], "Name": "Desmopressin Acetate", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000116": "Antidiuretic Agents"}, {"/categories/DBCAT000110": "Arginine Vasopressin"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003252": "Factor VIII Activator"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004437": "Increased Coagulation Factor VIII Activity"}, {"/categories/DBCAT004438": "Increased Coagulation Factor VIII Concentration"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT003608": "Pituitary"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000112": "Pituitary Hormones, Posterior"}, {"/categories/DBCAT002109": "Posterior Pituitary Lobe Hormones"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT003253": "Vasopressin Analog"}, {"/categories/DBCAT002108": "Vasopressin and Analogues"}, {"/categories/DBCAT000111": "Vasopressins"}]}, "0104040A0": {"Conditions": [{"/indications/DBCOND0091915": "Carcinoid syndrome diarrhea"}], "Name": "Telotristat Ethyl", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT001158": "Antidiarrheals"}, {"/categories/DBCAT003820": "Tryptophan Hydroxylase Inhibitor"}]}, "0603020X0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0056839": "Aggressive Lymphoma"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0013979": "Disseminated tuberculosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0085210": "Giant Cells Arteritis"}, {"/indications/DBCOND0000969": "Graves Ophthalmopathy"}, {"/indications/DBCOND0000794": "Hepatitis, Autoimmune"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0036665": "Metastatic Castration Resistant Prostate Cancer"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0022042": "Pain caused by Herpes zoster"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0027985": "Pulmonary Fibrosis"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0067187": "Takayasu's Disease"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0021770": "Thyrotoxicosis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022026": "Bronchiolitis obliterans organizing pneumonia"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106150": "Fulminating Tuberculosis"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022035": "Solid organ rejection"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000746": "Pregnadienediols"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0702010E0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0005024": "Premenstrual Dysphoric Disorder"}, {"/indications/DBCOND0040526": "Severe Acne Vulgaris"}, {"/indications/DBCOND0022329": "Moderate Acne vulgaris"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Ethinylestradiol", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT001215": "Estrogenic Steroids, Alkylated"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT001216": "Norpregnatrienes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0901060P0": {"Conditions": [{"/indications/DBCOND0051348": "Chemotherapy Induced Neutropenia"}, {"/indications/DBCOND0020289": "Hematopoietic Subsyndrome of Acute Radiation Syndrome"}], "Name": "Pegfilgrastim", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000207": "Granulocyte Colony-Stimulating Factor"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004143": "Increased Myeloid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT003248": "Leukocyte Growth Factor"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000020": "Proteins"}]}, "0503032H0": {"Conditions": [{"/indications/DBCOND0023732": "Chronic hepatitis C genotype 1a"}, {"/indications/DBCOND0023728": "Chronic hepatitis C genotype 1b"}], "Name": "Dasabuvir", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003521": "Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT004208": "RNA Replicase Inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0202080M0": {"Conditions": [{"/indications/DBCOND0001374": "Acidosis, Renal Tubular"}, {"/indications/DBCOND0036164": "Calcium Nephrolithiasis"}, {"/indications/DBCOND0056665": "Cirrhosis of the Liver"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0029023": "Diabetes Insipidus"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0086660": "Hypertension,Essential"}, {"/indications/DBCOND0106208": "Hypokalemia caused by diuretics"}, {"/indications/DBCOND0022593": "Premenstrual tension with edema"}, {"/indications/DBCOND0015831": "Sodium retention"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0022495": "Prophylaxis of preeclampsia"}], "Name": "Hydrochlorothiazide/Potassium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001224": "Chlorothiazide"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "0803042U0": {"Conditions": [{"/indications/DBCOND0036665": "Metastatic Castration Resistant Prostate Cancer"}], "Name": "Enzalutamide", "Categories": [{"/categories/DBCAT004226": "Androgen Receptor Antagonists"}, {"/categories/DBCAT003360": "Androgen Receptor Inhibitor"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002767": "Antiandrogens, non-steroidal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT003110": "Cytochrome P-450 CYP2C19 Inducers (moderate)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT003109": "Cytochrome P-450 CYP2C9 Inducers (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004507": "Cytochrome P-450 CYP2D6 Inducers (moderate)"}, {"/categories/DBCAT004508": "Cytochrome P-450 CYP2D6 Inducers (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004170": "Cytochrome P450 3A4 Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}]}, "0106020M0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Senna", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001196": "Anthracenes"}, {"/categories/DBCAT001296": "Anthraquinones"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002553": "Contact Laxatives"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001604": "Plant Extracts"}, {"/categories/DBCAT001210": "Plant Preparations"}, {"/categories/DBCAT000386": "Quinones"}]}, "0202020L0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Furosemide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002223": "High-Ceiling Diuretics"}, {"/categories/DBCAT002450": "High-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004077": "Increased Diuresis at Loop of Henle"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004546": "Ototoxic agents"}, {"/categories/DBCAT000543": "Sodium Potassium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0801030X0": {"Conditions": [{"/indications/DBCOND0037926": "Advanced Ovarian Cancer"}, {"/indications/DBCOND0038198": "Breast Cancer Metastatic"}, {"/indications/DBCOND0046439": "Locally Advanced Biliary Tract Cancer"}, {"/indications/DBCOND0039376": "Locally Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0050164": "Locally Advanced Pancreatic Adenocarcinoma"}, {"/indications/DBCOND0046438": "Metastatic Biliary Tract Cancer"}, {"/indications/DBCOND0054408": "Metastatic Bladder Cancer"}, {"/indications/DBCOND0087270": "Non-small Cell Lung Cancer (NSCLC), Stage IV"}, {"/indications/DBCOND0021244": "Advanced Bladder cancer"}, {"/indications/DBCOND0025282": "Stage 4 Pancreatic adenocarcinoma"}], "Name": "Gemcitabine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000685": "Antimetabolites, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT003348": "Nucleoside Metabolic Inhibitor"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002372": "Pyrimidine Analogues"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000869": "Ribonucleotide Reductases, antagonists & inhibitors"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0102000R0": {"Conditions": [{"/indications/DBCOND0031662": "Peptic Ulcers"}], "Name": "Mepenzolate Bromide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT001929": "Diphenylacetic Acids"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}]}, "0803042H0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0089463": "C Prostatic Carcinoma"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0089462": "Stage B2 Prostatic Carcinoma"}, {"/indications/DBCOND0021415": "Stage D2 Prostatic carcinoma"}], "Name": "Flutamide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT004226": "Androgen Receptor Antagonists"}, {"/categories/DBCAT003360": "Androgen Receptor Inhibitor"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002767": "Antiandrogens, non-steroidal"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}]}, "0604011G0": {"Conditions": [{"/indications/DBCOND0001269": "Atrophic Vaginitis"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0022319": "Advanced androgen dependent Prostate cancer"}], "Name": "Estradiol", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002429": "Androgens and Estrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001293": "Estradiol"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT004753": "Estradiol, agonists"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004754": "Estrogens, agonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002465": "Intravaginal Contraceptives"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1203030K0": {"Conditions": [{"/indications/DBCOND0022396": "Phlegm"}, {"/indications/DBCOND0094614": "Chest congestion"}], "Name": "Guaifenesin", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000847": "Guaiacol"}, {"/categories/DBCAT000561": "Methyl Ethers"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000812": "Phenyl Ethers"}, {"/categories/DBCAT000132": "Respiratory System Agents"}]}, "0203020D0": {"Conditions": [{"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0029078": "Tachycardia, Supraventricular"}, {"/indications/DBCOND0022811": "Recurrent Ventricular fibrillation"}, {"/indications/DBCOND0022814": "Recurrent hemodynamically unstable Ventricular tachycardia"}], "Name": "Amiodarone Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002208": "Antiarrhythmics, Class III"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003984": "BSEP/ABCB11 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002616": "Cytochrome P-450 CYP2A6 Inhibitors (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT004035": "Cytochrome P-450 CYP2C8 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004161": "Cytochrome P450 1A2 Inhibitors"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000519": "Potassium Channel Blockers"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1001030Y0": {"Conditions": [{"/indications/DBCOND0081004": "Active Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis"}, {"/indications/DBCOND0114943": "Moderate-to-severe Plaque Psoriasis"}, {"/indications/DBCOND0109811": "Moderately to Severely Active Rheumatoid Arthritis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0025138": "Psoriatic arthritis aggravated"}, {"/indications/DBCOND0053724": "Severe Crohn's Disease"}, {"/indications/DBCOND0020385": "Active Ankylosing spondylitis"}, {"/indications/DBCOND0023528": "Moderate Crohn's disease"}, {"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Certolizumab Pegol", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001914": "Immunoglobulin Fab Fragments"}, {"/categories/DBCAT001915": "Immunoglobulin Fragments"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT001722": "Peptide Fragments"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT001605": "Polyethylene Glycols"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002087": "Tumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors"}, {"/categories/DBCAT003245": "Tumor Necrosis Factor Blocker"}, {"/categories/DBCAT004095": "Tumor Necrosis Factor Receptor Blocking Activity"}]}, "0501013E0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0051397": "Gastrointestinal Infections"}, {"/indications/DBCOND0014024": "Genitourinary tract infection"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0021126": "Infection caused by eikenella corrodens"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0021128": "Salmonella"}, {"/indications/DBCOND0087961": "Salmonella Typhi Infection"}, {"/indications/DBCOND0021129": "Shigella"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0106114": "Subcutaneous bacterial infection"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0021130": "Perinatal group B streptococcus"}], "Name": "Ampicillin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003682": "Aminopenicillins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002304": "Penicillins With Extended Spectrum"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0501120Q0": {"Conditions": [{"/indications/DBCOND0014043": "Cystitis"}, {"/indications/DBCOND0025415": "Gonococcal cervicitis"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0025413": "Pyelitis"}, {"/indications/DBCOND0014040": "Pyelonephritis"}, {"/indications/DBCOND0063099": "Spontaneous Bacterial Peritonitis (SBP)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0014600": "Urethritis gonococcal"}], "Name": "Norfloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0601021H0": {"Conditions": [{"/indications/DBCOND0043991": "Gestational Diabetes Mellitus (GDM)"}, {"/indications/DBCOND0033981": "Glycemic Control"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Glibenclamide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT004763": "Glyburide"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000635": "Urea"}]}, "0404000V0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}], "Name": "Guanfacine", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT002214": "Antiadrenergic Agents, Centrally Acting"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002413": "Imidazoline Receptor Agonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}]}, "1310050P0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0407020U0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Pentazocine Lactate", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002436": "Benzomorphan Derivatives"}, {"/categories/DBCAT001035": "Benzomorphans"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003387": "Partial Opioid Agonist/Antagonist"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0408010N0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0054185": "Febrile Convulsions"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0025451": "Hyperbilirubinemia"}, {"/indications/DBCOND0028731": "Menopausal Symptoms"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0068142": "Withdrawal Symptoms"}, {"/indications/DBCOND0021688": "Generalized seizure"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Phenobarbital", "Categories": [{"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000728": "Barbiturates"}, {"/categories/DBCAT002391": "Barbiturates and Derivatives"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT004670": "Cytochrome P-450 2C18 Inducers"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002612": "Cytochrome P-450 CYP1A2 Inducers (strong)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT004674": "Cytochrome P-450 CYP2C18 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004491": "Cytochrome P-450 CYP3A5 Inducers (strong)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT001139": "Phenobarbital and similars"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT004611": "UGT2B7 inducers"}]}, "0109020B0": {"Conditions": [{"/indications/DBCOND0000908": "Homocystinuria"}], "Name": "Betaine Hydrochloride", "Categories": [{"/categories/DBCAT002546": "Acid Preparations"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002151": "Amino Acids and Derivatives"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT004828": "Betaine"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002547": "Digestives, Incl. Enzymes"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000277": "Lipotropic Agents"}, {"/categories/DBCAT004227": "Methylating Activity"}, {"/categories/DBCAT003561": "Methylating Agent"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0209000W0": {"Conditions": [{"/indications/DBCOND0094088": "Thrombotic events"}], "Name": "Abciximab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001914": "Immunoglobulin Fab Fragments"}, {"/categories/DBCAT001915": "Immunoglobulin Fragments"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT001722": "Peptide Fragments"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801050I0": {"Conditions": [{"/indications/DBCOND0045345": "Advanced Pancreatic Cancer"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0032507": "Cervical Cancers"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0041878": "Hepatobiliary Cancers"}, {"/indications/DBCOND0026492": "Hepatoblastomas"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0045917": "Malignant Neoplasm of Stomach"}, {"/indications/DBCOND0032185": "Medulloblastomas"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0068543": "Ovarian Cancer Metastatic"}, {"/indications/DBCOND0029910": "Pleural Mesotheliomas"}, {"/indications/DBCOND0041025": "Primary Central Nervous System Lymphoma (PCNSL)"}, {"/indications/DBCOND0054384": "Recurrent Endometrial Cancer"}, {"/indications/DBCOND0029144": "Refractory Hodgkin Lymphoma"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0036007": "Thymic Cancer"}, {"/indications/DBCOND0021244": "Advanced Bladder cancer"}, {"/indications/DBCOND0021462": "Metastatic Anal cancer"}, {"/indications/DBCOND0021457": "Metastatic Endometrial cancer"}, {"/indications/DBCOND0021461": "Metastatic Penile cancer"}, {"/indications/DBCOND0021456": "Metastatic Testicular cancer"}, {"/indications/DBCOND0024997": "Refractory Non-Hodgkin's lymphoma"}, {"/indications/DBCOND0021464": "Refractory gestational trophoblastic disease"}], "Name": "Cisplatin", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000713": "Cross-Linking Reagents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003021": "Platinum Compounds"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}]}, "0503010T0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Indinavir", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004488": "Cytochrome P-450 CYP3A5 Inhibitors (weak)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004497": "Cytochrome P-450 CYP3A7 Inhibitors (weak)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "1103010B0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0106142": "Acute Otitis Externa caused by Pseudomonas Aeruginosa"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0032963": "Acute Uncomplicated Pyelonephritis"}, {"/indications/DBCOND0021622": "Acute exacerbation of chronic bronchitis caused by Moraxella catarrhalis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0021574": "Conjunctivitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080536": "Corneal Ulcers caused by Serratia marcescens"}, {"/indications/DBCOND0080537": "Corneal Ulcers caused by Staphylococcus aureus"}, {"/indications/DBCOND0080538": "Corneal Ulcers caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080539": "Corneal Ulcers caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0080540": "Corneal Ulcers caused by Streptococcus Viridans Group"}, {"/indications/DBCOND0080535": "Corneal Ulcers caused by pseudomonas aeruginosa"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0021614": "Lower respiratory tract infection caused by Enterobacter cloacae"}, {"/indications/DBCOND0021611": "Lower respiratory tract infection caused by Escherichia coli"}, {"/indications/DBCOND0021616": "Lower respiratory tract infection caused by Haemophilus influenzae"}, {"/indications/DBCOND0021618": "Lower respiratory tract infection caused by Haemophilus parainfluenzae"}, {"/indications/DBCOND0021612": "Lower respiratory tract infection caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021615": "Lower respiratory tract infection caused by Proteus mirabilis"}, {"/indications/DBCOND0021620": "Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021640": "Plague caused by Yersinia pestis"}, {"/indications/DBCOND0045585": "Sinusitis, Acute"}, {"/indications/DBCOND0021628": "Typhoid fever caused by Salmonella typhi"}, {"/indications/DBCOND0021593": "UTI caused by Citrobacter diversus"}, {"/indications/DBCOND0021595": "UTI caused by Citrobacter frendii"}, {"/indications/DBCOND0021602": "UTI caused by Entercococcus faecalis"}, {"/indications/DBCOND0089465": "UTI caused by Enterobacter cloacae"}, {"/indications/DBCOND0021582": "UTI caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021591": "UTI caused by Morganella morganii"}, {"/indications/DBCOND0021587": "UTI caused by Proteus mirabilis"}, {"/indications/DBCOND0021589": "UTI caused by Providencia rettgeri"}, {"/indications/DBCOND0021596": "UTI caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0021585": "UTI caused by Serratia marcescens"}, {"/indications/DBCOND0021598": "UTI caused by methicillin-susceptible Staphylococcus epidermidis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0021563": "Acute otitis externa caused by Staphylococcus aureus"}, {"/indications/DBCOND0021604": "Acute, uncomplicated Cystitis caused by Escherichia coli"}, {"/indications/DBCOND0021606": "Acute, uncomplicated Cystitis caused by Staphylococcus saprophyticus"}, {"/indications/DBCOND0021608": "Chronic Prostatitis caused by Escherichia coli"}, {"/indications/DBCOND0021610": "Chronic Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0021634": "Complicated Pyelonephritis caused by Escherichia coli"}, {"/indications/DBCOND0021632": "Complicated UTI caused by Escherichia coli"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0021637": "Inhaled anthrax caused by Bacillus anthracis"}, {"/indications/DBCOND0020975": "Skin-structure infections"}, {"/indications/DBCOND0021631": "Uncomplicated Gonorrhea caused by Neisseria gonorrhoeae"}], "Name": "Ciprofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001596": "Ciprofloxacin and isotope"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0407041B0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}], "Name": "Almotriptan", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT001190": "Migraine Disorders"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}]}, "0601023Y0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Exenatide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000472": "Anti-Obesity Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT001367": "Bodily Secretions"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT001368": "Fluids and Secretions"}, {"/categories/DBCAT002693": "GLP-1 Agonists"}, {"/categories/DBCAT001327": "Glucagon-Like Peptide 1"}, {"/categories/DBCAT004144": "Glucagon-like Peptide-1 (GLP-1) Agonists"}, {"/categories/DBCAT004598": "Glucagon-like peptide-1 (GLP-1) analogues"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT003758": "Incretin Mimetics"}, {"/categories/DBCAT001316": "Incretins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000185": "Toxins, Biological"}, {"/categories/DBCAT001328": "Venoms"}]}, "0205020H0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}], "Name": "Methyldopa", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000464": "Dihydroxyphenylalanine"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT000485": "Sympatholytics"}, {"/categories/DBCAT000465": "Tyrosine"}]}, "0501021B0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0089198": "Infection and inflammatory reaction due to internal prosthetic device, implant, and graft"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Cefadroxil", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT001072": "Cephalexin"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002385": "First-Generation Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0403010W0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}], "Name": "Protriptyline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0504080A0": {"Conditions": [{"/indications/DBCOND0021343": "Malaria caused by Plasmodium falciparum"}, {"/indications/DBCOND0034749": "Pneumonia, Interstitial Plasma Cell"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0022803": "Acute, uncomplicated Malaria caused by plasmodium falciparum"}, {"/indications/DBCOND0022809": "Mild Babesiosis"}, {"/indications/DBCOND0022806": "Mild Pneumocystis jiroveci pneumonia"}, {"/indications/DBCOND0022808": "Moderate Babesiosis"}, {"/indications/DBCOND0022805": "Moderate Pneumocystis jiroveci pneumonia"}], "Name": "Atovaquone", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000382": "Naphthoquinones"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000386": "Quinones"}]}, "0908010I0": {"Conditions": [{"/indications/DBCOND0025639": "Gaucher's Disease Type 1"}, {"/indications/DBCOND0020405": "Type 3 Gaucher disease"}], "Name": "Imiglucerase", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000147": "Enzyme Replacement Therapy"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000146": "Gaucher Disease"}, {"/categories/DBCAT001323": "Glucosidases"}, {"/categories/DBCAT000166": "Glycoside Hydrolases"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT003262": "Hydrolytic Lysosomal Glucocerebroside-specific Enzyme"}, {"/categories/DBCAT000097": "Recombinant Proteins"}]}, "1304000X0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0604012J0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0043809": "Premature Births"}, {"/indications/DBCOND0084804": "Primary Amenorrhoea"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0025773": "Stage 3 adenocarcinoma of the uterine corpus"}, {"/indications/DBCOND0025774": "Stage 4 adenocarcinoma of the uterine corpus"}], "Name": "Hydroxyprogesterone Caproate", "Categories": [{"/categories/DBCAT005016": "17-alpha-Hydroxyprogesterone"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000829": "Corpus Luteum Hormones"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000991": "Hydroxyprogesterones"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000992": "Progesterone and Derivatives"}, {"/categories/DBCAT000686": "Progesterone Congeners"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000309": "Steroids"}]}, "0603020D0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Valerate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1310030L0": {"Conditions": [{"/indications/DBCOND0042727": "Cold Sore"}], "Name": "Penciclovir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT003320": "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "0304010K0": {"Conditions": [{"/indications/DBCOND0032786": "Allergic Reactions"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0052289": "Anorexia Nervosa (AN)"}, {"/indications/DBCOND0013542": "Cold urticaria"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0036443": "Cushing's Disease"}, {"/indications/DBCOND0021227": "Decreased appetite caused by Chronic disease"}, {"/indications/DBCOND0021216": "Dermatographic urticaria"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021226": "Sexual dysfunction caused by antipsychotic agents"}, {"/indications/DBCOND0021224": "Sexual dysfunction caused by fluoxetine"}, {"/indications/DBCOND0021222": "Sexual dysfunction caused by monoamine oxidase inhibitors"}, {"/indications/DBCOND0021220": "Sexual dysfunction caused by tricyclic antidepressants"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}], "Name": "Cyproheptadine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003687": "Miscellaneous Derivatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "0309010Y0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine HCl/Dextrometh Hydrob", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0501060D0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0803042T0": {"Conditions": [{"/indications/DBCOND0036665": "Metastatic Castration Resistant Prostate Cancer"}], "Name": "Abiraterone", "Categories": [{"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002640": "Cytochrome P-450 CYP2C19 Inhibitors (moderate)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003461": "Cytochrome P450 17A1 Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT000309": "Steroids"}]}, "1203010U0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0116954": "Acute epididymo-orchitis caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0011318": "Anal chlamydia infection"}, {"/indications/DBCOND0106325": "Bacterial Infection caused by Enterobacter aerogenes"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0069537": "Chlamydial Urethritis"}, {"/indications/DBCOND0014462": "Chlamydial cervicitis"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0031183": "Clostridium Infections"}, {"/indications/DBCOND0014610": "Epididymo-orchitis gonococcal"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0077690": "Infection Due to Escherichia Coli"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0053857": "Inhalational Anthrax (Post-Exposure)"}, {"/indications/DBCOND0080081": "Intestinal Amebiasis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0116947": "Rectal infection"}, {"/indications/DBCOND0116946": "Rectal infection caused by Chlamydia Trachomatis"}, {"/indications/DBCOND0116948": "Recurring fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0021921": "Relapsing fever caused by Borrelia recurrentis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0056153": "Secondary Syphilis"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0014242": "Tick-borne fever"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020776": "Trachoma inclusion conjunctivitis"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0053861": "Typhus Fever"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Doxycycline Hyclate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0106060B0": {"Conditions": [{"/indications/DBCOND0038981": "Opioid Induced Constipation (OIC)"}], "Name": "Naloxegol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002566": "Peripheral Opioid Receptor Antagonists"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0405020U0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0013142": "Cholestatic pruritus"}, {"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Naltrexone/Bupropion", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001048": "Alcohol Deterrents"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002441": "Drugs Used in Alcohol Dependence"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT001081": "Naloxone"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003713": "Opiate Antagonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0409010C0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Benserazide Hydrochloride", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000469": "Hydrazines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}]}, "0304010Y0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0020815": "Pruritis"}], "Name": "Alimemazine Tartrate", "Categories": [{"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002337": "Phenothiazine Derivatives"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0206030Z0": {"Conditions": [{"/indications/DBCOND0040763": "Chronic Angina"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Ranolazine", "Categories": [{"/categories/DBCAT000598": "Acetanilides"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0501060J0": {"Conditions": [{"/indications/DBCOND0080530": "Severe Bacterial Infections"}], "Name": "Lincomycin Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "1202010C0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0033683": "Chronic Rhinosinusitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0021673": "Corticosteroid-responsive Dermatosis"}, {"/indications/DBCOND0021089": "Recurrent nasal polyps"}], "Name": "Beclometasone Dipropionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "0202010D0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Chlorothiazide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "1203010K0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0022396": "Phlegm"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0112719": "Minor ache"}, {"/indications/DBCOND0112720": "Minor pain"}], "Name": "Choline Salicylate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}]}, "0503010B0": {"Conditions": [{"/indications/DBCOND0035352": "Human Immunodeficiency Virus (HIV)"}], "Name": "Nevirapine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003302": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002245": "Non-Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003641": "Nonnucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "1106000AF": {"Conditions": [{"/indications/DBCOND0022426": "Hypotrichosis of the eyelashes"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Bimatoprost", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000676": "Prostaglandins F, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1106000AG": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Timolol & Brimonidine", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "1106000AD": {"Conditions": [{"/indications/DBCOND0074237": "Ocular Hypertension"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}], "Name": "Latanoprost & Timolol", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000676": "Prostaglandins F, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1106000AE": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}], "Name": "Travoprost", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000676": "Prostaglandins F, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}]}, "0801040R0": {"Conditions": [{"/indications/DBCOND0030392": "Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0039376": "Locally Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0028795": "Recurrent Cervical Cancer"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0025384": "Recurrent, IV-B Cervical cancer"}], "Name": "Vinorelbine", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000527": "Indole Alkaloids"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000526": "Secologanin Tryptamine Alkaloids"}, {"/categories/DBCAT000718": "Tubulin Modulators"}, {"/categories/DBCAT000714": "Vinca Alkaloids"}]}, "1106000AC": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Brinzolamide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1106000AA": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0096893": "Facial erythema"}], "Name": "Brimonidine Tartrate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000920": "Quinoxalines"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}]}, "1106000AL": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Brinzolamide/Brimonidine", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1106000AM": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}], "Name": "Tafluprost & Timolol", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT004146": "Increased Prostaglandin Activity"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT004145": "Prostaglandin Receptor Agonists"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1106000AJ": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Brinzolamide & Timolol", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1106000AK": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}], "Name": "Tafluprost", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT004146": "Increased Prostaglandin Activity"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT004145": "Prostaglandin Receptor Agonists"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1106000AH": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Timolol & Travoprost", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "1106000AI": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Timolol & Bimatoprost", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0501090V0": {"Conditions": [{"/indications/DBCOND0040628": "Tuberculosis, Multidrug Resistant"}], "Name": "Bedaquiline", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003502": "Diarylquinoline Antimycobacterial"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT001913": "Mycobacterium tuberculosis"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "0501011T0": {"Conditions": [{"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000330": "Endocarditis, Subacute Bacterial"}, {"/indications/DBCOND0000230": "Erysipelas"}, {"/indications/DBCOND0106280": "Erysipelas caused by susceptible streptococci"}, {"/indications/DBCOND0014098": "Erysipeloid"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0025727": "Non-venereal endemic syphilis"}, {"/indications/DBCOND0106285": "Otitis Media caused by susceptible pneumococci"}, {"/indications/DBCOND0000229": "Pinta"}, {"/indications/DBCOND0106284": "Pneumonia caused by susceptible pneumococci"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0021147": "Rat-bite fever"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0000389": "Scarlet Fever"}, {"/indications/DBCOND0106279": "Scarlet Fever caused by susceptible streptococci"}, {"/indications/DBCOND0056153": "Secondary Syphilis"}, {"/indications/DBCOND0106281": "Skin Structures and Soft Tissue Infections caused by susceptible streptococci"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014494": "Tertiary syphilis"}, {"/indications/DBCOND0106278": "Upper Respiratory Tract Infection caused by susceptible streptococci"}, {"/indications/DBCOND0000236": "Yaws"}], "Name": "Procaine Benzylpenicillin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000585": "Aminobenzoates"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT002365": "Beta-Lactamase Sensitive Penicillins"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT000584": "para-Aminobenzoates"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT001979": "Procaine"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0905013F0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}], "Name": "Magnesium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}]}, "040201060": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0020745": "Bipolar 1 Disorder"}, {"/indications/DBCOND0035583": "Bipolar Disorder With Manic or Mixed Episodes"}, {"/indications/DBCOND0003735": "Delirium"}, {"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0089536": "Major depressive disorder, recurrent episode"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Olanzapine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT003038": "Cytochrome P-450 CYP2C9 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002317": "Diazepines, Oxazepines, Thiazepines and Oxepines"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "0802030E0": {"Conditions": [{"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0030547": "B-Cell Chronic Lymphocytic Leukemia"}, {"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0036413": "Relapsing Remitting Multiple Sclerosis (RRMS)"}, {"/indications/DBCOND0029148": "T-Cell Prolymphocytic Leukemia"}], "Name": "Alemtuzumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004258": "CD52-directed Antibody Interactions"}, {"/categories/DBCAT003274": "CD52-directed Cytolytic Antibody"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0801020G0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0032507": "Cervical Cancers"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0053665": "Intracranial Germ Cell Tumors"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0032536": "Malignant Pleural Effusions"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0028492": "Penile Cancer"}, {"/indications/DBCOND0004383": "Pneumothorax"}, {"/indications/DBCOND0029824": "Testicular Cancer"}, {"/indications/DBCOND0046120": "Vulvar Cancers"}, {"/indications/DBCOND0020884": "Early Kaposi's sarcoma"}], "Name": "Bleomycin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT004732": "Bleomycin"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT003319": "Cytoprotective Agent"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000678": "Glycopeptides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000052": "Peptides"}]}, "1108020A0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0121216": "Inflammatory Disease of the Oral Cavity"}, {"/indications/DBCOND0121217": "Inflammatory Disease of the throat"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0089301": "Operation site inflammation"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0001062": "Photophobia"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021856": "Acute Musculoskeletal injury"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0121215": "Localized soft tissue rheumatism"}, {"/indications/DBCOND0121211": "Mild to moderate joint pain"}, {"/indications/DBCOND0121212": "Mild to moderate pain"}, {"/indications/DBCOND0112720": "Minor pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0121206": "Perioperative miosis"}], "Name": "Diclofenac Sodium", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1305030C0": {"Conditions": [{"/indications/DBCOND0051557": "Graft Versus Host Disease (GVHD)"}, {"/indications/DBCOND0047700": "Heart Transplant Rejection"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0054228": "Liver Transplant Rejection"}, {"/indications/DBCOND0030626": "Oral Lichen Planus"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0005724": "Pyoderma Gangrenosum"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0005560": "Vitiligo"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0025272": "Refractory Atopic dermatitis"}, {"/indications/DBCOND0025310": "Refractory Rheumatoid arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Tacrolimus", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003276": "Calcineurin Inhibitor Immunosuppressant"}, {"/categories/DBCAT000199": "Calcineurin Inhibitors"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004756": "Tacrolimus"}]}, "0106040J0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0023344": "Sour stomach"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Magnesium Hydroxide", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003784": "Emollients Demulcents and Protectants"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001847": "Hydroxides"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004845": "Magnesium Hydroxide"}, {"/categories/DBCAT002704": "Magnesium Salts"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0701020K0": {"Conditions": [{"/indications/DBCOND0035700": "Hyperglycemias"}], "Name": "Mifepristone", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT001154": "Abortifacient Agents, Steroidal"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001156": "Luteolytic Agents"}, {"/categories/DBCAT001155": "Menstruation-Inducing Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004251": "Progestational Hormone Receptor Antagonists"}, {"/categories/DBCAT002473": "Progesterone Receptor Modulators"}, {"/categories/DBCAT003408": "Progestin Antagonist"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "1108020AB": {"Conditions": [{"/indications/DBCOND0043958": "Subfoveal Choroidal Neovascularization"}], "Name": "Verteporfin", "Categories": [{"/categories/DBCAT002389": "Antineovascularisation Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002390": "Ocular Vascular Disorder Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004154": "Photoabsorption"}, {"/categories/DBCAT003355": "Photoenhancer"}, {"/categories/DBCAT004155": "Photosensitizing Activity"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT001084": "Porphyrins"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1108020AC": {"Conditions": [{"/indications/DBCOND0035431": "Neovascular Age-Related Macular Degeneration"}], "Name": "Pegaptanib Sodium", "Categories": [{"/categories/DBCAT002389": "Antineovascularisation Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002390": "Ocular Vascular Disorder Agents"}, {"/categories/DBCAT001720": "Oligonucleotides"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT001405": "Polynucleotides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT001633": "Vascular Endothelial Growth Factor A"}]}, "1108020AF": {"Conditions": [{"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Nepafenac", "Categories": [{"/categories/DBCAT000493": "Acetamides"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1108020AG": {"Conditions": [{"/indications/DBCOND0054268": "Ocular Pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Bromfenac", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002899": "Hydrocarbons, Brominated"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1108020AD": {"Conditions": [{"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0055389": "Retinopathy, Diabetic"}, {"/indications/DBCOND0043958": "Subfoveal Choroidal Neovascularization"}, {"/indications/DBCOND0031080": "Wet Age-Related Macular Degeneration"}], "Name": "Ranibizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000222": "Angiogenesis Inhibitors"}, {"/categories/DBCAT000213": "Angiogenesis Modulating Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT002389": "Antineovascularisation Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000221": "Growth Inhibitors"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT002390": "Ocular Vascular Disorder Agents"}, {"/categories/DBCAT002732": "Ophthalmics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT003817": "Vascular Endothelial Growth Factor Inhibitor"}, {"/categories/DBCAT004320": "Vascular Endothelial Growth Factor Inhibitors"}]}, "0402010D0": {"Conditions": [{"/indications/DBCOND0057405": "Acute Intermittent Porphyria (AIP)"}, {"/indications/DBCOND0021358": "Apprehension"}, {"/indications/DBCOND0018633": "Mania"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}, {"/indications/DBCOND0032311": "Oppositional Defiant Disorder"}, {"/indications/DBCOND0017791": "Restlessness"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0021430": "Intractable singultus"}, {"/indications/DBCOND0021364": "Severe behavioural problems"}, {"/indications/DBCOND0021367": "Short term Hyperactivity"}], "Name": "Chlorpromazine Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002366": "Phenothiazines With Aliphatic Side-Chain"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1108020AH": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "0704030C0": {"Conditions": [{"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Ammonium Chloride", "Categories": [{"/categories/DBCAT002512": "Acidifiers"}, {"/categories/DBCAT003775": "Acidifying Agents"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "1003020AA": {"Conditions": [{"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0021344": "Backache"}, {"/indications/DBCOND0033437": "Bruises"}, {"/indications/DBCOND0055353": "Muscle Cramps"}, {"/indications/DBCOND0086718": "Orthopaedic Related Pain (Musculoskeletal Pain)"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}], "Name": "Capsaicin", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT001692": "Alkynes"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT003726": "Basic Lotions and Liniments"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002570": "Capsaicin and Similar Agents"}, {"/categories/DBCAT004829": "Capsaicin, antagonists & inhibitors"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001122": "Fatty Acids, Monounsaturated"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT001691": "Polyunsaturated Alkamides"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000442": "Solanaceous Alkaloids"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "1003020AB": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "1003020AE": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0023821": "Minor aches"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Methyl Salicylate/Levomenthol", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT003228": "Betula"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001550": "Fixatives"}, {"/categories/DBCAT003229": "Gaultheria"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT001210": "Plant Preparations"}, {"/categories/DBCAT000579": "Salicylates"}]}, "0410030D0": {"Conditions": [{"/indications/DBCOND0110726": "Abrupt opioid withdrawal"}], "Name": "Lofexidine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000977": "Imidazolines"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}]}, "0604020K0": {"Conditions": [{"/indications/DBCOND0048343": "Hypergonadotropic Hypogonadism"}, {"/indications/DBCOND0037480": "Idiopathic Hypogonadotropic Hypogonadism"}, {"/indications/DBCOND0001010": "Puberty, Delayed"}, {"/indications/DBCOND0021988": "Inoperable, metastatic Breast cancer"}], "Name": "Testosterone", "Categories": [{"/categories/DBCAT002430": "3-Oxoandrosten (4) Derivatives"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT002429": "Androgens and Estrogens"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT001013": "Androstenols"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003981": "OAT3/SLC22A8 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003968": "Testosterone and derivatives"}, {"/categories/DBCAT001014": "Testosterone Congeners"}, {"/categories/DBCAT004744": "Testosterone, antagonists & inhibitors"}]}, "0206020F0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Felodipine", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0401010Z0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Zopiclone", "Categories": [{"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002725": "Hypnotics (Nonbenzodiazepine)"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT001294": "Sleep Initiation and Maintenance Disorders"}]}, "0801010D0": {"Conditions": [{"/indications/DBCOND0043325": "Astrocytomas"}, {"/indications/DBCOND0087392": "Brain Stem Gliomas"}, {"/indications/DBCOND0038149": "Ependymomas"}, {"/indications/DBCOND0043840": "Glioblastomas"}, {"/indications/DBCOND0032185": "Medulloblastomas"}, {"/indications/DBCOND0058867": "Metastatic Brain Tumors"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0030512": "Recurrent Glioblastoma Multiforme"}, {"/indications/DBCOND0029144": "Refractory Hodgkin Lymphoma"}, {"/indications/DBCOND0028542": "Refractory Multiple Myeloma"}, {"/indications/DBCOND0020801": "High grade newly diagnosed Glioma"}, {"/indications/DBCOND0024997": "Refractory Non-Hodgkin's lymphoma"}], "Name": "Carmustine", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000634": "Nitroso Compounds"}, {"/categories/DBCAT000633": "Nitrosourea Compounds"}, {"/categories/DBCAT002264": "Nitrosoureas"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT000635": "Urea"}]}, "0104010D0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Chalk", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "0304010W0": {"Conditions": [{"/indications/DBCOND0024457": "Allergic edema"}, {"/indications/DBCOND0024456": "Allergic urticaria"}, {"/indications/DBCOND0078258": "Anaphylactic Reaction"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0022721": "Dermographism"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0022333": "Postoperative pain"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0080552": "Acute Allergic Reactions"}, {"/indications/DBCOND0024459": "Perioperative nausea and vomiting"}, {"/indications/DBCOND0022511": "Upper respiratory symptoms"}], "Name": "Promethazine Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT003678": "Miscellaneous Anxiolytics Sedatives and Hypnotics"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002337": "Phenothiazine Derivatives"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1502010Z0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0028410": "Hemolytic Anemia"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0106428": "Acute Idiopathic Nephrotic Syndrome"}, {"/indications/DBCOND0106435": "Acute Lupus Erythematosus"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0106427": "Bullous dermaitits herpetiformis"}, {"/indications/DBCOND0106425": "Cancer-associated hypercalcemia"}, {"/indications/DBCOND0106432": "Cystic tumors of aponeurosis"}, {"/indications/DBCOND0106433": "Cystic tumors of tendon"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106429": "Inflammatory lesions of granuloma annulare"}, {"/indications/DBCOND0106430": "Inflammatory lessions of lichen planus"}, {"/indications/DBCOND0106431": "Inflammatory lessions of lichen sumplex"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0106426": "Occular inflammatory conditions"}, {"/indications/DBCOND0106424": "Permphigus"}, {"/indications/DBCOND0106423": "Severe Allergic Reactions"}], "Name": "Bupivacaine Hydrochloride & Fentanyl Cit", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1310011C0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0014785": "Eczema impetiginous"}, {"/indications/DBCOND0093812": "Eczema of the nuchal nape of the neck"}, {"/indications/DBCOND0014775": "Folliculitis"}, {"/indications/DBCOND0093810": "Fungal ear infection caused by Aspergillus niger"}, {"/indications/DBCOND0033173": "Infantile Eczema"}, {"/indications/DBCOND0005735": "Intertrigo"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0093819": "Moniliasis"}, {"/indications/DBCOND0088936": "Nummular Dermatitis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0093817": "Pruritis of the scroti"}, {"/indications/DBCOND0005710": "Pruritus Ani"}, {"/indications/DBCOND0001342": "Pruritus Vulvae"}, {"/indications/DBCOND0014093": "Pyoderma"}, {"/indications/DBCOND0019955": "Stasis dermatitis"}, {"/indications/DBCOND0030966": "Tinea Capitis"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0093818": "Bacterial dermatoses"}, {"/indications/DBCOND0093814": "Chronic otitis externa"}, {"/indications/DBCOND0093820": "Disseminated Neurodermatitis"}, {"/indications/DBCOND0093821": "Localized Neurodermatitis"}], "Name": "Clioquinol", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002552": "Hydroxyquinoline Derivatives"}, {"/categories/DBCAT001262": "Hydroxyquinolines"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003679": "Miscellaneous Antifungals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT001618": "Oxyquinoline"}, {"/categories/DBCAT002551": "Quinoline Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}]}, "0101010J0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0023032": "Upset stomach"}], "Name": "Magnesium Trisilicate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT001373": "Silicates"}, {"/categories/DBCAT001374": "Silicic Acid"}, {"/categories/DBCAT001377": "Silicon Compounds"}, {"/categories/DBCAT001375": "Silicon Dioxide"}]}, "0201020M0": {"Conditions": [{"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}], "Name": "Milrinone Lactate", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000588": "Aminopyridines"}, {"/categories/DBCAT000587": "Amrinone"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000590": "Phosphodiesterase 3 Inhibitors"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0206020T0": {"Conditions": [{"/indications/DBCOND0000496": "Atrial Flutter"}, {"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0028068": "Hypertrophic Cardiomyopathy"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0058642": "Paroxysmal Supraventricular Tachycardia"}, {"/indications/DBCOND0108540": "Prinzmetal's variant angina"}, {"/indications/DBCOND0022090": "Secondary prevention MI"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Verapamil Hydrochloride", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003976": "Calcium Channel Blockers (Nondihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003669": "Miscellaneous Calcium-channel Blocking Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002442": "Phenylalkylamine Derivatives"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002327": "Selective Calcium Channel Blockers With Direct Cardiac Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004529": "Verapamil"}, {"/categories/DBCAT002850": "Verapamil and analogues"}]}, "0605010T0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0063952": "Acute Rheumatic Fever"}, {"/indications/DBCOND0029087": "Adrenal Insufficiency"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0020565": "Panhypopituitarism"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0023002": "Periarteritis nodosa"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0013449": "Scleroderma"}, {"/indications/DBCOND0066232": "Still's Disease"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0023005": "Acquired hemolytic jaundice"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}], "Name": "Tetracosactide", "Categories": [{"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003759": "Adrenocortical Insufficiency"}, {"/categories/DBCAT001331": "Adrenocorticotropic Hormone"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001332": "Melanocortins"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT003608": "Pituitary"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT001333": "Pro-Opiomelanocortin"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "1305020L0": {"Conditions": [{"/indications/DBCOND0024337": "Idiopathic Vitiligo"}, {"/indications/DBCOND0025586": "Refractory peripheral cutaneous T-cell lymphoma"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}], "Name": "Methoxsalen", "Categories": [{"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002388": "Antipsoriatics for Systemic Use"}, {"/categories/DBCAT002153": "Antipsoriatics for Topical Use"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001075": "Coloring Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000713": "Cross-Linking Reagents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000968": "Furocoumarins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT004154": "Photoabsorption"}, {"/categories/DBCAT003372": "Photoactivated Radical Generator"}, {"/categories/DBCAT004155": "Photosensitizing Activity"}, {"/categories/DBCAT000335": "Photosensitizing Agents"}, {"/categories/DBCAT002408": "Psoralens for Systemic Use"}, {"/categories/DBCAT002407": "Psoralens for Topical Use"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000334": "Radiation-Sensitizing Agents"}]}, "0606010U0": {"Conditions": [{"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0022002": "Osteoporosis caused by glucocorticoid"}, {"/indications/DBCOND0036937": "Primary Osteoporosis"}], "Name": "Teriparatide", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT004660": "Bone Anabolic Agents"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002102": "Calcium Homeostasis"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004661": "Parathyroid Agents"}, {"/categories/DBCAT002565": "Parathyroid Hormones and Analogues"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT004821": "Teriparatide"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0302000R0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0038236": "Seasonal Allergies"}, {"/indications/DBCOND0087977": "Skin Inflammation"}], "Name": "Mometasone Furoate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000309": "Steroids"}]}, "1104010M0": {"Conditions": [{"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0112785": "Androgenital syndrome"}, {"/indications/DBCOND0024264": "Itching"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0009004": "Thyroiditis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0112786": "Cryptitis"}], "Name": "Hydrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT001103": "Administration, Topical"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT001102": "Aerosols"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0703021L0": {"Conditions": [{"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0018394": "Pregnancy"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Levonorgestrel", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004113": "Inhibit Ovum Fertilization"}, {"/categories/DBCAT000797": "Norgestrel"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT003338": "Progestin-containing Intrauterine Device"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0407020B0": {"Conditions": [{"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Buprenorphine", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002315": "Drugs Used in Opioid Dependence"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002486": "Oripavine Derivatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0205052AD": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Azilsartan Medoxomil", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT004209": "Decreased Blood Pressure"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000626": "Oxazoles"}]}, "0205052AE": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}], "Name": "Sacubitril/Valsartan", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004016": "Neprilysin Inhibitor"}, {"/categories/DBCAT001007": "Neprilysin, antagonists & inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}]}, "0205052AB": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0058109": "Severe Hypertension"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}], "Name": "Olmesartan Medoxomil/Amlodipine", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT002173": "Angiotensin II Antagonists, Plain"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT000407": "Tetrazoles"}]}, "0404000E0": {"Conditions": [{"/indications/DBCOND0025127": "Primary apnea of premature newborns"}, {"/indications/DBCOND0068086": "Tiredness"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Caffeine Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT003635": "Anorexigenic Agents & Respiratory and CNS Stimulants"}, {"/categories/DBCAT000505": "Apnea"}, {"/categories/DBCAT004728": "Caffeine"}, {"/categories/DBCAT002675": "Caffeine and Caffeine Containing Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004212": "Central Nervous System Stimulation"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000508": "Purinergic P1 Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003636": "Respiratory and CNS Stimulants"}, {"/categories/DBCAT002181": "Tests for Gastric Secretion"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT001034": "Xanthine derivatives"}]}, "1201010AA": {"Conditions": [{"/indications/DBCOND0028872": "Addison's Disease"}, {"/indications/DBCOND0039238": "Orthostatic Intolerance"}, {"/indications/DBCOND0062048": "Postural Orthostatic Tachycardia Syndrome (POTS)"}, {"/indications/DBCOND0022162": "Salt wasting form Congenital adrenal hyperplasia"}], "Name": "Fludrocortisone Acetate", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001861": "Mineralocorticoids"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0605010Z0": {"Conditions": [{"/indications/DBCOND0000951": "Acromegaly"}], "Name": "Pegvisomant", "Categories": [{"/categories/DBCAT000182": "Acromegaly"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002096": "Anterior Pituitary Lobe Hormones and Analogues"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT004665": "Cytochrome P-450 CYP2C18 Inhibitors"}, {"/categories/DBCAT004669": "Cytochrome P-450 CYP2C18 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003273": "Growth Hormone Receptor Antagonist"}, {"/categories/DBCAT004283": "Growth Hormone Receptor Antagonists"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000095": "Pituitary Hormones, Anterior"}, {"/categories/DBCAT000181": "Receptors, Somatotropin, antagonists & inhibitors"}, {"/categories/DBCAT003620": "Somatotropin Antagonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "1201010AC": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0106142": "Acute Otitis Externa caused by Pseudomonas Aeruginosa"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0032963": "Acute Uncomplicated Pyelonephritis"}, {"/indications/DBCOND0021622": "Acute exacerbation of chronic bronchitis caused by Moraxella catarrhalis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0021574": "Conjunctivitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080536": "Corneal Ulcers caused by Serratia marcescens"}, {"/indications/DBCOND0080537": "Corneal Ulcers caused by Staphylococcus aureus"}, {"/indications/DBCOND0080538": "Corneal Ulcers caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080539": "Corneal Ulcers caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0080540": "Corneal Ulcers caused by Streptococcus Viridans Group"}, {"/indications/DBCOND0080535": "Corneal Ulcers caused by pseudomonas aeruginosa"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0021614": "Lower respiratory tract infection caused by Enterobacter cloacae"}, {"/indications/DBCOND0021611": "Lower respiratory tract infection caused by Escherichia coli"}, {"/indications/DBCOND0021616": "Lower respiratory tract infection caused by Haemophilus influenzae"}, {"/indications/DBCOND0021618": "Lower respiratory tract infection caused by Haemophilus parainfluenzae"}, {"/indications/DBCOND0021612": "Lower respiratory tract infection caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021615": "Lower respiratory tract infection caused by Proteus mirabilis"}, {"/indications/DBCOND0021620": "Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021640": "Plague caused by Yersinia pestis"}, {"/indications/DBCOND0045585": "Sinusitis, Acute"}, {"/indications/DBCOND0021628": "Typhoid fever caused by Salmonella typhi"}, {"/indications/DBCOND0021593": "UTI caused by Citrobacter diversus"}, {"/indications/DBCOND0021595": "UTI caused by Citrobacter frendii"}, {"/indications/DBCOND0021602": "UTI caused by Entercococcus faecalis"}, {"/indications/DBCOND0089465": "UTI caused by Enterobacter cloacae"}, {"/indications/DBCOND0021582": "UTI caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021591": "UTI caused by Morganella morganii"}, {"/indications/DBCOND0021587": "UTI caused by Proteus mirabilis"}, {"/indications/DBCOND0021589": "UTI caused by Providencia rettgeri"}, {"/indications/DBCOND0021596": "UTI caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0021585": "UTI caused by Serratia marcescens"}, {"/indications/DBCOND0021598": "UTI caused by methicillin-susceptible Staphylococcus epidermidis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0021563": "Acute otitis externa caused by Staphylococcus aureus"}, {"/indications/DBCOND0021604": "Acute, uncomplicated Cystitis caused by Escherichia coli"}, {"/indications/DBCOND0021606": "Acute, uncomplicated Cystitis caused by Staphylococcus saprophyticus"}, {"/indications/DBCOND0021608": "Chronic Prostatitis caused by Escherichia coli"}, {"/indications/DBCOND0021610": "Chronic Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0021634": "Complicated Pyelonephritis caused by Escherichia coli"}, {"/indications/DBCOND0021632": "Complicated UTI caused by Escherichia coli"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0021637": "Inhaled anthrax caused by Bacillus anthracis"}, {"/indications/DBCOND0020975": "Skin-structure infections"}, {"/indications/DBCOND0021631": "Uncomplicated Gonorrhea caused by Neisseria gonorrhoeae"}], "Name": "Ciprofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001596": "Ciprofloxacin and isotope"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "1201010AB": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0014179": "Cervicitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0064479": "Hansen's Disease"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0063099": "Spontaneous Bacterial Peritonitis (SBP)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0022868": "Acute Pelvic inflammatory disease"}, {"/indications/DBCOND0022865": "Acute, uncomplicated Gonorrhea"}, {"/indications/DBCOND0022871": "Chronic suppurative Otitis media"}, {"/indications/DBCOND0022869": "Uncomplicated Cystitis"}], "Name": "Ofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0801050X0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0024172": "FAB classification M3 Acute promyelocytic leukemia"}, {"/indications/DBCOND0036306": "Solar Lentigines"}, {"/indications/DBCOND0024211": "Facial fine wrinkling"}, {"/indications/DBCOND0025747": "Moderate Melasma"}, {"/indications/DBCOND0022269": "Mottled hyperpigmentation"}, {"/indications/DBCOND0025746": "Severe Melasma"}, {"/indications/DBCOND0024176": "Severe, recalcitrant Cystic acne"}, {"/indications/DBCOND0024174": "Tactile roughness of facial skin"}], "Name": "Tretinoin", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT003717": "Cell Stimulants and Proliferants"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT002161": "Retinoids for Topical Use in Acne"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "1201010AF": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0106142": "Acute Otitis Externa caused by Pseudomonas Aeruginosa"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0032963": "Acute Uncomplicated Pyelonephritis"}, {"/indications/DBCOND0021622": "Acute exacerbation of chronic bronchitis caused by Moraxella catarrhalis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0021574": "Conjunctivitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0021576": "Conjunctivitis caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080536": "Corneal Ulcers caused by Serratia marcescens"}, {"/indications/DBCOND0080537": "Corneal Ulcers caused by Staphylococcus aureus"}, {"/indications/DBCOND0080538": "Corneal Ulcers caused by Staphylococcus epidermidis"}, {"/indications/DBCOND0080539": "Corneal Ulcers caused by Streptococcus Pneumoniae"}, {"/indications/DBCOND0080540": "Corneal Ulcers caused by Streptococcus Viridans Group"}, {"/indications/DBCOND0080535": "Corneal Ulcers caused by pseudomonas aeruginosa"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0021626": "Infectious diarrhea"}, {"/indications/DBCOND0021614": "Lower respiratory tract infection caused by Enterobacter cloacae"}, {"/indications/DBCOND0021611": "Lower respiratory tract infection caused by Escherichia coli"}, {"/indications/DBCOND0021616": "Lower respiratory tract infection caused by Haemophilus influenzae"}, {"/indications/DBCOND0021618": "Lower respiratory tract infection caused by Haemophilus parainfluenzae"}, {"/indications/DBCOND0021612": "Lower respiratory tract infection caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021615": "Lower respiratory tract infection caused by Proteus mirabilis"}, {"/indications/DBCOND0021620": "Lower respiratory tract infection caused by penicillin-susceptible Streptococcus pneumoniae"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021640": "Plague caused by Yersinia pestis"}, {"/indications/DBCOND0045585": "Sinusitis, Acute"}, {"/indications/DBCOND0021628": "Typhoid fever caused by Salmonella typhi"}, {"/indications/DBCOND0021593": "UTI caused by Citrobacter diversus"}, {"/indications/DBCOND0021595": "UTI caused by Citrobacter frendii"}, {"/indications/DBCOND0021602": "UTI caused by Entercococcus faecalis"}, {"/indications/DBCOND0089465": "UTI caused by Enterobacter cloacae"}, {"/indications/DBCOND0021582": "UTI caused by Klebsiella pneumoniae"}, {"/indications/DBCOND0021591": "UTI caused by Morganella morganii"}, {"/indications/DBCOND0021587": "UTI caused by Proteus mirabilis"}, {"/indications/DBCOND0021589": "UTI caused by Providencia rettgeri"}, {"/indications/DBCOND0021596": "UTI caused by Pseudomonas aeruginosa"}, {"/indications/DBCOND0021585": "UTI caused by Serratia marcescens"}, {"/indications/DBCOND0021598": "UTI caused by methicillin-susceptible Staphylococcus epidermidis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0021563": "Acute otitis externa caused by Staphylococcus aureus"}, {"/indications/DBCOND0021604": "Acute, uncomplicated Cystitis caused by Escherichia coli"}, {"/indications/DBCOND0021606": "Acute, uncomplicated Cystitis caused by Staphylococcus saprophyticus"}, {"/indications/DBCOND0021608": "Chronic Prostatitis caused by Escherichia coli"}, {"/indications/DBCOND0021610": "Chronic Prostatitis caused by Proteus mirabilis"}, {"/indications/DBCOND0021634": "Complicated Pyelonephritis caused by Escherichia coli"}, {"/indications/DBCOND0021632": "Complicated UTI caused by Escherichia coli"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0021637": "Inhaled anthrax caused by Bacillus anthracis"}, {"/indications/DBCOND0020975": "Skin-structure infections"}, {"/indications/DBCOND0021631": "Uncomplicated Gonorrhea caused by Neisseria gonorrhoeae"}], "Name": "Ciprofloxacin/Fluocinolone", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT001596": "Ciprofloxacin and isotope"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0502050A0": {"Conditions": [{"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0026247": "Cryptococcal infections"}, {"/indications/DBCOND0007469": "Fungal endocarditis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0073780": "Meningitis, Fungal"}, {"/indications/DBCOND0045797": "Systemic Candidiasis"}, {"/indications/DBCOND0014386": "Urinary tract infection fungal"}, {"/indications/DBCOND0022118": "Disseminated Cryptococcosis"}, {"/indications/DBCOND0024242": "Prophylaxis of Candida Infections"}], "Name": "Flucytosine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT001267": "Cytosine"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001268": "Fluorouracil and prodrugs"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003428": "Nucleoside Analog Antifungal"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0902021Q0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "1310020G0": {"Conditions": [{"/indications/DBCOND0112742": "Muscle_spasm"}], "Name": "Chlorphenesin", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000876": "Propylene Glycols"}]}, "0103050E0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0070241": "Erosive Esophagitis(EE)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0039707": "NSAID Associated Gastric Ulcers"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0022243": "Maintenance of healing Erosive esophagitis"}, {"/indications/DBCOND0022241": "Postendoscopy Bleeding"}], "Name": "Esomeprazole", "Categories": [{"/categories/DBCAT000768": "2-Pyridinylmethylsulfinylbenzimidazoles"}, {"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT001099": "Omeprazole"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000541": "Proton Pump Inhibitors"}, {"/categories/DBCAT003638": "Proton-pump Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0801060A0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0022174": "Acute erythroid leukemia"}, {"/indications/DBCOND0006978": "Acute monocytic leukaemia"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}], "Name": "Daunorubicin/Cytarabine", "Categories": [{"/categories/DBCAT003352": "Anthracycline Topoisomerase Inhibitor"}, {"/categories/DBCAT000874": "Anthracyclines"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000873": "Daunorubicin"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0702020P0": {"Conditions": [{"/indications/DBCOND0078869": "Diaper Dermatitis"}, {"/indications/DBCOND0080575": "Fungal infection of nail"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0022776": "Cutaneous candidiasis infection"}], "Name": "Miconazole Nitrate", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "0304020Y0": {"Conditions": [{"/indications/DBCOND0078144": "Severe Eosinophilic Asthma"}], "Name": "Mepolizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003472": "Interleukin-5 Antagonist"}, {"/categories/DBCAT004230": "Interleukin-5 Antagonists"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0802020Y0": {"Conditions": [{"/indications/DBCOND0066662": "Kidney Transplant Rejection"}], "Name": "Belatacept", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004361": "CD80-directed Antibody Interactions"}, {"/categories/DBCAT004362": "CD86-directed Antibody Interactions"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000152": "Immunoconjugates"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT003474": "Selective T Cell Costimulation Blocker"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT004360": "T Lymphocyte Costimulation Activity Blockade"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0402010R0": {"Conditions": [{"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0003654": "Tics"}], "Name": "Pimozide", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002501": "Diphenylbutylpiperidine Derivatives"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003680": "Miscellaneous Antipsychotics"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0503032G0": {"Conditions": [{"/indications/DBCOND0023734": "With compensated cirrhosis Chronic hepatitis C genotype 1a"}, {"/indications/DBCOND0023731": "With compensated cirrhosis Chronic hepatitis C genotype 1b"}, {"/indications/DBCOND0023733": "Without cirrhosis Chronic hepatitis C genotype 1a"}, {"/indications/DBCOND0023729": "Without cirrhosis Chronic hepatitis C genotype 1b"}, {"/indications/DBCOND0023727": "Without cirrhosis Chronic hepatitis C genotype 4"}], "Name": "Paritaprevir/Ritonavir/Ombitasvir", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004186": "HCV NS3/4A Protease Inhibitors"}, {"/categories/DBCAT002768": "NS3/4A Protease Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "1502020P0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0901060Q0": {"Conditions": [{"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0026814": "Neutropenias"}], "Name": "Lipegfilgrastim", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000207": "Granulocyte Colony-Stimulating Factor"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000020": "Proteins"}]}, "0204000E0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0041468": "Refractory Hypertension"}, {"/indications/DBCOND0020944": "Secondary prevention Myocardial infarction"}, {"/indications/DBCOND0021770": "Thyrotoxicosis"}, {"/indications/DBCOND0055354": "Ventricular Tachyarrhythmias"}, {"/indications/DBCOND0101766": "Supraventricular tachyarrhythmias"}], "Name": "Atenolol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003890": "QTc shortening agents"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0801030Y0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0017375": "Mesothelioma"}, {"/indications/DBCOND0029910": "Pleural Mesotheliomas"}, {"/indications/DBCOND0089354": "Urothelial carcinoma ureter metastatic"}, {"/indications/DBCOND0022054": "Locally advanced nonsquamous non-small cell lung cancer"}, {"/indications/DBCOND0022053": "Metastatic nonsquamous non-small cell lung cancer"}, {"/indications/DBCOND0025384": "Recurrent, IV-B Cervical cancer"}, {"/indications/DBCOND0022057": "Unresectable Thymoma"}], "Name": "Pemetrexed", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000289": "Amino Acids, Acidic"}, {"/categories/DBCAT000288": "Amino Acids, Dicarboxylic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002290": "Folic Acid Analogues"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT000339": "Glutamates"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}]}, "0107010G0": {"Conditions": [{"/indications/DBCOND0000608": "Hemorrhoids"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0005710": "Pruritus Ani"}, {"/indications/DBCOND0062614": "Skin Irritation"}], "Name": "Cinchocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0203020U0": {"Conditions": [{"/indications/DBCOND0073289": "Atrial Fibrillation and Flutter"}, {"/indications/DBCOND0021343": "Malaria caused by Plasmodium falciparum"}, {"/indications/DBCOND0022436": "Pseudobulbar affect"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Quinidine Sulfate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002277": "Antiarrhythmics, Class Ia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000904": "Cinchona Alkaloids"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002610": "Cytochrome P-450 CYP1A2 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT003898": "Cytochrome P-450 CYP2C8 Inducers (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT004032": "Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001604": "Plant Extracts"}, {"/categories/DBCAT001210": "Plant Preparations"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0803042K0": {"Conditions": [{"/indications/DBCOND0031019": "Advanced Breast Cancer"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0059537": "Stage I Breast Carcinoma"}, {"/indications/DBCOND0020265": "Advanced carcinoma of the prostate"}, {"/indications/DBCOND0020271": "Stage M1 hormone dependent carcinoma of the prostate"}, {"/indications/DBCOND0027849": "Stage T2b carcinoma of the prostate"}, {"/indications/DBCOND0027848": "Stage T2c carcinoma of the prostate"}, {"/indications/DBCOND0020275": "Stage T3 carcinoma of the prostate"}, {"/indications/DBCOND0020274": "Stage T4 carcinoma of the prostate"}], "Name": "Goserelin Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT004658": "Gonadotropins and Antigonadotropins"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0604011X0": {"Conditions": [{"/indications/DBCOND0033523": "Breast Cancer Invasive Nos"}, {"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0022002": "Osteoporosis caused by glucocorticoid"}], "Name": "Raloxifene Hydrochloride", "Categories": [{"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000619": "Benzylidene Compounds"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003693": "Estrogen Agonist-antagonists"}, {"/categories/DBCAT003358": "Estrogen Agonist/Antagonist"}, {"/categories/DBCAT000786": "Estrogen Antagonists"}, {"/categories/DBCAT000917": "Estrogen Receptor Modulators"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000918": "Selective Estrogen Receptor Modulators"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000618": "Stilbenes"}, {"/categories/DBCAT000916": "Tamoxifen"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1309000G0": {"Conditions": [{"/indications/DBCOND0057011": "Dermatitis, Eczematous"}, {"/indications/DBCOND0036024": "Dry Skin"}], "Name": "Arachis Oil", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT001419": "Detergents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT001209": "Plant Oils"}, {"/categories/DBCAT001210": "Plant Preparations"}]}, "0205051I0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0055215": "Symptomatic Congestive Heart Failure"}, {"/indications/DBCOND0021850": "Asymptomatic Left ventricular dysfunction"}], "Name": "Enalapril Maleate", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004209": "Decreased Blood Pressure"}, {"/categories/DBCAT000375": "Dipeptides"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "040801020": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0034367": "Bipolar Disorder (BD)"}, {"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0031292": "Seizure, Absence"}, {"/indications/DBCOND0119337": "Seizure, multiple types"}, {"/indications/DBCOND0024512": "Acute Manic episode"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Valproic Acid", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002301": "Fatty Acid Derivatives"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT001486": "Histone Deacetylase Inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003983": "OAT3/SLC22A8 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT000731": "Pentanoic Acids"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004612": "UGT1A3 substrates with narrow therapeutic index"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT004531": "UGT1A6 substrate with narrow therapeutic index"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004544": "UGT1A9 substrates with narrow therapeutic index"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT004613": "UGT2B7 substrates with narrow therapeutic index"}, {"/categories/DBCAT000732": "Valerates"}]}, "0501020AD": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0082137": "Neutropenia, Febrile"}, {"/indications/DBCOND0014040": "Pyelonephritis"}, {"/indications/DBCOND0036867": "Severe Pneumonia"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0025522": "Moderate Pneumonia"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Cefepime", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT002531": "Fourth-Generation Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0501020AA": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Cefprozil", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0803042E0": {"Conditions": [{"/indications/DBCOND0070333": "Advanced Prostate Carcinoma"}, {"/indications/DBCOND0036371": "Metastatic Hormone Refractory Prostate Cancer"}, {"/indications/DBCOND0018486": "Paraphilia"}, {"/indications/DBCOND0077433": "Severe Acne"}], "Name": "Cyproterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT001625": "Cyproterone"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "1001030X0": {"Conditions": [{"/indications/DBCOND0025138": "Psoriatic arthritis aggravated"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0020385": "Active Ankylosing spondylitis"}, {"/indications/DBCOND0020388": "Moderate Ulcerative colitis"}, {"/indications/DBCOND0023311": "Moderate, active Rheumatoid arthritis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Golimumab", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}, {"/categories/DBCAT002087": "Tumor Necrosis Factor Alpha (TNF-\u03b1) Inhibitors"}, {"/categories/DBCAT003245": "Tumor Necrosis Factor Blocker"}, {"/categories/DBCAT004095": "Tumor Necrosis Factor Receptor Blocking Activity"}]}, "1303000M0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0023142": "Runny nose"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Mepyramine Maleate", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000588": "Aminopyridines"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}, {"/categories/DBCAT002468": "Substituted Ethylene Diamines"}]}, "1002020T0": {"Conditions": [{"/indications/DBCOND0027968": "Acute Low Back Pain"}, {"/indications/DBCOND0072795": "Drug Withdrawal Headache"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0002241": "Muscle Spasticity"}, {"/indications/DBCOND0024115": "Seizures"}, {"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Tizanidine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000977": "Imidazolines"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0501011W0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0069365": "Clostridial Infection"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0007468": "Endocarditis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0089302": "Neisseria gonorrhoeae arthritis"}, {"/indications/DBCOND0024235": "Pasteurella infections"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0036867": "Severe Pneumonia"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0025806": "Rat bite fever"}, {"/indications/DBCOND0025804": "Severe Pneumococcal infection"}, {"/indications/DBCOND0021438": "Severe Staphylococcal infection"}], "Name": "Benethamine Penicillin/Benzylpenicillin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002295": "Beta-Lactam Antibacterials"}, {"/categories/DBCAT002365": "Beta-Lactamase Sensitive Penicillins"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003683": "Natural Penicillins"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000740": "Penicillin G"}, {"/categories/DBCAT000702": "Penicillins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0501120P0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0014179": "Cervicitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0053855": "Complicated Urinary Tract Infections"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0064479": "Hansen's Disease"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0004132": "Otitis Externa"}, {"/indications/DBCOND0005935": "Prostatitis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0063099": "Spontaneous Bacterial Peritonitis (SBP)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0022868": "Acute Pelvic inflammatory disease"}, {"/indications/DBCOND0022865": "Acute, uncomplicated Gonorrhea"}, {"/indications/DBCOND0022871": "Chronic suppurative Otitis media"}, {"/indications/DBCOND0022869": "Uncomplicated Cystitis"}], "Name": "Ofloxacin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0901040C0": {"Conditions": [{"/indications/DBCOND0039050": "Severe Aplastic Anemia (SAA)"}, {"/indications/DBCOND0027194": "Thrombocytopenias"}, {"/indications/DBCOND0025596": "Refractory Aplastic anemia"}, {"/indications/DBCOND0021524": "Refractory immune thrombocytopenia"}], "Name": "Eltrombopag", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT004193": "Increased Megakaryocyte Maturation"}, {"/categories/DBCAT004194": "Increased Platelet Production"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT003455": "Thrombopoietin Receptor Agonist"}, {"/categories/DBCAT004195": "Thrombopoietin Receptor Agonists"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004454": "UGT1A3 Inhibitors"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004455": "UGT1A4 Inhibitors"}, {"/categories/DBCAT002665": "UGT1A6 Inhibitors"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}, {"/categories/DBCAT004457": "UGT2B15 Inhibitors"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}]}, "0403010F0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}], "Name": "Clomipramine Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0801050J0": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}], "Name": "Crisantaspase", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004271": "Asparaginase"}, {"/categories/DBCAT003249": "Asparagine-specific Enzyme"}, {"/categories/DBCAT004603": "Thyroxine-binding globulin inhibitors"}]}, "0407020T0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Pentazocine Hydrochloride", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002436": "Benzomorphan Derivatives"}, {"/categories/DBCAT001035": "Benzomorphans"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003387": "Partial Opioid Agonist/Antagonist"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0703023L0": {"Conditions": [{"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0018394": "Pregnancy"}, {"/indications/DBCOND0023177": "Moderate vasomotor symptoms"}, {"/indications/DBCOND0023178": "Severe vasomotor symptoms"}], "Name": "Levonorgestrel", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004113": "Inhibit Ovum Fertilization"}, {"/categories/DBCAT000797": "Norgestrel"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT003338": "Progestin-containing Intrauterine Device"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0408010I0": {"Conditions": [{"/indications/DBCOND0030469": "Petit Mal Epilepsy"}], "Name": "Ethosuximide", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT004032": "Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002417": "Succinimide Derivatives"}, {"/categories/DBCAT000987": "Succinimides"}]}, "0209000V0": {"Conditions": [{"/indications/DBCOND0000554": "Coronary Artery Disease"}, {"/indications/DBCOND0054784": "Postoperative Thromboembolism"}, {"/indications/DBCOND0085133": "Strokes"}], "Name": "Dipyridamole & Aspirin", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003720": "Miscellaneous Vasodilatating Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0701010I0": {"Conditions": [{"/indications/DBCOND0040920": "Gestational Trophoblastic Disease"}], "Name": "Dinoprostone", "Categories": [{"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT004759": "Dinoprostone, antagonists & inhibitors"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT001121": "Prostaglandins E"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000218": "Uterotonic agents"}]}, "0503010S0": {"Conditions": [{"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}], "Name": "Stavudine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000858": "Thymidine"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0601023Z0": {"Conditions": [{"/indications/DBCOND0055384": "Polycystic Ovaries Syndrome"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Metformin Hydrochloride/Vildagliptin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000761": "Biguanides"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}]}, "0505060I0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021877": "Ascaris lumbricoides infection"}, {"/indications/DBCOND0014308": "Cutaneous larva migrans"}, {"/indications/DBCOND0014450": "Demodicidosis"}, {"/indications/DBCOND0014309": "Gnathostomiasis"}, {"/indications/DBCOND0089193": "Mansonella ozzardi infection"}, {"/indications/DBCOND0089466": "Mansonella streptocerca infection"}, {"/indications/DBCOND0004268": "Oesophagostomiasis"}, {"/indications/DBCOND0009881": "Onchocerciasis"}, {"/indications/DBCOND0043220": "Pediculosis Capitis"}, {"/indications/DBCOND0000256": "Scabies"}, {"/indications/DBCOND0004262": "Trichuriasis"}, {"/indications/DBCOND0025183": "Wuchereria bancroftii infection"}], "Name": "Ivermectin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT000944": "Anthelmintics"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002421": "Avermectines"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000857": "Insecticides"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002731": "Pediculicides"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT003648": "Scabicides and Pediculicides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1310020X0": {"Conditions": [{"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}], "Name": "Sulconazole Nitrate", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}]}, "1302010P0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "0801050D0": {"Conditions": [{"/indications/DBCOND0045726": "Esophageal Cancers"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0034432": "Locally Advanced Breast Cancer (LABC)"}, {"/indications/DBCOND0046917": "Lung Cancer Small Cell Lung Cancer (SCLC)"}, {"/indications/DBCOND0054408": "Metastatic Bladder Cancer"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0036371": "Metastatic Hormone Refractory Prostate Cancer"}, {"/indications/DBCOND0043377": "Metastatic Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0032497": "Node Positive Breast Cancer"}, {"/indications/DBCOND0068543": "Ovarian Cancer Metastatic"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0025496": "Advanced untreated gastric adenocarcinoma"}, {"/indications/DBCOND0025497": "Locally advanced Squamous cell carcinoma of head and neck"}, {"/indications/DBCOND0025494": "Locally advanced untreated non small cell lung cancer"}, {"/indications/DBCOND0025498": "Metastatic Squamous cell carcinoma of head and neck"}, {"/indications/DBCOND0025489": "Refractory, locally advanced Non small cell lung cancer"}, {"/indications/DBCOND0025490": "Refractory, metastatic Non small cell lung cancer"}], "Name": "Docetaxel", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001310": "Cyclodecanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000381": "Diterpenes"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004205": "Microtubule Inhibition"}, {"/categories/DBCAT002734": "Microtubule Inhibitors"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002720": "Taxane Derivatives"}, {"/categories/DBCAT001309": "Taxoids"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "0501021E0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0025366": "Bacterial Urinary Tract Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0021701": "Flu caused by Influenza"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}], "Name": "Cefoxitin Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT000654": "Cephamycins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "0901030N0": {"Conditions": [{"/indications/DBCOND0031070": "Anemias"}], "Name": "Methoxy Polyethylene Glycol-Epoetin Beta", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000020": "Proteins"}]}, "1304000Y0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0052432": "Polyps, Nasal"}, {"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0038236": "Seasonal Allergies"}, {"/indications/DBCOND0087977": "Skin Inflammation"}], "Name": "Mometasone Furoate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0208010F0": {"Conditions": [{"/indications/DBCOND0013324": "Cystitis interstitial"}], "Name": "Pentosan Polysulfate Sodium", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}, {"/categories/DBCAT002207": "Urologicals"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0704020N0": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Tolterodine", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT001243": "Cresols"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT003744": "Genitourinary Smooth Muscle Relaxants"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT001002": "Phenylpropanolamine"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0604012M0": {"Conditions": [{"/indications/DBCOND0005025": "Amenorrhea"}, {"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0030098": "Metastatic Renal Cell Carcinoma"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0021883": "Metastatic Endometrial carcinoma"}], "Name": "Medroxyprogesterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT000829": "Corpus Luteum Hormones"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000991": "Hydroxyprogesterones"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000993": "Medroxyprogesterone"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002358": "Pregnen (4) Derivatives"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000992": "Progesterone and Derivatives"}, {"/categories/DBCAT000686": "Progesterone Congeners"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0304030G0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0603020C0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0304010H0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Clemastine Fumarate", "Categories": [{"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0207010F0": {"Conditions": [{"/indications/DBCOND0029401": "Arrythmias"}, {"/indications/DBCOND0025070": "Circulatory collapse and shock"}, {"/indications/DBCOND0112632": "Hypotension caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction"}, {"/indications/DBCOND0112633": "Urine flow decreased caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction"}, {"/indications/DBCOND0112631": "Decreased cardiac output caused by Trauma, endotoxic septicemia, Open-heart Surgery, Renal Failure, chronic cardiac decompensation, Myocardial Infarction"}], "Name": "Dopamine Hydrochloride", "Categories": [{"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT004760": "Dopamine, metabolism"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003733": "Selective Beta 1-adrenergic Agonists"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0103010D0": {"Conditions": [{"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0024446": "Hypersecretion gastric"}, {"/indications/DBCOND0021007": "Active Duodenal ulcer"}, {"/indications/DBCOND0021422": "Active Gastric ulcer"}, {"/indications/DBCOND0022472": "Benign gastric ulcers"}, {"/indications/DBCOND0021420": "Maintenance therapy Duodenal ulcer"}], "Name": "Cimetidine", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003809": "Cytochrome P-450 CYP3A5 Inhibitors (moderate)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003802": "Cytochrome P-450 CYP3A7 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}]}, "1203020P0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0031183": "Clostridium Infections"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0080081": "Intestinal Amebiasis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0040526": "Severe Acne Vulgaris"}, {"/indications/DBCOND0021129": "Shigella"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0022329": "Moderate Acne vulgaris"}], "Name": "Minocycline Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0501060E0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin Phosphate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "1103010C0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Chloramphenicol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002381": "Amphenicols"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001884": "Chloramphenicol"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT000875": "Nitrobenzenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1203010T0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0801010S0": {"Conditions": [{"/indications/DBCOND0013362": "Amyloidosis"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0054935": "Ovarian Epithelial Cancer"}, {"/indications/DBCOND0106224": "Severe Hodgkin Lymphoma"}], "Name": "Melphalan", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000681": "Mustard Compounds"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002289": "Nitrogen Mustard Analogues"}, {"/categories/DBCAT000680": "Nitrogen Mustard Compounds"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0403010X0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0049114": "Alzheimer's Disease (AD)"}, {"/indications/DBCOND0060453": "Dementias"}, {"/indications/DBCOND0079665": "Eating Disorders Symptoms"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0002221": "Fibromyalgia"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Trazodone Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT003849": "Antidepressive Agents, Triazolopyridine"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT004614": "Peripheral alpha-1 blockers"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001044": "Pyridones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0206020I0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Isradipine", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1106000P0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}], "Name": "Dorzolamide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0304010F0": {"Conditions": [{"/indications/DBCOND0106182": "Acute nasopharyngitis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Brompheniramine Maleate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT001157": "Pheniramine"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003731": "Propylamine Derivatives"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002362": "Substituted Alkylamines"}]}, "0206030Y0": {"Conditions": [{"/indications/DBCOND0112034": "Chronic, stable, symptomatic Heart Failure"}, {"/indications/DBCOND0025783": "Symptomatic left ventricular ejection fraction \u2264 35% Chronic heart failure"}], "Name": "Ivabradine", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004369": "Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists"}, {"/categories/DBCAT003515": "Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker"}, {"/categories/DBCAT003708": "Miscellaneous Cardiac Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0305010W0": {"Conditions": [{"/indications/DBCOND0024339": "Anesthetic complication pulmonary"}, {"/indications/DBCOND0021711": "Acute Hypercapnia"}, {"/indications/DBCOND0021705": "Drug-induced Respiratory depression"}, {"/indications/DBCOND0097584": "Postoperative respiratory depression"}], "Name": "Doxapram Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT004082": "Increased Medullary Respiratory Drive"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT000132": "Respiratory System Agents"}]}, "0607020T0": {"Conditions": [{"/indications/DBCOND0043429": "Advanced Prostate Cancer"}], "Name": "Triptorelin", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT001156": "Luteolytic Agents"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}]}, "0503010A0": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}], "Name": "Lamivudine & Zidovudine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT004749": "Zalcitabine"}]}, "1002020H0": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0022458": "Acute Muscle spasm"}], "Name": "Cyclobenzaprine Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004231": "Centrally-mediated Muscle Relaxation"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}]}, "1103010F0": {"Conditions": [{"/indications/DBCOND0021311": "Acute Crusting Rhinitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0039241": "Corneal Abrasions"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0021315": "Stye"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0021310": "Acute rhino-sinusitis"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0020325": "Nasal carriage of staphylococci"}], "Name": "Framycetin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000880": "Neomycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0212000M0": {"Conditions": [{"/indications/DBCOND0022749": "Atherosclerosis"}, {"/indications/DBCOND0078488": "Atherosclerotic Cardiovascular Diseases"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0040592": "Coronary Heart Disease (CHD)"}, {"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}], "Name": "Fluvastatin Sodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT001257": "Heptanoic Acids"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0205020E0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0051106": "Human Growth Hormone Deficiency"}, {"/indications/DBCOND0068470": "Menopausal Hot Flushes"}, {"/indications/DBCOND0025068": "Opiate withdrawal symptoms"}, {"/indications/DBCOND0032311": "Oppositional Defiant Disorder"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0021809": "Sialorrhea caused by clozapine"}, {"/indications/DBCOND0021810": "Diabetic diarrhea"}, {"/indications/DBCOND0021815": "Methadone withdrawal"}, {"/indications/DBCOND0021807": "Severe Cancer pain"}], "Name": "Clonidine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT002214": "Antiadrenergic Agents, Centrally Acting"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT004037": "Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002413": "Imidazoline Receptor Agonists"}, {"/categories/DBCAT000977": "Imidazolines"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000485": "Sympatholytics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}]}, "1303000N0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0409030C0": {"Conditions": [{"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0025570": "Hemiballismus"}, {"/indications/DBCOND0053941": "Huntington's Disease (HD)"}, {"/indications/DBCOND0031588": "Tardive Dyskinesia"}, {"/indications/DBCOND0025571": "Senile chorea"}], "Name": "Tetrabenazine", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001626": "Quinolizines"}, {"/categories/DBCAT003448": "Vesicular Monoamine Transporter 2 Inhibitor"}, {"/categories/DBCAT004435": "Vesicular Monoamine Transporter 2 Inhibitors"}]}, "0607010B0": {"Conditions": [{"/indications/DBCOND0000951": "Acromegaly"}, {"/indications/DBCOND0003637": "Neuroleptic Malignant Syndrome"}, {"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}, {"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}, {"/indications/DBCOND0020755": "Idiopathic hyperprolactinemic disorder"}], "Name": "Bromocriptine", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000605": "Ergolines"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003643": "Ergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT000741": "Ergotamines"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002256": "Prolactine Inhibitors"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}]}, "0503010AS": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}], "Name": "Lamivudine/Tenofovir Disop/Doravirine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT004749": "Zalcitabine"}]}, "0503010AR": {"Conditions": [{"/indications/DBCOND0049565": "Infections, Cytomegalovirus"}], "Name": "Letermovir", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT003110": "Cytochrome P-450 CYP2C19 Inducers (moderate)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004173": "Cytochrome P450 2C19 Inducers"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT003991": "Cytomegalovirus DNA Terminase Complex Inhibitor"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004445": "DNA Terminase Complex Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "0503010AQ": {"Conditions": [{"/indications/DBCOND0112709": "Stable antiretroviral regimen, less than 50 HIV-1 RNA copies HIV-1"}, {"/indications/DBCOND0112706": "Untreated with antiretrovirals HIV-1"}], "Name": "Bictegravir/Emtricitabine/Tenofovir Alaf", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0503010AP": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Dolutegravir/Rilpivirine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001873": "HIV Integrase Inhibitors"}, {"/categories/DBCAT003484": "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor"}, {"/categories/DBCAT001872": "Integrase Inhibitors"}, {"/categories/DBCAT003994": "Miscellaneous Antiretrovirals*"}, {"/categories/DBCAT004367": "Multidrug and Toxin Extrusion Transporter 1 Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0503010AK": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Darunavir/Cobicistat", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000766": "Furans"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0503010AJ": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Elvitegravir", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004107": "Cytochrome P450 2C9 Inducers"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001732": "HIV Integrase"}, {"/categories/DBCAT001873": "HIV Integrase Inhibitors"}, {"/categories/DBCAT003484": "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0503010AI": {"Conditions": [{"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}, {"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Cobicistat", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0503010AH": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Dolutegravir", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001873": "HIV Integrase Inhibitors"}, {"/categories/DBCAT003484": "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor"}, {"/categories/DBCAT001872": "Integrase Inhibitors"}, {"/categories/DBCAT003994": "Miscellaneous Antiretrovirals*"}, {"/categories/DBCAT004367": "Multidrug and Toxin Extrusion Transporter 1 Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0503010AN": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Efavirenz/Emtricitabine/Tenofovir Disop", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002640": "Cytochrome P-450 CYP2C19 Inhibitors (moderate)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002701": "Cytochrome P-450 CYP3A4 Inducers (moderate)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT003899": "Cytochrome P-450 CYP3A7 Inducers (moderate)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004211": "Cytochrome P450 2C19 Inhibitors"}, {"/categories/DBCAT004132": "Cytochrome P450 2C9 Inhibitors"}, {"/categories/DBCAT004106": "Cytochrome P450 3A Inducers"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003302": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002245": "Non-Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003641": "Nonnucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "0503010AM": {"Conditions": [{"/indications/DBCOND0054009": "HIV-1-infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}, {"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Emtricitabine & Tenofovir Alafenamide", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0302000C0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0033683": "Chronic Rhinosinusitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0021673": "Corticosteroid-responsive Dermatosis"}, {"/indications/DBCOND0021089": "Recurrent nasal polyps"}], "Name": "Beclometasone Dipropionate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000825": "Steroids, Chlorinated"}]}, "0503010AC": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Darunavir", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004062": "Cytochrome P450 2D6 Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000766": "Furans"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0503010AB": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Tipranavir", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}]}, "0503010AA": {"Conditions": [{"/indications/DBCOND0054009": "HIV-1-infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}, {"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}, {"/indications/DBCOND0021409": "Post exposure HIV transmission"}], "Name": "Emtricitabine & Tenofovir Disoproxil", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0503010AG": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Rilpivirine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003302": "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT002245": "Non-Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003641": "Nonnucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "0501090Q0": {"Conditions": [{"/indications/DBCOND0013995": "Mycobacterium avium complex infection"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0025407": "Late phase Tuberculosis"}], "Name": "Rifabutin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT003034": "Cytochrome P-450 CYP2B6 Inducers (weak)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT003110": "Cytochrome P-450 CYP2C19 Inducers (moderate)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT003898": "Cytochrome P-450 CYP2C8 Inducers (weak)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT001006": "Lactams, Macrocyclic"}, {"/categories/DBCAT003895": "P-glycoprotein inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT003383": "Rifamycin Antimycobacterial"}, {"/categories/DBCAT001005": "Rifamycins"}]}, "0310000E0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0503010AD": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Maraviroc", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003447": "CCR5 Co-receptor Antagonist"}, {"/categories/DBCAT001623": "CCR5 Receptor Antagonists"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000220": "HIV Fusion Inhibitors"}, {"/categories/DBCAT000486": "Triazoles"}, {"/categories/DBCAT000219": "Viral Fusion Protein Inhibitors"}]}, "0207030A0": {"Conditions": [{"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0031400": "Angioneurotic Edema"}, {"/indications/DBCOND0053782": "Arterial Hypotension"}, {"/indications/DBCOND0020313": "Bleeding"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0043125": "Idiopathic Anaphylaxis"}, {"/indications/DBCOND0022101": "Laryngotracheobronchitis"}, {"/indications/DBCOND0057582": "Mild Intermittent Asthma"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0034654": "Respiratory Distress"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0058229": "Uterine Contractions"}, {"/indications/DBCOND0000505": "Ventricular Fibrillation"}, {"/indications/DBCOND0108201": "Complete atrioventricular heart block"}, {"/indications/DBCOND0115963": "Resuscitation in cardiac arrest following anesthetic accidents"}, {"/indications/DBCOND0093970": "Serious allergic reactions"}, {"/indications/DBCOND0100523": "Severe hypersensitivity"}, {"/indications/DBCOND0022099": "Unresponsive Asystole"}, {"/indications/DBCOND0022100": "Unresponsive Bradycardia"}], "Name": "Adrenaline", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT001159": "Adrenergic beta-1 Receptor Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003710": "Dental Agents"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000798": "Epinephrine and similars"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002444": "Local Hemostatics"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002382": "Sympathomimetics in Glaucoma Therapy"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0206010K0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}], "Name": "Isosorbide Mononitrate", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000158": "Delayed-Action Preparations"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001173": "Isosorbide"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000756": "Nitric Oxide Donors"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT000647": "Sorbitol"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}]}, "1003020F0": {"Conditions": [{"/indications/DBCOND0051417": "Acute Sore Throat"}, {"/indications/DBCOND0025691": "Mucositis of the oro-pharyngeal"}], "Name": "Benzydamine Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001180": "Indazoles"}, {"/categories/DBCAT003782": "Mouthwashes and Gargles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "1306010F0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin Phosphate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "0301011R0": {"Conditions": [{"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0003949": "Hyperkalemia"}], "Name": "Salbutamol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "1302030Z0": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Oxide", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "0402010C0": {"Conditions": [{"/indications/DBCOND0042732": "Suicidal Behaviour"}, {"/indications/DBCOND0047251": "Treatment-resistant Schizophrenia"}, {"/indications/DBCOND0021006": "Advanced dopaminomimetic psychosis"}], "Name": "Clozapine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002317": "Diazepines, Oxazepines, Thiazepines and Oxepines"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000793": "GABA Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "0107010Z0": {"Conditions": [{"/indications/DBCOND0005733": "Diaper Rash"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}], "Name": "Zinc Oxide", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT003789": "Basic Powders and Demulcents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003558": "Copper Absorption Inhibitor"}, {"/categories/DBCAT001169": "Cosmetics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001170": "Household Products"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT000860": "Oxides"}, {"/categories/DBCAT000861": "Oxygen Compounds"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001143": "Radiation-Protective Agents"}, {"/categories/DBCAT003790": "Sunscreen Agents"}, {"/categories/DBCAT001358": "Sunscreening Agents"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT001980": "Zinc Compounds"}]}, "1311010I0": {"Conditions": [{"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Isopropyl Alcohol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT001183": "Solvents"}]}, "1104020L0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0020934": "Tendinitis"}], "Name": "Indometacin", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0105040A0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0034753": "Conjunctivitis, Vernal"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0002834": "Urticaria Pigmentosa"}], "Name": "Sodium Cromoglicate", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001225": "Chromones"}, {"/categories/DBCAT004761": "Cromolyn Sodium"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT003742": "Mast-cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1306010T0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}], "Name": "Sulfur", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT001956": "Chalcogens"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT002550": "Preparations Containing Sulfur"}, {"/categories/DBCAT004849": "Sulfur"}]}, "030902020": {"Conditions": [{"/indications/DBCOND0025076": "Acute radiation sickness"}], "Name": "Potassium Iodide", "Categories": [{"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT004964": "Antithyroid agents"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT001845": "Iodides"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT004827": "Potassium Iodide"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "0410030E0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0013142": "Cholestatic pruritus"}, {"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0066540": "Severe Pain"}], "Name": "Naltrexone Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001048": "Alcohol Deterrents"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002441": "Drugs Used in Alcohol Dependence"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT001081": "Naloxone"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003713": "Opiate Antagonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0405010M0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Methylcellulose", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT002593": "Bulk-Forming Laxatives"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001448": "Cellulose"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT001022": "Glucans"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "0107040A0": {"Conditions": [{"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0022215": "Angina attack"}, {"/indications/DBCOND0059462": "Chronic Anal Fissures"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0064285": "Coronary Artery Spasm"}, {"/indications/DBCOND0024761": "Gastroesophageal variceal hemorrhage prophylaxis"}, {"/indications/DBCOND0077899": "Perioperative Hypertension"}, {"/indications/DBCOND0022221": "Esophageal spastic disorders"}], "Name": "Glyceryl Trinitrate", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002737": "Antianginal Agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001096": "Explosive Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003394": "Nitrate Vasodilator"}, {"/categories/DBCAT003688": "Nitrates and Nitrites"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT002456": "Organic Nitrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT004272": "Vasodilation"}, {"/categories/DBCAT002457": "Vasodilators Used in Cardiac Diseases"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1106000B0": {"Conditions": [{"/indications/DBCOND0035716": "Angle Closure Glaucoma"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0008063": "Familial periodic paralysis"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0024755": "Other and unspecified effects of high altitude"}, {"/indications/DBCOND0022351": "Cystine renal calculi"}, {"/indications/DBCOND0024395": "Drug-induced edema"}, {"/indications/DBCOND0022682": "Nonuveitic secondary glaucoma"}], "Name": "Acetazolamide", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT003725": "Antiglaucoma Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0702020V0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "110802070": {"Conditions": [{"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0029481": "Cystoid Macular Edema"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056180": "Ocular Itching"}, {"/indications/DBCOND0054268": "Ocular Pain"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0050988": "Pseudophakic Cystoid Macular Edema"}, {"/indications/DBCOND0021335": "Acute Pericarditis"}, {"/indications/DBCOND0112012": "Acute, moderate Pain"}, {"/indications/DBCOND0112011": "Acute, severe Pain"}, {"/indications/DBCOND0021338": "Chronic aphakic cystoid macular edema"}, {"/indications/DBCOND0021341": "Intraoperative miosis"}, {"/indications/DBCOND0106137": "Postoperative ocular pain"}], "Name": "Ketorolac Trometamol", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000550": "Mydriatics"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002676": "Tromethamine"}]}, "1104010F0": {"Conditions": [{"/indications/DBCOND0031682": "Dermatitis, Allergic Contact"}, {"/indications/DBCOND0057011": "Dermatitis, Eczematous"}], "Name": "Clobetasone Butyrate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001828": "Ointments"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "1310011B0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Chloramphenicol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002381": "Amphenicols"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001884": "Chloramphenicol"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT000875": "Nitrobenzenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0601040H0": {"Conditions": [{"/indications/DBCOND0020361": "Severe Hypoglycemia"}], "Name": "Glucagon", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT003548": "Antihypoglycemic Agent"}, {"/categories/DBCAT004427": "Decreased GI Motility"}, {"/categories/DBCAT004426": "Decreased GI Smooth Muscle Tone"}, {"/categories/DBCAT004428": "Decreased Glycolysis"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000091": "Gastrointestinal Hormones"}, {"/categories/DBCAT003549": "Gastrointestinal Motility Inhibitor"}, {"/categories/DBCAT004689": "Glucagon"}, {"/categories/DBCAT004688": "Glucagon, antagonists & inhibitors"}, {"/categories/DBCAT003609": "Glycogenolytic Agents"}, {"/categories/DBCAT002111": "Glycogenolytic Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004424": "Increased Gluconeogenesis"}, {"/categories/DBCAT004425": "Increased Glycogenolysis"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000120": "Proglucagon"}, {"/categories/DBCAT000121": "Protein Precursors"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0502020A0": {"Conditions": [{"/indications/DBCOND0000148": "Blastomycosis"}, {"/indications/DBCOND0022874": "Chromomycosis"}, {"/indications/DBCOND0048700": "Chronic Mucocutaneous Candidiasis (CMC)"}, {"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0063178": "Endogenous Cushing's Syndrome"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0000150": "Paracoccidioidomycosis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0045797": "Systemic Candidiasis"}, {"/indications/DBCOND0121746": "Tinea Corporis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121745": "Tinea Corporis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121744": "Tinea Corporis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121742": "Tinea Cruris caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121741": "Tinea Cruris caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121740": "Tinea Cruris caused by Trichophyton rubrum"}, {"/indications/DBCOND0121749": "Tinea Pedis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121748": "Tinea Pedis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121747": "Tinea Pedis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121738": "Cutaneous candidiasis caused by candida spp."}, {"/indications/DBCOND0121750": "Recalcitrant Dermatophytosis"}, {"/indications/DBCOND0121736": "Tinea versicolor caused by Malassezia infection"}], "Name": "Ketoconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002616": "Cytochrome P-450 CYP2A6 Inhibitors (moderate)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004187": "Cytochrome P450 3A5 Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}]}, "1501050X0": {"Conditions": [{"/indications/DBCOND0024375": "Muscle fasciculation caused by succinylcholine"}], "Name": "Rocuronium Bromide", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT001010": "Androstanols"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002205": "Muscle Relaxants, Peripherally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT000511": "Neuromuscular Blocking Agents"}, {"/categories/DBCAT004165": "Neuromuscular Nondepolarizing Blockade"}, {"/categories/DBCAT002684": "Neuromuscular-Blocking Agents (Nondepolarizing)"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "0101010M0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0019548": "Aspiration"}, {"/indications/DBCOND0023055": "Bloating"}, {"/indications/DBCOND0012364": "Calcinosis"}, {"/indications/DBCOND0093825": "Gastroesophgeal reflux"}, {"/indications/DBCOND0050299": "Gastrointestinal Bleedings"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0093830": "Hyperacidity"}, {"/indications/DBCOND0009085": "Hyperparathyroidism"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0057786": "Renal Stones"}, {"/indications/DBCOND0023344": "Sour stomach"}, {"/indications/DBCOND0074522": "Stress Ulcers"}], "Name": "Magaldrate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT002569": "Aluminium Compounds"}, {"/categories/DBCAT004681": "Aluminum and magnesium containing antacids"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT002578": "Antacids With Antiflatulents"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT001847": "Hydroxides"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}]}, "0407010S0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin & Paracetamol", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0205052B0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0058109": "Severe Hypertension"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}], "Name": "Olmesartan Medoxomil", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002170": "Angiotensin II Antagonists and Calcium Channel Blockers"}, {"/categories/DBCAT002173": "Angiotensin II Antagonists, Plain"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT000407": "Tetrazoles"}]}, "0402030Q0": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0034367": "Bipolar Disorder (BD)"}, {"/indications/DBCOND0036406": "Complex Partial Seizures"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0031292": "Seizure, Absence"}, {"/indications/DBCOND0119337": "Seizure, multiple types"}, {"/indications/DBCOND0024512": "Acute Manic episode"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}], "Name": "Valproic Acid", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT004033": "Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002301": "Fatty Acid Derivatives"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT001486": "Histone Deacetylase Inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003983": "OAT3/SLC22A8 Substrates with Narrow Therapeutic Index"}, {"/categories/DBCAT000731": "Pentanoic Acids"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004612": "UGT1A3 substrates with narrow therapeutic index"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT004531": "UGT1A6 substrate with narrow therapeutic index"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004544": "UGT1A9 substrates with narrow therapeutic index"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}, {"/categories/DBCAT004613": "UGT2B7 substrates with narrow therapeutic index"}, {"/categories/DBCAT000732": "Valerates"}]}, "1310012F0": {"Conditions": [{"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0025273": "Mild Atopic dermatitis"}, {"/indications/DBCOND0106246": "Mild Dermatitis caused by Staphylococcus aureusis"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0106245": "Moderate Dermatitis caused by Staphylococcus aureusis"}], "Name": "Fusidic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT001504": "Cholestadienes"}, {"/categories/DBCAT001503": "Cholestadienols"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003765": "Other Miscellaneous Antibacterial Agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002542": "Steroid Antibacterials"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0606020V0": {"Conditions": [{"/indications/DBCOND0028830": "Bone Metastases"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0038793": "Paget's Disease"}], "Name": "Zoledronic Acid", "Categories": [{"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}]}, "1001010D0": {"Conditions": [{"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Diflunisal", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003965": "UGT1A9 Inhibitors"}]}, "0302000U0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Ciclesonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "1501070F0": {"Conditions": [{"/indications/DBCOND0024482": "Sedation caused by benzodiazepine"}], "Name": "Flumazenil", "Categories": [{"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003432": "Benzodiazepine Antagonist"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000367": "Protective Agents"}]}, "0407020E0": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}], "Name": "Dextropropoxyphene", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002316": "Diphenylpropylamine Derivatives"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0902021N0": {"Conditions": [{"/indications/DBCOND0015839": "Hypokalaemia"}], "Name": "Potassium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002463": "Potassium"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "1202020H0": {"Conditions": [{"/indications/DBCOND0023338": "Eye redness"}, {"/indications/DBCOND0059607": "Nasal Stuffiness"}], "Name": "Naphazoline Nitrate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000538": "Adrenergic alpha-1 Receptor Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000818": "Nasal Decongestants"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002352": "Sympathomimetics Used as Decongestants"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0801050Y0": {"Conditions": [{"/indications/DBCOND0032665": "Advanced Melanoma"}, {"/indications/DBCOND0046976": "Glioblastoma Multiforme (GBM)"}, {"/indications/DBCOND0041025": "Primary Central Nervous System Lymphoma (PCNSL)"}, {"/indications/DBCOND0078241": "Refractory Ewing Sarcoma"}, {"/indications/DBCOND0047201": "Refractory Neuroblastoma"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0024429": "Advanced Neuroendocrine tumor"}, {"/indications/DBCOND0024423": "Refractory Anaplastic astrocytoma"}, {"/indications/DBCOND0024424": "Refractory, advanced Mycosis fungoides"}, {"/indications/DBCOND0089470": "Refractory, advanced Sezary Syndrome"}], "Name": "Temozolomide", "Categories": [{"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004985": "Dacarbazine"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001163": "Triazenes"}]}, "1310012P0": {"Conditions": [{"/indications/DBCOND0014786": "Acinetobacter infection"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0024177": "Entamoebic histolytica infection"}, {"/indications/DBCOND0026355": "Escherichia infections"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0032133": "Klebsiella Infections"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0051354": "Neisseria Gonorrhoeae Infection"}, {"/indications/DBCOND0024179": "Ornithosis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0077433": "Severe Acne"}, {"/indications/DBCOND0033039": "Shigella Infection"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0089467": "Skin infection caused by Staphylococcus aureus"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0025276": "Bacterial upper respiratory tract infections"}, {"/indications/DBCOND0024183": "Clostridia infections"}], "Name": "Tetracycline Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004752": "Tetracycline, antagonists & inhibitors"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "1001030A0": {"Conditions": [{"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Auranofin", "Categories": [{"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT001222": "Aurothioglucose"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003194": "Gold Compounds"}, {"/categories/DBCAT002492": "Gold Preparations"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001223": "Organogold Compounds"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT002476": "Specific Antirheumatic Agents"}]}, "1310020F0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}], "Name": "Benzoyl Peroxide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT002029": "Peroxides"}]}, "0304020X0": {"Conditions": [{"/indications/DBCOND0034097": "Chronic Idiopathic Urticaria"}, {"/indications/DBCOND0034141": "Moderate Asthma"}, {"/indications/DBCOND0039302": "Severe Asthma"}], "Name": "Omalizumab", "Categories": [{"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT003256": "Anti-IgE"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004419": "Decreased IgE Activity"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT004420": "IgE-directed Antibody Interactions"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0204000T0": {"Conditions": [{"/indications/DBCOND0000496": "Atrial Flutter"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0025284": "Severe ventricular arrhythmias"}], "Name": "Sotalol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT004094": "Cardiac Rhythm Alteration"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000485": "Sympatholytics"}]}, "0402010Q0": {"Conditions": [{"/indications/DBCOND0018735": "Depression"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0106094": "Moderate Agitation"}, {"/indications/DBCOND0106093": "Moderate Anxiety"}, {"/indications/DBCOND0106185": "Moderate Depressed mood"}, {"/indications/DBCOND0023114": "Severe Anxiety"}, {"/indications/DBCOND0106184": "Severe Depressed mood"}, {"/indications/DBCOND0021212": "Severe Nausea and vomiting"}, {"/indications/DBCOND0102779": "Severe agitation"}], "Name": "Perphenazine", "Categories": [{"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002373": "Phenothiazines With Piperazine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1003020Z0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0020934": "Tendinitis"}], "Name": "Indometacin", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0702010G0": {"Conditions": [{"/indications/DBCOND0001269": "Atrophic Vaginitis"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0022319": "Advanced androgen dependent Prostate cancer"}], "Name": "Estradiol", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002429": "Androgens and Estrogens"}, {"/categories/DBCAT002464": "Antiandrogens and Estrogens"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001293": "Estradiol"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT004753": "Estradiol, agonists"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004754": "Estrogens, agonists"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002465": "Intravaginal Contraceptives"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0503032F0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}, {"/indications/DBCOND0024500": "Chronic hepatitis C genotype 5"}, {"/indications/DBCOND0023526": "Genotype 6 chronic hepatitis C infection"}], "Name": "Sofosbuvir/Ledipasvir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003504": "Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT000292": "Nucleotides"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000913": "Pyrimidine Nucleotides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000291": "Ribonucleotides"}, {"/categories/DBCAT004208": "RNA Replicase Inhibitors"}, {"/categories/DBCAT001520": "Uracil Nucleotides"}, {"/categories/DBCAT001919": "Uridine Monophosphate"}]}, "0109010G0": {"Conditions": [{"/indications/DBCOND0023938": "Radiolucent Cholesterol gallstones"}], "Name": "Chenodeoxycholic Acid", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002534": "Bile Acid Preparations"}, {"/categories/DBCAT004599": "Bile acids and derivatives"}, {"/categories/DBCAT001384": "Bile Acids and Salts"}, {"/categories/DBCAT002536": "Bile and Liver Therapy"}, {"/categories/DBCAT002535": "Bile Therapy"}, {"/categories/DBCAT001383": "Cholanes"}, {"/categories/DBCAT001382": "Cholic Acids"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT001381": "Deoxycholic Acid"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}]}, "1304000H0": {"Conditions": [{"/indications/DBCOND0031682": "Dermatitis, Allergic Contact"}, {"/indications/DBCOND0057011": "Dermatitis, Eczematous"}], "Name": "Clobetasone Butyrate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001828": "Ointments"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "1309000I0": {"Conditions": [{"/indications/DBCOND0000148": "Blastomycosis"}, {"/indications/DBCOND0022874": "Chromomycosis"}, {"/indications/DBCOND0048700": "Chronic Mucocutaneous Candidiasis (CMC)"}, {"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0063178": "Endogenous Cushing's Syndrome"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0000150": "Paracoccidioidomycosis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}, {"/indications/DBCOND0045797": "Systemic Candidiasis"}, {"/indications/DBCOND0121746": "Tinea Corporis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121745": "Tinea Corporis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121744": "Tinea Corporis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121742": "Tinea Cruris caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121741": "Tinea Cruris caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121740": "Tinea Cruris caused by Trichophyton rubrum"}, {"/indications/DBCOND0121749": "Tinea Pedis caused by Epidermophyton floccosumin"}, {"/indications/DBCOND0121748": "Tinea Pedis caused by Trichophyton mentagrophytes"}, {"/indications/DBCOND0121747": "Tinea Pedis caused by Trichophyton rubrum"}, {"/indications/DBCOND0121738": "Cutaneous candidiasis caused by candida spp."}, {"/indications/DBCOND0121750": "Recalcitrant Dermatophytosis"}, {"/indications/DBCOND0121736": "Tinea versicolor caused by Malassezia infection"}], "Name": "Ketoconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002616": "Cytochrome P-450 CYP2A6 Inhibitors (moderate)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT003801": "Cytochrome P-450 CYP3A7 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004187": "Cytochrome P450 3A5 Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}]}, "0503022D0": {"Conditions": [{"/indications/DBCOND0075539": "CMV Infections"}, {"/indications/DBCOND0022602": "CMV colitis"}, {"/indications/DBCOND0000283": "Cytomegalovirus Retinitis"}, {"/indications/DBCOND0025048": "Cytomegalovirus gastroesophagitis"}, {"/indications/DBCOND0022605": "Varicella-zoster Progressive outer retinal necrosis"}, {"/indications/DBCOND0022600": "Acute Herpetic keratitis"}, {"/indications/DBCOND0025216": "Cytomegalovirus neurological disease"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Ganciclovir", "Categories": [{"/categories/DBCAT004570": "Acyclovir"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003339": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004762": "Ganciclovir"}, {"/categories/DBCAT002865": "Ganciclovir and prodrug"}, {"/categories/DBCAT001027": "Guanine"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT003306": "Nucleoside Analog Antiviral"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT002190": "Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0411000F0": {"Conditions": [{"/indications/DBCOND0050184": "Dementia Alzheimer's Type"}, {"/indications/DBCOND0060453": "Dementias"}, {"/indications/DBCOND0037266": "Diffuse Lewy Body Disease"}, {"/indications/DBCOND0046569": "Mild Dementia"}], "Name": "Galantamine", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT001051": "Amaryllidaceae Alkaloids"}, {"/categories/DBCAT002344": "Anti-Dementia Drugs"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000278": "Nootropic Agents"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1203030M0": {"Conditions": [{"/indications/DBCOND0029450": "Postherpetic Neuralgia"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Lidocaine Hydrochloride", "Categories": [{"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT003317": "Amide Local Anesthetic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002281": "Analgesics and Anesthetics"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT002279": "Anesthetics for Topical Use"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002278": "Antiarrhythmics, Class Ib"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004115": "Local Anesthesia"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004617": "Neuraxial Anesthetics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0504060B0": {"Conditions": [{"/indications/DBCOND0105297": "Chagas' Disease caused by Typanosoma cruzi"}], "Name": "Benznidazole", "Categories": [{"/categories/DBCAT002322": "Agents Against Leishmaniasis and Trypanosomiasis"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000955": "Mutagens"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001101": "Trypanocidal Agents"}]}, "110802050": {"Conditions": [{"/indications/DBCOND0004515": "Heartburn"}], "Name": "Sodium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001532": "Buffers"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT002728": "Citric Acid Derivatives"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT001548": "Food Preservatives"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003770": "Miscellaneous Anticoagulants"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0601021X0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Tolbutamide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002094": "Diagnostic Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000841": "Sulfonylurea Compounds"}, {"/categories/DBCAT002233": "Sulfonylureas"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002510": "Tests for Diabetes"}, {"/categories/DBCAT000635": "Urea"}]}, "0604011K0": {"Conditions": [{"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0031473": "Heavy Menstrual Bleeding"}, {"/indications/DBCOND0106455": "Advanced Hormone-dependent prostate cancer"}, {"/indications/DBCOND0106451": "Moderate Menopausal Vasomotor Symptoms"}, {"/indications/DBCOND0106454": "Moderate menopausal vulvovaginal atrophy"}, {"/indications/DBCOND0106450": "Severe Menopausal Vasomotor Symptoms"}, {"/indications/DBCOND0106453": "Severe menopausal vulvovaginal atrophy"}], "Name": "Estradiol Valerate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT001293": "Estradiol"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT004753": "Estradiol, agonists"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT003006": "Estrogen Contraceptives"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0902011U0": {"Conditions": [{"/indications/DBCOND0015839": "Hypokalaemia"}], "Name": "Potassium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT002463": "Potassium"}, {"/categories/DBCAT001113": "Potassium Compounds"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "0407041R0": {"Conditions": [{"/indications/DBCOND0025093": "Migraine with acute onset aura"}, {"/indications/DBCOND0025332": "Acute Migraine without aura"}], "Name": "Rizatriptan", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT001190": "Migraine Disorders"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}]}, "0104020L0": {"Conditions": [{"/indications/DBCOND0089496": "Chronic Functional Diarrhea"}, {"/indications/DBCOND0024414": "Intestinal stoma leak"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0102291": "Severe or persistent diarrhea"}], "Name": "Loperamide Hydrochloride", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT001158": "Antidiarrheals"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002293": "Antipropulsives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0301020Q0": {"Conditions": [{"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Tiotropium", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000535": "Parasympatholytics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000888": "Scopolamine Derivatives"}, {"/categories/DBCAT000602": "Tropanes"}]}, "0403020M0": {"Conditions": [{"/indications/DBCOND0024196": "Exogenous depression"}, {"/indications/DBCOND0021660": "Neurotic depression"}, {"/indications/DBCOND0022312": "Atypical Depressive disorder"}], "Name": "Phenelzine Sulfate", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000469": "Hydrazines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002461": "Monoamine Oxidase Inhibitors, Non-Selective"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0501040C0": {"Conditions": [{"/indications/DBCOND0047809": "Bacterial Sepsis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0009899": "Endophthalmitis"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0014184": "Infective pulmonary exacerbation of cystic fibrosis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0030048": "Lung Infection"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0013995": "Mycobacterium avium complex infection"}, {"/indications/DBCOND0042236": "Neonatal Sepsis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0079683": "Respiratory Tract Infection Bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0023282": "Hospital-acquired bacterial pneumonia"}, {"/indications/DBCOND0023151": "Minor burns"}, {"/indications/DBCOND0080530": "Severe Bacterial Infections"}, {"/indications/DBCOND0020905": "Severe Urinary tract infection"}], "Name": "Amikacin", "Categories": [{"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000915": "Kanamycin"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}]}, "0803020H0": {"Conditions": [{"/indications/DBCOND0005025": "Amenorrhea"}, {"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0030098": "Metastatic Renal Cell Carcinoma"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0021883": "Metastatic Endometrial carcinoma"}], "Name": "Medroxyprogesterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT000829": "Corpus Luteum Hormones"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000991": "Hydroxyprogesterones"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000993": "Medroxyprogesterone"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002358": "Pregnen (4) Derivatives"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000992": "Progesterone and Derivatives"}, {"/categories/DBCAT000686": "Progesterone Congeners"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0311010B0": {"Conditions": [{"/indications/DBCOND0093824": "Mild Idiopathic Pulmonary Fibrosis"}, {"/indications/DBCOND0093823": "Moderate Idiopathic Pulmonary Fibrosis"}], "Name": "Pirfenidone", "Categories": [{"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT003767": "Antifibrotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001044": "Pyridones"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0501070K0": {"Conditions": [{"/indications/DBCOND0118557": "Bacteremia caused by Enterobacter aerogenes"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0020932": "Bacterial eye infection"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0014631": "Klebsiella bacteraemia"}, {"/indications/DBCOND0020991": "Meningitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Polymyxin B Sulfate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT003403": "Polymyxin-class Antibacterial"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0209000U0": {"Conditions": [{"/indications/DBCOND0032387": "Stent Thrombosis"}, {"/indications/DBCOND0085133": "Strokes"}], "Name": "Ticlopidine Hydrochloride", "Categories": [{"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002640": "Cytochrome P-450 CYP2C19 Inhibitors (moderate)"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT003038": "Cytochrome P-450 CYP2C9 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000531": "Purinergic P2 Receptor Antagonists"}, {"/categories/DBCAT000532": "Purinergic P2Y Receptor Antagonists"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000530": "Thienopyridines"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "0205010J0": {"Conditions": [{"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0086660": "Hypertension,Essential"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}, {"/indications/DBCOND0058109": "Severe Hypertension"}], "Name": "Hydralazine Hydrochloride", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT004240": "Arteriolar Vasodilation"}, {"/categories/DBCAT003332": "Arteriolar Vasodilator"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002851": "Hydralazine"}, {"/categories/DBCAT002524": "Hydrazinophthalazine Derivatives"}, {"/categories/DBCAT002525": "Hydrazinophthalazine Derivatives and Diuretics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT001325": "Phthalazines"}, {"/categories/DBCAT001326": "Pyridazines"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1305020W0": {"Conditions": [{"/indications/DBCOND0033035": "Hyperparathyroidism, Secondary"}, {"/indications/DBCOND0020582": "Hypocalcemia"}, {"/indications/DBCOND0016488": "Osteodystrophy"}, {"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0057073": "Vitamin D Resistant Rickets"}], "Name": "Calcitriol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002153": "Antipsoriatics for Topical Use"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT004713": "Calcitriol"}, {"/categories/DBCAT004714": "Calcitriol, antagonists & inhibitors"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0408010H0": {"Conditions": [{"/indications/DBCOND0043509": "Acute Bipolar Depression"}, {"/indications/DBCOND0030095": "Bipolar I Disorder"}, {"/indications/DBCOND0021688": "Generalized seizure"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0023494": "Primary Generalized tonic-clonic seizure"}], "Name": "Lamotrigine", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT000922": "Triazines"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "1902070S0": {"Conditions": [{"/indications/DBCOND0024718": "Toxic effect of hydrocyanic acid and cyanides"}], "Name": "Sodium Thiosulfate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT001036": "Sulfates"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001037": "Sulfuric Acids"}]}, "0503010R0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Saquinavir Mesylate", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003808": "Cytochrome P-450 CYP3A5 Inhibitors (strong)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT004497": "Cytochrome P-450 CYP3A7 Inhibitors (weak)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "0401020K0": {"Conditions": [{"/indications/DBCOND0033368": "Alcohol Withdrawal Syndrome(AWS)"}, {"/indications/DBCOND0027904": "Anxiety Disorders"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0032649": "Refractory Epilepsy"}, {"/indications/DBCOND0022505": "Refractory seizure disorders"}, {"/indications/DBCOND0024404": "Skeletal muscle spasm"}], "Name": "Diazepam", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000563": "Anesthetics, General"}, {"/categories/DBCAT000683": "Anesthetics, Intravenous"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1002020Y0": {"Conditions": [{"/indications/DBCOND0021346": "Anorexia, weight loss, AIDS"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}], "Name": "Dronabinol/Cannabidiol", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT002342": "Antiemetics and Antinauseants"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000909": "Cannabinoid Receptor Agonists"}, {"/categories/DBCAT002709": "Cannabinoids and similars"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000908": "Hallucinogens"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003691": "Miscellaneous Antiemetics"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0205020J0": {"Conditions": [{"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0020044": "Hypertensive crisis"}], "Name": "Methyldopate Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT000464": "Dihydroxyphenylalanine"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT000485": "Sympatholytics"}, {"/categories/DBCAT000465": "Tyrosine"}]}, "0901030M0": {"Conditions": [{"/indications/DBCOND0061539": "Atypical Hemolytic Uremic Syndrome (aHUS)"}, {"/indications/DBCOND0055334": "Neuromyelitis Optica Spectrum Disorder"}, {"/indications/DBCOND0079913": "Paroxysmal Nocturnal Haemoglobinuria (PNH)"}], "Name": "Eculizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT001769": "Complement Inactivating Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0501040U0": {"Conditions": [{"/indications/DBCOND0020977": "Cystic fibrosis, Pseudomonas aeruginosa infection"}, {"/indications/DBCOND0009894": "Eye infection bacterial"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0022159": "Septicemia gram-negative"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0112044": "Recurrent Complicated Urinary Tract Infection"}, {"/indications/DBCOND0106159": "Steroid-responsive inflammation"}], "Name": "Tobramycin", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000915": "Kanamycin"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT001066": "Nebramycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0603020T0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0068835": "Acute Exacerbation of Chronic Obstructive Pulmonary Disease"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0005683": "Aspergillosis, Allergic Bronchopulmonary"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0037423": "Bell's Palsy"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0026236": "Corneal injuries"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0009942": "Cyclitis"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0022084": "Exacerbation of asthma"}, {"/indications/DBCOND0076158": "Herpes Zoster Keratitis"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0055123": "Hypersensitivity Pneumonitis"}, {"/indications/DBCOND0031843": "Idiopathic Pulmonary Fibrosis (IPF)"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0027895": "Pneumonia, Aspiration"}, {"/indications/DBCOND0027942": "Pneumonia, Pneumocystis Carinii"}, {"/indications/DBCOND0002208": "Polymyalgia Rheumatica"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0030946": "Rejection, Transplant"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0073800": "Secondary Adrenal Insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0043409": "Sj\u00f6gren's Syndrome"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0022388": "Superficial punctate keratitis"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0013289": "Vasculitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0024958": "Idiopathic Bronchiolitis obliterans with organizing pneumonia"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021956": "Primary adrenocoritical insufficiency"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0024953": "Severe Seborrhoeic dermatitis"}, {"/indications/DBCOND0022384": "Severe alcoholic liver disease"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Prednisolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0501021D0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0047809": "Bacterial Sepsis"}, {"/indications/DBCOND0025366": "Bacterial Urinary Tract Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014280": "CNS ventriculitis"}, {"/indications/DBCOND0055550": "Central Nervous System Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0024946": "Gonococcal arthritis"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000208": "Lyme Neuroborreliosis"}, {"/indications/DBCOND0014778": "Meningitis bacterial"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}], "Name": "Cefotaxime Sodium", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000567": "Cephacetrile"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "0501070Y0": {"Conditions": [{"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0020467": "Right-sided Infective pericarditis"}], "Name": "Daptomycin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT003619": "Cyclic Lipopeptides"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003272": "Lipopeptide Antibacterial"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "1304000Z0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0403040B0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0029996": "Seasonal Affective Disorder (SAD)"}], "Name": "Bupropion Hydrochloride", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003429": "Aminoketone"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000440": "Dopamine Uptake Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004066": "Increased Dopamine Activity"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003624": "Miscellaneous Antidepressants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001282": "Propiophenones"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT004978": "Smoking Cessation Agents"}]}, "0901030S0": {"Conditions": [{"/indications/DBCOND0112590": "Anemia caused by Zidovudine"}, {"/indications/DBCOND0031070": "Anemias"}], "Name": "Epoetin Theta", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT004684": "Erythropoietin, genetics"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0301040R0": {"Conditions": [{"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0003949": "Hyperkalemia"}], "Name": "Salbutamol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "0402020V0": {"Conditions": [{"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Pipotiazine Palmitate", "Categories": [{"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002446": "Phenothiazines With Piperidine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0603020B0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1304000T0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}], "Name": "Fludroxycortide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "0405020E0": {"Conditions": [{"/indications/DBCOND0052669": "Exogenous Obesity"}], "Name": "Diethylpropion Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000431": "Amphetamines"}, {"/categories/DBCAT000472": "Anti-Obesity Agents"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000473": "Appetite Depressants"}, {"/categories/DBCAT004277": "Appetite Suppression"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT004278": "Increased Sympathetic Activity"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT002730": "Stimulants"}, {"/categories/DBCAT003292": "Sympathomimetic Amine Anorectic"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0409010S0": {"Conditions": [{"/indications/DBCOND0053495": "Parkinson's Disease (PD)"}], "Name": "Tolcapone", "Categories": [{"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000719": "Benzophenones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002655": "COMT Inhibitors"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT001591": "Nitrophenols"}, {"/categories/DBCAT000420": "Phenols"}]}, "0304010I0": {"Conditions": [{"/indications/DBCOND0034097": "Chronic Idiopathic Urticaria"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0058495": "Respiratory Allergy"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Cetirizine Hydrochloride", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002325": "Piperazine Derivatives"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0202010T0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Methyclothiazide", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000575": "Benzothiadiazines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000576": "Thiazides"}]}, "0803042V0": {"Conditions": [{"/indications/DBCOND0112676": "Nonmetastatic Prostate Cancer"}], "Name": "Apalutamide", "Categories": [{"/categories/DBCAT002554": "Antiandrogens"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT002641": "Cytochrome P-450 CYP2C19 Inducers (strong)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT003039": "Cytochrome P-450 CYP2C9 Inducers (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT002137": "Hormone Antagonists and Related Agents"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003933": "OATP1B1/SLCO1B1 Inducers"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002819": "Prostatic Neoplasms, drug therapy"}]}, "2012": {"Conditions": [{"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Swabs", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT001183": "Solvents"}]}, "0301030H0": {"Conditions": [{"/indications/DBCOND0020847": "Bronchoconstriction"}], "Name": "Choline Theophyllinate", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT003651": "Respiratory Smooth Muscle Relaxants"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000264": "Trimethyl Ammonium Compounds"}, {"/categories/DBCAT001034": "Xanthine derivatives"}, {"/categories/DBCAT002274": "Xanthines and Adrenergics"}]}, "1001040P0": {"Conditions": [{"/indications/DBCOND0004938": "Hyperuricemia"}, {"/indications/DBCOND0033514": "Platelet Aggregation"}], "Name": "Sulfinpyrazone", "Categories": [{"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001278": "Phenylbutazone"}, {"/categories/DBCAT002493": "Preparations Increasing Uric Acid Excretion"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT001145": "Pyrazolones"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT001241": "Uricosuric Agents"}]}, "0703022M0": {"Conditions": [{"/indications/DBCOND0005025": "Amenorrhea"}, {"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001317": "Endometrial Hyperplasia"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0030098": "Metastatic Renal Cell Carcinoma"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}, {"/indications/DBCOND0021883": "Metastatic Endometrial carcinoma"}], "Name": "Medroxyprogesterone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT000829": "Corpus Luteum Hormones"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000991": "Hydroxyprogesterones"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000993": "Medroxyprogesterone"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002358": "Pregnen (4) Derivatives"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000992": "Progesterone and Derivatives"}, {"/categories/DBCAT000686": "Progesterone Congeners"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0304010G0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0022511": "Upper respiratory symptoms"}], "Name": "Chlorphenamine Maleate", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT001157": "Pheniramine"}, {"/categories/DBCAT003731": "Propylamine Derivatives"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT002362": "Substituted Alkylamines"}]}, "1202010A0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}], "Name": "Azelastine Hydrochloride", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003036": "Cytochrome P-450 CYP2E1 Inhibitors (weak)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT000422": "Lipoxygenase Inhibitors"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT001326": "Pyridazines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0202010F0": {"Conditions": [{"/indications/DBCOND0036164": "Calcium Nephrolithiasis"}], "Name": "Chlortalidone", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000719": "Benzophenones"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002299": "Low-Ceiling Diuretics, Excl. Thiazides"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT000723": "Phthalic Acids"}, {"/categories/DBCAT000722": "Phthalimides"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003322": "Thiazide-like Diuretic"}]}, "1203020C0": {"Conditions": [{"/indications/DBCOND0000138": "Coccidioidomycosis"}, {"/indications/DBCOND0000141": "Histoplasmosis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0030131": "Invasive Fungal Infections"}, {"/indications/DBCOND0013913": "Leishmaniasis"}, {"/indications/DBCOND0000139": "Meningitis, Cryptococcal"}, {"/indications/DBCOND0073780": "Meningitis, Fungal"}, {"/indications/DBCOND0051127": "Mucocutaneous Leishmaniasis"}, {"/indications/DBCOND0021843": "Penicillium marneffei infection"}, {"/indications/DBCOND0033119": "Visceral Leishmaniasis"}, {"/indications/DBCOND0022121": "Candidal cystitis"}, {"/indications/DBCOND0022118": "Disseminated Cryptococcosis"}, {"/indications/DBCOND0022122": "Fungal endophthalmitis"}, {"/indications/DBCOND0022119": "Fungal osteoarticular infections"}, {"/indications/DBCOND0022123": "Ocular aspergillosis"}, {"/indications/DBCOND0025294": "Refractory aspergillosis"}, {"/indications/DBCOND0022131": "Severe Coccidioidomycosis"}, {"/indications/DBCOND0022126": "Severe Cryptococcosis"}, {"/indications/DBCOND0022140": "Severe Fungal infection caused by Basidiobolus spp."}, {"/indications/DBCOND0022137": "Severe Fungal infection caused by Conidiobolus spp."}, {"/indications/DBCOND0022143": "Severe Fungal infection caused by sporotrichosis spp."}, {"/indications/DBCOND0022132": "Severe Histoplasmosis"}, {"/indications/DBCOND0022144": "Severe Mucocutaneous leishmaniasis"}, {"/indications/DBCOND0022128": "Severe North American blastomycosis"}, {"/indications/DBCOND0022130": "Severe Systemic candidiasis"}], "Name": "Amphotericin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001054": "Biomimetic Materials"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000064": "Drug Carriers"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT001062": "Investigative Techniques"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003390": "Lipid-based Polyene Antifungal"}, {"/categories/DBCAT001064": "Liposomes"}, {"/categories/DBCAT000983": "Membranes, Artificial"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0106060A0": {"Conditions": [{"/indications/DBCOND0038981": "Opioid Induced Constipation (OIC)"}], "Name": "Methylnaltrexone Bromide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT001081": "Naloxone"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002566": "Peripheral Opioid Receptor Antagonists"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0212000L0": {"Conditions": [{"/indications/DBCOND0022961": "Fredrickson type IIb hyperlipidemia"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0040848": "Homozygous Sitosterolemia"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}], "Name": "Ezetimibe", "Categories": [{"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT001211": "Azetidines"}, {"/categories/DBCAT001212": "Azetines"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004477": "Decreased Cholesterol Absorption"}, {"/categories/DBCAT003418": "Dietary Cholesterol Absorption Inhibitor"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "1902070A0": {"Conditions": [{"/indications/DBCOND0047315": "Acetaminophen Overdose"}], "Name": "Acetylcysteine", "Categories": [{"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000246": "Amino Acids, Neutral"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000247": "Amino Acids, Sulfur"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003463": "Antidote for Acetaminophen Overdose"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000315": "Cysteine"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000864": "Free Radical Scavengers"}, {"/categories/DBCAT004189": "Increased Glutathione Concentration"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT004190": "Reduction Activity"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0803043N0": {"Conditions": [{"/indications/DBCOND0000951": "Acromegaly"}, {"/indications/DBCOND0080526": "Metastatic Carcinoid Tumors"}, {"/indications/DBCOND0020531": "Profuse watery diarrhea"}], "Name": "Octreotide Acetate", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002136": "Somatostatin and Analogues"}, {"/categories/DBCAT004140": "Somatostatin Receptor Agonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0704020AA": {"Conditions": [{"/indications/DBCOND0035149": "Back Pain Lower Back Chronic"}, {"/indications/DBCOND0070113": "Chemotherapy-induced Peripheral Neuropathy (CIPN)"}, {"/indications/DBCOND0033876": "Chronic Musculoskeletal Pain"}, {"/indications/DBCOND0049986": "Diabetic Peripheral Neuropathy (DPN)"}, {"/indications/DBCOND0002221": "Fibromyalgia"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0066726": "Stress Urinary Incontinence (SUI)"}], "Name": "Duloxetine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002715": "Serotonin and Noradrenaline Reuptake Inhibitors"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "0704020AC": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Darifenacin Hydrobromide", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0704020AB": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Solifenacin", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT002330": "Drugs Used in Benign Prostatic Hypertrophy"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000905": "Quinuclidines"}, {"/categories/DBCAT001295": "Tetrahydroisoquinolines"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0704020AE": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Mirabegron", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT001740": "Adrenergic beta-3 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003777": "Selective Beta 3-adrenergic Agonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0704020AD": {"Conditions": [{"/indications/DBCOND0001419": "Urinary Bladder, Overactive"}], "Name": "Fesoterodine Fumarate", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002216": "Drugs for Urinary Frequency and Incontinence"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000517": "Urological Agents"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0105010E0": {"Conditions": [{"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0024827": "Polyarticular juvenile rheumatoid arthritis, chronic or unspecified"}, {"/indications/DBCOND0011080": "Proctitis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0022617": "Mild Ulcerative Colitis"}, {"/indications/DBCOND0020388": "Moderate Ulcerative colitis"}], "Name": "Sulfasalazine", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT003404": "Aminosalicylate"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1501080B0": {"Conditions": [{"/indications/DBCOND0004999": "Malignant Hyperthermia"}, {"/indications/DBCOND0020611": "Spasticity"}], "Name": "Dantrolene Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002520": "Dantrolene and Derivatives"}, {"/categories/DBCAT004296": "Decreased Striated Muscle Contraction"}, {"/categories/DBCAT004297": "Decreased Striated Muscle Tone"}, {"/categories/DBCAT003756": "Direct-acting Skeletal Muscle Relaxants"}, {"/categories/DBCAT000612": "Hydantoins"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT000613": "Imidazolidines"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000187": "Neuromuscular Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}]}, "0606020A0": {"Conditions": [{"/indications/DBCOND0002088": "Osteogenesis Imperfecta"}, {"/indications/DBCOND0015928": "Osteoporosis"}, {"/indications/DBCOND0022002": "Osteoporosis caused by glucocorticoid"}, {"/indications/DBCOND0038793": "Paget's Disease"}], "Name": "Alendronic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}]}, "0502040C0": {"Conditions": [{"/indications/DBCOND0000135": "Candidemia"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0096402": "Intra-abdominal abscesses"}, {"/indications/DBCOND0022124": "Invasive, refractory Aspergillosis"}, {"/indications/DBCOND0021483": "Pleural space infections"}], "Name": "Caspofungin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003336": "Echinocandin Antifungal"}, {"/categories/DBCAT003671": "Echinocandins"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "0205052Q0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Telmisartan", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT004595": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"}, {"/categories/DBCAT004593": "Angiotensin II receptor blockers (ARBs) and diuretics"}, {"/categories/DBCAT004594": "Angiotensin II receptor blockers (ARBs), plain"}, {"/categories/DBCAT000409": "Angiotensin II Type 1 Receptor Blockers"}, {"/categories/DBCAT001168": "Angiotensin II Type 2 Receptor Blockers"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT001053": "Biphenyl Compounds"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "1201010Q0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106167": "Fulminating Pulmonary Tuberculosis"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Hydrocortisone", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0701010T0": {"Conditions": [{"/indications/DBCOND0015046": "Abortion induced incomplete"}, {"/indications/DBCOND0024295": "Inevitable abortion"}, {"/indications/DBCOND0053150": "Postpartum Bleeding"}], "Name": "Oxytocin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004294": "Increased Uterine Smooth Muscle Contraction or Tone"}, {"/categories/DBCAT004295": "Oxytocin"}, {"/categories/DBCAT002139": "Oxytocin and Analogues"}, {"/categories/DBCAT004704": "Oxytocin, analogs & derivatives"}, {"/categories/DBCAT004703": "Oxytocin, antagonists & inhibitors"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT000096": "Pituitary Hormones"}, {"/categories/DBCAT000112": "Pituitary Hormones, Posterior"}, {"/categories/DBCAT002109": "Posterior Pituitary Lobe Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT000218": "Uterotonic agents"}]}, "0406000J0": {"Conditions": [{"/indications/DBCOND0031743": "Diabetic Gastroparesis"}, {"/indications/DBCOND0039183": "Gastrointestinal Symptoms"}, {"/indications/DBCOND0025455": "Upper gastrointestinal motility disorders"}], "Name": "Domperidone", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003753": "Prokinetic Agents"}, {"/categories/DBCAT002422": "Propulsives"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0802030G0": {"Conditions": [{"/indications/DBCOND0041114": "Refractory Follicular Lymphoma"}, {"/indications/DBCOND0023512": "Previously untreated Chronic lymphocytic leukemia"}], "Name": "Obinutuzumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000175": "Antigens, CD20"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004203": "CD20-directed Antibody Interactions"}, {"/categories/DBCAT003269": "CD20-directed Cytolytic Antibody"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "1003020G0": {"Conditions": [{"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0021344": "Backache"}, {"/indications/DBCOND0033437": "Bruises"}, {"/indications/DBCOND0026745": "Muscle pains"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0005372": "Sunburn"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0023151": "Minor burns"}, {"/indications/DBCOND0094888": "Skin rashes"}], "Name": "Camphor", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT003726": "Basic Lotions and Liniments"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT001420": "Bornanes"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT001046": "Monoterpenes"}, {"/categories/DBCAT001045": "Norbornanes"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001604": "Plant Extracts"}, {"/categories/DBCAT001210": "Plant Preparations"}, {"/categories/DBCAT000366": "Terpenes"}]}, "0304010Z0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0021183": "Mild Angioedema"}, {"/indications/DBCOND0024139": "Mild urticaria"}, {"/indications/DBCOND0106116": "Upper respiratory discomfort"}], "Name": "Triprolidine Hydrochloride", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1108010K0": {"Conditions": [{"/indications/DBCOND0001193": "Corneal Edema"}, {"/indications/DBCOND0003946": "Dehydration"}, {"/indications/DBCOND0030819": "Hyponatremias"}, {"/indications/DBCOND0023682": "Nasal irritation"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023348": "Hypochloremic state"}], "Name": "Sodium Chloride", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001114": "Chlorides"}, {"/categories/DBCAT000942": "Chlorine Compounds"}, {"/categories/DBCAT003618": "Diluents"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001115": "Hydrochloric Acid"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT002589": "Sodium"}, {"/categories/DBCAT001355": "Sodium Compounds"}]}, "0906040C0": {"Conditions": [{"/indications/DBCOND0033035": "Hyperparathyroidism, Secondary"}, {"/indications/DBCOND0020582": "Hypocalcemia"}, {"/indications/DBCOND0016488": "Osteodystrophy"}, {"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0057073": "Vitamin D Resistant Rickets"}], "Name": "Calcitriol", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002154": "Antipsoriatics"}, {"/categories/DBCAT002153": "Antipsoriatics for Topical Use"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT004713": "Calcitriol"}, {"/categories/DBCAT004714": "Calcitriol, antagonists & inhibitors"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000308": "Cholestanes"}, {"/categories/DBCAT000307": "Cholestenes"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000313": "Membrane Lipids"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000311": "Secosteroids"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000312": "Sterols"}, {"/categories/DBCAT002152": "Vitamin D and Analogues"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "0602010Z0": {"Conditions": [{"/indications/DBCOND0009036": "Hypothyroidism"}, {"/indications/DBCOND0020856": "Myxedema coma"}, {"/indications/DBCOND0020853": "Euthyroid Goitre"}, {"/indications/DBCOND0021309": "Thyrotropin dependent Thyroid cancer"}], "Name": "Levothyroxine Sodium & Liothyronine", "Categories": [{"/categories/DBCAT004965": "Agents used to treat hypothyroidism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}]}, "1001022K0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Methylprednisolone Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001203": "Methylprednisolone"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "1002010K0": {"Conditions": [{"/indications/DBCOND0002242": "Muscle Weakness"}], "Name": "Guanidine Hydrochloride", "Categories": [{"/categories/DBCAT003369": "Acetylcholine Releasing Agent"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT004421": "Increased Acetylcholine Activity"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT004525": "MATE 1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT004526": "MATE 2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}]}, "0801020K0": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0035254": "Acute Myeloblastic Leukemia"}, {"/indications/DBCOND0050728": "Advanced Endometrial Cancer"}, {"/indications/DBCOND0060596": "Advanced Soft Tissue Sarcoma"}, {"/indications/DBCOND0017114": "Bladder transitional cell carcinoma"}, {"/indications/DBCOND0031061": "Carcinoma, Bronchogenic"}, {"/indications/DBCOND0033196": "Gastric Carcinoma"}, {"/indications/DBCOND0039252": "Kaposi's Sarcoma AIDS Related"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0032184": "Neuroblastomas"}, {"/indications/DBCOND0068543": "Ovarian Cancer Metastatic"}, {"/indications/DBCOND0030071": "Ovarian Carcinoma"}, {"/indications/DBCOND0074861": "Sarcoma, Bone"}, {"/indications/DBCOND0001518": "Sezary Syndrome"}, {"/indications/DBCOND0056871": "Soft Tissue Sarcoma (STS)"}, {"/indications/DBCOND0032753": "Thyroid Carcinoma"}, {"/indications/DBCOND0092565": "Waldenstr\u00f6m's Macroglobulinemia (WM)"}, {"/indications/DBCOND0021654": "Wilms' tumor"}, {"/indications/DBCOND0021657": "Advanced Thymoma"}, {"/indications/DBCOND0022592": "Advanced uterine sarcoma"}], "Name": "Doxorubicin Hydrochloride", "Categories": [{"/categories/DBCAT003352": "Anthracycline Topoisomerase Inhibitor"}, {"/categories/DBCAT000874": "Anthracyclines"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000873": "Daunorubicin"}, {"/categories/DBCAT000872": "Doxorubicin"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "1104010W0": {"Conditions": [{"/indications/DBCOND0054268": "Ocular Pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Loteprednol Etabonate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000979": "Androstadienes"}, {"/categories/DBCAT000981": "Androstanes"}, {"/categories/DBCAT000980": "Androstenes"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000309": "Steroids"}]}, "1104020M0": {"Conditions": [{"/indications/DBCOND0089178": "Acute atopic conjunctivitis"}, {"/indications/DBCOND0054398": "Conjunctivitis, Giant Papillary"}, {"/indications/DBCOND0034753": "Conjunctivitis, Vernal"}, {"/indications/DBCOND0036467": "Vernal Keratoconjunctivitis"}], "Name": "Lodoxamide Trometamol", "Categories": [{"/categories/DBCAT001527": "Acids, Aldehydic"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001559": "Glyoxylates"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1003020U0": {"Conditions": [{"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0121216": "Inflammatory Disease of the Oral Cavity"}, {"/indications/DBCOND0121217": "Inflammatory Disease of the throat"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060692": "Knee Osteoarthritis (Knee OA)"}, {"/indications/DBCOND0089301": "Operation site inflammation"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0001062": "Photophobia"}, {"/indications/DBCOND0035847": "Post-Operative Pain"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0021856": "Acute Musculoskeletal injury"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}, {"/indications/DBCOND0121215": "Localized soft tissue rheumatism"}, {"/indications/DBCOND0121211": "Mild to moderate joint pain"}, {"/indications/DBCOND0121212": "Mild to moderate pain"}, {"/indications/DBCOND0112720": "Minor pain"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0121206": "Perioperative miosis"}], "Name": "Diclofenac Sodium", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT003912": "Cyclooxygenase-2 (COX-2) Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0704030E0": {"Conditions": [{"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Phenazopyridine Hydrochloride", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000588": "Aminopyridines"}, {"/categories/DBCAT003654": "Antipruritics and Local Anesthetics"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0604012P0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}], "Name": "Norethisterone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002454": "Estren Derivatives"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004982": "Norethindrone"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "1108020U0": {"Conditions": [{"/indications/DBCOND0037906": "Acute Exacerbation of Chronic Bronchitis (AECB)"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0014061": "Sinusitis"}, {"/indications/DBCOND0106073": "Bacterial ocular infections"}, {"/indications/DBCOND0106074": "Post-operative infection"}, {"/indications/DBCOND0102820": "Post-operative inflammation"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Moxifloxacin Hydrochloride", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002228": "Fluoroquinolones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003300": "Quinolone Antimicrobial"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0401010T0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Temazepam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0801010F0": {"Conditions": [{"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0071554": "Hodgkins Disease (HD)"}, {"/indications/DBCOND0089324": "Nephrotic syndrome with lesion of minimal change glomerulonephritis"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0092565": "Waldenstr\u00f6m's Macroglobulinemia (WM)"}, {"/indications/DBCOND0020887": "Giant follicular lymphoma"}], "Name": "Chlorambucil", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000681": "Mustard Compounds"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT002289": "Nitrogen Mustard Analogues"}, {"/categories/DBCAT000680": "Nitrogen Mustard Compounds"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1106000C0": {"Conditions": [{"/indications/DBCOND0035716": "Angle Closure Glaucoma"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0008063": "Familial periodic paralysis"}, {"/indications/DBCOND0021730": "Grand mal Generalized tonic-clonic seizure"}, {"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0046770": "Open Angle Glaucoma (OAG)"}, {"/indications/DBCOND0024755": "Other and unspecified effects of high altitude"}, {"/indications/DBCOND0022351": "Cystine renal calculi"}, {"/indications/DBCOND0024395": "Drug-induced edema"}, {"/indications/DBCOND0022682": "Nonuveitic secondary glaucoma"}], "Name": "Acetazolamide Sodium", "Categories": [{"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT003725": "Antiglaucoma Agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0407010B0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0119112": "Atherothrombotic cerebral infarction"}, {"/indications/DBCOND0057913": "Cardiovascular Disease (CVD)"}, {"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0054617": "Colorectal Adenomas"}, {"/indications/DBCOND0063246": "Colorectal Cancers"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0032134": "Morbidity"}, {"/indications/DBCOND0000706": "Mucocutaneous Lymph Node Syndrome"}, {"/indications/DBCOND0079381": "Muscle Contraction"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0119105": "Myocardial Infarction (MI), first occurrence"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0030912": "Preeclampsia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0027340": "Spondyloarthropathies"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0029433": "Tension Headache"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0081466": "Acute Inflammation"}, {"/indications/DBCOND0102609": "Death by myocardial infarction"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Aspirin", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT004321": "Decreased Prostaglandin Production"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}]}, "0607010C0": {"Conditions": [{"/indications/DBCOND0020755": "Idiopathic hyperprolactinemic disorder"}], "Name": "Cabergoline", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000605": "Ergolines"}, {"/categories/DBCAT000606": "Ergot Alkaloids and Derivatives"}, {"/categories/DBCAT003643": "Ergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002256": "Prolactine Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001689": "Serotonin 5-HT2 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}]}, "0503010AL": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Atazanavir & Cobicistat", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT003042": "Cytochrome P-450 CYP2C8 Inhibitors (weak)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004051": "Cytochrome P450 3A Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000552": "HIV Protease Inhibitors"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT004220": "UDP Glucuronosyltransferases Inhibitors"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}]}, "0405010P0": {"Conditions": [{"/indications/DBCOND0023881": "BMI >30 kg/m2"}, {"/indications/DBCOND0021975": "Weight gain therapy"}], "Name": "Orlistat", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000472": "Anti-Obesity Agents"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003425": "Intestinal Lipase Inhibitor"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT004196": "Lipase Inhibitors"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT003746": "Miscellaneous GI Drugs"}, {"/categories/DBCAT002499": "Peripherally Acting Antiobesity Products"}]}, "0205051Y0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0086660": "Hypertension,Essential"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0025304": "NYHA Class I Congestive heart failure"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}], "Name": "Perindopril Arginine", "Categories": [{"/categories/DBCAT002176": "ACE Inhibitors and Calcium Channel Blockers"}, {"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0206020R0": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0078508": "Hypertensive Emergency"}, {"/indications/DBCOND0073410": "Premature Labour"}, {"/indications/DBCOND0041552": "Pulmonary Edemas"}, {"/indications/DBCOND0051788": "Pulmonary Hypertension (PH)"}, {"/indications/DBCOND0040958": "Raynaud's Phenomenon"}, {"/indications/DBCOND0072914": "Ureteral Calculus"}, {"/indications/DBCOND0039062": "Vasospastic Angina"}], "Name": "Nifedipine", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT004596": "Beta blocking agents and calcium channel blockers"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003977": "Calcium Channel Blockers (Dihydropyridine)"}, {"/categories/DBCAT002343": "Calcium Channel Blockers and Diuretics"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000994": "Contraceptive Agents, Male"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002270": "Dihydropyridine Derivatives"}, {"/categories/DBCAT000643": "Dihydropyridines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002271": "Selective Calcium Channel Blockers With Mainly Vascular Effects"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0205052C0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0025714": "Chronic heart failure with reduced ejection fraction (NYHA Class II)"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}, {"/indications/DBCOND0025716": "Chronic heart failure with reduced ejection fraction (NYHA Class IV)"}], "Name": "Candesartan Cilexetil", "Categories": [{"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003287": "Angiotensin 2 Receptor Blocker"}, {"/categories/DBCAT002172": "Angiotensin II Antagonists and Diuretics"}, {"/categories/DBCAT000408": "Angiotensin Receptor Antagonists"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}]}, "0402030P0": {"Conditions": [{"/indications/DBCOND0034548": "Acute Mania"}], "Name": "Lithium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000733": "Antimanic Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT001348": "Lithium Compounds"}, {"/categories/DBCAT003323": "Mood Stabilizer"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}]}, "0905022S0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}], "Name": "Sevelamer", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002340": "Bile Acid Sequestrants"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004097": "Phosphate Chelating Activity"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT004573": "Polystyrene Sulfonates"}, {"/categories/DBCAT000623": "Sequestering Agents"}]}, "1001010K0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0020934": "Tendinitis"}], "Name": "Indometacin", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT000759": "Tocolytic Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004456": "UGT2B7 Inhibitors"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0703021N0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0024350": "Endometriosis related pain"}, {"/indications/DBCOND0039501": "Estrogen Deficiency"}, {"/indications/DBCOND0066876": "Postmenopausal Osteoporosis (PMO)"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0035305": "Vasomotor Symptoms"}, {"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}], "Name": "Norethisterone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002454": "Estren Derivatives"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT004982": "Norethindrone"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0606020W0": {"Conditions": [{"/indications/DBCOND0028830": "Bone Metastases"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0015928": "Osteoporosis"}], "Name": "Ibandronic Acid", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT001016": "Bisphosphonates"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT002165": "Drugs Affecting Bone Structure and Mineralization"}, {"/categories/DBCAT002166": "Drugs for Treatment of Bone Diseases"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0501130K0": {"Conditions": [{"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Methenamine Mandelate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000260": "Keto Acids"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}]}, "0302000T0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Acetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0801050Z0": {"Conditions": [{"/indications/DBCOND0109682": "Chronic Eczema of the hand"}, {"/indications/DBCOND0021486": "Cutaneous lesions"}, {"/indications/DBCOND0093522": "Refractory Eczema of the hand"}, {"/indications/DBCOND0109683": "Severe Eczema of the hand"}], "Name": "Alitretinoin", "Categories": [{"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000356": "Carotenoids"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000357": "Cyclohexenes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000355": "Retinoids"}, {"/categories/DBCAT000366": "Terpenes"}, {"/categories/DBCAT004751": "Tretinoin"}, {"/categories/DBCAT001110": "Vitamin A"}, {"/categories/DBCAT000230": "Vitamins"}, {"/categories/DBCAT002724": "Vitamins (Fat Soluble)"}]}, "1501070G0": {"Conditions": [{"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0058333": "Opioid Overdose"}, {"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0034868": "Respiratory Depression"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0000299": "Shock, Septic"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Naloxone Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003713": "Opiate Antagonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002566": "Peripheral Opioid Receptor Antagonists"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1310020I0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0024347": "Seborrheic dermatitis of the scalp"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0025459": "Mild Onychomycosis"}, {"/indications/DBCOND0025458": "Moderate Onychomycosis"}], "Name": "Ciclopirox Olamine", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT004416": "Decreased DNA Replication"}, {"/categories/DBCAT004151": "Decreased Protein Synthesis"}, {"/categories/DBCAT004417": "Decreased RNA Replication"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT003754": "Hydroxypyridones"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT001044": "Pyridones"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "0801040H0": {"Conditions": [{"/indications/DBCOND0060596": "Advanced Soft Tissue Sarcoma"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0028467": "Immune Thrombocytopenic Purpura ( ITP )"}, {"/indications/DBCOND0035013": "Kaposi s Sarcoma (KS)"}, {"/indications/DBCOND0021755": "Letterer-Siwe disease"}, {"/indications/DBCOND0046916": "Lung Cancer Non-Small Cell Cancer (NSCLC)"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0030058": "Metastatic Melanoma"}, {"/indications/DBCOND0024723": "Advanced Alibert-Bazin syndrome"}, {"/indications/DBCOND0021754": "Advanced Testicular cancer"}, {"/indications/DBCOND0021517": "Histiocytic lymphoma"}, {"/indications/DBCOND0021753": "Refractory Breast cancer"}], "Name": "Vinblastine Sulfate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000717": "Antineoplastic Agents, Phytogenic"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000527": "Indole Alkaloids"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000526": "Secologanin Tryptamine Alkaloids"}, {"/categories/DBCAT000718": "Tubulin Modulators"}, {"/categories/DBCAT000714": "Vinca Alkaloids"}]}, "040702050": {"Conditions": [{"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0073745": "Refractory Chronic Cough"}], "Name": "Hydromorphone Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0410010A0": {"Conditions": [{"/indications/DBCOND0027943": "Alcohol Dependence"}], "Name": "Acamprosate Calcium", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001048": "Alcohol Deterrents"}, {"/categories/DBCAT000893": "Alkanes"}, {"/categories/DBCAT000890": "Alkanesulfonic Acids"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002183": "Drugs Used in Addictive Disorders"}, {"/categories/DBCAT002441": "Drugs Used in Alcohol Dependence"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001584": "Taurine"}]}, "1001022Y0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0106147": "Chapped skin"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0106146": "Diaper rashj"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0077772": "Inflammation of Mouth"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0051119": "Post-Herpetic Neuralgia (PHN)"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0087977": "Skin Inflammation"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021963": "Acute Multiple sclerosis"}, {"/indications/DBCOND0021972": "Acute Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0024352": "Cystic tumour of the ganglia"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021954": "Severe Erythema multiforme"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021967": "Unresponsive to topical ocular inflammation"}], "Name": "Triamcinolone Hexacetonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT001009": "Protein-Lysine 6-Oxidase, antagonists & inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT001008": "Triamcinolone"}, {"/categories/DBCAT004743": "Triamcinolone Acetonide"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0402010P0": {"Conditions": [{"/indications/DBCOND0020753": "Psychosis"}], "Name": "Pericyazine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000801": "Phenothiazines"}, {"/categories/DBCAT002446": "Phenothiazines With Piperidine Structure"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0901012K0": {"Conditions": [{"/indications/DBCOND0031349": "Iron Deficiency"}], "Name": "Iron Dextran", "Categories": [{"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT001023": "Biopolymers"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001181": "Dextrans"}, {"/categories/DBCAT000753": "Ferric Compounds"}, {"/categories/DBCAT001022": "Glucans"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003555": "Parenteral Iron Replacement"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT002729": "Supplements"}]}, "0106030A0": {"Conditions": [{"/indications/DBCOND0057011": "Dermatitis, Eczematous"}, {"/indications/DBCOND0036024": "Dry Skin"}], "Name": "Arachis Oil", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT001419": "Detergents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT001209": "Plant Oils"}, {"/categories/DBCAT001210": "Plant Preparations"}]}, "0503032E0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0057091": "Chronic Hepatitis C Virus (HCV) Infection"}, {"/indications/DBCOND0024498": "Chronic hepatitis C genotype 2"}, {"/indications/DBCOND0024499": "Chronic hepatitis C genotype 3"}], "Name": "Daclatasvir", "Categories": [{"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004102": "Breast Cancer Resistance Protein Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003783": "HCV Replication Complex Inhibitors"}, {"/categories/DBCAT003507": "Hepatitis C Virus NS5A Inhibitor"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}]}, "1304000I0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0025273": "Mild Atopic dermatitis"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}], "Name": "Desonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}]}, "0802010G0": {"Conditions": [{"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0044732": "Disseminated Sclerosis"}, {"/indications/DBCOND0047591": "Immune Thrombocytopenia"}, {"/indications/DBCOND0066662": "Kidney Transplant Rejection"}, {"/indications/DBCOND0034112": "Nephritis, Lupus"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0009937": "Uveitis"}], "Name": "Azathioprine", "Categories": [{"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003303": "Purine Antimetabolite"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000316": "Sulfhydryl Compounds"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001221": "Thionucleosides"}, {"/categories/DBCAT002714": "Thiopurine Analogs"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0204000C0": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}], "Name": "Acebutolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002265": "Beta Blocking Agents, Selective, and Thiazides"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "1309000H0": {"Conditions": [{"/indications/DBCOND0031762": "Androgenetic Alopecia"}, {"/indications/DBCOND0020964": "Severe, symptomatic Hypertension"}], "Name": "Minoxidil", "Categories": [{"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002307": "Arteriolar Smooth Muscle, Agents Acting On"}, {"/categories/DBCAT004240": "Arteriolar Vasodilation"}, {"/categories/DBCAT003332": "Arteriolar Vasodilator"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003665": "Direct Vasodilators"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002332": "Pyrimidine Derivatives"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0503022E0": {"Conditions": [{"/indications/DBCOND0000283": "Cytomegalovirus Retinitis"}, {"/indications/DBCOND0030497": "Genital Herpes"}, {"/indications/DBCOND0000240": "Herpes Labialis"}, {"/indications/DBCOND0025036": "Herpetic whitlow"}, {"/indications/DBCOND0059021": "Varicella Zoster Virus Infection"}], "Name": "Foscarnet Sodium", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004260": "Chelating Activity"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000698": "Organophosphonates"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT002404": "Phosphonic Acid Derivatives"}, {"/categories/DBCAT000950": "Phosphonoacetic Acid"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003368": "Pyrophosphate Analog DNA Polymerase Inhibitor"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}]}, "0107010E0": {"Conditions": [{"/indications/DBCOND0103705": "Malodorous flatulence"}], "Name": "Bismuth Subgallate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT001158": "Antidiarrheals"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT003915": "Bismuth containing drugs"}, {"/categories/DBCAT000113": "Coagulants"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000420": "Phenols"}]}, "0202030S0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0004927": "Ascites"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0004744": "Hirsutism"}, {"/indications/DBCOND0015839": "Hypokalaemia"}, {"/indications/DBCOND0041635": "Primary Hyperaldosteronism"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}, {"/indications/DBCOND0025716": "Chronic heart failure with reduced ejection fraction (NYHA Class IV)"}, {"/indications/DBCOND0021152": "Idiopathic hyperaldosteronism"}], "Name": "Spironolactone", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003684": "Mineralocorticoid (Aldosterone) Receptor Antagonists"}, {"/categories/DBCAT000844": "Mineralocorticoid Receptor Antagonists"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002346": "Potassium-Sparing Agents"}, {"/categories/DBCAT002702": "Potassium-Sparing Diuretics"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "0411000G0": {"Conditions": [{"/indications/DBCOND0022662": "Mild Vascular dementia"}, {"/indications/DBCOND0106440": "Moderate Alzheimer's Type Dementia"}, {"/indications/DBCOND0022661": "Moderate Vascular dementia"}, {"/indications/DBCOND0025403": "Moderate dementia of the Alzheimer's type"}, {"/indications/DBCOND0106225": "Severe Alzheimer's Type Dementia"}, {"/indications/DBCOND0025402": "Severe dementia of the Alzheimer's type"}], "Name": "Memantine Hydrochloride", "Categories": [{"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT002344": "Anti-Dementia Drugs"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT003897": "Cytochrome P-450 CYP2A6 Inhibitors (weak)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT003040": "Cytochrome P-450 CYP2C19 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT003658": "Miscellaneous Central Nervous System Agents"}, {"/categories/DBCAT003424": "N-methyl-D-aspartate Receptor Antagonist"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002156": "Psychoanaleptics"}]}, "0307000K0": {"Conditions": [{"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}], "Name": "Dornase Alfa", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT004188": "Decreased Respiratory Secretion Viscosity"}, {"/categories/DBCAT002873": "Deoxyribonucleases"}, {"/categories/DBCAT002871": "Endodeoxyribonucleases"}, {"/categories/DBCAT002872": "Endonucleases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000190": "Esterases"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003546": "Recombinant Human Deoxyribonuclease 1"}]}, "0501022A0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0035990": "Complicated Intra-Abdominal Infections"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0024188": "Complicated skin infection bacterial"}], "Name": "Meropenem", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT001395": "Carbapenems"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003321": "Penem Antibacterial"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001394": "Thienamycins"}]}, "0203020I0": {"Conditions": [{"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0085135": "Ventricular Tachycardia (VT)"}, {"/indications/DBCOND0022901": "Severe Atrioventricular nodal reentrant tachycardia"}, {"/indications/DBCOND0022902": "Severe Paroxysmal atrial fibrillation"}, {"/indications/DBCOND0022899": "Severe Paroxysmal supraventricular tachycardia"}, {"/indications/DBCOND0080565": "Severe Supraventricular Tachycardias"}, {"/indications/DBCOND0022904": "Severe Sustained ventricular tachycardia"}, {"/indications/DBCOND0025284": "Severe ventricular arrhythmias"}], "Name": "Flecainide Acetate", "Categories": [{"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT003865": "Antiarrhythmics, Class I"}, {"/categories/DBCAT002518": "Antiarrhythmics, Class Ic"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "1001030Z0": {"Conditions": [{"/indications/DBCOND0023491": "Active autoantibody-positive Systemic lupus erythematosus"}], "Name": "Belimumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT004413": "B Lymphocyte Stimulator-directed Antibody Interactions"}, {"/categories/DBCAT003495": "B Lymphocyte Stimulator-specific Inhibitor"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004412": "Decreased B Lymphocyte Activation"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0503010AE": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Raltegravir", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001873": "HIV Integrase Inhibitors"}, {"/categories/DBCAT003484": "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor"}, {"/categories/DBCAT001872": "Integrase Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "1310011Y0": {"Conditions": [{"/indications/DBCOND0060388": "Wound Sepsis"}], "Name": "Silver Sulfadiazine", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT001680": "Sulfadiazine"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0702010K0": {"Conditions": [{"/indications/DBCOND0046622": "Vulvovaginal Atrophy"}], "Name": "Estrone", "Categories": [{"/categories/DBCAT001040": "17-Ketosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000672": "Estradiol Congeners"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT000620": "Estrogens"}, {"/categories/DBCAT004748": "Estrone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001041": "Ketosteroids"}, {"/categories/DBCAT002269": "Natural and Semisynthetic Estrogens, Plain"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0301020R0": {"Conditions": [{"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}], "Name": "Aclidinium Bromide", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000572": "Aza Compounds"}, {"/categories/DBCAT000571": "Azabicyclo Compounds"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}]}, "0407020V0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Pethidine Hydrochloride", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004680": "High-risk opioids"}, {"/categories/DBCAT000881": "Isonipecotic Acids"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002384": "Phenylpiperidine Derivatives"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0408010K0": {"Conditions": [{"/indications/DBCOND0024634": "Refractory absence Seizures"}], "Name": "Mesuximide", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000725": "Imides"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002417": "Succinimide Derivatives"}]}, "1306030B0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021877": "Ascaris lumbricoides infection"}, {"/indications/DBCOND0014308": "Cutaneous larva migrans"}, {"/indications/DBCOND0014450": "Demodicidosis"}, {"/indications/DBCOND0014309": "Gnathostomiasis"}, {"/indications/DBCOND0089193": "Mansonella ozzardi infection"}, {"/indications/DBCOND0089466": "Mansonella streptocerca infection"}, {"/indications/DBCOND0004268": "Oesophagostomiasis"}, {"/indications/DBCOND0009881": "Onchocerciasis"}, {"/indications/DBCOND0043220": "Pediculosis Capitis"}, {"/indications/DBCOND0000256": "Scabies"}, {"/indications/DBCOND0004262": "Trichuriasis"}, {"/indications/DBCOND0025183": "Wuchereria bancroftii infection"}], "Name": "Ivermectin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000638": "Agrochemicals"}, {"/categories/DBCAT000944": "Anthelmintics"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002421": "Avermectines"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000857": "Insecticides"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002731": "Pediculicides"}, {"/categories/DBCAT000639": "Pesticides"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT003648": "Scabicides and Pediculicides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0204000V0": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0074237": "Ocular Hypertension"}], "Name": "Timolol", "Categories": [{"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003675": "EENT Drugs, Miscellaneous"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000804": "Thiadiazoles"}, {"/categories/DBCAT000348": "Thiazoles"}]}, "0701030N0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0029977": "Chronic Bronchitis"}, {"/indications/DBCOND0004300": "Pulmonary Emphysema"}], "Name": "Orciprenaline Sulfate", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003747": "Non-selective Beta-adrenergic Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT000759": "Tocolytic Agents"}]}, "0407041M0": {"Conditions": [{"/indications/DBCOND0025093": "Migraine with acute onset aura"}, {"/indications/DBCOND0025332": "Acute Migraine without aura"}], "Name": "Naratriptan Hydrochloride", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT002225": "Antimigraine Preparations"}, {"/categories/DBCAT000285": "Biogenic Amines"}, {"/categories/DBCAT000468": "Biogenic Monoamines"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT004538": "Monoamine Oxidase A Substrates"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002224": "Selective Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT003639": "Selective Serotonin Agonists"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004121": "Serotonin 1b Receptor Agonists"}, {"/categories/DBCAT004122": "Serotonin 1d Receptor Agonists"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT003299": "Serotonin-1b and Serotonin-1d Receptor Agonist"}, {"/categories/DBCAT003231": "Triptans"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0208020Y0": {"Conditions": [{"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0025031": "Deep vein thrombosis recurrent"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0023266": "Recurrent pulmonary embolism"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0077405": "Systemic Embolism"}], "Name": "Rivaroxaban", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000012": "Antithrombins"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT001775": "Factor Xa Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000802": "Morpholines"}, {"/categories/DBCAT000803": "Oxazines"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000001": "Serine Proteinase Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "0501070X0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0024824": "Clostridium difficile infection recurrence"}, {"/indications/DBCOND0000786": "Hepatic Encephalopathy"}, {"/indications/DBCOND0030069": "Irritable Bowel Syndrome (IBS)"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}], "Name": "Rifaximin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT002641": "Cytochrome P-450 CYP2C19 Inducers (strong)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT001006": "Lactams, Macrocyclic"}, {"/categories/DBCAT003433": "Rifamycin Antibacterial"}, {"/categories/DBCAT001005": "Rifamycins"}]}, "0209000Z0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0032387": "Stent Thrombosis"}], "Name": "Ticagrelor", "Categories": [{"/categories/DBCAT000251": "Adenosine"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT003038": "Cytochrome P-450 CYP2C9 Inhibitors (weak)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT004187": "Cytochrome P450 3A5 Inhibitors"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003400": "P2Y12 Platelet Inhibitor"}, {"/categories/DBCAT004298": "Phenylalanine Hydroxylase Activators"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000531": "Purinergic P2 Receptor Antagonists"}, {"/categories/DBCAT000532": "Purinergic P2Y Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000258": "Ribonucleosides"}]}, "0501021G0": {"Conditions": [{"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0014615": "Arthritis gonococcal"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0047809": "Bacterial Sepsis"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0008476": "Conjunctivitis gonococcal neonatal"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0014148": "Epididymitis"}, {"/indications/DBCOND0004178": "Epiglottitis"}, {"/indications/DBCOND0025007": "Gonococcal infection of pharynx"}, {"/indications/DBCOND0014594": "Gonococcal pelvic inflammatory disease"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000208": "Lyme Neuroborreliosis"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0025004": "Ophthalmia neonatorum due to gonococcus"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0042748": "Prosthetic Joint Infection"}, {"/indications/DBCOND0087961": "Salmonella Typhi Infection"}, {"/indications/DBCOND0037400": "Septic Arthritis"}, {"/indications/DBCOND0025006": "Shigellosis"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0014595": "Vulvovaginitis gonococcal"}, {"/indications/DBCOND0000415": "Whipple Disease"}, {"/indications/DBCOND0024205": "Complicated Urinary tract infection bacterial"}, {"/indications/DBCOND0020981": "Uncomplicated Gonorrhea"}, {"/indications/DBCOND0025003": "Uncomplicated Urinary tract infection bacterial"}], "Name": "Ceftriaxone Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000566": "Cefotaxime"}, {"/categories/DBCAT000567": "Cephacetrile"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "0901030L0": {"Conditions": [{"/indications/DBCOND0031070": "Anemias"}], "Name": "Epoetin Delta", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "1305030B0": {"Conditions": [{"/indications/DBCOND0005560": "Vitiligo"}, {"/indications/DBCOND0020949": "Intertriginous psoriasis"}, {"/indications/DBCOND0025273": "Mild Atopic dermatitis"}, {"/indications/DBCOND0025271": "Moderate Atopic dermatitis"}, {"/indications/DBCOND0025272": "Refractory Atopic dermatitis"}], "Name": "Pimecrolimus", "Categories": [{"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT003276": "Calcineurin Inhibitor Immunosuppressant"}, {"/categories/DBCAT000199": "Calcineurin Inhibitors"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003612": "Misc. Skin and Mucous Membrane Agents"}, {"/categories/DBCAT000767": "Peptidylprolyl Isomerase, antagonists & inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0801050F0": {"Conditions": [{"/indications/DBCOND0046846": "Advanced Cervical Cancer"}, {"/indications/DBCOND0050728": "Advanced Endometrial Cancer"}, {"/indications/DBCOND0029906": "Advanced Esophageal Cancers"}, {"/indications/DBCOND0076376": "Advanced Head and Neck Cancer"}, {"/indications/DBCOND0032665": "Advanced Melanoma"}, {"/indications/DBCOND0030392": "Advanced Non-Small Cell Lung Cancer"}, {"/indications/DBCOND0037455": "Advanced Ovarian Carcinoma"}, {"/indications/DBCOND0036681": "Advanced Sarcoma"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}, {"/indications/DBCOND0028595": "Neuroendocrine Carcinoma of the Skin"}, {"/indications/DBCOND0017372": "Pleural mesothelioma malignant"}, {"/indications/DBCOND0029144": "Refractory Hodgkin Lymphoma"}, {"/indications/DBCOND0001198": "Retinoblastoma"}, {"/indications/DBCOND0021244": "Advanced Bladder cancer"}, {"/indications/DBCOND0022521": "Advanced Small cell lung cancer"}, {"/indications/DBCOND0021754": "Advanced Testicular cancer"}, {"/indications/DBCOND0021657": "Advanced Thymoma"}, {"/indications/DBCOND0022523": "Advanced thymic carcinoma"}, {"/indications/DBCOND0024997": "Refractory Non-Hodgkin's lymphoma"}], "Name": "Carboplatin", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000713": "Cross-Linking Reagents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT003021": "Platinum Compounds"}]}, "0603020S0": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Methylprednisolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001203": "Methylprednisolone"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001204": "Prednisolone"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0109010H0": {"Conditions": [{"/indications/DBCOND0008385": "Inborn error in primary bile acid synthesis"}, {"/indications/DBCOND0029017": "Peroxisomal Disorders"}], "Name": "Cholic Acid", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002534": "Bile Acid Preparations"}, {"/categories/DBCAT004599": "Bile acids and derivatives"}, {"/categories/DBCAT001384": "Bile Acids and Salts"}, {"/categories/DBCAT002536": "Bile and Liver Therapy"}, {"/categories/DBCAT002535": "Bile Therapy"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT001383": "Cholanes"}, {"/categories/DBCAT001382": "Cholic Acids"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003933": "OATP1B1/SLCO1B1 Inducers"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT000309": "Steroids"}]}, "0603020AA": {"Conditions": [{"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0059917": "Adrenocortical Hyperfunction"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0009847": "Choroiditis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0028130": "Cushing's Syndrome"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0060562": "Diabetic Macular Edema (DME)"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0003950": "Hypercalcemia"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0067243": "Inflammatory Reaction"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0063558": "Macular Edema (ME)"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0045693": "Post-traumatic Osteoarthritis"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0053683": "Tuberculosis Infection"}, {"/indications/DBCOND0052139": "Tuberculosis Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Dexamethasone Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000063": "Antineoplastic Agents, Hormonal"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT003980": "BSEP/ABCB11 inducers"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002248": "Corticosteroids, Moderately Potent (Group II)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT003900": "Cytochrome P-450 CYP3A5 Inducers (moderate)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004502": "Cytochrome P-450 CYP3A7 Inducers (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002722": "Inducers of Drug Clearance"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0103010T0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0070241": "Erosive Esophagitis(EE)"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0041138": "Healing"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0118756": "Pathological gastric hypersecretion"}, {"/indications/DBCOND0045072": "Peptic Ulcer Disease"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0074522": "Stress Ulcers"}, {"/indications/DBCOND0028386": "Systemic Mastocytosis"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}, {"/indications/DBCOND0108495": "Active duodenal ulcers"}, {"/indications/DBCOND0022472": "Benign gastric ulcers"}], "Name": "Ranitidine Hydrochloride", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002870": "Cytochrome P-450 CYP1A2 Inhibitors (weak)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002835": "Elements, Radioactive"}, {"/categories/DBCAT000766": "Furans"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT002980": "Isotopes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003839": "Radioisotopes"}]}, "0103040M0": {"Conditions": [{"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0037315": "Incomplete Abortion"}, {"/indications/DBCOND0043248": "Missed Abortion"}, {"/indications/DBCOND0080092": "Postpartum Haemorrhage (PPH)"}], "Name": "Misoprostol", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT000855": "Abortifacient Agents, Nonsteroidal"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT003415": "Prostaglandin E1 Analog"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT001193": "Prostaglandins E, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT000218": "Uterotonic agents"}]}, "0901030R0": {"Conditions": [{"/indications/DBCOND0048758": "Essential Thrombocythemia (ET)"}, {"/indications/DBCOND0050085": "Head and Neck Carcinoma"}, {"/indications/DBCOND0034131": "Hypereosinophilic Syndromes"}, {"/indications/DBCOND0020306": "Melanoma"}, {"/indications/DBCOND0038150": "Meningiomas"}, {"/indications/DBCOND0068543": "Ovarian Cancer Metastatic"}, {"/indications/DBCOND0062825": "Polycythemia Vera (PV)"}, {"/indications/DBCOND0051876": "Sickle Cell Disorders"}, {"/indications/DBCOND0112023": "Chronic, refractory Myeloid Leukemia"}, {"/indications/DBCOND0025356": "Inoperable Ovarian cancer"}], "Name": "Hydroxycarbamide", "Categories": [{"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001227": "Antisickling Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000635": "Urea"}]}, "1311050K0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Hexachlorophene", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001112": "Chlorobenzenes"}, {"/categories/DBCAT001111": "Chlorophenols"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000856": "Hydrocarbons, Chlorinated"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}]}, "0403040AB": {"Conditions": [{"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}], "Name": "Vortioxetine", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT002341": "Serotonin 5-HT3 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0403040AA": {"Conditions": [{"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}], "Name": "Levomilnacipran", "Categories": [{"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT001393": "Cyclopropanes"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT005019": "Milnacipran"}, {"/categories/DBCAT003624": "Miscellaneous Antidepressants"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT004068": "Norepinephrine Uptake Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002715": "Serotonin and Noradrenaline Reuptake Inhibitors"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0212000X0": {"Conditions": [{"/indications/DBCOND0090131": "Acute Coronary Events"}, {"/indications/DBCOND0065446": "Cardiovascular Outcomes"}, {"/indications/DBCOND0051452": "Coronary Artery Atherosclerosis"}, {"/indications/DBCOND0052707": "Coronary Death"}, {"/indications/DBCOND0022726": "Dysbetalipoproteinemia"}, {"/indications/DBCOND0084407": "Elevated Triglycerides (TG)"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0037835": "High Cholesterol"}, {"/indications/DBCOND0031916": "Hyperlipidemias"}, {"/indications/DBCOND0027900": "Myocardial Infarction"}, {"/indications/DBCOND0032062": "Myocardial Revascularization"}, {"/indications/DBCOND0020597": "Secondary prevention cardiovascular event"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0084405": "Transient Ischaemic Attack (TIA)"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}, {"/indications/DBCOND0068093": "The Mortality Rate"}], "Name": "Pravastatin Sodium", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "1304000U0": {"Conditions": [{"/indications/DBCOND0019992": "Dermatosis"}], "Name": "Halcinonide", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002571": "Corticosteroids, Very Potent (Group IV)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000309": "Steroids"}]}, "1202010P0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0034753": "Conjunctivitis, Vernal"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}, {"/indications/DBCOND0022571": "Keratoconjunctivitis"}, {"/indications/DBCOND0058482": "Perennial Allergic Rhinitis (PAR)"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0002834": "Urticaria Pigmentosa"}], "Name": "Sodium Cromoglicate", "Categories": [{"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT002323": "Agents for Dermatitis, Excluding Corticosteroids"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000370": "Benzopyrans"}, {"/categories/DBCAT001225": "Chromones"}, {"/categories/DBCAT004761": "Cromolyn Sodium"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT003742": "Mast-cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0208040A0": {"Conditions": [{"/indications/DBCOND0023709": "Anticoagulant effects of dabigatran"}], "Name": "Idarucizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000014": "Antibodies, Monoclonal, Humanized"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT003787": "Antihemorrhagic Agents, Miscellaneous"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT003522": "Humanized Monoclonal Antibody Fragment"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0803042Q0": {"Conditions": [{"/indications/DBCOND0043429": "Advanced Prostate Cancer"}, {"/indications/DBCOND0040295": "Central Precocious Puberty (CPP)"}], "Name": "Histrelin Acetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002090": "Endocrine Therapy"}, {"/categories/DBCAT003246": "Gonadotropin Releasing Hormone Receptor Agonist"}, {"/categories/DBCAT004268": "Gonadotropin Releasing Hormone Receptor Agonists"}, {"/categories/DBCAT002742": "Gonadotropin-releasing hormone agonist"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT002089": "Hormones and Related Agents"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT000051": "Oligopeptides"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000053": "Pituitary Hormone-Releasing Hormones"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "1203030P0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0503010Q0": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}, {"/indications/DBCOND0035016": "Human Immunodeficiency Virus (HIV) Infections"}], "Name": "Lamivudine", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT001088": "Cytidine"}, {"/categories/DBCAT001087": "Deoxycytidine"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT002657": "OCT2 Substrates"}, {"/categories/DBCAT004582": "OCT2 substrates with narrow therapeutic index"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000610": "Pyrimidine Nucleosides"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT004749": "Zalcitabine"}]}, "1001030L0": {"Conditions": [{"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Leflunomide", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}]}, "1203040K0": {"Conditions": [{"/indications/DBCOND0025037": "Irritation lips"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0010471": "Throat irritation"}], "Name": "Phenol", "Categories": [{"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT001171": "Disinfectants"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000894": "Pharmaceutical Solutions"}, {"/categories/DBCAT002462": "Phenol and Derivatives"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT002392": "Sclerosing Agents for Local Injection"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT000895": "Solutions"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0309010L0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}], "Name": "Dextromethorphan Hydrobromide", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000939": "Excitatory Amino Acid Agents"}, {"/categories/DBCAT000940": "Excitatory Amino Acid Antagonists"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002723": "NMDA Receptor Antagonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT002302": "Opium Alkaloids and Derivatives"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT003364": "Sigma-1 Agonist"}, {"/categories/DBCAT004207": "Sigma-1 Receptor Agonists"}, {"/categories/DBCAT003365": "Uncompetitive N-methyl-D-aspartate Receptor Antagonist"}, {"/categories/DBCAT004206": "Uncompetitive NMDA Receptor Antagonists"}]}, "0304010D0": {"Conditions": [{"/indications/DBCOND0019903": "Pruritus"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}], "Name": "Loratadine", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT000743": "Benzocycloheptenes"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000882": "Cyproheptadine"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000742": "Dibenzocycloheptenes"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0206040X0": {"Conditions": [{"/indications/DBCOND0000739": "Intermittent Claudication"}], "Name": "Cilostazol", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000653": "Neuroprotective Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000590": "Phosphodiesterase 3 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000407": "Tetrazoles"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "1202010F0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0409020S0": {"Conditions": [{"/indications/DBCOND0024062": "Parkinsonian Syndromes"}, {"/indications/DBCOND0021074": "Extra-pyramidal symptoms"}], "Name": "Procyclidine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT002324": "Tertiary Amines"}]}, "020400080": {"Conditions": [{"/indications/DBCOND0075514": "Chronic Stable Angina Pectoris"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0022829": "LVEF \u226440% Left ventricular dysfunction"}, {"/indications/DBCOND0025082": "NYHA Class I or II heart failure"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0025715": "Chronic heart failure with reduced ejection fraction (NYHA Class III)"}, {"/indications/DBCOND0025716": "Chronic heart failure with reduced ejection fraction (NYHA Class IV)"}], "Name": "Carvedilol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT004124": "Adrenergic beta2-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002420": "Alpha and Beta Blocking Agents"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT001187": "Carbazoles"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000528": "Indoles"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0301012F0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0023028": "Idiopathic orthostatic hypotension"}], "Name": "Ephedrine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003674": "Alpha-and Beta-adrenergic Agonists"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT002189": "Antiobesity Preparations, Excl. Diet Products"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000437": "Central Nervous System Stimulants"}, {"/categories/DBCAT002188": "Centrally Acting Antiobesity Products"}, {"/categories/DBCAT004572": "Cholinesterase substrates"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004776": "Ephedrine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003727": "Herbs and Natural Products"}, {"/categories/DBCAT004067": "Increased Norepinephrine Activity"}, {"/categories/DBCAT002350": "Mydriatics and Cycloplegics"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003440": "Norepinephrine Releasing Agent"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}, {"/categories/DBCAT002349": "Sympathomimetics Excl. Antiglaucoma Preparations"}, {"/categories/DBCAT002348": "Sympathomimetics, Plain"}, {"/categories/DBCAT000165": "Vasoconstrictor Agents"}]}, "0504010F0": {"Conditions": [{"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0080562": "Extraintestinal Amebiasis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0037230": "Polymorphic Light Eruption (PLE)"}, {"/indications/DBCOND0000759": "Porphyria Cutanea Tarda"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0021892": "Acute, uncomplicated Malaria"}], "Name": "Chloroquine Phosphate", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT001399": "Chloroquine"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000998": "Filaricides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0212000K0": {"Conditions": [{"/indications/DBCOND0069203": "Dyslipidemia (Fredrickson Type \u2161a)"}], "Name": "Colestipol Hydrochloride", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000811": "Anion Exchange Resins"}, {"/categories/DBCAT002340": "Bile Acid Sequestrants"}, {"/categories/DBCAT004184": "Bile-acid Binding Activity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT000623": "Sequestering Agents"}]}, "0504010L0": {"Conditions": [{"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0036602": "Uncomplicated Malaria"}], "Name": "Mefloquine Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002335": "Methanolquinolines"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}]}, "0208010D0": {"Conditions": [{"/indications/DBCOND0034735": "Acute Coronary Syndromes (ACS)"}, {"/indications/DBCOND0044748": "Deep Vein Thrombosis (DVT)"}, {"/indications/DBCOND0061688": "ST Segment Elevation Myocardial Infarction (STEMI)"}], "Name": "Enoxaparin", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002680": "Heparin (Low Molecular Weight)"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT002505": "Heparin Group"}, {"/categories/DBCAT002743": "Heparins"}, {"/categories/DBCAT000669": "Polysaccharides"}]}, "0205020G0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0017962": "Migraine"}], "Name": "Guanfacine Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002651": "Adrenergic alpha-2 Receptor Agonists"}, {"/categories/DBCAT000536": "Adrenergic alpha-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000343": "Amidines"}, {"/categories/DBCAT002214": "Antiadrenergic Agents, Centrally Acting"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003378": "Central alpha-2 Adrenergic Agonist"}, {"/categories/DBCAT003700": "Central Alpha-agonists"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000342": "Guanidines"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002413": "Imidazoline Receptor Agonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000845": "Phenylacetates"}]}, "0502040B0": {"Conditions": [{"/indications/DBCOND0034378": "Abscesses"}, {"/indications/DBCOND0020999": "Aspergillosis"}, {"/indications/DBCOND0000135": "Candidemia"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0034299": "Infections, Fungal"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0021837": "Disseminated Candidiasis"}, {"/indications/DBCOND0024242": "Prophylaxis of Candida Infections"}], "Name": "Micafungin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT002654": "COMT Substrates"}, {"/categories/DBCAT003336": "Echinocandin Antifungal"}, {"/categories/DBCAT003671": "Echinocandins"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "1310020V0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1201010P0": {"Conditions": [{"/indications/DBCOND0021311": "Acute Crusting Rhinitis"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0039241": "Corneal Abrasions"}, {"/indications/DBCOND0080525": "Infection NOS"}, {"/indications/DBCOND0014761": "Skin bacterial infection"}, {"/indications/DBCOND0021315": "Stye"}, {"/indications/DBCOND0009948": "Ulcerative keratitis"}, {"/indications/DBCOND0021310": "Acute rhino-sinusitis"}, {"/indications/DBCOND0021314": "Bacterial blepharitis"}, {"/indications/DBCOND0020325": "Nasal carriage of staphylococci"}], "Name": "Framycetin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000880": "Neomycin"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0212000Y0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}, {"/indications/DBCOND0031771": "Heterozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0037835": "High Cholesterol"}, {"/indications/DBCOND0040863": "Homozygous Familial Hypercholesterolemia"}, {"/indications/DBCOND0022047": "History of coronary heart disease cardiovascular event"}, {"/indications/DBCOND0022051": "History of stroke or other cerebrovacular disease cardiovascular event"}, {"/indications/DBCOND0024692": "Mixed hypercholesterolemia"}], "Name": "Simvastatin", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000390": "Anticholesteremic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT003033": "Cytochrome P-450 CYP2B6 Inhibitors (weak)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000391": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"}, {"/categories/DBCAT000274": "Hypolipidemic Agents"}, {"/categories/DBCAT002168": "Lipid Modifying Agents"}, {"/categories/DBCAT002167": "Lipid Modifying Agents, Plain"}, {"/categories/DBCAT000275": "Lipid Regulating Agents"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0401030T0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Secobarbital Sodium", "Categories": [{"/categories/DBCAT002735": "Adjuvants"}, {"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000728": "Barbiturates"}, {"/categories/DBCAT002297": "Barbiturates, Plain"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT004484": "Cytochrome P-450 CYP2C19 Inducers (unknown strength)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000919": "Nicotinic Antagonists"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}]}, "0401020V0": {"Conditions": [{"/indications/DBCOND0044056": "Acute Alcohol Withdrawal"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0021352": "Acute Anxiety"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Clorazepate Dipotassium", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0802030F0": {"Conditions": [{"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0035157": "Granulomatosis With Polyangiitis"}, {"/indications/DBCOND0000668": "Microscopic Polyangiitis"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0040643": "Pemphigus Vulgaris (PV)"}, {"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0115948": "Moderate to severe pemphigus vulgaris"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Rituximab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000172": "Antibodies, Monoclonal, Murine-Derived"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT004966": "Antineoplastic Agents, Immunological"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT004203": "CD20-directed Antibody Interactions"}, {"/categories/DBCAT003269": "CD20-directed Cytolytic Antibody"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "040201030": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0034548": "Acute Mania"}, {"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0041089": "Gilles de la Tourette's Syndrome"}, {"/indications/DBCOND0012283": "Irritability"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0031101": "Posttraumatic Stress Disorders"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0044715": "Treatment Resistant Major Depressive Disorder"}, {"/indications/DBCOND0022235": "Severe Dementia Alzheimer's type"}], "Name": "Risperidone", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT000729": "Pyrimidinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0801020D0": {"Conditions": [{"/indications/DBCOND0034847": "Cancer of the Ovary"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0040920": "Gestational Trophoblastic Disease"}, {"/indications/DBCOND0027071": "Rhabdomyosarcomas"}, {"/indications/DBCOND0066822": "Sarcoma, Osteogenic"}, {"/indications/DBCOND0021654": "Wilms' tumor"}, {"/indications/DBCOND0022542": "Metastatic nonseminomatous Testicular cancer"}], "Name": "Dactinomycin", "Categories": [{"/categories/DBCAT003417": "Actinomycin"}, {"/categories/DBCAT002488": "Actinomycines"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}]}, "0901020F0": {"Conditions": [{"/indications/DBCOND0034287": "Advanced Colorectal Cancer"}, {"/indications/DBCOND0029906": "Advanced Esophageal Cancers"}, {"/indications/DBCOND0036667": "Advanced Gastric Cancer"}, {"/indications/DBCOND0050427": "Bladder Cancers"}, {"/indications/DBCOND0024088": "Folic acid antagonist overdose"}, {"/indications/DBCOND0058909": "Pancreatic Cancer Metastatic"}, {"/indications/DBCOND0022071": "Methotrexate toxicity"}, {"/indications/DBCOND0022074": "Pyrimethamine hematologic toxicity"}], "Name": "Folinic Acid", "Categories": [{"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000223": "Coenzymes"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002110": "Detoxifying Agents for Antineoplastic Treatment"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT004536": "Folate Analog"}, {"/categories/DBCAT004537": "Folic Acid"}, {"/categories/DBCAT001033": "Folic Acid and Derivatives"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004981": "Formyltetrahydrofolates"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000354": "Pterins"}, {"/categories/DBCAT004542": "Tetrahydrofolates"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT000230": "Vitamins"}]}, "1306010D0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0000021": "Babesiosis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0011135": "Colitis"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0038584": "Infective Endocarditis"}, {"/indications/DBCOND0042813": "Intra-Abdominal Infections"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0014303": "Osteomyelitis"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0021403": "Pelvic cellulitis"}, {"/indications/DBCOND0011150": "Peritonitis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0028384": "Pneumonia, Bacterial"}, {"/indications/DBCOND0000142": "Pneumonia, Pneumocystis"}, {"/indications/DBCOND0019699": "Pneumonitis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0020764": "Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0022103": "Bacterial rhinosinusitis"}], "Name": "Clindamycin Hydrochloride", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004079": "Decreased Sebaceous Gland Activity"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT001291": "Lincomycin"}, {"/categories/DBCAT003755": "Lincomycins"}, {"/categories/DBCAT003431": "Lincosamide Antibacterial"}, {"/categories/DBCAT001292": "Lincosamides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000663": "Pyrrolidines"}]}, "1108010J0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0908010P0": {"Conditions": [{"/indications/DBCOND0023710": "Deficiencies in enzymes of the urea cycle"}], "Name": "Sodium Phenylbutyrate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004166": "Ammonium Ion Binding Activity"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT002683": "Urea Cycle Disorder Agents"}, {"/categories/DBCAT002164": "Various Alimentary Tract and Metabolism Products"}]}, "1001010P0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0043723": "Acute Migraine"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0016433": "Arthritis"}, {"/indications/DBCOND0021344": "Backache"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0020934": "Tendinitis"}, {"/indications/DBCOND0001908": "Toothache"}], "Name": "Naproxen", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002123": "Antigout Preparations"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT001137": "Naphthaleneacetic Acids"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0403030X0": {"Conditions": [{"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0068470": "Menopausal Hot Flushes"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}], "Name": "Escitalopram", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004729": "Citalopram"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT000545": "Nitriles"}, {"/categories/DBCAT000544": "Propylamines"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002772": "Selective Serotonin Reuptake Inhibitors"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "0801020J0": {"Conditions": [{"/indications/DBCOND0030518": "Acute Lymphocytic Leukemia (ALL)"}, {"/indications/DBCOND0022174": "Acute erythroid leukemia"}, {"/indications/DBCOND0006978": "Acute monocytic leukaemia"}, {"/indications/DBCOND0032540": "Leukemia Acute Myeloid Leukemia (AML)"}], "Name": "Daunorubicin", "Categories": [{"/categories/DBCAT003352": "Anthracycline Topoisomerase Inhibitor"}, {"/categories/DBCAT000874": "Anthracyclines"}, {"/categories/DBCAT002347": "Anthracyclines and Related Substances"}, {"/categories/DBCAT000679": "Antibiotics, Antineoplastic"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002288": "Cytotoxic Antibiotics and Related Substances"}, {"/categories/DBCAT000873": "Daunorubicin"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000549": "Topoisomerase II Inhibitors"}, {"/categories/DBCAT000548": "Topoisomerase Inhibitors"}]}, "0901020T0": {"Conditions": [{"/indications/DBCOND0034596": "Vitamin B12 Deficiency"}], "Name": "Mecobalamin", "Categories": [{"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000237": "Corrinoids"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT004535": "VITAMIN B12 AND FOLIC ACID"}, {"/categories/DBCAT000230": "Vitamins"}]}, "1104010V0": {"Conditions": [{"/indications/DBCOND0081707": "Anterior Uveitis (AU)"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Rimexolone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0106050M0": {"Conditions": [{"/indications/DBCOND0017962": "Migraine"}], "Name": "Magnesium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003004": "Laxatives, magnesium containing"}, {"/categories/DBCAT001038": "Magnesium Compounds"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT004026": "Metal divalent cations"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}]}, "030902040": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0031602": "Oral Mucositis"}, {"/indications/DBCOND0024062": "Parkinsonian Syndromes"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0035432": "Skin Rash"}, {"/indications/DBCOND0048259": "Sleeplessness"}, {"/indications/DBCOND0024669": "Upper respiratory tract hypersensitivity reaction, site unspecified"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0022265": "Dermatographism"}], "Name": "Diphenhydramine Hydrochloride", "Categories": [{"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT000564": "Anesthetics"}, {"/categories/DBCAT000661": "Anesthetics, Local"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003673": "Ethanolamine Derivatives"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT003748": "First Generation Antihistamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}]}, "1104020N0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0080546": "Itching of the eye"}], "Name": "Nedocromil Sodium", "Categories": [{"/categories/DBCAT001093": "4-Quinolones"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0604012S0": {"Conditions": [{"/indications/DBCOND0005025": "Amenorrhea"}, {"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0021097": "Endometrial hyperplasia caused by conjugated estrogen"}, {"/indications/DBCOND0001338": "Infertility, Female"}, {"/indications/DBCOND0018394": "Pregnancy"}, {"/indications/DBCOND0032020": "Secondary Amenorrhea"}, {"/indications/DBCOND0021100": "Recurrent spontaneous preterm birth"}], "Name": "Progesterone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003986": "BCRP/ABCG2 Inducers"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000829": "Corpus Luteum Hormones"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003934": "OATP1B3 inducers"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT000992": "Progesterone and Derivatives"}, {"/categories/DBCAT004736": "Progesterone, antagonists & inhibitors"}, {"/categories/DBCAT003338": "Progestin-containing Intrauterine Device"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "1106000L0": {"Conditions": [{"/indications/DBCOND0074237": "Ocular Hypertension"}, {"/indications/DBCOND0046720": "Open-angle Glaucoma (OAG)"}], "Name": "Latanoprost", "Categories": [{"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT004677": "Prostaglandin analogs reducing intraocular pressure (IOP)"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000676": "Prostaglandins F, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0304010R0": {"Conditions": [{"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0035712": "Allergies"}, {"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0023142": "Runny nose"}, {"/indications/DBCOND0021161": "Acute Rhinitis"}], "Name": "Mepyramine Maleate", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000588": "Aminopyridines"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT002285": "Antihistamines for Topical Use"}, {"/categories/DBCAT002280": "Antipruritics, Incl. Antihistamines, Anesthetics, Etc."}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002624": "Cytochrome P-450 CYP2D6 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT001256": "Sleep Aids, Pharmaceutical"}, {"/categories/DBCAT002468": "Substituted Ethylene Diamines"}]}, "0105030A0": {"Conditions": [{"/indications/DBCOND0053724": "Severe Crohn's Disease"}, {"/indications/DBCOND0033634": "Severe Ulcerative Colitis"}, {"/indications/DBCOND0023528": "Moderate Crohn's disease"}, {"/indications/DBCOND0020388": "Moderate Ulcerative colitis"}], "Name": "Vedolizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003280": "Integrin Receptor Antagonist"}, {"/categories/DBCAT004289": "Integrin Receptor Antagonists"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0409030A0": {"Conditions": [{"/indications/DBCOND0031445": "Cervical Dystonia"}, {"/indications/DBCOND0001979": "Sialorrhea"}], "Name": "Botulinum Toxin Type B", "Categories": [{"/categories/DBCAT000130": "Acetylcholine Release Inhibitors"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT001366": "Amphibian Venoms"}, {"/categories/DBCAT000129": "Anti-Dyskinesia Agents"}, {"/categories/DBCAT000186": "Bacterial Proteins"}, {"/categories/DBCAT000184": "Bacterial Toxins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT001367": "Bodily Secretions"}, {"/categories/DBCAT000183": "Botulinum Toxins"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT000068": "Endopeptidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT001368": "Fluids and Secretions"}, {"/categories/DBCAT001047": "Ganglion Blockers"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000140": "Metalloendopeptidases"}, {"/categories/DBCAT000141": "Metalloproteases"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002205": "Muscle Relaxants, Peripherally Acting Agents"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000125": "Neurotoxins"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000069": "Peptide Hydrolases"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000185": "Toxins, Biological"}, {"/categories/DBCAT001328": "Venoms"}]}, "0502000T0": {"Conditions": [{"/indications/DBCOND0037929": "Fungal Keratitis"}, {"/indications/DBCOND0022362": "Fungal blepharitis"}, {"/indications/DBCOND0022360": "Fungal conjunctivitis"}], "Name": "Natamycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT003407": "Polyene Antimicrobial"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "0501030P0": {"Conditions": [{"/indications/DBCOND0014803": "Actinomycosis"}, {"/indications/DBCOND0000387": "Anthrax"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0013893": "Bartonellosis"}, {"/indications/DBCOND0014686": "Brucellosis"}, {"/indications/DBCOND0034234": "Chlamydial Infections"}, {"/indications/DBCOND0000439": "Cholera"}, {"/indications/DBCOND0031183": "Clostridium Infections"}, {"/indications/DBCOND0005168": "Conjunctivitis, Inclusion"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0021925": "Infection caused by Campylobacter fetus"}, {"/indications/DBCOND0021394": "Infection caused by staphylococci"}, {"/indications/DBCOND0080081": "Intestinal Amebiasis"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0034253": "Meningococcal Meningitis"}, {"/indications/DBCOND0025061": "Necrotizing ulcerative gingivostomatitis"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0000445": "Plague"}, {"/indications/DBCOND0000420": "Psittacosis"}, {"/indications/DBCOND0000418": "Q Fever"}, {"/indications/DBCOND0000379": "Relapsing Fever"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0013896": "Rickettsialpox"}, {"/indications/DBCOND0000434": "Rocky Mountain Spotted Fever"}, {"/indications/DBCOND0040526": "Severe Acne Vulgaris"}, {"/indications/DBCOND0021129": "Shigella"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0000421": "Tularemia"}, {"/indications/DBCOND0013886": "Typhus"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0000236": "Yaws"}, {"/indications/DBCOND0022329": "Moderate Acne vulgaris"}], "Name": "Minocycline Hydrochloride", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000617": "Naphthacenes"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002418": "Tetracyclines"}]}, "0501050A0": {"Conditions": [{"/indications/DBCOND0040750": "Acute Bacterial Sinusitis (ABS)"}, {"/indications/DBCOND0023111": "Acute Otitis Media"}, {"/indications/DBCOND0117154": "Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections"}, {"/indications/DBCOND0021549": "Acute maxillary sinusitis caused by M. catarrhalis"}, {"/indications/DBCOND0014179": "Cervicitis"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0035308": "Conjunctivitis, Bacterial"}, {"/indications/DBCOND0059547": "Genital Ulcer Disease (GUD)"}, {"/indications/DBCOND0058270": "Pelvic Inflammatory Disease (PID)"}, {"/indications/DBCOND0010494": "Pharyngitis"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0014722": "Tonsillitis bacterial"}, {"/indications/DBCOND0033890": "Travelers' Diarrhea"}, {"/indications/DBCOND0053868": "Uncomplicated Skin and Skin Structure Infections"}, {"/indications/DBCOND0001395": "Urethritis"}], "Name": "Azithromycin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT004520": "Cytochrome P-450 CYP2A6 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0103050T0": {"Conditions": [{"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0000852": "Duodenal Ulcer"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0077290": "Gastro-esophageal Reflux Disease (GERD)"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0039707": "NSAID Associated Gastric Ulcers"}, {"/indications/DBCOND0055841": "Non-erosive Reflux Disease (NERD)"}, {"/indications/DBCOND0000825": "Zollinger-Ellison Syndrome"}], "Name": "Rabeprazole Sodium", "Categories": [{"/categories/DBCAT000768": "2-Pyridinylmethylsulfinylbenzimidazoles"}, {"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000540": "Anti-Ulcer Agents"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT002470": "Butylpyrazolidines"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT000541": "Proton Pump Inhibitors"}, {"/categories/DBCAT003638": "Proton-pump Inhibitors"}, {"/categories/DBCAT000650": "Pyrazoles"}, {"/categories/DBCAT001145": "Pyrazolones"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000769": "Sulfoxides"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}]}, "1305020I0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Coal Tar & Corticosteroid Preparations", "Categories": [{"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003796": "Keratoplastic Agents"}, {"/categories/DBCAT002027": "Tars"}]}, "0606010V0": {"Conditions": [{"/indications/DBCOND0020582": "Hypocalcemia"}, {"/indications/DBCOND0022862": "Parathyroid deficiency"}], "Name": "Parathyroid Hormone", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002102": "Calcium Homeostasis"}, {"/categories/DBCAT004967": "Calcium-Regulating Hormones and Agents"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002565": "Parathyroid Hormones and Analogues"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}]}, "1309000Q0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone-Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "1201010B0": {"Conditions": [{"/indications/DBCOND0041609": "Acute Otitis Externa"}, {"/indications/DBCOND0025199": "External ear infection NOS"}, {"/indications/DBCOND0080525": "Infection NOS"}], "Name": "Acetic Acid", "Categories": [{"/categories/DBCAT000495": "Acetates"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000197": "Indicators and Reagents"}, {"/categories/DBCAT000195": "Laboratory Chemicals"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002544": "Organic Acids"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0402010AB": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0030095": "Bipolar I Disorder"}, {"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0054747": "Generalized Anxiety Disorder (GAD)"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0033099": "Obsessive Compulsive Disorder (OCD)"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0031588": "Tardive Dyskinesia"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Quetiapine", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT001304": "Azepines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT002317": "Diazepines, Oxazepines, Thiazepines and Oxepines"}, {"/categories/DBCAT001302": "Dibenzothiazepines"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT001303": "Thiazepines"}, {"/categories/DBCAT001305": "Thiepins"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "1001010J0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0040212": "Cystic Fibrosis (CF)"}, {"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0071251": "Gastric Ulcer (GU)"}, {"/indications/DBCOND0027627": "Headaches"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0085997": "Menstrual Cramps"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0069560": "Pain, Acute"}, {"/indications/DBCOND0038696": "Patent Ductus Arteriosus (PDA)"}, {"/indications/DBCOND0007278": "Pericarditis"}, {"/indications/DBCOND0077933": "Primary Dysmenorrhoea"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Ibuprofen", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT002467": "Antiinflammatory Products for Vaginal Administration"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003907": "COX-1 Inhibitors"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000976": "Phenylpropionates"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0402010AG": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0020745": "Bipolar 1 Disorder"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0044715": "Treatment Resistant Major Depressive Disorder"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Ziprasidone Hydrochloride", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003889": "Cytochrome P-450 CYP3A4 Substrates (moderate)"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002255": "Indole Derivatives"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0905022T0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}], "Name": "Lanthanum Carbonate", "Categories": [{"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT001340": "Elements"}, {"/categories/DBCAT001864": "Kidney Failure, Chronic"}, {"/categories/DBCAT001862": "Lanthanoid Series Elements"}, {"/categories/DBCAT004830": "Lanthanum"}, {"/categories/DBCAT004585": "Metal cations"}, {"/categories/DBCAT001341": "Metals"}, {"/categories/DBCAT001863": "Metals, Rare Earth"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}]}, "0402010AE": {"Conditions": [{"/indications/DBCOND0006112": "Delusional Parasitosis"}, {"/indications/DBCOND0033299": "Schizoaffective Disorders"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Paliperidone", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000628": "Isoxazoles"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000349": "Pyrimidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0402010AD": {"Conditions": [{"/indications/DBCOND0078942": "Acute Agitation"}, {"/indications/DBCOND0020745": "Bipolar 1 Disorder"}, {"/indications/DBCOND0012283": "Irritability"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0020753": "Psychosis"}, {"/indications/DBCOND0036286": "Psychotic Depression"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0040918": "Tourette's Disorder"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Aripiprazole", "Categories": [{"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003890": "QTc shortening agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0402010AJ": {"Conditions": [{"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Cariprazine", "Categories": [{"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000734": "Serotonin 5-HT1 Receptor Agonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0402010AI": {"Conditions": [{"/indications/DBCOND0055089": "Acute Depressive Episode"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Lurasidone", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT001356": "Adrenergic alpha-2 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002255": "Indole Derivatives"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001739": "Serotonin 5-HT1 Receptor Antagonists"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000348": "Thiazoles"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0301030S0": {"Conditions": [{"/indications/DBCOND0020847": "Bronchoconstriction"}], "Name": "Theophylline", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000518": "Phosphodiesterase 5 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000507": "Purinergic Agents"}, {"/categories/DBCAT000506": "Purinergic Antagonists"}, {"/categories/DBCAT000508": "Purinergic P1 Receptor Antagonists"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003651": "Respiratory Smooth Muscle Relaxants"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}, {"/categories/DBCAT001034": "Xanthine derivatives"}, {"/categories/DBCAT002274": "Xanthines and Adrenergics"}]}, "0605010Y0": {"Conditions": [{"/indications/DBCOND0009256": "Hypogonadism"}, {"/indications/DBCOND0066992": "Infertilities"}], "Name": "Lutropin Alfa", "Categories": [{"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000107": "Gonadotropins"}, {"/categories/DBCAT004658": "Gonadotropins and Antigonadotropins"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}]}, "0408010X0": {"Conditions": [{"/indications/DBCOND0082377": "Infantile Spasms (IS)"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}, {"/indications/DBCOND0022730": "Refractory Complex partial seizures"}], "Name": "Vigabatrin", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000424": "Aminobutyrates"}, {"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT000425": "Butyrates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002301": "Fatty Acid Derivatives"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000423": "gamma-Aminobutyric Acid"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}]}, "1310020H0": {"Conditions": [{"/indications/DBCOND0005674": "Candidiasis, Cutaneous"}, {"/indications/DBCOND0024299": "Fungal infection of the dermal"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0043009": "Ringworm"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0112599": "Symptomatic Tinea Corporis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112597": "Symptomatic Tinea Cruris caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}, {"/indications/DBCOND0112595": "Symptomatic Tinea Pedis caused by Trichophyton mentagrophytes, Trichophyton rubrum, Epidermophyton floccosum"}], "Name": "Clotrimazole", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002620": "Cytochrome P-450 CYP2B6 Inhibitors (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002631": "Cytochrome P-450 CYP2E1 Inhibitors (moderate)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004500": "Cytochrome P-450 CYP3A7 Inducers (strong)"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003934": "OATP1B3 inducers"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "1001010X0": {"Conditions": [{"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Nabumetone", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT001617": "Butanones"}, {"/categories/DBCAT003908": "COX-2 Inhibitors"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000720": "Ketones"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000887": "Selective Cyclooxygenase 2 Inhibitors (NSAIDs)"}]}, "0304020Z0": {"Conditions": [{"/indications/DBCOND0078144": "Severe Eosinophilic Asthma"}], "Name": "Reslizumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT003773": "Interleukin Antagonists"}, {"/categories/DBCAT005013": "Interleukin-5"}, {"/categories/DBCAT003472": "Interleukin-5 Antagonist"}, {"/categories/DBCAT004230": "Interleukin-5 Antagonists"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0703021C0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0037449": "Polycystic Ovarian Syndrome"}], "Name": "Etynodiol Diacetate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0204000R0": {"Conditions": [{"/indications/DBCOND0021767": "Akathisia caused by antipsychotic use"}, {"/indications/DBCOND0027898": "Angina Pectoris"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0024761": "Gastroesophageal variceal hemorrhage prophylaxis"}, {"/indications/DBCOND0034319": "Hemangiomas"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0089309": "Idiopathic hypertrophic subaortic stenosis"}, {"/indications/DBCOND0017962": "Migraine"}, {"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0057747": "Obstructive Hypertrophic Cardiomyopathy"}, {"/indications/DBCOND0071223": "Performance Anxiety"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0120873": "Proliferating Infantile Hemangioma"}, {"/indications/DBCOND0070681": "Supraventricular Arrhythmias"}, {"/indications/DBCOND0021763": "Tachyarrhythmia caused by Digitalis intoxication"}, {"/indications/DBCOND0021765": "Tachyarrhythmia caused by catecholamine excess"}, {"/indications/DBCOND0000975": "Thyroid Crisis"}, {"/indications/DBCOND0021770": "Thyrotoxicosis"}, {"/indications/DBCOND0021772": "Tremor caused by lithium"}, {"/indications/DBCOND0082481": "Tremor, Essential"}, {"/indications/DBCOND0085135": "Ventricular Tachycardia (VT)"}], "Name": "Propranolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002266": "Beta Blocking Agents and Thiazides"}, {"/categories/DBCAT002338": "Beta Blocking Agents, Non-Selective"}, {"/categories/DBCAT002339": "Beta Blocking Agents, Non-Selective, and Thiazides"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT000383": "Naphthalenes"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000482": "Phenoxypropanolamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0504050T0": {"Conditions": [{"/indications/DBCOND0025524": "Dientamoeba fragilis infection"}, {"/indications/DBCOND0023106": "Hepatic coma"}, {"/indications/DBCOND0021913": "Acute Intestinal amebiasis"}, {"/indications/DBCOND0023105": "Chronic Intestinal amebiasis"}], "Name": "Paromomycin Sulfate", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000853": "Aminoglycoside Antibacterials"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}]}, "1302030N0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1104010D0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1108020X0": {"Conditions": [{"/indications/DBCOND0038690": "Adenocarcinoma of the Ovaries"}, {"/indications/DBCOND0029215": "Breast Adenocarcinoma"}, {"/indications/DBCOND0089350": "Papillary transitional cell carcinoma of bladder"}, {"/indications/DBCOND0024630": "Malignant effusion"}], "Name": "Thiotepa", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001595": "Aziridines"}, {"/categories/DBCAT000711": "Azirines"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT002621": "Cytochrome P-450 CYP2B6 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT002548": "Ethylene Imines"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000952": "Phosphoramides"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}, {"/categories/DBCAT001594": "Triethylenephosphoramide"}]}, "1104020X0": {"Conditions": [{"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}], "Name": "Emedastine", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003399": "Histamine H1 Inhibitors"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "1304000J0": {"Conditions": [{"/indications/DBCOND0070073": "Psoriasis Vulgaris (Plaque Psoriasis)"}, {"/indications/DBCOND0021673": "Corticosteroid-responsive Dermatosis"}], "Name": "Desoximetasone", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000963": "Dexamethasone"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000746": "Pregnadienediols"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}]}, "1001010S0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0032843": "Colorectal Polyps"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0025179": "Tendonitis exacerbated"}, {"/indications/DBCOND0021889": "Acute Subacromial bursitis"}, {"/indications/DBCOND0021887": "Acute supraspinatus tendinitis"}], "Name": "Sulindac", "Categories": [{"/categories/DBCAT002310": "Acetic Acid Derivatives and Related Substances"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000931": "Indenes"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "1309000K0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Pyrithione Zinc", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003920": "Gallium Radioisotopes"}, {"/categories/DBCAT000194": "Indium Radioisotopes"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT001840": "Radiopharmaceuticals"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0205051J0": {"Conditions": [{"/indications/DBCOND0000983": "Diabetic Nephropathies"}, {"/indications/DBCOND0027920": "Heart Failure"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}], "Name": "Fosinopril Sodium", "Categories": [{"/categories/DBCAT002175": "ACE Inhibitors and Diuretics"}, {"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002171": "Agents Acting on the Renin-Angiotensin System"}, {"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000415": "Angiotensin-Converting Enzyme Inhibitors"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000389": "Imines"}, {"/categories/DBCAT000388": "Imino Acids"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000924": "Phosphinic Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000927": "Proline"}, {"/categories/DBCAT000002": "Protease Inhibitors"}]}, "0411000D0": {"Conditions": [{"/indications/DBCOND0024420": "Dementia due to Parkinson's disease"}, {"/indications/DBCOND0037266": "Diffuse Lewy Body Disease"}, {"/indications/DBCOND0024419": "Mild Dementia Alzheimer's type"}, {"/indications/DBCOND0106440": "Moderate Alzheimer's Type Dementia"}, {"/indications/DBCOND0024418": "Moderate Dementia Alzheimer's type"}, {"/indications/DBCOND0106225": "Severe Alzheimer's Type Dementia"}, {"/indications/DBCOND0022235": "Severe Dementia Alzheimer's type"}], "Name": "Donepezil Hydrochloride", "Categories": [{"/categories/DBCAT002344": "Anti-Dementia Drugs"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000930": "Indans"}, {"/categories/DBCAT000931": "Indenes"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000278": "Nootropic Agents"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0407020G0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Dihydrocodeine Tartrate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0501110C0": {"Conditions": [{"/indications/DBCOND0037490": "Abscess, Intra-Abdominal"}, {"/indications/DBCOND0029985": "Acne Rosacea"}, {"/indications/DBCOND0021893": "Amebiasis"}, {"/indications/DBCOND0109271": "Anaerobic Infection"}, {"/indications/DBCOND0020464": "Bacteremia"}, {"/indications/DBCOND0055408": "Bacterial Infection Due to Helicobacter Pylori (H. Pylori)"}, {"/indications/DBCOND0071525": "Bacterial Vaginosis (BV)"}, {"/indications/DBCOND0000922": "Balantidiasis"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0014282": "Brain abscess"}, {"/indications/DBCOND0115192": "CNS Infection"}, {"/indications/DBCOND0076400": "Clostridium Difficile Infection (CDI)"}, {"/indications/DBCOND0014226": "Empyema"}, {"/indications/DBCOND0031293": "Endocarditis, Bacterial"}, {"/indications/DBCOND0000376": "Endometritis"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0083355": "Infection, Bacteroides"}, {"/indications/DBCOND0046593": "Intraabdominal Infections"}, {"/indications/DBCOND0068891": "Lower Respiratory Infection"}, {"/indications/DBCOND0014729": "Lower respiratory tract infection bacterial"}, {"/indications/DBCOND0000321": "Lung Abscess"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0117815": "Parasitic infection NOS"}, {"/indications/DBCOND0010286": "Periodontitis"}, {"/indications/DBCOND0011141": "Peritonitis bacterial"}, {"/indications/DBCOND0014196": "Pneumonia"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0000880": "Pouchitis"}, {"/indications/DBCOND0024985": "Septicemia bacterial anaerobic"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0000386": "Tetanus"}, {"/indications/DBCOND0014159": "Tubo-ovarian abscess"}, {"/indications/DBCOND0001395": "Urethritis"}, {"/indications/DBCOND0024983": "Asymptomatic Trichomoniasis"}, {"/indications/DBCOND0020657": "Entamoeba histolytica"}, {"/indications/DBCOND0025546": "Hepatic abscess"}, {"/indications/DBCOND0024987": "Refractory Sinusitis"}, {"/indications/DBCOND0024984": "Symptomatic Trichomoniasis"}], "Name": "Metronidazole", "Categories": [{"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT004528": "Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT002220": "Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT003714": "Miscellaneous Antiprotozoals"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000765": "Nitro Compounds"}, {"/categories/DBCAT003414": "Nitroimidazole Antimicrobial"}, {"/categories/DBCAT002484": "Nitroimidazole Derivatives"}, {"/categories/DBCAT001188": "Nitroimidazoles"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0501022B0": {"Conditions": [{"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0020907": "Endomyometritis"}, {"/indications/DBCOND0079459": "Gynaecological infection"}, {"/indications/DBCOND0030470": "Pelvic Infections"}, {"/indications/DBCOND0014040": "Pyelonephritis"}, {"/indications/DBCOND0035678": "Septic Abortion"}, {"/indications/DBCOND0047720": "Surgical Site Infections"}, {"/indications/DBCOND0080529": "Severe Intra-abdominal Infections"}, {"/indications/DBCOND0020905": "Severe Urinary tract infection"}, {"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Ertapenem Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT001395": "Carbapenems"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003321": "Penem Antibacterial"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1203030A0": {"Conditions": [{"/indications/DBCOND0059047": "Throat Pain"}], "Name": "Amylmetacresol", "Categories": [{"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT003735": "Miscellaneous Anti-infectives"}, {"/categories/DBCAT000420": "Phenols"}]}, "1103010T0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0015480": "Animal bite"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0051086": "Bone and Joint Infections"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0027964": "Lyme Disease"}, {"/indications/DBCOND0000354": "Maxillary Sinusitis"}, {"/indications/DBCOND0014275": "Meningitis"}, {"/indications/DBCOND0008863": "Otitis media bacterial"}, {"/indications/DBCOND0047801": "Skin and Subcutaneous Tissue Bacterial Infections"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0022787": "Mild Streptococcal pharyngitis"}, {"/indications/DBCOND0022789": "Mild Streptococcal tonsillitis"}, {"/indications/DBCOND0022786": "Moderate Streptococcal pharyngitis"}, {"/indications/DBCOND0022788": "Moderate Streptococcal tonsillitis"}], "Name": "Cefuroxime Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002239": "Second-Generation Cephalosporins"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}]}, "1310011X0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0009989": "Conjunctivitis"}, {"/indications/DBCOND0000280": "Trachoma"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Sulfacetamide Sodium", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000636": "Sulfanilamides"}, {"/categories/DBCAT003334": "Sulfonamide Antibacterial"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0301020S0": {"Conditions": [{"/indications/DBCOND0030070": "Airway Obstruction"}, {"/indications/DBCOND0029401": "Arrythmias"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0024446": "Hypersecretion gastric"}, {"/indications/DBCOND0019589": "Increased bronchial secretion"}, {"/indications/DBCOND0024444": "Muscarinic effects caused by neostigmine"}, {"/indications/DBCOND0024449": "Muscarinic effects caused by pyridostigmine"}, {"/indications/DBCOND0030389": "Neurocardiogenic Syncope"}, {"/indications/DBCOND0031662": "Peptic Ulcers"}, {"/indications/DBCOND0010371": "Salivary hypersecretion"}, {"/indications/DBCOND0024439": "Chronic, severe Salivary hypersecretion"}, {"/indications/DBCOND0021170": "Pharyngeal secretions"}], "Name": "Glycopyrronium Bromide", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT003668": "Antimuscarinics Antispasmodics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT002215": "Drugs for Functional Gastrointestinal Disorders"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002229": "Synthetic Anticholinergics, Quaternary Ammonium Compounds"}]}, "0407020Y0": {"Conditions": [{"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0020636": "Moderate Pain"}, {"/indications/DBCOND0024422": "Obstetrical analgesia during labor and delivery therapy"}], "Name": "Nalbuphine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002712": "Mixed Agonist / Antagonist Opioids"}, {"/categories/DBCAT002424": "Morphinan Derivatives"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003704": "Opiate Partial Agonists"}, {"/categories/DBCAT003382": "Opioid Agonist/Antagonist"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT003866": "Semi-synthetic Opioids"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}]}, "0701021A0": {"Conditions": [{"/indications/DBCOND0035700": "Hyperglycemias"}], "Name": "Mifepristone/Misoprostol", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT001154": "Abortifacient Agents, Steroidal"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT001156": "Luteolytic Agents"}, {"/categories/DBCAT001155": "Menstruation-Inducing Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004251": "Progestational Hormone Receptor Antagonists"}, {"/categories/DBCAT002473": "Progesterone Receptor Modulators"}, {"/categories/DBCAT003408": "Progestin Antagonist"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0801050U0": {"Conditions": [{"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0032978": "Oligodendrogliomas"}, {"/indications/DBCOND0041025": "Primary Central Nervous System Lymphoma (PCNSL)"}, {"/indications/DBCOND0111730": "Stage III Hodgkin's Disease"}, {"/indications/DBCOND0111729": "Stage IV Hodgkin's Disease"}], "Name": "Procarbazine Hydrochloride", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000775": "Benzamides and benzamide derivatives"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002513": "Methylhydrazines"}, {"/categories/DBCAT001004": "Monoamine Oxidase Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}]}, "1108030AB": {"Conditions": [{"/indications/DBCOND0089540": "Leber's hereditary optic atrophy neuropathy"}], "Name": "Idebenone", "Categories": [{"/categories/DBCAT000368": "Antioxidants"}, {"/categories/DBCAT001600": "Benzoquinones"}, {"/categories/DBCAT000223": "Coenzymes"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT002180": "Psychostimulants, Agents Used for Adhd and Nootropics"}, {"/categories/DBCAT000386": "Quinones"}]}, "1302010G0": {"Conditions": [{"/indications/DBCOND0057011": "Dermatitis, Eczematous"}, {"/indications/DBCOND0036024": "Dry Skin"}], "Name": "Arachis Oil", "Categories": [{"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000108": "Biological Products"}, {"/categories/DBCAT000109": "Complex Mixtures"}, {"/categories/DBCAT001419": "Detergents"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000299": "Oils"}, {"/categories/DBCAT001209": "Plant Oils"}, {"/categories/DBCAT001210": "Plant Preparations"}]}, "1310050L0": {"Conditions": [{"/indications/DBCOND0119333": "Vaginal atrophy with infection"}], "Name": "Chlorquinaldol", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT003171": "Chloroquinolinols"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002552": "Hydroxyquinoline Derivatives"}, {"/categories/DBCAT001262": "Hydroxyquinolines"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT001618": "Oxyquinoline"}, {"/categories/DBCAT002551": "Quinoline Derivatives"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT003420": "Standardized Chemical Allergen"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0501070I0": {"Conditions": [{"/indications/DBCOND0027917": "Bacterial Infections"}], "Name": "Colistimethate Sodium", "Categories": [{"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT003403": "Polymyxin-class Antibacterial"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}]}, "0503032D0": {"Conditions": [{"/indications/DBCOND0053690": "Chronic Hepatitis C Genotype 1"}, {"/indications/DBCOND0023725": "Chronic hepatitis C genotype 4"}], "Name": "Simeprevir", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT004597": "Antivirals for treatment of HCV infections"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004087": "Cytochrome P450 3A4 Inhibitors"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004186": "HCV NS3/4A Protease Inhibitors"}, {"/categories/DBCAT003771": "HCV Protease Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002768": "NS3/4A Protease Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT004174": "Organic Anion Transporting Polypeptide 1B1 Inhibitors"}, {"/categories/DBCAT004175": "Organic Anion Transporting Polypeptide 1B3 Inhibitors"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0601023U0": {"Conditions": [{"/indications/DBCOND0029752": "Type 2 Diabetes Mellitus"}], "Name": "Nateglinide", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000242": "Amino Acids, Essential"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000358": "Cyclohexanes"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT003395": "Glinide"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003861": "Oral Hypoglycemics"}, {"/categories/DBCAT000466": "Phenylalanine"}, {"/categories/DBCAT004105": "Potassium Channel Antagonists"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0901030C0": {"Conditions": [{"/indications/DBCOND0089208": "Chronic renal failure anemia"}], "Name": "Nandrolone Decanoate", "Categories": [{"/categories/DBCAT001012": "Anabolic Agents"}, {"/categories/DBCAT001011": "Androgens"}, {"/categories/DBCAT000089": "Bone Density Conservation Agents"}, {"/categories/DBCAT001043": "Estranes"}, {"/categories/DBCAT001042": "Estrenes"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000674": "Gonadal Hormones"}, {"/categories/DBCAT000673": "Gonadal Steroid Hormones"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT004539": "Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates"}, {"/categories/DBCAT002677": "Nandrolone and esters"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT001014": "Testosterone Congeners"}]}, "0505010D0": {"Conditions": [{"/indications/DBCOND0022064": "Ancylostoma caninum infection"}, {"/indications/DBCOND0022060": "Ancylostoma duodenale infection"}, {"/indications/DBCOND0021877": "Ascaris lumbricoides infection"}, {"/indications/DBCOND0014311": "Capillariasis"}, {"/indications/DBCOND0022058": "Enterobius vermicularis infection"}, {"/indications/DBCOND0009884": "Filariasis"}, {"/indications/DBCOND0000918": "Giardiasis"}, {"/indications/DBCOND0022061": "Necatoriasis due to necator americanus"}, {"/indications/DBCOND0051061": "Strongyloides Stercoralis Infection"}, {"/indications/DBCOND0025130": "Taenia solium infection"}, {"/indications/DBCOND0009840": "Toxocariasis"}, {"/indications/DBCOND0022059": "Whipworm infection"}], "Name": "Mebendazole", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000944": "Anthelmintics"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003367": "Antihelminthic"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002403": "Benzimidazole Derivatives"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "0408010D0": {"Conditions": [{"/indications/DBCOND0036250": "Diabetic Peripheral Neuropathic Pain (DPN)"}, {"/indications/DBCOND0020832": "Partial onset seizure Epilepsy"}], "Name": "Oxcarbazepine", "Categories": [{"/categories/DBCAT003307": "Anti-epileptic Agent"}, {"/categories/DBCAT000455": "Anticonvulsants"}, {"/categories/DBCAT004984": "Carbamazepine"}, {"/categories/DBCAT002411": "Carboxamide Derivatives"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT004152": "Decreased Central Nervous System Disorganized Electrical Activity"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT003860": "Enzyme Inducing Antiepileptic Drugs"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT003640": "Miscellaneous Anticonvulsants"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT000615": "Voltage-Gated Sodium Channel Blockers"}]}, "0208020X0": {"Conditions": [{"/indications/DBCOND0029451": "Deep Venous Thrombosis"}, {"/indications/DBCOND0025031": "Deep vein thrombosis recurrent"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0023266": "Recurrent pulmonary embolism"}, {"/indications/DBCOND0085133": "Strokes"}, {"/indications/DBCOND0077405": "Systemic Embolism"}], "Name": "Dabigatran Etexilate", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000012": "Antithrombins"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT000002": "Protease Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}, {"/categories/DBCAT000001": "Serine Proteinase Inhibitors"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004544": "UGT1A9 substrates with narrow therapeutic index"}]}, "0501021F0": {"Conditions": [{"/indications/DBCOND0040791": "Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)"}, {"/indications/DBCOND0021543": "Acute maxillary sinusitis"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0020780": "Gonorrhea"}, {"/indications/DBCOND0059550": "Otitis Media (OM)"}, {"/indications/DBCOND0056080": "Streptococcal Pharyngitis"}, {"/indications/DBCOND0021135": "Streptococcal tonsillitis"}, {"/indications/DBCOND0053856": "Uncomplicated Urinary Tract Infections"}, {"/indications/DBCOND0025265": "Uncomplicated skin and subcutaneous tissue bacterial infections"}], "Name": "Cefpodoxime", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000569": "beta-Lactams"}, {"/categories/DBCAT000566": "Cefotaxime"}, {"/categories/DBCAT000567": "Cephacetrile"}, {"/categories/DBCAT000568": "Cephalosporins"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT000851": "Prodrugs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000573": "Thiazines"}, {"/categories/DBCAT002268": "Third-Generation Cephalosporins"}]}, "0403010S0": {"Conditions": [{"/indications/DBCOND0022478": "Depressive illness"}, {"/indications/DBCOND0006119": "Dysthymic Disorder"}, {"/indications/DBCOND0059192": "Feeling Anxious"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0022479": "Manic depressive illness"}], "Name": "Maprotiline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT001196": "Anthracenes"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000347": "Antidepressive Agents, Second-Generation"}, {"/categories/DBCAT003850": "Antidepressive Agents, Tetracyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0209000Y0": {"Conditions": [{"/indications/DBCOND0048671": "Cardiovascular Events"}], "Name": "Prasugrel", "Categories": [{"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000149": "Antiplatelet agents"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004081": "Decreased Platelet Aggregation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT003400": "P2Y12 Platelet Inhibitor"}, {"/categories/DBCAT000513": "Piperazines"}, {"/categories/DBCAT002125": "Platelet Aggregation Inhibitors Excl. Heparin"}, {"/categories/DBCAT000532": "Purinergic P2Y Receptor Antagonists"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}, "1103010P0": {"Conditions": [{"/indications/DBCOND0037929": "Fungal Keratitis"}, {"/indications/DBCOND0022362": "Fungal blepharitis"}, {"/indications/DBCOND0022360": "Fungal conjunctivitis"}], "Name": "Natamycin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT004049": "Cytochrome P-450 CYP3A4 Inhibitors (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003385": "Polyene Antifungal"}, {"/categories/DBCAT003407": "Polyene Antimicrobial"}, {"/categories/DBCAT000497": "Polyketides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002132": "Stomatological Preparations"}]}, "1203030AA": {"Conditions": [{"/indications/DBCOND0112729": "Mouth infection"}, {"/indications/DBCOND0099523": "Throat infection"}], "Name": "Dichlorobenzyl Alcohol/Amylmetacresol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000417": "Benzyl Compounds"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002106": "Throat Preparations"}]}, "0106040X0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}], "Name": "Macrogol 4000", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001055": "Drug Delivery Systems"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT001371": "Ethylene Glycols"}, {"/categories/DBCAT001545": "Excipients"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT004540": "Pegylated agents"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT001429": "Pharmaceutical Vehicles"}, {"/categories/DBCAT001605": "Polyethylene Glycols"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT004092": "Stimulation Large Intestine Fluid/Electrolyte Secretion"}, {"/categories/DBCAT000898": "Surface-Active Agents"}]}, "0301040P0": {"Conditions": [{"/indications/DBCOND0000492": "Adams-Stokes Syndrome"}, {"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0031003": "Cardiac Arrest"}, {"/indications/DBCOND0115251": "Cardiac electrical storm"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0032425": "Heart Block"}, {"/indications/DBCOND0020135": "Hypoperfusion"}, {"/indications/DBCOND0000550": "Shock, Cardiogenic"}, {"/indications/DBCOND0000299": "Shock, Septic"}, {"/indications/DBCOND0070941": "Symptomatic Bradycardia"}, {"/indications/DBCOND0007621": "Syncope"}, {"/indications/DBCOND0000480": "Torsades de Pointes"}, {"/indications/DBCOND0102378": "Arrhythmia of ventricular origin"}, {"/indications/DBCOND0022711": "Beta blocker overdose"}], "Name": "Isoprenaline Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT002217": "Adrenergic and Dopaminergic Agents"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002232": "Adrenergics for Systemic Use"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT002218": "Cardiac Stimulants Excl. Cardiac Glycosides"}, {"/categories/DBCAT002210": "Cardiac Therapy"}, {"/categories/DBCAT000589": "Cardiotonic Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000467": "Catecholamines"}, {"/categories/DBCAT000419": "Catechols"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003747": "Non-selective Beta-adrenergic Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000438": "Sympathomimetics"}]}, "0901030Q0": {"Conditions": [{"/indications/DBCOND0112590": "Anemia caused by Zidovudine"}, {"/indications/DBCOND0031070": "Anemias"}], "Name": "Epoetin Zeta", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT002721": "Erythropoiesis-Stimulating Agents"}, {"/categories/DBCAT000081": "Erythropoietin"}, {"/categories/DBCAT004684": "Erythropoietin, genetics"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT004159": "Increased Erythroid Cell Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}]}, "0505030A0": {"Conditions": [{"/indications/DBCOND0004279": "Ascariasis"}, {"/indications/DBCOND0030923": "Hookworm Infection"}, {"/indications/DBCOND0021473": "Hydatid disease caused by Echinococcus granulosus"}, {"/indications/DBCOND0021470": "Neurocysticercosis caused by Taenia solium"}, {"/indications/DBCOND0021474": "Other specified protozoal diseases"}], "Name": "Albendazole", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000944": "Anthelmintics"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000945": "Anticestodal Agents"}, {"/categories/DBCAT003367": "Antihelminthic"}, {"/categories/DBCAT000715": "Antimitotic Agents"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT000943": "Antiplatyhelmintic Agents"}, {"/categories/DBCAT002403": "Benzimidazole Derivatives"}, {"/categories/DBCAT000770": "Benzimidazoles"}, {"/categories/DBCAT000800": "Carbamates"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT004391": "Cytochrome P450 1A Inducers"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000716": "Mitosis Modulators"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000718": "Tubulin Modulators"}]}, "0106050N0": {"Conditions": [{"/indications/DBCOND0081526": "Acute Renal Failure (ARF)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0021121": "Increased intraocular pressure"}], "Name": "Mannitol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT001104": "Diuretics, Osmotic"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT000376": "Flavoring Agents"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000377": "Food Additives"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT004977": "Food Ingredients"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT002460": "i.v. Solutions"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003715": "Kidney Function"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004090": "Osmotic Activity"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT001240": "Pharmaceutic Aids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT002459": "Solutions Producing Osmotic Diuresis"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT000378": "Sweetening Agents"}]}, "1304000V0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0022248": "Allergic corneal marginal ulcers"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0067874": "Anterior Segment Inflammation"}, {"/indications/DBCOND0075845": "Aspiration Pneumonitis"}, {"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0067007": "Atopic Dermatitis (AD)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0054010": "Corneal Inflammation"}, {"/indications/DBCOND0052193": "Crohn's Disease (CD)"}, {"/indications/DBCOND0039390": "Dermatitis, Contact"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0022247": "Drug hypersensitivity reaction"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0022033": "Erythroblastopenia"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0032017": "Idiopathic Thrombocytopenic Purpura (ITP)"}, {"/indications/DBCOND0001138": "Iridocyclitis"}, {"/indications/DBCOND0001139": "Iritis"}, {"/indications/DBCOND0091792": "Leukemia, Acute"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0006372": "Loeffler's syndrome"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0027863": "Optic Neuritis"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0022017": "Primary adrenocortical insufficiency"}, {"/indications/DBCOND0018907": "Proteinuria"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021971": "Rheumatic heart disease, unspecified"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0009391": "Secondary adrenocortical insufficiency"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0005745": "Serum Sickness"}, {"/indications/DBCOND0067529": "Severe Seborrheic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0016437": "Synovitis"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021949": "Acute Bursitis"}, {"/indications/DBCOND0021950": "Acute Tenosynovitis"}, {"/indications/DBCOND0022016": "Diffuse posterior uveitis"}, {"/indications/DBCOND0106168": "Disseminated Pulmonary Tuberculosis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0106167": "Fulminating Pulmonary Tuberculosis"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021323": "Severe Psoriasis"}, {"/indications/DBCOND0022034": "Subacute Bursitis"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0022031": "Systemic Dermatomyositis"}, {"/indications/DBCOND0022604": "Varicella-zoster virus acute retinal necrosis"}], "Name": "Hydrocortisone", "Categories": [{"/categories/DBCAT001068": "11-Hydroxycorticosteroids"}, {"/categories/DBCAT001070": "17-Hydroxycorticosteroids"}, {"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002425": "Corticosteroids for Local Oral Treatment"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002458": "Corticosteroids, Weak (Group I)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT001067": "Hydrocortisone and derivatives"}, {"/categories/DBCAT001069": "Hydroxycorticosteroids"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000827": "Pregnenediones"}, {"/categories/DBCAT000828": "Pregnenes"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "1202010Q0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0080546": "Itching of the eye"}], "Name": "Nedocromil Sodium", "Categories": [{"/categories/DBCAT001093": "4-Quinolones"}, {"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002453": "Antiallergic Agents, Excl. Corticosteroids"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT004192": "Decreased Histamine Release"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002745": "Mast Cell Stabilizers"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000903": "Quinolones"}, {"/categories/DBCAT003611": "Respiratory Agents, Miscellaneous"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0202010V0": {"Conditions": [{"/indications/DBCOND0020707": "Edema"}, {"/indications/DBCOND0035554": "Mild Hypertension"}, {"/indications/DBCOND0021489": "Moderate Hypertension"}], "Name": "Metolazone", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT002300": "Low-Ceiling Diuretics and Potassium-Sparing Agents"}, {"/categories/DBCAT002299": "Low-Ceiling Diuretics, Excl. Thiazides"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003863": "Non Potassium Sparing Diuretics"}, {"/categories/DBCAT000883": "Quinazolines"}, {"/categories/DBCAT000948": "Quinazolinones"}, {"/categories/DBCAT000577": "Sodium Chloride Symporter Inhibitors"}, {"/categories/DBCAT000514": "Sulfonamides"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT003322": "Thiazide-like Diuretic"}]}, "1001030AA": {"Conditions": [{"/indications/DBCOND0032162": "Oral Ulcers"}, {"/indications/DBCOND0025138": "Psoriatic arthritis aggravated"}, {"/indications/DBCOND0025583": "Severe Plaque psoriasis"}, {"/indications/DBCOND0020390": "Moderate Plaque psoriasis"}], "Name": "Apremilast", "Categories": [{"/categories/DBCAT004569": "Agents reducing cytokine levels"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000724": "Isoindoles"}, {"/categories/DBCAT001410": "Phosphodiesterase 4 Inhibitors"}, {"/categories/DBCAT000509": "Phosphodiesterase Inhibitors"}, {"/categories/DBCAT000722": "Phthalimides"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}]}, "0503031B0": {"Conditions": [{"/indications/DBCOND0060842": "Hepatitis B Chronic Infection"}], "Name": "Entecavir", "Categories": [{"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003351": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT003686": "Nucleosides and Nucleotides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}]}, "1001030AC": {"Conditions": [{"/indications/DBCOND0023311": "Moderate, active Rheumatoid arthritis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Baricitinib", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT001212": "Azetines"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT003500": "Janus Kinase Inhibitor"}, {"/categories/DBCAT004108": "Janus Kinase Inhibitors"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003954": "MATE 2 Substrates"}, {"/categories/DBCAT004526": "MATE 2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1001030AB": {"Conditions": [{"/indications/DBCOND0020318": "Moderate Rheumatoid arthritis"}, {"/indications/DBCOND0020317": "Severe Rheumatoid arthritis"}], "Name": "Tofacitinib", "Categories": [{"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT001910": "Janus Kinase 3, antagonists & inhibitors"}, {"/categories/DBCAT003500": "Janus Kinase Inhibitor"}, {"/categories/DBCAT004108": "Janus Kinase Inhibitors"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT002129": "Selective Immunosuppressants"}]}, "1001030AD": {"Conditions": [{"/indications/DBCOND0023311": "Moderate, active Rheumatoid arthritis"}, {"/indications/DBCOND0020226": "Severe, active Rheumatoid arthritis"}], "Name": "Sarilumab", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000016": "Antibodies"}, {"/categories/DBCAT000015": "Antibodies, Monoclonal"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003020": "Biologics for Rheumatoid Arthritis Treatment"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002718": "Cytochrome P-450 CYP3A4 Inducers (weak)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003604": "Disease-modifying Antirheumatic Agents"}, {"/categories/DBCAT000022": "Globulins"}, {"/categories/DBCAT000017": "Immunoglobulins"}, {"/categories/DBCAT000023": "Immunoproteins"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT004312": "Interleukin 6 Receptor Antagonists"}, {"/categories/DBCAT002105": "Interleukin Inhibitors"}, {"/categories/DBCAT003466": "Interleukin-6 Receptor Antagonist"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000018": "Serum Globulins"}]}, "0901011H0": {"Conditions": [{"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Ferrous Gluconate", "Categories": [{"/categories/DBCAT001390": "Anemia, Iron-Deficiency"}, {"/categories/DBCAT003764": "Antianemia Drugs"}, {"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT002537": "Iron Bivalent, Oral Preparations"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}]}, "1902070Q0": {"Conditions": [{"/indications/DBCOND0030983": "Opioid Dependence"}, {"/indications/DBCOND0058333": "Opioid Overdose"}, {"/indications/DBCOND0020815": "Pruritis"}, {"/indications/DBCOND0034868": "Respiratory Depression"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0000299": "Shock, Septic"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Naloxone Hydrochloride", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000900": "Antidotes"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003815": "Cytochrome P-450 CYP3A Inhibitors (strong)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002647": "Cytochrome P-450 CYP3A4 Inhibitors (strong)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003713": "Opiate Antagonists"}, {"/categories/DBCAT000935": "Opioid Antagonists"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002566": "Peripheral Opioid Receptor Antagonists"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}]}, "0304010E0": {"Conditions": [{"/indications/DBCOND0034084": "Pollen Allergy"}, {"/indications/DBCOND0084837": "Seasonal Allergic Rhinitis (SAR)"}, {"/indications/DBCOND0112020": "Chronic, uncomplicated Idiopathic urticaria"}], "Name": "Fexofenadine Hydrochloride", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000772": "Histamine H1 Antagonists, Non-Sedating"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002661": "OAT3/SLC22A8 Substrates"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0309010C0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Codeine Phosphate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000738": "Antitussive Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002303": "Cough and Cold Preparations"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000690": "Morphinans"}, {"/categories/DBCAT000689": "Morphine Derivatives"}, {"/categories/DBCAT000479": "Narcotics"}, {"/categories/DBCAT002292": "Natural Opium Alkaloids"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT004549": "OCT1 inhibitors"}, {"/categories/DBCAT004550": "OCT1 substrates"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000692": "Opiate Alkaloids"}, {"/categories/DBCAT003293": "Opioid Agonist"}, {"/categories/DBCAT000480": "Opioids"}, {"/categories/DBCAT002302": "Opium Alkaloids and Derivatives"}, {"/categories/DBCAT000691": "Phenanthrenes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0501100H0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0066235": "Bullous Systemic Lupus Erythematosus"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0064479": "Hansen's Disease"}, {"/indications/DBCOND0040643": "Pemphigus Vulgaris (PV)"}, {"/indications/DBCOND0045626": "Relapsing Polychondritis"}, {"/indications/DBCOND0020761": "Mild Pneumocystis pneumonia"}, {"/indications/DBCOND0020766": "Mild Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0020760": "Moderate Pneumocystis pneumonia"}, {"/indications/DBCOND0020765": "Moderate Toxoplasma gondii encephalitis"}, {"/indications/DBCOND0020771": "Refractory Idiopathic thrombocytopenic purpura"}], "Name": "Dapsone", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002257": "Drugs for Treatment of Lepra"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000523": "Folic Acid Antagonists"}, {"/categories/DBCAT000611": "Leprostatic Agents"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003644": "Miscellaneous Antimycobacterials"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1203040M0": {"Conditions": [{"/indications/DBCOND0020975": "Skin-structure infections"}], "Name": "Povidone-Iodine", "Categories": [{"/categories/DBCAT000364": "Alkenes"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000103": "Anti-Infective Agents, Local"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002319": "Antiseptics and Disinfectants"}, {"/categories/DBCAT000806": "Biomedical and Dental Materials"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000365": "Hydrocarbons, Acyclic"}, {"/categories/DBCAT001846": "Iodine Compounds"}, {"/categories/DBCAT002559": "Iodine Products"}, {"/categories/DBCAT001868": "Iodophors"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT000809": "Macromolecular Substances"}, {"/categories/DBCAT002321": "Medicated Dressings"}, {"/categories/DBCAT002320": "Medicated Dressings With Antiinfectives"}, {"/categories/DBCAT002574": "Medicated Shampoos"}, {"/categories/DBCAT003645": "Miscellaneous Local Anti-infectives"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT001360": "Plastics"}, {"/categories/DBCAT000363": "Polyenes"}, {"/categories/DBCAT000805": "Polymers"}, {"/categories/DBCAT001870": "Polyvinyls"}, {"/categories/DBCAT001869": "Povidone"}, {"/categories/DBCAT000663": "Pyrrolidines"}, {"/categories/DBCAT000973": "Pyrrolidinones"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT001871": "Vinyl Compounds"}]}, "0101012B0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0023033": "Barbiturate intoxication"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0003949": "Hyperkalemia"}, {"/indications/DBCOND0043658": "Metabolic Acidosis"}, {"/indications/DBCOND0024301": "Pruritis of the skin"}, {"/indications/DBCOND0062614": "Skin Irritation"}, {"/indications/DBCOND0023032": "Upset stomach"}, {"/indications/DBCOND0023035": "Methyl alcohol poisoning"}, {"/indications/DBCOND0023038": "Prophylaxis of Contrast-induced nephropathy"}, {"/indications/DBCOND0023034": "Salicylate poisoning"}, {"/indications/DBCOND0023036": "Severe Diarrhea"}], "Name": "Sodium Bicarbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT001354": "Bicarbonates"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT002150": "Blood Substitutes and Perfusion Solutions"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002438": "Electrolyte Solutions"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT003718": "Hemodialysis Solution"}, {"/categories/DBCAT002149": "I.V. Solution Additives"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT003315": "Radiographic Contrast Agent"}, {"/categories/DBCAT002528": "Salt Solutions"}, {"/categories/DBCAT001355": "Sodium Compounds"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "0901011F0": {"Conditions": [{"/indications/DBCOND0047602": "Iron Deficiency Anemia (IDA)"}], "Name": "Ferrous Fumarate", "Categories": [{"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT002537": "Iron Bivalent, Oral Preparations"}, {"/categories/DBCAT000754": "Iron Compounds"}, {"/categories/DBCAT002144": "Iron Preparations"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT000755": "Organometallic Compounds"}, {"/categories/DBCAT000235": "Physiological Phenomena"}, {"/categories/DBCAT001391": "Trace Elements"}]}, "0701010D0": {"Conditions": [{"/indications/DBCOND0021187": "Refractory postpartum uterine hemorrhage"}], "Name": "Carboprost", "Categories": [{"/categories/DBCAT000854": "Abortifacient Agents"}, {"/categories/DBCAT000855": "Abortifacient Agents, Nonsteroidal"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000350": "Eicosanoids"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000300": "Fatty Acids, Unsaturated"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT000877": "Glycols"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000876": "Propylene Glycols"}, {"/categories/DBCAT000353": "Prostaglandins"}, {"/categories/DBCAT000676": "Prostaglandins F, Synthetic"}, {"/categories/DBCAT000677": "Prostaglandins, Synthetic"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002676": "Tromethamine"}, {"/categories/DBCAT000218": "Uterotonic agents"}]}, "0503010N0": {"Conditions": [{"/indications/DBCOND0045921": "Human Immunodeficiency Virus Type 1 (HIV-1) Infection"}], "Name": "Didanosine", "Categories": [{"/categories/DBCAT000124": "Anti-HIV Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000123": "Anti-Retroviral Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000276": "Antimetabolites"}, {"/categories/DBCAT000066": "Antiviral Agents"}, {"/categories/DBCAT002141": "Antivirals for Systemic Use"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000597": "Deoxyribonucleosides"}, {"/categories/DBCAT000928": "Dideoxynucleosides"}, {"/categories/DBCAT002140": "Direct Acting Antivirals"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000257": "Glycosides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003359": "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor"}, {"/categories/DBCAT001184": "Inosine"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT000256": "Nucleic Acids, Nucleotides, and Nucleosides"}, {"/categories/DBCAT002376": "Nucleoside and Nucleotide Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT002755": "Nucleoside Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000255": "Nucleosides"}, {"/categories/DBCAT003904": "OAT1/SLC22A6 Substrates"}, {"/categories/DBCAT000252": "Purine Nucleosides"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000594": "Reverse Transcriptase Inhibitors"}, {"/categories/DBCAT000258": "Ribonucleosides"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0505050P0": {"Conditions": [{"/indications/DBCOND0026172": "Cestode infections"}, {"/indications/DBCOND0022685": "Cysticercosis"}, {"/indications/DBCOND0022684": "Liver fluke infection"}, {"/indications/DBCOND0027225": "Trematode infections"}, {"/indications/DBCOND0022683": "Schistosoma infection"}], "Name": "Praziquantel", "Categories": [{"/categories/DBCAT000944": "Anthelmintics"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT003367": "Antihelminthic"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002496": "Antitrematodals"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002495": "Quinoline Derivatives and Related Substances"}]}, "1307000M0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0601012S0": {"Conditions": [{"/indications/DBCOND0063084": "Diabetes Mellitus (DM)"}], "Name": "Isophane Insulin", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002698": "Blood Glucose Lowering Agents"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT004504": "Cytochrome P-450 CYP1A2 Inducers (unknown strength)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002117": "Drugs Used in Diabetes"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000170": "Insulin"}, {"/categories/DBCAT000135": "Insulin, Short-Acting"}, {"/categories/DBCAT002116": "Insulins and Analogues"}, {"/categories/DBCAT003127": "Insulins and Analogues for Inhalation"}, {"/categories/DBCAT002120": "Insulins and Analogues for Injection, Fast-Acting"}, {"/categories/DBCAT002119": "Insulins and Analogues for Injection, Intermediate- or Long-Acting Combined With Fast-Acting"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}]}, "0401020G0": {"Conditions": [{"/indications/DBCOND0021352": "Acute Anxiety"}, {"/indications/DBCOND0023114": "Severe Anxiety"}], "Name": "Bromazepam", "Categories": [{"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000449": "Benzodiazepinones"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002178": "Muscle Relaxants"}, {"/categories/DBCAT002177": "Muscle Relaxants, Centrally Acting Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}]}, "0704050G0": {"Conditions": [{"/indications/DBCOND0012298": "Mobility decreased"}], "Name": "Apomorphine Hydrochloride", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT002867": "Anti-Parkinson Agents (Dopamine Agonist)"}, {"/categories/DBCAT002254": "Anti-Parkinson Drugs"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT001090": "Aporphines"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT001091": "Benzylisoquinolines"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000607": "Dopamine Agonists"}, {"/categories/DBCAT002206": "Drugs Used in Erectile Dysfunction"}, {"/categories/DBCAT001092": "Emetics"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000551": "Isoquinolines"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003649": "Nonergot-derivative Dopamine Receptor Agonists"}, {"/categories/DBCAT003632": "Opiate Agonists"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT002207": "Urologicals"}]}, "0504010G0": {"Conditions": [{"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0080562": "Extraintestinal Amebiasis"}, {"/indications/DBCOND0034555": "Plasmodium Infections"}, {"/indications/DBCOND0037230": "Polymorphic Light Eruption (PLE)"}, {"/indications/DBCOND0000759": "Porphyria Cutanea Tarda"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0013300": "Sarcoidosis"}, {"/indications/DBCOND0021892": "Acute, uncomplicated Malaria"}], "Name": "Chloroquine Sulfate", "Categories": [{"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT003930": "Agents that produce neuromuscular block (indirect)"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT001655": "alpha-Galactosidase, antagonists & inhibitors"}, {"/categories/DBCAT000999": "Amebicides"}, {"/categories/DBCAT000997": "Aminoquinolines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000524": "Antimalarials"}, {"/categories/DBCAT000986": "Antinematodal Agents"}, {"/categories/DBCAT000522": "Antiparasitic Agents"}, {"/categories/DBCAT002212": "Antiparasitic Products, Insecticides and Repellents"}, {"/categories/DBCAT002211": "Antiprotozoals"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT001399": "Chloroquine"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000998": "Filaricides"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000788": "Quinolines"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "0208010K0": {"Conditions": [{"/indications/DBCOND0022770": "Clotting"}, {"/indications/DBCOND0022765": "Consumption coagulopathy"}, {"/indications/DBCOND0052606": "Disseminated Intravascular Coagulation (DIC)"}, {"/indications/DBCOND0028936": "Interstitial Cystitis"}, {"/indications/DBCOND0035304": "Pulmonary Embolism (PE)"}, {"/indications/DBCOND0048867": "ST Elevation Myocardial Infarction (STEMI)"}, {"/indications/DBCOND0022145": "Thromboembolism"}, {"/indications/DBCOND0034329": "Thrombosis, Venous"}, {"/indications/DBCOND0032056": "Unstable Angina Pectoris"}, {"/indications/DBCOND0047323": "Venous Thromboembolism (VTE)"}, {"/indications/DBCOND0022766": "Embolization"}, {"/indications/DBCOND0022767": "Peripheral arterial embolism"}], "Name": "Heparin Sodium", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT002393": "Antivaricose Therapy"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT001272": "Glycosaminoglycans"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT001307": "Heparin and similars"}, {"/categories/DBCAT002505": "Heparin Group"}, {"/categories/DBCAT002743": "Heparins"}, {"/categories/DBCAT002447": "Heparins or Heparinoids for Topical Use"}, {"/categories/DBCAT003605": "Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000669": "Polysaccharides"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0905011D0": {"Conditions": [{"/indications/DBCOND0023031": "Acid indigestion"}, {"/indications/DBCOND0004515": "Heartburn"}, {"/indications/DBCOND0015896": "Hyperphosphataemia"}, {"/indications/DBCOND0023344": "Sour stomach"}], "Name": "Calcium Carbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001346": "Alkalies"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT001353": "Antacids"}, {"/categories/DBCAT003760": "Antacids and Adsorbents"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT001284": "Calcium Compounds"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT001345": "Carbon Compounds, Inorganic"}, {"/categories/DBCAT001343": "Carbonates"}, {"/categories/DBCAT001344": "Carbonic Acid"}, {"/categories/DBCAT002221": "Drugs for Acid Related Disorders"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT003882": "Gastric Acid Lowering Agents"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT004552": "Polyvalent cation containing laxatives, antacids, oral supplements"}, {"/categories/DBCAT003709": "Replacement Preparations"}]}, "1202030R0": {"Conditions": [{"/indications/DBCOND0000235": "Impetigo"}, {"/indications/DBCOND0106112": "Impetigo caused by Staphylococccus aureus"}, {"/indications/DBCOND0106113": "Impetigo caused by streptococcus pyogenes"}, {"/indications/DBCOND0021118": "Secondary infection Skin infection"}, {"/indications/DBCOND0024316": "Staphylococcus aurea colonization of the nasal passage"}], "Name": "Mupirocin", "Categories": [{"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002363": "Antibiotics for Topical Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000834": "Epoxy Compounds"}, {"/categories/DBCAT000562": "Ethers"}, {"/categories/DBCAT000835": "Ethers, Cyclic"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT004737": "Mupirocin"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT000371": "Pyrans"}, {"/categories/DBCAT003344": "RNA Synthetase Inhibitor Antibacterial"}, {"/categories/DBCAT004255": "RNA Synthetase Inhibitors"}]}, "0905022C0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}], "Name": "Calcium Acetate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001614": "Arylsulfonates"}, {"/categories/DBCAT001615": "Arylsulfonic Acids"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0901040B0": {"Conditions": [{"/indications/DBCOND0023252": "Chronic immune thrombocytopenia"}, {"/indications/DBCOND0021524": "Refractory immune thrombocytopenia"}], "Name": "Romiplostim", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT000082": "Colony-Stimulating Factors"}, {"/categories/DBCAT000079": "Cytokines"}, {"/categories/DBCAT000084": "Glycoconjugates"}, {"/categories/DBCAT000083": "Glycoproteins"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000086": "Hematopoietic Cell Growth Factors"}, {"/categories/DBCAT000115": "Hemostatics"}, {"/categories/DBCAT004193": "Increased Megakaryocyte Maturation"}, {"/categories/DBCAT004194": "Increased Platelet Production"}, {"/categories/DBCAT000080": "Intercellular Signaling Peptides and Proteins"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000030": "Receptors, Cell Surface"}, {"/categories/DBCAT000029": "Receptors, Immunologic"}, {"/categories/DBCAT001695": "Receptors, Thrombopoietin, agonists"}, {"/categories/DBCAT000097": "Recombinant Proteins"}, {"/categories/DBCAT003455": "Thrombopoietin Receptor Agonist"}, {"/categories/DBCAT004195": "Thrombopoietin Receptor Agonists"}]}, "0502040A0": {"Conditions": [{"/indications/DBCOND0056521": "Bloodstream Infections"}, {"/indications/DBCOND0000135": "Candidemia"}, {"/indications/DBCOND0040096": "Esophageal Candidiasis"}, {"/indications/DBCOND0114657": "Fungal peritonitis caused by Candida"}, {"/indications/DBCOND0114656": "Intraabdominal Abscess caused by Candida"}, {"/indications/DBCOND0031838": "Invasive Aspergillosis"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0024242": "Prophylaxis of Candida Infections"}], "Name": "Anidulafungin", "Categories": [{"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003336": "Echinocandin Antifungal"}, {"/categories/DBCAT003671": "Echinocandins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}]}, "020400070": {"Conditions": [{"/indications/DBCOND0040606": "Nonvalvular Atrial Fibrillation"}, {"/indications/DBCOND0029078": "Tachycardia, Supraventricular"}, {"/indications/DBCOND0020631": "Intraoperative Hypertension"}, {"/indications/DBCOND0020628": "Intraoperative Tachycardia"}, {"/indications/DBCOND0020634": "Noncompensatory Sinus tachycardia"}, {"/indications/DBCOND0020632": "Postoperative Hypertension"}, {"/indications/DBCOND0020630": "Postoperative Tachycardia"}], "Name": "Esmolol Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000458": "Adrenergic beta-1 Receptor Antagonists"}, {"/categories/DBCAT000456": "Adrenergic beta-Antagonists"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT002186": "Beta Blocking Agents, Selective"}, {"/categories/DBCAT002681": "Beta-Blockers (Beta1 Selective)"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT000484": "Propanols"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0501090R0": {"Conditions": [{"/indications/DBCOND0013142": "Cholestatic pruritus"}, {"/indications/DBCOND0036907": "MRSA Infection"}, {"/indications/DBCOND0042748": "Prosthetic Joint Infection"}, {"/indications/DBCOND0025409": "Asymptomatic Neisseria meningitidis carrier of the nasopharynx"}, {"/indications/DBCOND0025405": "Initial phase Tuberculosis"}, {"/indications/DBCOND0025407": "Late phase Tuberculosis"}], "Name": "Rifampicin", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000630": "Antibiotics, Antitubercular"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002244": "Antimycobacterials"}, {"/categories/DBCAT003667": "Antituberculosis Agents"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT000614": "Cytochrome P-450 CYP1A2 Inducers"}, {"/categories/DBCAT002612": "Cytochrome P-450 CYP1A2 Inducers (strong)"}, {"/categories/DBCAT002617": "Cytochrome P-450 CYP2A6 Inducers"}, {"/categories/DBCAT003105": "Cytochrome P-450 CYP2A6 Inducers (moderate)"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT002622": "Cytochrome P-450 CYP2B6 Inducers (strong)"}, {"/categories/DBCAT001246": "Cytochrome P-450 CYP2C19 Inducers"}, {"/categories/DBCAT002641": "Cytochrome P-450 CYP2C19 Inducers (strong)"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT002645": "Cytochrome P-450 CYP2C8 Inducers (strong)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT001245": "Cytochrome P-450 CYP2C9 Inducers"}, {"/categories/DBCAT004527": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)"}, {"/categories/DBCAT002626": "Cytochrome P-450 CYP2D6 Inducers"}, {"/categories/DBCAT004509": "Cytochrome P-450 CYP2D6 Inducers (strength unknown)"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003816": "Cytochrome P-450 CYP3A Inducers (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT002649": "Cytochrome P-450 CYP3A4 Inducers (strong)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004491": "Cytochrome P-450 CYP3A5 Inducers (strong)"}, {"/categories/DBCAT004499": "Cytochrome P-450 CYP3A7 Inducers"}, {"/categories/DBCAT004500": "Cytochrome P-450 CYP3A7 Inducers (strong)"}, {"/categories/DBCAT004501": "Cytochrome P-450 CYP3A7 Inducers (weak)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002243": "Drugs for Treatment of Tuberculosis"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000570": "Lactams"}, {"/categories/DBCAT001006": "Lactams, Macrocyclic"}, {"/categories/DBCAT000611": "Leprostatic Agents"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT000593": "Nucleic Acid Synthesis Inhibitors"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT003433": "Rifamycin Antibacterial"}, {"/categories/DBCAT001005": "Rifamycins"}, {"/categories/DBCAT003925": "UGT1A1 Inducers"}, {"/categories/DBCAT003967": "UGT1A9 Inducers"}]}, "0406000H0": {"Conditions": [{"/indications/DBCOND0025341": "Labyrinthine disorder"}, {"/indications/DBCOND0066647": "Meni\u00e8re's Disease"}, {"/indications/DBCOND0035529": "Motion Sickness"}, {"/indications/DBCOND0028521": "Nausea and vomiting"}, {"/indications/DBCOND0050669": "Post-Operative Nausea and Vomiting (PONV)"}, {"/indications/DBCOND0022946": "Radiation therapy induced nausea and vomiting"}], "Name": "Dimenhydrinate", "Categories": [{"/categories/DBCAT000443": "Alkaloids"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000454": "Antiemetics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000721": "Benzhydryl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT001217": "Diphenhydramine"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000896": "Pharmaceutical Preparations"}, {"/categories/DBCAT000253": "Purines"}, {"/categories/DBCAT000504": "Purinones"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "040201020": {"Conditions": [{"/indications/DBCOND0030827": "Schizophrenic Disorders"}], "Name": "Tiotixene", "Categories": [{"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002672": "Antipsychotic Agents (First Generation [Typical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000436": "Dopamine Agents"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT002478": "Thioxanthene Derivatives"}, {"/categories/DBCAT001167": "Thioxanthenes"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT001074": "Xanthenes"}]}, "1003020E0": {"Conditions": [{"/indications/DBCOND0030938": "Warts"}], "Name": "Cantharidin", "Categories": [{"/categories/DBCAT000546": "Benzofurans"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT001178": "Irritants"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0901020G0": {"Conditions": [{"/indications/DBCOND0034979": "Neural Tube Defects (NTDs)"}, {"/indications/DBCOND0022071": "Methotrexate toxicity"}], "Name": "Folic Acid", "Categories": [{"/categories/DBCAT002099": "Antianemic Preparations"}, {"/categories/DBCAT000351": "Autacoids"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT000234": "Diet, Food, and Nutrition"}, {"/categories/DBCAT002740": "Dietary Supplements"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT004537": "Folic Acid"}, {"/categories/DBCAT001033": "Folic Acid and Derivatives"}, {"/categories/DBCAT000232": "Food"}, {"/categories/DBCAT000233": "Food and Beverages"}, {"/categories/DBCAT000214": "Growth Substances"}, {"/categories/DBCAT000087": "Hematinics"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000352": "Inflammation Mediators"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT000231": "Micronutrients"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT000332": "Pigments, Biological"}, {"/categories/DBCAT000333": "Pteridines"}, {"/categories/DBCAT000354": "Pterins"}, {"/categories/DBCAT002729": "Supplements"}, {"/categories/DBCAT000236": "Vitamin B Complex"}, {"/categories/DBCAT004535": "VITAMIN B12 AND FOLIC ACID"}, {"/categories/DBCAT000230": "Vitamins"}]}, "1306010C0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0029828": "Acne Vulgaris"}], "Name": "Benzoyl Peroxide", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT002029": "Peroxides"}]}, "1106000AB": {"Conditions": [{"/indications/DBCOND0034700": "Elevated Intraocular Pressure"}], "Name": "Dorzolamide & Timolol", "Categories": [{"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000410": "Antihypertensive Agents"}, {"/categories/DBCAT000727": "Carbonic Anhydrase Inhibitors"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000515": "Sulfones"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "0602010T0": {"Conditions": [{"/indications/DBCOND0009036": "Hypothyroidism"}, {"/indications/DBCOND0020856": "Myxedema coma"}, {"/indications/DBCOND0020853": "Euthyroid Goitre"}, {"/indications/DBCOND0021309": "Thyrotropin dependent Thyroid cancer"}], "Name": "Levothyroxine Sodium & Potassium Iodide", "Categories": [{"/categories/DBCAT004965": "Agents used to treat hypothyroidism"}, {"/categories/DBCAT000243": "Amino Acids"}, {"/categories/DBCAT000262": "Amino Acids, Aromatic"}, {"/categories/DBCAT000244": "Amino Acids, Cyclic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002644": "Cytochrome P-450 CYP2C8 Inhibitors (moderate)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT002666": "P-glycoprotein/ABCB1 Inducers"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002707": "Thyroid Products"}, {"/categories/DBCAT004601": "Thyroxine-binding globulin substrates"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004530": "UGT1A1 substrates with narrow therapeutic index"}]}, "0301011U0": {"Conditions": [{"/indications/DBCOND0072519": "Asthma Bronchial"}, {"/indications/DBCOND0031289": "Chronic Obstructive Pulmonary Disease (COPD)"}, {"/indications/DBCOND0062491": "Exercise-Induced Bronchoconstriction (EIB)"}], "Name": "Salmeterol", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT002231": "Adrenergics, Inhalants"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT002866": "Agents to Treat Airway Disease"}, {"/categories/DBCAT001198": "Albuterol"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000555": "Bronchodilator Agents"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT002643": "Cytochrome P-450 CYP2C8 Inhibitors (strong)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT000270": "Ethanolamines"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT003723": "Selective Beta 2-adrenergic Agonists"}, {"/categories/DBCAT003677": "Sympathomimetic (Adrenergic) Agents"}]}, "1203040H0": {"Conditions": [{"/indications/DBCOND0077413": "Occasional Constipation"}, {"/indications/DBCOND0042226": "Ocular Irritation"}], "Name": "Glycerol", "Categories": [{"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT003627": "Basic Ointments and Protectants"}, {"/categories/DBCAT000085": "Carbohydrates"}, {"/categories/DBCAT004059": "Cell-mediated Immunity"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT001261": "Cryoprotective Agents"}, {"/categories/DBCAT002632": "Cytochrome P-450 CYP2E1 Inducers"}, {"/categories/DBCAT004496": "Cytochrome P-450 CYP2E1 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002415": "Drugs for Constipation"}, {"/categories/DBCAT002539": "Enemas"}, {"/categories/DBCAT004058": "Increased Histamine Release"}, {"/categories/DBCAT004060": "Increased IgG Production"}, {"/categories/DBCAT002155": "Irrigating Solutions"}, {"/categories/DBCAT001927": "Laxatives"}, {"/categories/DBCAT003529": "Non-Standardized Chemical Allergen"}, {"/categories/DBCAT003379": "Osmotic Laxatives"}, {"/categories/DBCAT003729": "Other Cold and Cough Preparations"}, {"/categories/DBCAT003697": "Other Diagnostics"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT000367": "Protective Agents"}, {"/categories/DBCAT001183": "Solvents"}, {"/categories/DBCAT000648": "Sugar Alcohols"}, {"/categories/DBCAT004975": "Triose Sugar Alcohols"}]}, "0403010N0": {"Conditions": [{"/indications/DBCOND0036220": "Attention Deficit Disorder With Hyperactivity (ADHD)"}, {"/indications/DBCOND0059447": "Bulimia Nervosa (BN)"}, {"/indications/DBCOND0018540": "Enuresis"}, {"/indications/DBCOND0030181": "Major Depressive Disorder (MDD)"}, {"/indications/DBCOND0035909": "Pain, Neuropathic"}, {"/indications/DBCOND0032724": "Panic Disorders"}, {"/indications/DBCOND0038601": "Post Traumatic Stress Disorder (PTSD)"}], "Name": "Imipramine Hydrochloride", "Categories": [{"/categories/DBCAT000435": "Adrenergic Agents"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT000439": "Adrenergic Uptake Inhibitors"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT004553": "Agents that reduce seizure threshold"}, {"/categories/DBCAT000533": "Anticholinergic Agents"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000744": "Antidepressive Agents, Tricyclic"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003877": "Combined Inhibitors of Serotonin/Norepinephrine Reuptake"}, {"/categories/DBCAT000402": "Cytochrome P-450 CYP1A2 Inhibitors"}, {"/categories/DBCAT002611": "Cytochrome P-450 CYP1A2 Inhibitors (moderate)"}, {"/categories/DBCAT004503": "Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT004029": "Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004030": "Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT004034": "Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT002625": "Cytochrome P-450 CYP2D6 Inhibitors (moderate)"}, {"/categories/DBCAT002726": "Cytochrome P-450 CYP2D6 Inhibitors (weak)"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT004031": "Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT004493": "Cytochrome P-450 CYP2E1 Inhibitors (strength unknown)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT004036": "Cytochrome P-450 CYP3A7 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000792": "Dibenzazepines"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT003988": "Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004739": "Imipramine"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000534": "Muscarinic Antagonists"}, {"/categories/DBCAT003972": "Narrow Therapeutic Index Drugs"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000400": "Neurotransmitter Uptake Inhibitors"}, {"/categories/DBCAT002305": "Non-Selective Monoamine Reuptake Inhibitors"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT004027": "P-glycoprotein/ABCB1 Substrates with narrow therapeutic index"}, {"/categories/DBCAT002156": "Psychoanaleptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT001320": "Serotonin 5-HT2 Receptor Antagonists"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT002706": "Serotonin Modulators"}, {"/categories/DBCAT000604": "Serotonin Receptor Antagonists"}, {"/categories/DBCAT004609": "Tertiary amine tricyclic antidepressants"}, {"/categories/DBCAT003664": "Tricyclics and Other Norepinephrine-reuptake Inhibitors"}]}, "0905047A0": {"Conditions": [{"/indications/DBCOND0005708": "Dandruff"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Selenium Sulfide", "Categories": [{"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002602": "Selenium Compounds"}]}, "0704030G0": {"Conditions": [{"/indications/DBCOND0001374": "Acidosis, Renal Tubular"}, {"/indications/DBCOND0023599": "Hypocitraturic calcium oxalate nephrolithiasis"}, {"/indications/DBCOND0023598": "Uric acid lithiasis"}], "Name": "Potassium Citrate", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT004224": "Alkalinizing Activity"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT003446": "Calculi Dissolution Agent"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT001578": "Citrates"}, {"/categories/DBCAT001953": "Citric Acid"}, {"/categories/DBCAT002728": "Citric Acid Derivatives"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000852": "Expectorants"}, {"/categories/DBCAT003517": "Metabolic Alkalinizer"}, {"/categories/DBCAT002308": "Mineral Supplements"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT002463": "Potassium"}, {"/categories/DBCAT003554": "Potassium Salt"}, {"/categories/DBCAT003709": "Replacement Preparations"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT001579": "Tricarboxylic Acids"}, {"/categories/DBCAT003862": "Urinary Alkalinisers"}]}, "1002010M0": {"Conditions": [{"/indications/DBCOND0024373": "Curarization therapy"}, {"/indications/DBCOND0028961": "Myasthenia Gravis"}, {"/indications/DBCOND0033485": "Neuromuscular Blockade"}, {"/indications/DBCOND0023060": "Ogilvie's syndrome"}, {"/indications/DBCOND0057006": "Postoperative Urinary Retention"}, {"/indications/DBCOND0025519": "Post-operative intestinal atony"}], "Name": "Neostigmine Bromide", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000268": "Ammonium Compounds"}, {"/categories/DBCAT002192": "Antiglaucoma Preparations and Miotics"}, {"/categories/DBCAT000434": "Autonomic Agents"}, {"/categories/DBCAT000126": "Cholinergic Agents"}, {"/categories/DBCAT000815": "Cholinesterase Inhibitors"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT000269": "Nitrogen Compounds"}, {"/categories/DBCAT000267": "Onium Compounds"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT003681": "Parasympathomemetic (Cholinergic) Agents"}, {"/categories/DBCAT000448": "Parasympathomimetics"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001230": "Phenylammonium Compounds"}, {"/categories/DBCAT000265": "Quaternary Ammonium Compounds"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0802040U0": {"Conditions": [{"/indications/DBCOND0044732": "Disseminated Sclerosis"}], "Name": "Glatiramer Acetate", "Categories": [{"/categories/DBCAT000090": "Adjuvants, Immunologic"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT003615": "Immunomodulatory Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000031": "Membrane Proteins"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT003911": "T-Lymphocytes, Helper-Inducer, immunology"}, {"/categories/DBCAT001682": "Vesicular Transport Proteins"}]}, "1306010Q0": {"Conditions": [{"/indications/DBCOND0019842": "Acne"}, {"/indications/DBCOND0065881": "Actinic Keratosis (AK)"}, {"/indications/DBCOND0025321": "Corns"}, {"/indications/DBCOND0020030": "Hyperkeratosis"}, {"/indications/DBCOND0000246": "Molluscum Contagiosum"}, {"/indications/DBCOND0045994": "Plantar Warts"}, {"/indications/DBCOND0013339": "Psoriasis"}, {"/indications/DBCOND0036095": "Seborrheic Dermatitis"}], "Name": "Salicylic Acid", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000580": "Hydroxybenzoates"}, {"/categories/DBCAT000884": "Keratolytic Agents"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT003445": "Nitrogen Binding Agent"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT003946": "OAT3/SLC22A8 Inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT000420": "Phenols"}, {"/categories/DBCAT000579": "Salicylates"}, {"/categories/DBCAT001197": "Salicylic Acid"}, {"/categories/DBCAT002147": "Salicylic Acid and Derivatives"}, {"/categories/DBCAT000897": "Sclerosing Solutions"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}]}, "030902050": {"Conditions": [{"/indications/DBCOND0032786": "Allergic Reactions"}, {"/indications/DBCOND0053380": "Allergic Rhinitis (AR)"}, {"/indications/DBCOND0102707": "Anaphylactic-type reactions"}, {"/indications/DBCOND0013604": "Angioedema"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}, {"/indications/DBCOND0027255": "Urticarias"}, {"/indications/DBCOND0030942": "Vasomotor Rhinitis"}, {"/indications/DBCOND0022265": "Dermatographism"}], "Name": "Carbinoxamine Maleate", "Categories": [{"/categories/DBCAT002286": "Aminoalkyl Ethers"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0301040L0": {"Conditions": [{"/indications/DBCOND0013567": "Bronchospasm"}, {"/indications/DBCOND0112704": "Bronchial congestion"}], "Name": "Etafedrine Hydrochloride", "Categories": [{"/categories/DBCAT000537": "Adrenergic Agonists"}, {"/categories/DBCAT003416": "Adrenergic beta-2 Receptor Agonists"}, {"/categories/DBCAT000553": "Adrenergic beta-Agonists"}, {"/categories/DBCAT004571": "Agents producing tachycardia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000272": "Alcohols"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000271": "Amino Alcohols"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000433": "Ethylamines"}, {"/categories/DBCAT000432": "Phenethylamines"}, {"/categories/DBCAT000483": "Propanolamines"}, {"/categories/DBCAT000484": "Propanols"}]}, "0801010H0": {"Conditions": [{"/indications/DBCOND0073466": "Acute Lymphoblastic Leukaemias (ALL)"}, {"/indications/DBCOND0029412": "Acute Myelocytic Leukemia"}, {"/indications/DBCOND0038690": "Adenocarcinoma of the Ovaries"}, {"/indications/DBCOND0028381": "Autoimmune Hemolytic Anemia"}, {"/indications/DBCOND0024153": "Burkitt's Lymphoma"}, {"/indications/DBCOND0054116": "Cancer, Breast"}, {"/indications/DBCOND0050885": "Chronic Lymphocytic Leukaemia (CLL)"}, {"/indications/DBCOND0036419": "Chronic Myeloid Leukemia (CML)"}, {"/indications/DBCOND0029099": "Disseminated Neuroblastoma"}, {"/indications/DBCOND0086609": "Ewing's Sarcoma (ES)"}, {"/indications/DBCOND0035157": "Granulomatosis With Polyangiitis"}, {"/indications/DBCOND0056190": "Juvenile Idiopathic Arthritis (JIA)"}, {"/indications/DBCOND0072929": "Lung Cancers"}, {"/indications/DBCOND0046006": "Lymphoma, Hodgkins"}, {"/indications/DBCOND0061382": "Minimal Change Nephrotic Syndrome (MCNS)"}, {"/indications/DBCOND0040908": "Multiple Myeloma (MM)"}, {"/indications/DBCOND0028961": "Myasthenia Gravis"}, {"/indications/DBCOND0034112": "Nephritis, Lupus"}, {"/indications/DBCOND0030854": "Non-Hodgkin's Lymphoma (NHL)"}, {"/indications/DBCOND0016977": "Ovarian germ cell tumour"}, {"/indications/DBCOND0071316": "Pheochromocytomas"}, {"/indications/DBCOND0001198": "Retinoblastoma"}, {"/indications/DBCOND0027071": "Rhabdomyosarcomas"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0092565": "Waldenstr\u00f6m's Macroglobulinemia (WM)"}, {"/indications/DBCOND0024723": "Advanced Alibert-Bazin syndrome"}, {"/indications/DBCOND0021517": "Histiocytic lymphoma"}, {"/indications/DBCOND0021520": "Metastatic gestational trophoblastic tumor"}, {"/indications/DBCOND0021516": "Mixed-cell type lymphoma"}, {"/indications/DBCOND0020320": "Recurrent Pericarditis"}, {"/indications/DBCOND0021526": "Refractory Small cell lung cancer"}, {"/indications/DBCOND0021524": "Refractory immune thrombocytopenia"}, {"/indications/DBCOND0021528": "Relapsed Wilm's tumor"}], "Name": "Cyclophosphamide", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT004116": "Alkylating Activity"}, {"/categories/DBCAT003311": "Alkylating Drugs"}, {"/categories/DBCAT000323": "Anions"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT000592": "Antineoplastic Agents, Alkylating"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT003909": "Cardiotoxic antineoplastic agents"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT001015": "Cytochrome P-450 CYP2B6 Inducers"}, {"/categories/DBCAT004516": "Cytochrome P-450 CYP2B6 Inducers (strength unknown)"}, {"/categories/DBCAT002619": "Cytochrome P-450 CYP2B6 Substrates"}, {"/categories/DBCAT004664": "Cytochrome P-450 CYP2C18 Substrates"}, {"/categories/DBCAT002638": "Cytochrome P-450 CYP2C19 Substrates"}, {"/categories/DBCAT001247": "Cytochrome P-450 CYP2C8 Inducers"}, {"/categories/DBCAT004480": "Cytochrome P-450 CYP2C8 Inducers (strength unknown)"}, {"/categories/DBCAT002642": "Cytochrome P-450 CYP2C8 Substrates"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000325": "Electrolytes"}, {"/categories/DBCAT000682": "Hydrocarbons, Halogenated"}, {"/categories/DBCAT000038": "Immunologic Factors"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT000324": "Ions"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT000681": "Mustard Compounds"}, {"/categories/DBCAT000955": "Mutagens"}, {"/categories/DBCAT000956": "Myeloablative Agonists"}, {"/categories/DBCAT002716": "Myelosuppressive Agents"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002289": "Nitrogen Mustard Analogues"}, {"/categories/DBCAT000680": "Nitrogen Mustard Compounds"}, {"/categories/DBCAT000150": "Noxae"}, {"/categories/DBCAT000699": "Organophosphorus Compounds"}, {"/categories/DBCAT000951": "Phosphoramide Mustards"}, {"/categories/DBCAT000952": "Phosphoramides"}, {"/categories/DBCAT000954": "Phosphoric Acids"}, {"/categories/DBCAT000925": "Phosphorus Acids"}, {"/categories/DBCAT000926": "Phosphorus Compounds"}, {"/categories/DBCAT000151": "Toxic Actions"}]}, "0401010V0": {"Conditions": [{"/indications/DBCOND0048259": "Sleeplessness"}], "Name": "Triazolam", "Categories": [{"/categories/DBCAT000730": "Adjuvants, Anesthesia"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT000404": "Anti-Anxiety Agents"}, {"/categories/DBCAT000451": "Benzazepines"}, {"/categories/DBCAT003883": "Benzodiazepine hypnotics and sedatives"}, {"/categories/DBCAT000450": "Benzodiazepines and benzodiazepine derivatives"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT003824": "CYP3A Substrates (Sensitive)"}, {"/categories/DBCAT000868": "Cytochrome P-450 CYP2C8 Inhibitors"}, {"/categories/DBCAT004479": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004028": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000428": "GABA Agents"}, {"/categories/DBCAT000453": "GABA Modulators"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT000452": "Hypnotics and Sedatives"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT003829": "Triazolobenzodiazepines"}]}, "1303000AA": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0030075": "Orofacial Pain"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}], "Name": "Menthol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0501050N0": {"Conditions": [{"/indications/DBCOND0029828": "Acne Vulgaris"}, {"/indications/DBCOND0106071": "Acute Otitis Media caused by Haemophilus Influenzae"}, {"/indications/DBCOND0117362": "Acute pelvic inflammatory disease caused by Neisseria Gonorrheae Infection"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0001290": "Chancroid"}, {"/indications/DBCOND0032096": "Chlamydia Trachomatis"}, {"/indications/DBCOND0020671": "Chlamydial ophthalmia neonatorum"}, {"/indications/DBCOND0037905": "Community Acquired Pneumonia (CAP)"}, {"/indications/DBCOND0000394": "Diphtheria"}, {"/indications/DBCOND0000222": "Erythrasma"}, {"/indications/DBCOND0000847": "Gastroparesis"}, {"/indications/DBCOND0005915": "Granuloma Inguinale"}, {"/indications/DBCOND0020658": "Intestinal amebiasis caused by entamoeba histolytica"}, {"/indications/DBCOND0062432": "Legionella Pneumophila Infections"}, {"/indications/DBCOND0000363": "Legionnaires' Disease"}, {"/indications/DBCOND0022677": "Listeria infection"}, {"/indications/DBCOND0035453": "Lower Respiratory Tract Infection (LRTI)"}, {"/indications/DBCOND0005917": "Lymphogranuloma Venereum"}, {"/indications/DBCOND0022621": "Nongonococcal urethritis"}, {"/indications/DBCOND0020670": "Ophthalmia neonatorum (gonococcal)"}, {"/indications/DBCOND0014696": "Pertussis"}, {"/indications/DBCOND0059577": "Postoperative Infections"}, {"/indications/DBCOND0056152": "Primary Syphilis"}, {"/indications/DBCOND0070409": "Respiratory Tract Infections (RTI)"}, {"/indications/DBCOND0043443": "Skin Structures and Soft Tissue Infections"}, {"/indications/DBCOND0032713": "Staphylococcal Skin Infections"}, {"/indications/DBCOND0014490": "Syphilis"}, {"/indications/DBCOND0042752": "Upper Respiratory Tract Infections"}, {"/indications/DBCOND0020662": "Ureaplasma urethritis"}, {"/indications/DBCOND0000336": "Whooping Cough"}, {"/indications/DBCOND0106069": "Inflammatory papular lesions"}, {"/indications/DBCOND0106072": "Predominant skin comedones, papules and pustules"}, {"/indications/DBCOND0023009": "Prophylaxis of Rheumatic fever"}, {"/indications/DBCOND0106070": "Pustular lesions"}, {"/indications/DBCOND0020661": "Skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes"}, {"/indications/DBCOND0020669": "Superficial ocular infections"}], "Name": "Erythromycin Stearate", "Categories": [{"/categories/DBCAT002163": "Anti-Acne Preparations"}, {"/categories/DBCAT002162": "Anti-Acne Preparations for Topical Use"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002201": "Antiinfectives for Treatment of Acne"}, {"/categories/DBCAT002660": "BSEP/ABCB11 Inhibitors"}, {"/categories/DBCAT003979": "BSEP/ABCB11 Substrates"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT003893": "Cytochrome P-450 CYP3A5 Inhibitors"}, {"/categories/DBCAT004487": "Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)"}, {"/categories/DBCAT003807": "Cytochrome P-450 CYP3A5 Substrates"}, {"/categories/DBCAT003892": "Cytochrome P-450 CYP3A7 Inhibitors"}, {"/categories/DBCAT004498": "Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)"}, {"/categories/DBCAT003800": "Cytochrome P-450 CYP3A7 Substrates"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000499": "Erythromycin and similars"}, {"/categories/DBCAT003634": "Erythromycins"}, {"/categories/DBCAT000048": "Gastrointestinal Agents"}, {"/categories/DBCAT000498": "Lactones"}, {"/categories/DBCAT003294": "Macrolide Antimicrobial"}, {"/categories/DBCAT000496": "Macrolides"}, {"/categories/DBCAT002202": "Macrolides, Lincosamides and Streptogramins"}, {"/categories/DBCAT002690": "Moderate Risk QTc-Prolonging Agents"}, {"/categories/DBCAT003931": "OATP1B1/SLCO1B1 Inhibitors"}, {"/categories/DBCAT002658": "OATP1B1/SLCO1B1 Substrates"}, {"/categories/DBCAT003932": "OATP1B3 inhibitors"}, {"/categories/DBCAT004563": "OATP1B3 substrates"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000501": "Protein Synthesis Inhibitors"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}]}, "0308000M0": {"Conditions": [{"/indications/DBCOND0024398": "Coughing"}, {"/indications/DBCOND0030075": "Orofacial Pain"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0059047": "Throat Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}], "Name": "Menthol", "Categories": [{"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT003297": "Antiarrhythmic agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000574": "Calcium Channel Blockers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003676": "Vasodilating Agents"}]}, "0502020B0": {"Conditions": [{"/indications/DBCOND0078869": "Diaper Dermatitis"}, {"/indications/DBCOND0080575": "Fungal infection of nail"}, {"/indications/DBCOND0038453": "Oropharyngeal Candidiasis"}, {"/indications/DBCOND0021492": "Pityriasis versicolor"}, {"/indications/DBCOND0047136": "Tinea Corporis"}, {"/indications/DBCOND0041588": "Tinea Cruris"}, {"/indications/DBCOND0000153": "Tinea Pedis"}, {"/indications/DBCOND0020784": "Vaginal yeast infection"}, {"/indications/DBCOND0022776": "Cutaneous candidiasis infection"}], "Name": "Miconazole", "Categories": [{"/categories/DBCAT000488": "14-alpha Demethylase Inhibitors"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000200": "Antifungal Agents"}, {"/categories/DBCAT002682": "Antifungal Agents (Vaginal)"}, {"/categories/DBCAT002197": "Antifungals for Dermatological Use"}, {"/categories/DBCAT002196": "Antifungals for Topical Use"}, {"/categories/DBCAT002259": "Antiinfectives and Antiseptics for Local Oral Treatment"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT002194": "Antimycotics for Systemic Use"}, {"/categories/DBCAT003230": "Azole Antifungals"}, {"/categories/DBCAT000397": "Chemically-Induced Disorders"}, {"/categories/DBCAT002614": "Cytochrome P-450 CYP2A6 Inhibitors"}, {"/categories/DBCAT002615": "Cytochrome P-450 CYP2A6 Inhibitors (strong)"}, {"/categories/DBCAT001285": "Cytochrome P-450 CYP2B6 Inhibitors"}, {"/categories/DBCAT004517": "Cytochrome P-450 CYP2B6 Inhibitors (strength unknown)"}, {"/categories/DBCAT000403": "Cytochrome P-450 CYP2C19 Inhibitors"}, {"/categories/DBCAT002639": "Cytochrome P-450 CYP2C19 Inhibitors (strong)"}, {"/categories/DBCAT004482": "Cytochrome P-450 CYP2C19 inhibitors (unknown strength)"}, {"/categories/DBCAT000489": "Cytochrome P-450 CYP2C9 Inhibitors"}, {"/categories/DBCAT002636": "Cytochrome P-450 CYP2C9 Inhibitors (moderate)"}, {"/categories/DBCAT002635": "Cytochrome P-450 CYP2C9 Inhibitors (strong)"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT002629": "Cytochrome P-450 CYP2E1 Inhibitors"}, {"/categories/DBCAT002630": "Cytochrome P-450 CYP2E1 Inhibitors (strong)"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002648": "Cytochrome P-450 CYP3A4 Inhibitors (moderate)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002247": "Gynecological Antiinfectives and Antiseptics"}, {"/categories/DBCAT000144": "Hormone Antagonists"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002195": "Imidazole and Triazole Derivatives"}, {"/categories/DBCAT002246": "Imidazole Derivatives"}, {"/categories/DBCAT000263": "Imidazoles"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000487": "Steroid Synthesis Inhibitors"}, {"/categories/DBCAT002132": "Stomatological Preparations"}, {"/categories/DBCAT001290": "Vaginal Creams, Foams, and Jellies"}]}, "0407010V0": {"Conditions": [{"/indications/DBCOND0039783": "Fevers"}, {"/indications/DBCOND0093532": "Pain NOS"}, {"/indications/DBCOND0066540": "Severe Pain"}, {"/indications/DBCOND0093533": "Mild Pain NOS"}, {"/indications/DBCOND0118556": "Minor aches and pains"}, {"/indications/DBCOND0020636": "Moderate Pain"}], "Name": "Paracetamol & Codeine Phosphate", "Categories": [{"/categories/DBCAT003969": "Acetaminophen and Prodrugs"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000599": "Anilides"}, {"/categories/DBCAT000637": "Aniline Compounds"}, {"/categories/DBCAT000735": "Antipyretics"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT002613": "Cytochrome P-450 CYP2A6 Substrates"}, {"/categories/DBCAT002623": "Cytochrome P-450 CYP2D6 Substrates"}, {"/categories/DBCAT002628": "Cytochrome P-450 CYP2E1 Substrates"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT002719": "Methemoglobinemia Associated Agents"}, {"/categories/DBCAT003661": "Miscellaneous Analgesics and Antipyretics"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004045": "UGT1A6 substrate"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}]}, "0402030R0": {"Conditions": [{"/indications/DBCOND0024284": "Mixed manic depressive episode"}, {"/indications/DBCOND0030827": "Schizophrenic Disorders"}, {"/indications/DBCOND0024512": "Acute Manic episode"}], "Name": "Asenapine", "Categories": [{"/categories/DBCAT003864": "Acid Reducers"}, {"/categories/DBCAT000777": "Adrenergic alpha-1 Receptor Antagonists"}, {"/categories/DBCAT000696": "Adrenergic alpha-Antagonists"}, {"/categories/DBCAT000457": "Adrenergic Antagonists"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000345": "Antidepressive Agents"}, {"/categories/DBCAT000529": "Antipsychotic Agents"}, {"/categories/DBCAT002673": "Antipsychotic Agents (Second Generation [Atypical])"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT000399": "Central Nervous System Depressants"}, {"/categories/DBCAT002609": "Cytochrome P-450 CYP1A2 Substrates"}, {"/categories/DBCAT000911": "Cytochrome P-450 CYP2D6 Inhibitors"}, {"/categories/DBCAT004505": "Cytochrome P-450 CYP2D6 Inhibitors (strength unknown)"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT002317": "Diazepines, Oxazepines, Thiazepines and Oxepines"}, {"/categories/DBCAT000603": "Dopamine Antagonists"}, {"/categories/DBCAT000879": "Dopamine D2 Receptor Antagonists"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT002689": "Highest Risk QTc-Prolonging Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT000933": "Histamine H2 Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002148": "Nervous System"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002185": "Psycholeptics"}, {"/categories/DBCAT000346": "Psychotropic Drugs"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT003826": "Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome"}, {"/categories/DBCAT000401": "Serotonin Agents"}, {"/categories/DBCAT000547": "Serotonin Receptor Agonists"}, {"/categories/DBCAT000398": "Tranquilizing Agents"}, {"/categories/DBCAT004564": "UGT1A4 substrates"}]}, "0703021P0": {"Conditions": [{"/indications/DBCOND0037989": "Dysfunctional Uterine Bleeding"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0001340": "Endometriosis"}, {"/indications/DBCOND0052994": "Hypermenorrhea"}, {"/indications/DBCOND0037449": "Polycystic Ovarian Syndrome"}], "Name": "Norgestrel", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003872": "Combination Contraceptives (with Estrogen and derivatives)"}, {"/categories/DBCAT000688": "Contraceptive Agents, Female"}, {"/categories/DBCAT000707": "Contraceptives, Oral"}, {"/categories/DBCAT000709": "Contraceptives, Oral, Synthetic"}, {"/categories/DBCAT001152": "Contraceptives, Postcoital"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT002114": "Genito Urinary System and Sex Hormones"}, {"/categories/DBCAT002291": "Hormonal Contraceptives for Systemic Use"}, {"/categories/DBCAT000705": "Norpregnanes"}, {"/categories/DBCAT000704": "Norpregnenes"}, {"/categories/DBCAT000706": "Norsteroids"}, {"/categories/DBCAT003003": "Progestin Contraceptives"}, {"/categories/DBCAT000708": "Progestins"}, {"/categories/DBCAT002296": "Progestogens and Estrogens, Sequential Preparations"}, {"/categories/DBCAT000061": "Reproductive Control Agents"}, {"/categories/DBCAT002113": "Sex Hormones and Modulators of the Genital System"}, {"/categories/DBCAT000309": "Steroids"}]}, "0501130E0": {"Conditions": [{"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}], "Name": "Methenamine Hippurate", "Categories": [{"/categories/DBCAT000583": "Acids, Carbocyclic"}, {"/categories/DBCAT000914": "Adamantane"}, {"/categories/DBCAT000494": "Amides"}, {"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT000631": "Anti-Infective Agents, Urinary"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000582": "Benzoates"}, {"/categories/DBCAT000359": "Cycloparaffins"}, {"/categories/DBCAT000581": "Hydroxy Acids"}, {"/categories/DBCAT000260": "Keto Acids"}, {"/categories/DBCAT000281": "Polyamines"}, {"/categories/DBCAT000629": "Renal Agents"}, {"/categories/DBCAT002710": "Urinary Acidifying Agents"}]}, "1201010E0": {"Conditions": [{"/indications/DBCOND0032167": "Acute Gouty Arthritis"}, {"/indications/DBCOND0025987": "Adrenal cortical hypofunctions"}, {"/indications/DBCOND0071530": "Alopecia Areata (AA)"}, {"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0004094": "Berylliosis"}, {"/indications/DBCOND0021259": "Bullous dermatitis herpetiformis"}, {"/indications/DBCOND0016442": "Bursitis"}, {"/indications/DBCOND0033416": "Congenital Adrenal Hyperplasia (CAH)"}, {"/indications/DBCOND0052431": "Congenital Hypoplastic Anemia"}, {"/indications/DBCOND0002234": "Dermatomyositis"}, {"/indications/DBCOND0019992": "Dermatosis"}, {"/indications/DBCOND0042421": "Discoid Lupus Erythematosus (DLE)"}, {"/indications/DBCOND0024353": "Edema of the cerebrum"}, {"/indications/DBCOND0015538": "Epicondylitis"}, {"/indications/DBCOND0019025": "Glomerulonephritis minimal lesion"}, {"/indications/DBCOND0028695": "Hypercalcemia of Malignancy"}, {"/indications/DBCOND0060499": "Keloid Scars"}, {"/indications/DBCOND0035632": "Leukemias"}, {"/indications/DBCOND0055937": "Lichen Planus (LP)"}, {"/indications/DBCOND0021286": "Lichen simplex chronicus"}, {"/indications/DBCOND0029690": "Lupus Erythematosus"}, {"/indications/DBCOND0046362": "Malignant Lymphomas"}, {"/indications/DBCOND0021271": "Multiple sclerosis exacerbation"}, {"/indications/DBCOND0057197": "Mycosis Fungoides (MF)"}, {"/indications/DBCOND0009302": "Necrobiosis lipoidica diabeticorum"}, {"/indications/DBCOND0001140": "Ophthalmia, Sympathetic"}, {"/indications/DBCOND0001806": "Pemphigus"}, {"/indications/DBCOND0024329": "Plaque psoriasis of the body"}, {"/indications/DBCOND0024328": "Plaque psoriasis of the scalp"}, {"/indications/DBCOND0013509": "Polymyositis"}, {"/indications/DBCOND0028320": "Psoriatic Arthritis"}, {"/indications/DBCOND0021287": "Psoriatic plaque"}, {"/indications/DBCOND0052963": "Pulmonary Tuberculosis (TB)"}, {"/indications/DBCOND0028424": "Pure Red Cell Aplasia"}, {"/indications/DBCOND0053624": "Regional Enteritis"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}, {"/indications/DBCOND0029920": "Rheumatoid Arthritis, Juvenile"}, {"/indications/DBCOND0021268": "Secondary thrombocytopenia"}, {"/indications/DBCOND0039302": "Severe Asthma"}, {"/indications/DBCOND0033062": "Severe Atopic Dermatitis"}, {"/indications/DBCOND0035161": "Stevens Johnson Syndrome"}, {"/indications/DBCOND0038683": "Systemic Lupus Erythematosus (SLE)"}, {"/indications/DBCOND0032828": "Temporal Arteritis"}, {"/indications/DBCOND0021269": "Trichinosis"}, {"/indications/DBCOND0036434": "Tuberculous Meningitis"}, {"/indications/DBCOND0052192": "Ulcerative Colitis (UC)"}, {"/indications/DBCOND0009937": "Uveitis"}, {"/indications/DBCOND0022249": "Acquired immune hemolytic anemia"}, {"/indications/DBCOND0021282": "Acute nonspecific tenosynovitis"}, {"/indications/DBCOND0021279": "Acute rheumatic carditis"}, {"/indications/DBCOND0021260": "Exfoliative erythroderma"}, {"/indications/DBCOND0021285": "Granuloma annulare lesions"}, {"/indications/DBCOND0021276": "Idiopathic eosinophilic pneumonias"}, {"/indications/DBCOND0022528": "Non-suppurative Thyroiditis"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}, {"/indications/DBCOND0021256": "Severe Allergic rhinitis"}, {"/indications/DBCOND0021253": "Severe Contact dermatitis"}, {"/indications/DBCOND0021257": "Severe Serum sickness"}, {"/indications/DBCOND0080533": "Severe Transfusion Reactions"}, {"/indications/DBCOND0021255": "Severe drug hypersensitivity reactions"}, {"/indications/DBCOND0021277": "Symptomatic Sarcoidosis"}, {"/indications/DBCOND0021281": "Synovitis of osteoarthritis"}], "Name": "Betamethasone Sodium Phosphate", "Categories": [{"/categories/DBCAT000556": "Adrenal Cortex Hormones"}, {"/categories/DBCAT003629": "Adrenals"}, {"/categories/DBCAT003935": "Agents Causing Muscle Toxicity"}, {"/categories/DBCAT002283": "Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000134": "Anti-Asthmatic Agents"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT000870": "Betamethasone"}, {"/categories/DBCAT004050": "Corticosteroid Hormone Receptor Agonists"}, {"/categories/DBCAT002235": "Corticosteroids"}, {"/categories/DBCAT002356": "Corticosteroids Acting Locally"}, {"/categories/DBCAT002378": "Corticosteroids for Systemic Use"}, {"/categories/DBCAT002377": "Corticosteroids for Systemic Use, Plain"}, {"/categories/DBCAT002236": "Corticosteroids, Dermatological Preparations"}, {"/categories/DBCAT002234": "Corticosteroids, Potent (Group III)"}, {"/categories/DBCAT000492": "Cytochrome P-450 CYP3A Inducers"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT003896": "Cytochrome P-450 CYP3A4 Inducers"}, {"/categories/DBCAT004039": "Cytochrome P-450 CYP3A4 Inducers (strength unknown)"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004489": "Cytochrome P-450 CYP3A5 Inducers"}, {"/categories/DBCAT004490": "Cytochrome P-450 CYP3A5 Inducers (strength unknown)"}, {"/categories/DBCAT000491": "Cytochrome P-450 Enzyme Inducers"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT002112": "Drugs for Obstructive Airway Diseases"}, {"/categories/DBCAT004974": "Fused-Ring Compounds"}, {"/categories/DBCAT000557": "Glucocorticoids"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT000047": "Immunosuppressive Agents"}, {"/categories/DBCAT002251": "Intestinal Antiinflammatory Agents"}, {"/categories/DBCAT002159": "Nasal Preparations"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000747": "Pregnadienes"}, {"/categories/DBCAT000826": "Pregnadienetriols"}, {"/categories/DBCAT000748": "Pregnanes"}, {"/categories/DBCAT000132": "Respiratory System Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000309": "Steroids"}, {"/categories/DBCAT000749": "Steroids, Fluorinated"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}, {"/categories/DBCAT002284": "Vasoprotectives"}]}, "0905022U0": {"Conditions": [{"/indications/DBCOND0015896": "Hyperphosphataemia"}], "Name": "Calcium Acetate/Magnesium Carbonate", "Categories": [{"/categories/DBCAT000322": "Acids"}, {"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT000321": "Acids, Noncarboxylic"}, {"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT001614": "Arylsulfonates"}, {"/categories/DBCAT001615": "Arylsulfonic Acids"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT000075": "Blood Coagulation Factors"}, {"/categories/DBCAT000758": "Calcium Salts"}, {"/categories/DBCAT000624": "Chelating Agents"}, {"/categories/DBCAT000196": "Compounds used in a research, industrial, or household setting"}, {"/categories/DBCAT002261": "Drugs for Treatment of Hyperkalemia and Hyperphosphatemia"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT001376": "Minerals"}, {"/categories/DBCAT003309": "Phosphate Binder"}, {"/categories/DBCAT003646": "Phosphate-removing Agents"}, {"/categories/DBCAT000623": "Sequestering Agents"}, {"/categories/DBCAT000891": "Sulfonic Acids"}, {"/categories/DBCAT000892": "Sulfur Acids"}, {"/categories/DBCAT000248": "Sulfur Compounds"}]}, "1001010I0": {"Conditions": [{"/indications/DBCOND0046486": "Ankylosing Spondylitis (AS)"}, {"/indications/DBCOND0003822": "Dysmenorrhea"}, {"/indications/DBCOND0056529": "Osteoarthritis (OA)"}, {"/indications/DBCOND0037418": "Pain, Inflammatory"}, {"/indications/DBCOND0027961": "Rheumatoid Arthritis"}], "Name": "Flurbiprofen", "Categories": [{"/categories/DBCAT000328": "Acids, Acyclic"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT004567": "Agents that produce hypertension"}, {"/categories/DBCAT000041": "Analgesics"}, {"/categories/DBCAT000040": "Analgesics, Non-Narcotic"}, {"/categories/DBCAT000046": "Anti-Inflammatory Agents"}, {"/categories/DBCAT000049": "Anti-Inflammatory Agents, Non-Steroidal"}, {"/categories/DBCAT003878": "Anti-Inflammatory Agents, Non-Steroidal (Non-Selective)"}, {"/categories/DBCAT002312": "Antiinflammatory and Antirheumatic Products"}, {"/categories/DBCAT002311": "Antiinflammatory and Antirheumatic Products, Non-Steroids"}, {"/categories/DBCAT002313": "Antiinflammatory Preparations, Non-Steroids for Topical Use"}, {"/categories/DBCAT000045": "Antirheumatic Agents"}, {"/categories/DBCAT000418": "Benzene Derivatives"}, {"/categories/DBCAT001053": "Biphenyl Compounds"}, {"/categories/DBCAT000044": "Central Nervous System Agents"}, {"/categories/DBCAT003910": "Cyclooxygenase Inhibitors"}, {"/categories/DBCAT002634": "Cytochrome P-450 CYP2C9 Substrates"}, {"/categories/DBCAT003987": "Drugs that are Mainly Renally Excreted"}, {"/categories/DBCAT000003": "Enzyme Inhibitors"}, {"/categories/DBCAT000301": "Fatty Acids"}, {"/categories/DBCAT000426": "Fatty Acids, Volatile"}, {"/categories/DBCAT000178": "Lipids"}, {"/categories/DBCAT002122": "Musculo-Skeletal System"}, {"/categories/DBCAT003959": "Nephrotoxic agents"}, {"/categories/DBCAT004608": "Non COX-2 selective NSAIDS"}, {"/categories/DBCAT004093": "Nonsteroidal Anti-inflammatory Compounds"}, {"/categories/DBCAT004041": "OAT1/SLC22A6 inhibitors"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003666": "Other Nonsteroidal Antiimflammatory Agents"}, {"/categories/DBCAT000043": "Peripheral Nervous System Agents"}, {"/categories/DBCAT001030": "Propionates"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000042": "Sensory System Agents"}, {"/categories/DBCAT002106": "Throat Preparations"}, {"/categories/DBCAT002314": "Topical Products for Joint and Muscular Pain"}, {"/categories/DBCAT002664": "UGT1A1 Inhibitors"}, {"/categories/DBCAT003871": "UGT1A1 Substrates"}, {"/categories/DBCAT004554": "UGT1A3 substrates"}, {"/categories/DBCAT003966": "UGT1A9 Substrates"}, {"/categories/DBCAT004610": "UGT2B7 substrates"}]}, "0210020K0": {"Conditions": [{"/indications/DBCOND0032772": "Acute Myocardial Infarction (AMI)"}, {"/indications/DBCOND0040959": "Cardiovascular Mortality"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}], "Name": "Reteplase", "Categories": [{"/categories/DBCAT004043": "Agents causing angioedema"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000007": "Anticoagulants"}, {"/categories/DBCAT000036": "Biological Factors"}, {"/categories/DBCAT002085": "Blood and Blood Forming Organs"}, {"/categories/DBCAT000019": "Blood Proteins"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT000068": "Endopeptidases"}, {"/categories/DBCAT000071": "Enzymes"}, {"/categories/DBCAT000072": "Enzymes and Coenzymes"}, {"/categories/DBCAT000011": "Fibrin Modulating Agents"}, {"/categories/DBCAT000013": "Fibrinolytic Agents"}, {"/categories/DBCAT000008": "Hematologic Agents"}, {"/categories/DBCAT000070": "Hydrolases"}, {"/categories/DBCAT000069": "Peptide Hydrolases"}, {"/categories/DBCAT000074": "Plasminogen Activators"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT000067": "Serine Endopeptidases"}, {"/categories/DBCAT000073": "Serine Proteases"}]}, "0803043P0": {"Conditions": [{"/indications/DBCOND0000951": "Acromegaly"}, {"/indications/DBCOND0023410": "Unresectable, locally advanced enteropancreatic neuroendocrine tumors"}, {"/indications/DBCOND0023413": "Unresectable, locally advanced gastroenteropancreatic neuroendocrine tumors"}, {"/indications/DBCOND0023409": "Unresectable, metastatic enteropancreatic neuroendocrine tumors"}, {"/indications/DBCOND0023412": "Unresectable, metastatic gastroenteropancreatic neuroendocrine tumors"}], "Name": "Lanreotide", "Categories": [{"/categories/DBCAT000182": "Acromegaly"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002703": "Bradycardia-Causing Agents"}, {"/categories/DBCAT000934": "Cytochrome P-450 CYP3A Inhibitors"}, {"/categories/DBCAT003232": "Cytochrome P-450 CYP3A4 Inhibitors"}, {"/categories/DBCAT002713": "Cytochrome P-450 CYP3A4 Inhibitors (weak)"}, {"/categories/DBCAT000394": "Cytochrome P-450 Enzyme Inhibitors"}, {"/categories/DBCAT000056": "Hormones"}, {"/categories/DBCAT000057": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"/categories/DBCAT002694": "Hyperglycemia-Associated Agents"}, {"/categories/DBCAT002695": "Hypoglycemia-Associated Agents"}, {"/categories/DBCAT000054": "Hypothalamic Hormones"}, {"/categories/DBCAT000059": "Nerve Tissue Proteins"}, {"/categories/DBCAT000058": "Neuropeptides"}, {"/categories/DBCAT003610": "Other Miscellaneous Therapeutic Agents"}, {"/categories/DBCAT000122": "Pancreatic Hormones"}, {"/categories/DBCAT000055": "Peptide Hormones"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT002097": "Pituitary and Hypothalamic Hormones and Analogues"}, {"/categories/DBCAT001948": "Pituitary Hormone Release Inhibiting Hormones"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002136": "Somatostatin and Analogues"}, {"/categories/DBCAT004140": "Somatostatin Receptor Agonists"}, {"/categories/DBCAT002098": "Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins"}]}, "0801050CL": {"Conditions": [{"/indications/DBCOND0031019": "Advanced Breast Cancer"}, {"/indications/DBCOND0032947": "Metastatic Breast Cancer (MBC)"}], "Name": "Abemaciclib", "Categories": [{"/categories/DBCAT000266": "Amines"}, {"/categories/DBCAT000024": "Antineoplastic Agents"}, {"/categories/DBCAT002086": "Antineoplastic and Immunomodulating Agents"}, {"/categories/DBCAT002662": "BCRP/ABCG2 Inhibitors"}, {"/categories/DBCAT002663": "BCRP/ABCG2 Substrates"}, {"/categories/DBCAT003919": "Cytochrome P-450 CYP3A Substrates"}, {"/categories/DBCAT002646": "Cytochrome P-450 CYP3A4 Substrates"}, {"/categories/DBCAT003973": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)"}, {"/categories/DBCAT004973": "Heterocyclic Compounds, Fused-Ring"}, {"/categories/DBCAT003325": "Kinase Inhibitor"}, {"/categories/DBCAT004244": "Kinase Inhibitors"}, {"/categories/DBCAT003950": "MATE 1 Inhibitors"}, {"/categories/DBCAT003951": "MATE 1 Substrates"}, {"/categories/DBCAT004525": "MATE 1 Substrates with a Narrow Therapeutic Index"}, {"/categories/DBCAT003953": "MATE 2 Inhibitors"}, {"/categories/DBCAT003957": "MATE inhibitors"}, {"/categories/DBCAT003956": "MATE substrates"}, {"/categories/DBCAT002667": "P-glycoprotein/ABCB1 Inhibitors"}, {"/categories/DBCAT002668": "P-glycoprotein/ABCB1 Substrates"}, {"/categories/DBCAT000737": "Protein Kinase Inhibitors"}, {"/categories/DBCAT000227": "Pyridines"}]}, "1103010Q0": {"Conditions": [{"/indications/DBCOND0118557": "Bacteremia caused by Enterobacter aerogenes"}, {"/indications/DBCOND0027917": "Bacterial Infections"}, {"/indications/DBCOND0020932": "Bacterial eye infection"}, {"/indications/DBCOND0014660": "Escherichia urinary tract infection"}, {"/indications/DBCOND0014631": "Klebsiella bacteraemia"}, {"/indications/DBCOND0020991": "Meningitis caused by Haemophilus influenzae"}, {"/indications/DBCOND0060443": "Meningitis, Bacterial"}, {"/indications/DBCOND0074404": "Urinary Tract Infections (UTIs)"}, {"/indications/DBCOND0021274": "Ocular inflammatory conditions"}], "Name": "Polymyxin B Sulphate", "Categories": [{"/categories/DBCAT002118": "Alimentary Tract and Metabolism"}, {"/categories/DBCAT000021": "Amino Acids, Peptides, and Proteins"}, {"/categories/DBCAT000104": "Anti-Bacterial Agents"}, {"/categories/DBCAT000065": "Anti-Infective Agents"}, {"/categories/DBCAT002130": "Antibacterials for Systemic Use"}, {"/categories/DBCAT002252": "Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents"}, {"/categories/DBCAT002131": "Antiinfectives for Systemic Use"}, {"/categories/DBCAT001130": "Antimicrobial Cationic Peptides"}, {"/categories/DBCAT002401": "Intestinal Antiinfectives"}, {"/categories/DBCAT000177": "Lipopeptides"}, {"/categories/DBCAT004545": "Neurotoxic agents"}, {"/categories/DBCAT002379": "Ophthalmological and Otological Preparations"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT002282": "Otologicals"}, {"/categories/DBCAT000052": "Peptides"}, {"/categories/DBCAT000099": "Peptides, Cyclic"}, {"/categories/DBCAT003403": "Polymyxin-class Antibacterial"}, {"/categories/DBCAT001129": "Polymyxins"}, {"/categories/DBCAT000102": "Pore Forming Cytotoxic Proteins"}, {"/categories/DBCAT000020": "Proteins"}, {"/categories/DBCAT002092": "Sensory Organs"}]}, "0202030C0": {"Conditions": [{"/indications/DBCOND0004927": "Ascites"}, {"/indications/DBCOND0036164": "Calcium Nephrolithiasis"}, {"/indications/DBCOND0033011": "Congestive Heart Failure (CHF)"}, {"/indications/DBCOND0040789": "High Blood Pressure (Hypertension)"}, {"/indications/DBCOND0015839": "Hypokalaemia"}, {"/indications/DBCOND0055468": "Metabolic Alkalosis"}, {"/indications/DBCOND0001413": "Polyuria"}], "Name": "Amiloride Hydrochloride", "Categories": [{"/categories/DBCAT000988": "Acid Sensing Ion Channel Blockers"}, {"/categories/DBCAT003960": "Agents causing hyperkalemia"}, {"/categories/DBCAT000010": "Cardiovascular Agents"}, {"/categories/DBCAT004229": "Decreased Renal K+ Excretion"}, {"/categories/DBCAT000542": "Diuretics"}, {"/categories/DBCAT000817": "Epithelial Sodium Channel Blockers"}, {"/categories/DBCAT002696": "Hypotensive Agents"}, {"/categories/DBCAT004080": "Increased Diuresis"}, {"/categories/DBCAT000128": "Membrane Transport Modulators"}, {"/categories/DBCAT000114": "Natriuretic Agents"}, {"/categories/DBCAT003948": "OCT2 Inhibitors"}, {"/categories/DBCAT002346": "Potassium-Sparing Agents"}, {"/categories/DBCAT002702": "Potassium-Sparing Diuretics"}, {"/categories/DBCAT000459": "Pyrazines"}, {"/categories/DBCAT000600": "Sodium Channel Blockers"}]}, "1104020Y0": {"Conditions": [{"/indications/DBCOND0047182": "Asthma, Allergic"}, {"/indications/DBCOND0054397": "Conjunctivitis, Seasonal Allergic"}], "Name": "Ketotifen Fumarate", "Categories": [{"/categories/DBCAT000133": "Anti-Allergic Agents"}, {"/categories/DBCAT003719": "Antihistamine Drugs"}, {"/categories/DBCAT002287": "Antihistamines for Systemic Use"}, {"/categories/DBCAT000666": "Antipruritics"}, {"/categories/DBCAT002353": "Decongestants and Antiallergics"}, {"/categories/DBCAT002135": "Dermatologicals"}, {"/categories/DBCAT000651": "Histamine Agents"}, {"/categories/DBCAT000664": "Histamine Antagonists"}, {"/categories/DBCAT000665": "Histamine H1 Antagonists"}, {"/categories/DBCAT003399": "Histamine H1 Inhibitors"}, {"/categories/DBCAT000127": "Neurotransmitter Agents"}, {"/categories/DBCAT002091": "Ophthalmologicals"}, {"/categories/DBCAT003740": "Other Antihistamines"}, {"/categories/DBCAT000695": "Piperidines"}, {"/categories/DBCAT002691": "Potential QTc-Prolonging Agents"}, {"/categories/DBCAT003823": "QTc Prolonging Agents"}, {"/categories/DBCAT002092": "Sensory Organs"}, {"/categories/DBCAT000248": "Sulfur Compounds"}, {"/categories/DBCAT000374": "Thiophenes"}]}}